2884 genotypes with 5108 annotations displayed
of selected term and subterms
|
Searched Term: abnormal endocrine gland morphology
|
1700069L16Rikem1(IMPC)Mbp/1700069L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700069L16Rikem1(IMPC)Mbp/Mmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
2510009E07Rikem1(IMPC)Ccpcz/2510009E07Rikem1(IMPC)Ccpcz
(C57BL/6N-2510009E07Rikem1(IMPC)Ccpcz/Ccpcz)
|
abnormal adrenal gland morphology
|
J:211773
|
enlarged adrenal glands
|
J:211773
|
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal pineal gland morphology
|
J:239583
|
absent lobe of thyroid gland
|
J:239583
|
Aw/Aw
(involves: SM/J)
|
abnormal adrenal gland x-zone morphology
|
J:19308
|
Ay/a
(involves: KK)
|
abnormal pancreatic islet morphology
|
J:26460
|
degranulated pancreatic beta cells
|
J:26460
|
AA467197em1Nyam/AA467197em1Nyam
(C57BL/6J-AA467197em1Nyam)
|
abnormal thymus cortex morphology
|
J:347271
|
abnormal thymus medulla morphology
|
J:347271
|
Aadacem1(IMPC)Mbp/Aadacem1(IMPC)Mbp
(C57BL/6NCrl-Aadacem1(IMPC)Mbp/Mmucd)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Aadacl4em1(IMPC)Ccpcz/Aadacl4em1(IMPC)Ccpcz
(C57BL/6NCrl-Aadacl4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
|
enlarged adrenal glands
|
J:60210
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ)
|
abnormal thymus morphology
|
J:132254
|
Abca1tm1Jdm/Abca1tm1Jdm Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ)
|
abnormal thymus morphology
|
J:132254
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal adrenal gland morphology
|
J:64390
|
abnormal thymus morphology
|
J:64390
|
Abca5em1(IMPC)Ccpcz/Abca5em1(IMPC)Ccpcz
(C57BL/6NCrl-Abca5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
|
abnormal thyroid follicle morphology
|
J:99152
|
absent thyroid gland
|
J:99152
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
abnormal thyroid follicle morphology
|
J:99152
|
absent thyroid gland
|
J:99152
|
Abcb9tm1b(KOMP)Wtsi/Abcb9tm1b(KOMP)Wtsi
(C57BL/6N-Abcb9tm1b(KOMP)Wtsi/Tcp)
|
small adrenal glands
|
J:211773
|
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
|
thymus cortex hypoplasia
|
J:117326
|
Abcc8tm1.1Fmas/Abcc8+
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
abnormal pancreatic beta cell morphology
|
J:208932
|
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
abnormal pancreatic beta cell morphology
|
J:208932
|
Abcc10tm1Eah/Abcc10tm1Eah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thymus cortex hypoplasia
|
J:172648
|
Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal adrenal cortex morphology
|
J:94583
|
abnormal adrenal gland zona fasciculata morphology
|
J:94583
|
abnormal adrenal gland zona reticularis morphology
|
J:94583
|
Abcd1tm1Kds/Y Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal adrenal cortex morphology
|
J:94583
|
Abl1m1/Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))
|
abnormal thymus morphology
|
J:14644
|
decreased thymocyte number
|
J:14644
|
thymus cortex hypoplasia
|
J:14644
|
thymus hypoplasia
|
J:14644
|
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J)
|
decreased thymocyte number
|
J:72875
|
thymus atrophy
|
J:72875
|
Abl1tm2.2Goff/Abl1tm2.2Goff
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
thymus atrophy
|
J:166211
|
Acdacd/Acdacd
(involves: DW/J)
|
abnormal adrenal gland morphology
|
J:14144
|
Acdacd/Acdacd
(DW/J-Acdacd Pou1f1+)
|
abnormal adrenal gland morphology
|
J:18027
|
adrenal gland hypoplasia
|
J:18027
|
small adrenal glands
|
J:18027
|
Ace2em1(IMPC)Ccpcz/Ace2em1(IMPC)Ccpcz
(C57BL/6NCrl-Ace2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Acoxlem1(IMPC)Mbp/Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Actbtm4(cre/ERT2)Npa/Actb+ Sgpl1tm1.1Npa/Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6)
|
increased thymocyte number
|
J:199525
|
Actn4tm1a(EUCOMM)Wtsi/Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Acvr1btm1.1(KOMP)Vlcg/Acvr1b+
(C57BL/6N-Acvr1btm1.1(KOMP)Vlcg/Ucd)
|
small adrenal glands
|
J:211773
|
Adatm1Mw/Adatm1Mw Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal thymus corticomedullary boundary morphology
|
J:73418
|
small thymus
|
J:73418
|
Adam10tm1.1Khr/Adam10tm1.1Khr Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)
|
small thymus
|
J:179060
|
thymus hypoplasia
|
J:179060
|
Adam10tm1Zhu/Adam10tm1.1Zhu Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
thymus hypoplasia
|
J:139042
|
Adam10tm1Zhu/Adam10tm1Zhu Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J)
|
thymus hypoplasia
|
J:139042
|
Adam19tm1Asf/Adam19tm1Asf
(either: B6.129P2-Adam19tm1Asf or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal adrenal gland morphology
|
J:106261
|
Adamts1tm1Hku/Adamts1tm1Hku
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal adrenal medulla morphology
|
J:62260
|
Adamts3tm1b(KOMP)Wtsi/Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Adamts6b2b1879.1Clo/Adamts6b2b1879.1Clo
(C57BL/6J-Adamts6b2b1879.1Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2029Clo/Adamts6b2b2029Clo
(C57BL/6J-Adamts6b2b2029Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2182Clo/Adamts6b2b2182Clo
(C57BL/6J-Adamts6b2b2182Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2187.1Clo/Adamts6b2b2187.1Clo
(C57BL/6J-Adamts6b2b2187.1Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2228Clo/Adamts6b2b2228Clo
(C57BL/6J-Adamts6b2b2228Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2405Clo/Adamts6b2b2405Clo
(C57BL/6J-Adamts6b2b2405Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2407Clo/Adamts6b2b2407Clo
(C57BL/6J-Adamts6b2b2407Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2744Clo/Adamts6b2b2744Clo
(C57BL/6J-Adamts6b2b2744Clo)
|
thymus hypoplasia
|
J:175213
|
Adamts6b2b2966.2Clo/Adamts6b2b2966.2Clo
(C57BL/6J-Adamts6b2b2966.2Clo)
|
thymus hypoplasia
|
J:175213
|
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic beta cell number
|
J:129554
|
Adkem1(IMPC)Ccpcz/Adk+
(C57BL/6N-Adkem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Adnp2em3(IMPC)Tcp/Adnp2+
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp)
|
abnormal thymus morphology
|
J:211773
|
absent adrenal gland
|
J:211773
|
small adrenal glands
|
J:211773
|
Adrm1Gt(OST128063)Lex/Adrm1Gt(OST128063)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
enlarged thymus
|
J:166694
|
thymus hyperplasia
|
J:166694
|
Aff1Rob/Aff1+
(involves: BALB/cAnNCrl * C3H/HeN)
|
decreased thymus weight
|
J:82265
|
thymus hypoplasia
|
J:82265
|
Aff1tm1Cim/Aff1tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
thymus hypoplasia
|
J:63253
|
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
|
abnormal pancreatic islet morphology
|
J:226537
|
decreased pancreatic islet number
|
J:226537
|
Ago2tm1.1Tara/Ago2tm1.1Tara Lepob/Lepob Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
increased pancreatic beta cell mass
|
J:210552
|
increased pancreatic beta cell number
|
J:210552
|
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:210552
|
decreased pancreatic beta cell mass
|
J:210552
|
decreased pancreatic beta cell number
|
J:210552
|
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
enlarged pancreatic islets
|
J:186035
|
increased pancreatic beta cell number
|
J:186035
|
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac)
|
enlarged pancreatic islets
|
J:146649
|
increased pancreatic beta cell mass
|
J:146649
|
Agpat5em1(IMPC)Ccpcz/Agpat5em1(IMPC)Ccpcz
(C57BL/6NCrl-Agpat5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Aicdatm1(cre)Mnz/Aicda+ Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:153656
|
Aif1ltm1b(EUCOMM)Wtsi/Aif1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Aif1ltm1b(EUCOMM)Wtsi/Bay)
|
small thymus
|
J:211773
|
Aim2em1(IMPC)Ccpcz/Aim2em1(IMPC)Ccpcz
(C57BL/6N-Aim2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
AipGt(RRI002)Byg/Aip+
(involves: 129P2/OlaHsd * C57BL/6)
|
adrenal gland hyperplasia
|
J:165349
|
increased pituitary adenoma incidence
|
J:165349
|
increased prolactinoma incidence
|
J:165349
|
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus medulla morphology
|
J:83422
|
Airetm1Mmat/Airetm2Mmat
(involves: C57BL/6 * CBA)
|
abnormal thymus morphology
|
J:141379
|
Airetm1Mmat/Airetm2Mmat Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal thymus morphology
|
J:141379
|
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
|
absent adrenal gland
|
J:77873
|
thymus atrophy
|
J:77873
|
Airetm1Ptsn/Airetm1Ptsn
(C57BL/6-Airetm1Ptsn)
|
abnormal thymus medulla morphology
|
J:145910
|
Airetm2Mmat/Airetm2Mmat
(involves: C57BL/6 * CBA)
|
abnormal thymus morphology
|
J:141379
|
absent Hassall's corpuscle
|
J:141379
|
Ak7em1(IMPC)Ccpcz/Ak7+
(C57BL/6NCrl-Ak7em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:190017
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
decreased pancreatic beta cell number
|
J:149156
|
enlarged pancreatic islets
|
J:149156
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg Ptentm1Ppp/Pten+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
enlarged pancreatic islets
|
J:149156
|
Akt1tm1Nhy/Akt1tm1Nhy
(involves: 129/Sv * C57BL/6)
|
abnormal thymus morphology
|
J:71404
|
Akt1tm1Pnt/Akt1tm1Pnt Akt2tm1.1Mbb/Akt2tm1.1Mbb Akt3tm1Mbb/Akt3tm1Mbb Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
thymus hypoplasia
|
J:135903
|
Akt1tm1Pnt/Akt1tm1Pnt Akt2tm1.1Mbb/Akt2tm1.1Mbb Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
thymus hypoplasia
|
J:135903
|
Akt1tm1Pnt/Akt1tm1Pnt Akt3tm1Mbb/Akt3tm1Mbb Tg(Lck-cre)1Cwi/0
(Not Specified)
|
thymus hypoplasia
|
J:135903
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic islet number
|
J:71491
|
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg)
|
decreased pancreatic beta cell number
|
J:84606
|
Akt2tm1Rsg/Akt2tm1Rsg
(involves: C57BL/6 * DBA/1LacJ)
|
enlarged pancreatic islets
|
J:149156
|
Aladem1(IMPC)Tcp/Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Cmmr)
|
enlarged thymus
|
J:211773
|
small adrenal glands
|
J:211773
|
Aldh1a2tm1Dll/Aldh1a2tm1Ipc
(involves: CD-1)
|
absent parathyroid glands
|
J:81969
|
athymia
|
J:81969
|
thymus hypoplasia
|
J:81969
|
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA)
|
abnormal pancreatic beta cell differentiation
|
J:232360
|
abnormal pancreatic islet morphology
|
J:232360
|
increased pancreatic alpha cell number
|
J:232360
|
increased pancreatic beta cell mass
|
J:232360
|
increased pancreatic delta cell number
|
J:232360
|
pancreatic islet hyperplasia
|
J:232360
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
abnormal thymus morphology
|
J:188123
|
increased T cell derived lymphoma incidence
|
J:193232
|
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
degranulated pancreatic beta cells
|
J:100403
|
pancreatic islet hyperplasia
|
J:100403
|
Alox15tm1.1Nadl/Alox15tm1.1Nadl Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
increased pancreatic beta cell mass
|
J:224344
|
pancreatic islet hyperplasia
|
J:224344
|
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal thymus cortex morphology
|
J:39015
|
Alx3tm1Hubr/Alx3tm1Hubr
(involves: 129P2/OlaHsd)
|
decreased pancreatic beta cell mass
|
J:166436
|
small pancreatic islets
|
J:166436
|
am/am
(involves: 101 * CBA)
|
abnormal Rathke's pouch development
|
J:6435
|
Amelxem1(IMPC)Ccpcz/Y
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Amelxem1(IMPC)Ccpcz/Amelxem1(IMPC)Ccpcz
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Amhr2tm3(cre)Bhr/Amhr2+ Nr5a1tm1Klp/Nr5a1tm2Klp
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
small adrenal glands
|
J:91352
|
Angpt2em1(IMPC)Mbp/Angpt2em1(IMPC)Mbp
(C57BL/6NCrl-Angpt2em1(IMPC)Mbp/Mmucd)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Ank1nb/Ank1nb
(either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re))
|
abnormal thymus development
|
J:30699
|
Ano2em1(IMPC)Ccpcz/Ano2em1(IMPC)Ccpcz
(C57BL/6NCrl-Ano2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
anx/anx
(B6C3Fe a/a-anx/J)
|
increased thymus weight
|
J:7689
|
Anxa1em1(IMPC)Ccpcz/Anxa1em1(IMPC)Ccpcz
(C57BL/6NCrl-Anxa1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL)
|
abnormal corticotroph morphology
|
J:135972
|
abnormal folliculo-stellate cell morphology
|
J:135972
|
abnormal gonadotroph morphology
|
J:135972
|
abnormal lactotroph morphology
|
J:135972
|
abnormal somatotroph morphology
|
J:135972
|
decreased corticotroph cell size
|
J:135972
|
thin adrenal cortex
|
J:129587
|
Anxa7tm1Pll/Anxa7+
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:58572
|
enlarged pancreatic islets
|
J:58572
|
pancreatic islet hyperplasia
|
J:58572
|
Ap1g1fgt/Ap1g1fgt
(C57BL/6-Ap1g1fgt/KjnBoc)
|
abnormal thyroid follicle morphology
|
J:230572
|
abnormal thyroid follicular cell morphology
|
J:230572
|
abnormal thyroid gland morphology
|
J:230572
|
Ap2b1b2b2321Clo/Ap2b1b2b2321Clo
(C57BL/6J-Ap2b1b2b2321Clo)
|
thymus hypoplasia
|
J:175213
|
Apbb1ipem1(IMPC)Ccpcz/Apbb1ipem1(IMPC)Ccpcz
(C57BL/6N-Apbb1ipem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
ApcMin/Apc+
(B6.Cg-Brca2tm1Mbn ApcMin)
|
adrenal gland hyperplasia
|
J:67445
|
ApcMin/Apc+ Brca2tm1Mbn/Brca2+
(B6.Cg-Brca2tm1Mbn ApcMin)
|
abnormal adrenal gland morphology
|
J:67445
|
Apctm1Kk/Apctm1Kk Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
small thymus
|
J:100461
|
thymus hypoplasia
|
J:100461
|
Apctm2Rak/Apctm2Rak Tg(KRT14-cre)8Brn/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
abnormal Hassall's corpuscle morphology
|
J:114152
|
abnormal thymus morphology
|
J:114152
|
decreased thymocyte number
|
J:114152
|
small thymus
|
J:114152
|
Apctm2Rak/Apctm2Rak Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
decreased pancreatic beta cell mass
|
J:234310
|
decreased pancreatic islet number
|
J:234310
|
Apex2tm1Yun/Y
(B6.129S-Apex2tm1Yun)
|
decreased thymocyte number
|
J:95267
|
thymus atrophy
|
J:95267
|
Apoa1tm1Unc/Apoa1tm1Unc Ldlrtm1Her/Ldlrtm1Her
(B6.129-Ldlrtm1Her Apoa1tm1Unc)
|
abnormal adrenal gland morphology
|
J:85174
|
abnormal adrenal gland zona fasciculata morphology
|
J:85174
|
Apobec1em1(IMPC)Ccpcz/Apobec1em1(IMPC)Ccpcz
(C57BL/6NCrl-Apobec1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
abnormal adrenal cortex morphology
|
J:60585
|
abnormal adrenal gland morphology
|
J:60585
|
abnormal adrenal medulla morphology
|
J:60585
|
Apoetm1Unc/Apoetm1Unc Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr)
|
enlarged thymus
|
J:121671
|
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:125011
|
decreased pancreatic alpha cell number
|
J:125011
|
decreased pancreatic beta cell number
|
J:125011
|
decreased PP cell number
|
J:125011
|
small pancreatic islets
|
J:125011
|
Artm1Chc/Artm1.1Chc Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
enlarged thymus
|
J:87193
|
Araftm1Mmc/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
small thymus
|
J:33951
|
Araftm1Mmc/Araftm1Mmc
(involves: 129P2/OlaHsd * C57BL/6)
|
small thymus
|
J:33951
|
Arb2aem2(IMPC)Ccpcz/Arb2aem2(IMPC)Ccpcz
(C57BL/6NCrl-Arb2aem2(IMPC)Ccpcz/Ph)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Arb2aTg(Tyr)TpNpin/Arb2aTg(Tyr)TpNpin
(involves: FVB/N)
|
thymus hypoplasia
|
J:260599
|
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
abnormal pancreatic beta cell morphology
|
J:216529
|
Arg2em1(IMPC)Ccpcz/Arg2em1(IMPC)Ccpcz
(C57BL/6NCrl-Arg2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac)
|
thymus hypoplasia
|
J:101418
|
Arhgap5tm1Jset/Arhgap5tm1Jset
(involves: 129S2/SvPas * C57BL/6J)
|
small thymus
|
J:76484
|
Arhgap45em1Ciphe/Arhgap45em1Ciphe
(C57BL/6-Arhgap45em1Ciphe)
|
decreased DN1 thymic pro-T cell number
|
J:309971
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
abnormal thymus medulla morphology
|
J:140671
|
Arid5btm1Pjh/Arid5btm1Pjh
(involves: 129S4/SvJae * BALB/c)
|
abnormal adrenal gland zona reticularis morphology
|
J:70658
|
thymus cortex hypoplasia
|
J:70658
|
thymus hypoplasia
|
J:70658
|
Arl16em1(IMPC)Ccpcz/Arl16em1(IMPC)Ccpcz
(C57BL/6NCrl-Arl16em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Armc5tm1Stra/Armc5+
(involves: 129 * C57BL/6N * Swiss)
|
abnormal adrenal cortex morphology
|
J:244906
|
abnormal adrenal gland zona fasciculata morphology
|
J:244906
|
thin adrenal cortex
|
J:244906
|
Arnt2tm1Yfk/Arnt2tm1Yfk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neurohypophysis morphology
|
J:74118
|
ArpBALB/c/ArpBALB/c
(involves: B10.D2 * BALB/c)
|
thymus hyperplasia
|
J:6549
|
Arxtm1Gldn/Arxtm1Gldn Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL)
|
decreased pancreatic beta cell number
|
J:177838
|
Arxtm1Pgr/Y
(involves: 129/Sv * NMRI)
|
abnormal pancreatic delta cell morphology
|
J:86206
|
absent pancreatic alpha cells
|
J:86206
|
increased pancreatic beta cell number
|
J:86206
|
increased pancreatic delta cell number
|
J:86206
|
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
|
abnormal thymus morphology
|
J:285931
|
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1)
|
enlarged thymus
|
J:232306
|
Asb1em1(IMPC)Ccpcz/Asb1em1(IMPC)Ccpcz
(C57BL/6N-Asb1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Asb5em1(IMPC)Ccpcz/Asb5em1(IMPC)Ccpcz
(C57BL/6N-Asb5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Asb16em1(IMPC)Ccpcz/Asb16em1(IMPC)Ccpcz
(C57BL/6N-Asb16em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ascl1tm1And/Ascl1+
(involves: 129)
|
decreased solitary pulmonary neuroendocrine cell number
|
J:64088
|
Ascl1tm1And/Ascl1tm1And
(involves: 129)
|
absent solitary pulmonary neuroendocrine cells
|
J:64088,
J:113000
|
Ascl5em1(IMPC)Ccpcz/Ascl5em1(IMPC)Ccpcz
(C57BL/6NCrl-Ascl5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Asltm1Brle/Asltm1Brle
(involves: 129S7/SvEvBrd)
|
thymus cortex hypoplasia
|
J:180208
|
Asphd1em1(IMPC)Ccpcz/Asphd1em1(IMPC)Ccpcz
(C57BL/6NCrl-Asphd1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Asxl1tm1Bc/Asxl1tm1Bc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal thymus morphology
|
J:155898
|
Atad5Gt(RRF055)Byg/Atad5+
(involves: 129P2/OlaHsd)
|
increased T cell derived lymphoma incidence
|
J:176672
|
Atcayji/Atcayji
(Not Specified)
|
abnormal adenohypophysis morphology
|
J:14903
|
abnormal thymus cortex morphology
|
J:14903
|
abnormal thymus medulla morphology
|
J:14903
|
abnormal thymus morphology
|
J:14903
|
abnormal thyroid follicle morphology
|
J:14903
|
Atf3tm1Dron/Atf3tm1Dron
(B6.129X1-Atf3tm1Hai)
|
abnormal pancreatic islet morphology
|
J:91595
|
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
increased pancreatic beta cell mass
|
J:152695
|
Atg3tm1.1Ywh/Atg3tm1.1Ywh Tg(Lck-cre)548Jxm/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:172749
|
Atg5tm1Nmz/Atg5tm1Nmz
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal adenohypophysis morphology
|
J:110050
|
abnormal adrenal gland morphology
|
J:110050
|
Atg5tm1Nmz/Atg5tm1Nmz
(involves: 129 * BALB/c * C57BL/6)
|
abnormal thymus cortex morphology
|
J:140583
|
Atg5tm1Nmz/Atg5tm1Nmz Tg(CAG-EGFP/Map1lc3b)53Nmz/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thymus morphology
|
J:140583
|
Atg16l1tm1a(EUCOMM)Wtsi/Atg16l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal thymus topology
|
J:239583
|
Atl3em1(IMPC)Tcp/Atl3em1(IMPC)Tcp
(C57BL/6N-Atl3em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Atmtm1.1Mmpl/Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:226414
|
Atmtm1Awb/Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
increased T cell derived lymphoma incidence
|
J:34193
|
Atmtm1Awb/Atmtm1Awb
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:103922
|
Atmtm1Awb/Atmtm1Awb
(involves: 129S6/SvEvTac)
|
increased T cell derived lymphoma incidence
|
J:90941
|
Atmtm1Awb/Atmtm1Awb
(CByJ.129S6-Atmtm1Awb)
|
increased T cell derived lymphoma incidence
|
J:208539
|
Atmtm1Awb/Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb)
|
increased T cell derived lymphoma incidence
|
J:208539
|
Atmtm1Awb/Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x B6.129S6-Atmtm1Awb)F1 or (B6.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1)
|
increased T cell derived lymphoma incidence
|
J:208539
|
Atmtm1Awb/Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x A.129S6-Atmtm1Awb)F1 or (A.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1)
|
increased T cell derived lymphoma incidence
|
J:208539
|
Atmtm1Awb/Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J)
|
increased T cell derived lymphoma incidence
|
J:226414
|
Atmtm1Awb/Atmtm1Awb Rad52tm1Aps/Rad52tm1Aps
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased T cell derived lymphoma incidence
|
J:90941
|
Atmtm1Bal/Atmtm1Bal
(involves: 129S4/SvJae)
|
decreased thymocyte number
|
J:35914
|
increased T cell derived lymphoma incidence
|
J:35914
|
small thymus
|
J:35914
|
Atmtm1Fwa/Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:61201
|
increased T cell derived lymphoma incidence
|
J:61201
|
Atmtm1Led/Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
increased T cell derived lymphoma incidence
|
J:69726
|
small thymus
|
J:36561
|
thymus cortex hypoplasia
|
J:36561
|
Atmtm1Mfl/Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J)
|
decreased thymocyte number
|
J:69726
|
increased T cell derived lymphoma incidence
|
J:69726
|
small thymus
|
J:69726
|
Atmtm2.1Fwa/Atmtm2.1Fwa Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac)
|
decreased thymocyte number
|
J:277750
|
increased T cell derived lymphoma incidence
|
J:277750
|
Atmintm1.1Jhh/Atmintm1.1Jhh
(C57BL/6-Atmintm1.1Jhh)
|
thymus hypoplasia
|
J:167544
|
Atp1a1em1(IMPC)Ccpcz/Atp1a1+
(C57BL/6NCrl-Atp1a1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Atp6v1b2tm1b(KOMP)Wtsi/Atp6v1b2+
(C57BL/6N-Atp6v1b2tm1b(KOMP)Wtsi/Tcp)
|
small adrenal glands
|
J:211773
|
Atp11atm1a(KOMP)Wtsi/Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
abnormal thymus morphology
|
J:239583
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Atrtm1Bal/Atrtm2Bal Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
decreased thymocyte number
|
J:123200
|
Atrtm1Ofc/Atrtm1Ofc
(Not Specified)
|
decreased thymus weight
|
J:151542
|
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic beta cell number
|
J:135320
|
pancreatic islet hyperplasia
|
J:135320
|
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal adrenal gland morphology
|
J:110099
|
Avpr1btm1Gzt/Avpr1btm1Gzt
(involves: 129 * C57BL/6J)
|
small adrenal glands
|
J:87707
|
awgTg(GBts1env)832Pkw/awgTg(GBts1env)832Pkw
(involves: C57BL/6J * SJL)
|
thymus atrophy
|
J:43273
|
b2b954Clo/b2b954Clo
(C57BL/6J-b2b954Clo)
|
thymus hypoplasia
|
J:175213
|
b2b1249Clo/b2b1249Clo
(C57BL/6J-b2b1249Clo)
|
thymus hypoplasia
|
J:175213
|
b2b1702Clo/b2b1702Clo
(C57BL/6J-b2b1702Clo)
|
thymus hypoplasia
|
J:175213
|
b2b1941Clo/b2b1941Clo
(C57BL/6J-b2b1941Clo)
|
athymia
|
J:175213
|
b2b2187Clo/b2b2187Clo
(C57BL/6J-b2b2187Clo)
|
thymus hypoplasia
|
J:175213
|
b2b2463Clo/b2b2463Clo
(C57BL/6J-b2b2463Clo)
|
thymus hypoplasia
|
J:175213
|
b2b2588Clo/b2b2588Clo
(C57BL/6J-b2b2588Clo)
|
thymus hypoplasia
|
J:175213
|
b2b2696.2Clo/b2b2696.2Clo
(C57BL/6J-b2b2696.2Clo)
|
thymus hypoplasia
|
J:175213
|
b2b2736.2Clo/b2b2736.2Clo
(C57BL/6J-b2b2736.2Clo)
|
thymus hypoplasia
|
J:175213
|
b2b2736Clo/b2b2736Clo
(C57BL/6J-b2b2736Clo)
|
thymus hypoplasia
|
J:175213
|
b2b2821Clo/b2b2821Clo
(C57BL/6J-b2b2821Clo)
|
thymus hypoplasia
|
J:175213
|
b2b2966Clo/b2b2966Clo
(C57BL/6J-b2b2966Clo)
|
thymus hypoplasia
|
J:175213
|
b2b3077.2Clo/b2b3077.2Clo
(C57BL/6J-b2b3077.2Clo)
|
thymus hypoplasia
|
J:175213
|
b2b3077Clo/b2b3077Clo
(C57BL/6J-b2b3077Clo)
|
thymus hypoplasia
|
J:175213
|
b2b3121Clo/b2b3121Clo
(C57BL/6J-b2b3121Clo)
|
enlarged adrenal glands
|
J:175213
|
thymus hypoplasia
|
J:175213
|
b2b3260.2Clo/b2b3260.2Clo
(C57BL/6J-b2b3260.2Clo)
|
abnormal thymus morphology
|
J:175213
|
thymus hypoplasia
|
J:175213
|
b2b3260Clo/b2b3260Clo
(C57BL/6J-b2b3260Clo)
|
abnormal thymus morphology
|
J:175213
|
thymus hypoplasia
|
J:175213
|
B2mtm1Unc/B2mtm1Unc
(NOD.129P2-B2mtm1Unc)
|
abnormal pancreatic beta cell morphology
|
J:17000
|
B2mtm1Unc/B2mtm1Unc Prkdcscid/Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid)
|
increased T cell derived lymphoma incidence
|
J:102141
|
B4galt1tm1Shur/B4galt1tm1Shur
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal adenohypophysis development
|
J:37846
|
abnormal adrenal cortex morphology
|
J:37846
|
abnormal adrenal gland zona fasciculata morphology
|
J:37846
|
abnormal adrenal gland zona reticularis morphology
|
J:37846
|
small adenohypophysis
|
J:37846
|
small adrenal glands
|
J:37846
|
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
abnormal adrenal gland morphology
|
J:239583
|
abnormal neurohypophysis morphology
|
J:239583
|
abnormal thymus topology
|
J:239583
|
absent adenohypophysis
|
J:239583
|
Babam1em1(IMPC)Ccpcz/Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae)
|
decreased thymus weight
|
J:88139
|
small pancreatic islets
|
J:133563
|
small thymus
|
J:88139
|
thymus hypoplasia
|
J:88139
|
Badtm1Sjk/Badtm1Sjk
(involves: 129X1/SvJ)
|
increased pancreatic islet number
|
J:133563
|
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
|
decreased thymus weight
|
J:144416
|
thymus hypoplasia
|
J:144416
|
Bag4tm1Yeh/Bag4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hypoplasia
|
J:83559
|
Baxtm1Sjk/Baxtm1Sjk
(involves: 129X1/SvJ)
|
increased thymocyte number
|
J:29253
|
Bbc3tm1Gpz/Bbc3tm1Gpz Trp53tm1Brd/Trp53tm8Xu
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:170216
|
Bbs5tm1a(EUCOMM)Wtsi/Bbs5tm1a(EUCOMM)Wtsi
(C57BL/6-Bbs5tm1a(EUCOMM)Wtsi)
|
abnormal pituitary gland morphology
|
J:307098
|
small pituitary gland
|
J:307098
|
Bbs12em1(IMPC)Ccpcz/Bbs12+
(C57BL/6NCrl-Bbs12em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased thymocyte number
|
J:274469
|
decreased thymus weight
|
J:274469
|
small thymus
|
J:274469
|
thymus hypoplasia
|
J:274469
|
Bcl2tm1Dlo/Bcl2tm1Dlo
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:73660
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus morphology
|
J:15224
|
small thymus
|
J:15224
|
Bcl2tm1Tsu/Bcl2tm1Tsu
(involves: 129P2/OlaHsd * ICR)
|
small thymus
|
J:22391
|
thymus atrophy
|
J:22391
|
Bcl2l1tm1Ywh/Bcl2l1tm1Ywh Tg(Lck-cre)548Jxm/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:99012
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast Bmftm1Rjd/Bmftm1Rjd
(B6.129S-Bcl2l11tm1.1Ast Bmftm1Rjd)
|
increased thymocyte number
|
J:153652
|
Bcl2l11tm1.1Boui/Bcl2l11+ Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL)
|
increased T cell derived lymphoma incidence
|
J:186117
|
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv)
|
small thymus
|
J:40769
|
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
|
small thymus
|
J:40769
|
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:67297
|
Bcl11atm1Ngc/Bcl11a+
(involves: 129S1/Sv)
|
decreased DN2 thymocyte number
|
J:194616
|
Bcl11atm1Ngc/Bcl11atm1Ngc
(involves: 129S1/Sv * C57BL/6J)
|
small thymus
|
J:83646
|
thymus hypoplasia
|
J:83646
|
Bcl11atm2.1Peli/Bcl11atm2.1Peli Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
decreased DN2 thymocyte number
|
J:194616
|
Bcl11btm1.2Leid/Bcl11btm1.2Leid
(involves: C57BL/6 * SJL)
|
thymus hypoplasia
|
J:147182
|
Bcl11btm1Avram/Bcl11btm1Avram Tcratm1Mom/Tcratm1Mom Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:128515
|
Bcl11btm1Avram/Bcl11btm1Avram Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:128515
|
Bcl11btm1Avram/Bcl11btm1Avram Tg(Cd4-cre)1Cwi/? Tg(LCKprBCL2)36Sjk/?
(involves: 129 * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:128515
|
Bcl11btm1Jpk/Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal thymus cortex morphology
|
J:83651
|
abnormal thymus medulla morphology
|
J:83651
|
absent thymus corticomedullary boundary
|
J:83651
|
thymus hypoplasia
|
J:83651
|
Bcl11btm2.1Jpk/Bcl11b+ Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:210122
|
Betalinc1tm1Suss/Betalinc1tm1Suss
(involves: 129 * C57BL/6)
|
decreased pancreatic alpha cell number
|
J:231585
|
decreased pancreatic beta cell number
|
J:231585
|
decreased pancreatic epsilon cell number
|
J:231585
|
increased pancreatic delta cell number
|
J:231585
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:126780
|
decreased pancreatic beta cell mass
|
J:126780
|
decreased pancreatic islet number
|
J:126780
|
small pancreatic islets
|
J:126780
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:126780
|
decreased pancreatic beta cell mass
|
J:126780
|
decreased pancreatic islet number
|
J:126780
|
small pancreatic islets
|
J:126780
|
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
thymus hyperplasia
|
J:72651
|
Bidtm1Sjk/Bidtm1Sjk
(involves: 129X1/Sv * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:116520
|
Birc5tm1Mak/Birc5tm1Mak Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd)
|
abnormal thymus corticomedullary boundary morphology
|
J:90892
|
decreased thymocyte number
|
J:90892
|
small thymus
|
J:90892
|
Birc5tm1Wnt/Birc5tm1Emc Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:87435
|
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J)
|
enlarged pancreatic islets
|
J:177865
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
decreased pancreatic islet number
|
J:162641
|
Bmerb1em1(IMPC)Ccpcz/Bmerb1em1(IMPC)Ccpcz
(C57BL/6NCrl-Bmerb1em1(IMPC)Ccpcz/Ph)
|
abnormal adrenal gland morphology
|
J:211773
|
enlarged adrenal glands
|
J:211773
|
Bmftm1.1Ast/Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst)
|
increased T cell derived lymphoma incidence
|
J:133084
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
decreased thymocyte number
|
J:17712
|
thymus cortex hypoplasia
|
J:17712
|
Bmi1tm1Sgon/Bmi1tm1Sgon Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)
|
abnormal thymus morphology
|
J:221849
|
small thymus
|
J:221849
|
thymus atrophy
|
J:221849
|
Bmp4tm1Blh/Bmp4tm1Blh
(involves: 129S2/SvPas * Black Swiss)
|
absent Rathke's pouch
|
J:50517
|
Bmp10b2b2711Clo/Bmp10b2b2711Clo
(C57BL/6J-Bmp10b2b2711Clo)
|
thymus hypoplasia
|
J:175213
|
Bmpr1atm1Bhr/Bmpr1atm2.1Bhr Tg(Cga-cre)3Sac/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal pituitary gland development
|
J:121318
|
abnormal Rathke's pouch development
|
J:121318
|
Boktm1.1Ast/Boktm1.1Ast
(involves: BALB/cJ * C57BL/6)
|
increased thymus weight
|
J:203179
|
Braftm1(ARAF)Urr/Braftm1(ARAF)Urr
(involves: 129S1/Sv * C57BL/6 * CD-1)
|
decreased thymus weight
|
J:112971
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal thymus morphology
|
J:170095
|
decreased thymocyte number
|
J:170095
|
thymus atrophy
|
J:170095
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
abnormal thymus morphology
|
J:170095
|
decreased thymocyte number
|
J:170095
|
increased pheochromocytoma incidence
|
J:170095
|
thymus atrophy
|
J:170095
|
Braftm1Bbd/Braf+
(B6.129-Braftm1Bbd)
|
abnormal thymus morphology
|
J:170095
|
decreased thymocyte number
|
J:170095
|
thymus atrophy
|
J:170095
|
Braftm1Cpri/Braftm1Cpri Gnastm3Lsw/Gnastm3Lsw Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/NCr)
|
increased thyroid tumor incidence
|
J:168249
|
Braftm1Cpri/Braftm1Cpri Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * FVB/NCr)
|
increased thyroid carcinoma incidence
|
J:168249
|
increased thyroid tumor incidence
|
J:168249
|
Braftm1Cpri/Braftm1Cpri Tshrtm1Rmar/Tshrtm1Rmar Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S1/Sv * FVB/NCr)
|
abnormal thyroid follicle morphology
|
J:168249
|
increased thyroid tumor incidence
|
J:168249
|
small thyroid gland
|
J:168249
|
Braftm1Mmcm/Braf+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased thyroid carcinoma incidence
|
J:208854
|
Braftm1Mmcm/Braf+ Tg(Tg-cre/ERT2)#Mmcm/0
(involves: 129P2/OlaHsd)
|
abnormal thyroid follicle morphology
|
J:172205
|
abnormal thyroid gland morphology
|
J:172205
|
enlarged thyroid gland
|
J:172205
|
increased thyroid carcinoma incidence
|
J:172205
|
Braftm1Mmcm/Braf+ Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac)
|
increased thyroid carcinoma incidence
|
J:208854
|
Braftm1Mmcm/Braf+ Tg(TPO-cre/ERT2)1139Tyj/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac)
|
increased thyroid carcinoma incidence
|
J:208854
|
Braftm1Mmcm/Braf+ Trp53tm1Brn/Trp53tm3.1Tyj Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac)
|
increased thyroid carcinoma incidence
|
J:208854
|
Braftm1Mmcm/Braf+ Trp53tm3.1Tyj/Trp53+ Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac)
|
increased thyroid carcinoma incidence
|
J:208854
|
Braftm1Sva/Braftm1.1Sva Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal adenohypophysis morphology
|
J:121660
|
small adenohypophysis
|
J:121660
|
Braftm1Wds/Braftm1.1Wds Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal adenohypophysis morphology
|
J:121660
|
small adenohypophysis
|
J:121660
|
Braftm1Wds/Braftm1Wds Raf1tm2Bacc/Raf1tm2Bacc H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
abnormal thyroid gland morphology
|
J:144862
|
small thymus
|
J:144862
|
small thyroid gland
|
J:144862
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
enlarged thymus
|
J:81541
|
increased T cell derived lymphoma incidence
|
J:81541
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
increased T cell derived lymphoma incidence
|
J:81541
|
Brca1tm2Mak/Brca1tm2Mak Cdkn1atm1Tyj/Cdkn1atm1Tyj Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak Chek2tm1Mak/Chek2tm1Mak Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:90512
|
Brca1tm2Mak/Brca1tm2Mak Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak Tg(Lck-cre)548Jxm/? Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak Tg(Lck-cre)548Jxm/? Trp53tm1Brd/Trp53tm1Brd
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:90512
|
Brca1tm5.1Cxd/Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N)
|
increased T cell derived lymphoma incidence
|
J:155810
|
Brca2tm1Cam/Brca2tm1Cam
(involves: 129S/SvEv * MF1)
|
increased T cell derived lymphoma incidence
|
J:46812
|
increased thymus weight
|
J:46812
|
Brca2tm1Cbl/Brca2tm1Cbl
(either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2))
|
increased T cell derived lymphoma incidence
|
J:44386
|
Brca2tm1Mbn/Brca2+
(B6.Cg-Brca2tm1Mbn ApcMin)
|
adrenal gland hyperplasia
|
J:67445
|
Brd2em1(IMPC)Wtsi/Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
|
abnormal adenohypophysis morphology
|
J:239583
|
abnormal pineal gland morphology
|
J:239583
|
abnormal thymus topology
|
J:239583
|
small thymus
|
J:239583
|
small thyroid gland
|
J:239583
|
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg)
|
abnormal pancreatic islet morphology
|
J:159964
|
increased pancreatic beta cell number
|
J:159964
|
increased pancreatic islet number
|
J:159964
|
pancreatic islet hyperplasia
|
J:159964
|
Brd9em1(IMPC)Tcp/Brd9+
(C57BL/6N-Brd9em1(IMPC)Tcp/Cmmr)
|
small adrenal glands
|
J:211773
|
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd)
|
increased pituitary adenoma incidence
|
J:227115
|
Bsgtm1.1Znc/Bsgtm1.1Znc Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased thymocyte number
|
J:207886
|
decreased thymus weight
|
J:207886
|
Btbd3tm1b(EUCOMM)Hmgu/Btbd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Btbd3tm1b(EUCOMM)Hmgu/Ccpcz)
|
abnormal thyroid gland morphology
|
J:211773
|
enlarged thyroid gland
|
J:211773
|
Btbd7em1(IMPC)Ccpcz/Btbd7em1(IMPC)Ccpcz
(C57BL/6NCrl-Btbd7em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Btbd18em1(IMPC)Ccpcz/Btbd18em1(IMPC)Ccpcz
(C57BL/6NCrl-Btbd18em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Cabin1em1(IMPC)Ccpcz/Cabin1+
(C57BL/6NCrl-Cabin1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Cacna1atg-6J/Cacna1atg-6J
(involves: BALB/cByJ * C57BL/6J)
|
thymus atrophy
|
J:82238
|
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal pancreatic beta cell differentiation
|
J:72316
|
abnormal pancreatic islet morphology
|
J:72316
|
decreased pancreatic beta cell mass
|
J:72316
|
decreased pancreatic beta cell number
|
J:72316
|
decreased pancreatic islet number
|
J:72316
|
increased pancreatic alpha cell number
|
J:72316
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: C57BL/6)
|
decreased pancreatic alpha cell number
|
J:95377
|
Cacna2d2du-td/Cacna2d2du-td
(involves: DBA/2J)
|
abnormal pituitary gland morphology
|
J:12166
|
absent lactotrophs
|
J:5596
|
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
|
thymus hypoplasia
|
J:92396
|
Cacnb4lh/Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J)
|
absent thymus corticomedullary boundary
|
J:5281
|
small thymus
|
J:5281
|
Cacnb4lh/Cacnb4lh
(BALB/cGn-Cacnb4lh)
|
pituitary gland hyperplasia
|
J:12166
|
Cactinem1(IMPC)Ccpcz/Cactin+
(C57BL/6NCrl-Cactinem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
CacybpGT(OST39970)Lex/CacybpGT(OST39970)Lex
(involves: 129S5/SvEvBrd)
|
decreased thymocyte number
|
J:110899
|
small thymus medulla
|
J:110899
|
thymus hypoplasia
|
J:110899
|
Cadm1tm1.2Brd/Cadm1tm1.2Brd
(involves: 129S7/SvEvBrd)
|
increased pancreatic beta cell mass
|
J:210552
|
increased pancreatic beta cell number
|
J:210552
|
Cadpstm1Bros/Cadps+ Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:131014
|
Calb1em1(IMPC)Ccpcz/Calb1em1(IMPC)Ccpcz
(C57BL/6NCrl-Calb1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Calcatm1.1(cre/ERT2)Ptch/Calca+ Trp53tm1Brn/Trp53tm1Brn Rb1tm2Brn/Rb1tm2Brn
(involves: 129 * 129P2/OlaHsd * FVB/N)
|
increased thyroid tumor incidence
|
J:190366
|
Calcatm1.1(cre/ERT2)Ptch/Calca+ Trp53tm1Brn/Trp53tm1Brn Rb1tm2Brn/Rb1tm2Brn Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N)
|
increased thyroid tumor incidence
|
J:190366
|
Camk4em1(IMPC)Ccpcz/Camk4em1(IMPC)Ccpcz
(C57BL/6N-Camk4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Camltm1Rjb/Camltm2Rjb Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:100536
|
Camltm1Rjb/Camltm2Rjb Tg(Lck-cre)1Cwi/0 Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:100536
|
Canxem1(IMPC)Ccpcz/Canx+
(C57BL/6NCrl-Canxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Canxem1(IMPC)Ccpcz/Canxem1(IMPC)Ccpcz
(C57BL/6NCrl-Canxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Capza2tm1b(KOMP)Wtsi/Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Car6em1(IMPC)Ccpcz/Car6em1(IMPC)Ccpcz
(C57BL/6NCrl-Car6em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Card11em1(IMPC)Ccpcz/Card11em1(IMPC)Ccpcz
(C57BL/6NCrl-Card11em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Carm1tm2.1Mtb/Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)
|
thymus hypoplasia
|
J:159958
|
Carmil2bas/Carmil2bas
(involves: C3HeB/FeJ * C57BL/6)
|
enlarged thymus
|
J:205441
|
Casp3tm1Flv/Casp3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased thymocyte number
|
J:36821
|
Casp8tm1.1Raz/Casp8tm1.1Raz Ripk3tm1Vmd/Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
enlarged thymus
|
J:170814
|
Casp14em1(IMPC)Ccpcz/Casp14em1(IMPC)Ccpcz
(C57BL/6N-Casp14em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Casrtm1Ces/Casrtm1Ces
(involves: 129X1/SvJ * Black Swiss)
|
abnormal parathyroid gland chief cell morphology
|
J:29900
|
enlarged parathyroid gland
|
J:29900
|
parathyroid gland hyperplasia
|
J:29900
|
pigmented parathyroid gland
|
J:29900
|
Catsper3em2(IMPC)Mbp/Catsper3em2(IMPC)Mbp
(C57BL/6N-Catsper3em2(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
enlarged adrenal glands
|
J:211773
|
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ)
|
abnormal thyroid follicular cell morphology
|
J:119709
|
Cav1tm1Mls/Cav1tm1Mls
(STOCK Cav1tm1Mls/J)
|
abnormal thyroid follicular cell morphology
|
J:119709
|
Cbfbtm1Itan/Cbfbtm1Itan Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:125953
|
Cbfbtm1Spe/Cbfbtm1Spe Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))
|
small thymus
|
J:80670
|
Cbfbtm1Spe/Cbfbtm1Spe Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))
|
small thymus
|
J:80670
|
Cbfbtm1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal thymus cell ratio
|
J:124224
|
abnormal thymus morphology
|
J:124224
|
thymus hypoplasia
|
J:124224
|
Cbfbtm1Tok/Cbfbtm1Tok Tg(Gata1-Cbfb)1Tok/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
small thymus
|
J:80668
|
Cbfbtm2.1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal thymus cell ratio
|
J:124224
|
abnormal thymus morphology
|
J:124224
|
thymus hypoplasia
|
J:124224
|
Cbltm1.1Hua/Cbltm1.1Hua Lattm1Les/Lattm1Les
(involves: 129P2/OlaHsd)
|
abnormal thymus development
|
J:91369
|
thymus hypoplasia
|
J:91369
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6J)
|
abnormal thymus cell ratio
|
J:76895
|
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thymus morphology
|
J:103366
|
abnormal thymus size
|
J:103366
|
thymus hypoplasia
|
J:103366
|
Cbltm2Wlan/Cbltm2Wlan
(involves: 129X1/SvJ * C57BL/6)
|
abnormal thymus morphology
|
J:103366
|
abnormal thymus size
|
J:103366
|
thymus hypoplasia
|
J:103366
|
Cbx4tm1.1Gxu/Cbx4tm1.2Gxu Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal thymus development
|
J:194053
|
thymus atrophy
|
J:194053
|
thymus hypoplasia
|
J:194053
|
Cbx4tm1.2Gxu/Cbx4tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal thymus development
|
J:194053
|
thymus hypoplasia
|
J:194053
|
Ccdc6tm1Afus/Ccdc6tm1Afus
(involves: 129 * C57BL/6J)
|
thyroid gland hyperplasia
|
J:301625
|
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm)
|
pancreatic islet hyperplasia
|
J:189183
|
Ccdc80tm1Ppal/Ccdc80tm1Ppal
(Not Specified)
|
increased thyroid adenoma incidence
|
J:217742
|
Ccdc198em1(IMPC)Ccpcz/Ccdc198em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccdc198em1(IMPC)Ccpcz/Ph)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ccdc198em1Iad/Ccdc198em1Iad
(FVB.Cg-Pde6b+ Tyrc-ch Ccdc198em1Iad/J)
|
small adrenal glands
|
J:337480
|
Cckbrtm1Kpn/Cckbrtm1Kpn
(involves: 129S2/SvPas)
|
abnormal pancreatic delta cell morphology
|
J:49320
|
Ccl21atm1Yout/Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased thymocyte number
|
J:244640
|
small thymus medulla
|
J:244640
|
Ccl28em1(IMPC)Ccpcz/Ccl28em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccl28em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ccnb2tm1Thnt/Ccnb2tm1Thnt
(involves: 129P2/OlaHsd * C57BL/6)
|
small thymus
|
J:47430
|
Ccnctm1.1Pisc/Ccnctm1.1Pisc Tg(Lck-LMO1)11Sjk/0 Tg(Mx1-cre)1Cgn/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:217695
|
Ccnd1tm1Dsn/Ccnd1tm1Dsn Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129 * C57BL/6)
|
enlarged thymus
|
J:66707
|
increased pituitary adenoma incidence
|
J:66707
|
thymus hyperplasia
|
J:66707
|
Ccnd3tm1.1(Ccnd2)Iaai/Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac)
|
small thymus
|
J:192031
|
thymus hypoplasia
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified)
|
small thymus
|
J:192031
|
thymus hypoplasia
|
J:88120,
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
thymus hypoplasia
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Rb1tm2Brn/Rb1tm2Brn Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:88120
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased T cell derived lymphoma incidence
|
J:88120
|
Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
small thymus
|
J:192032
|
Ccr3em1(IMPC)Ccpcz/Ccr3em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccr3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor)
|
abnormal thymus cortex morphology
|
J:93960
|
small thymus medulla
|
J:93960
|
Ccr9tm1Ccb/Ccr9tm1Ccb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased thymocyte number
|
J:94596
|
Cd2aptm1Shaw/Cd2aptm1Shaw
(involves: 129X1/SvJ)
|
thymus atrophy
|
J:57971
|
Cd3em1Btlr/Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr)
|
abnormal thymus morphology
|
J:132486
|
small thymus
|
J:132486
|
Cd3etm1.1Geno/Cd3etm1.1Geno
(involves: C57BL/6)
|
increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
abnormal thymus cell ratio
|
J:192604
|
increased DN3 thymocyte number
|
J:192604
|
Cd3etm1Cpt/Cd3etm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
thymus hypoplasia
|
J:54756
|
Cd3etm1Cpt/Cd3etm1Cpt Tg(CD3E)26Cpt/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:54756
|
Cd3gtm1.1Cage/Cd3gtm1.1Cage
(B6.129P2-Cd3gtm1.1Cage)
|
decreased thymocyte number
|
J:153813
|
Cd3gtm1Amk/Cd3gtm1Amk
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:114561
|
thymus hypoplasia
|
J:77504
|
Cd3gtm1Amk/Cd3gtm1Amk Tg(Igh-Pim1)1Brn/0
(involves: 129P2/OlaHsd * C57BL/6LiA * CBA)
|
decreased thymocyte number
|
J:114561
|
Cd4tm1Jrp/Cd4tm1Jrp Tg(TcrAND)53Hed/0
(either: (involves: 129S2/SvPas * C57BL/6 * SJL) or (involves: 129S2/SvPas * C57BL/6 * C57BL/10 * SJL))
|
thymus hyperplasia
|
J:45168
|
Cd4tm1Mak/Cd4tm1Mak Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
small thymus medulla
|
J:12572
|
Cd5ltm1Nto/Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:52195
|
Cd7tm1Bfh/Cd7tm1Bfh
(involves: 129 * C57BL/6)
|
increased thymocyte number
|
J:48758
|
Cd7tm1Bfh/Cd7tm1Bfh
(B6.129-Cd7tm1Bfh)
|
increased thymocyte number
|
J:48758
|
Cd8b1tm1Litt/Cd8b1+ Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:110916
|
Cd8b1tm1Litt/Cd8b1tm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
decreased thymocyte number
|
J:110916
|
Cd8b1tm1Wpfl/Cd8b1tm1Wpfl
(involves: 129S2/SvPas)
|
decreased thymocyte number
|
J:19928
|
Cd19tm1(cre)Cgn/Cd19+ Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
increased T cell derived lymphoma incidence
|
J:160931
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas)
|
enlarged thymus
|
J:205441
|
Cd28tm1Mak/Cd28tm1Mak Rc3h1san/Rc3h1+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6JSfdAnu)
|
increased T cell derived lymphoma incidence
|
J:189087
|
Cd38em1(IMPC)Ccpcz/Cd38em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd38em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Cd38tm1Lnd/Cd38tm1Lnd
(B6.129P2-Cd38tm1Lnd)
|
decreased pancreatic beta cell mass
|
J:116576
|
disorganized pancreatic islets
|
J:116576
|
Cd40tm1Kik/Cd40tm1Kik Ltbrtm1Mmat/Ltbrtm1Mmat
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal thymus epithelium morphology
|
J:173115
|
abnormal thymus medulla morphology
|
J:173115
|
Cd40tm1Kik/Cd40tm1Kik Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal thymus epithelium morphology
|
J:173115
|
Cd247tm1Lov/Cd247tm1Lov
(involves: 129S4/SvJae)
|
decreased thymocyte number
|
J:14170
|
Cd247tm1Lov/Cd247tm1Lov Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:46914
|
Cd247tm1Mal/Cd247tm1Mal
(either: C57BL/6-Cd247tm1Mal or (involves: BALB/c * C57BL/6))
|
decreased thymocyte number
|
J:15272
|
Cd247tm1Mhu/Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased thymocyte number
|
J:15579
|
enlarged thymus cortex
|
J:15579
|
small thymus
|
J:15579
|
small thymus medulla
|
J:15579
|
thymus hypoplasia
|
J:15579
|
Cd247tm1Tks/Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:15271
|
small thymus medulla
|
J:15271
|
Cd247tm2.1Lov/Cd247tm2.1Lov
(Not Specified)
|
decreased thymocyte number
|
J:192915
|
Cdc73Gt(RRE190)Byg/Cdc73+
(B6.129P2-Cdc73Gt(RRE190)Byg)
|
increased parathyroid adenoma incidence
|
J:243366
|
increased parathyroid gland tumor incidence
|
J:243366
|
Cdc73tm1Btt/Cdc73+ Tg(PTH-cre)4167Slib/0
(Not Specified)
|
increased parathyroid adenoma incidence
|
J:243366
|
increased parathyroid gland tumor incidence
|
J:243366
|
Cdc73tm1Btt/Cdc73tm1Btt Tg(PTH-cre)4167Slib/0
(Not Specified)
|
increased parathyroid adenoma incidence
|
J:243366
|
increased parathyroid gland tumor incidence
|
J:243366
|
Cdh1tm2Kem/Cdh1tm2Kem Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal pancreatic islet morphology
|
J:196410
|
increased pancreatic beta cell mass
|
J:196410
|
Cdk4tm1.1Bbd/Cdk4+
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
increased pancreatic beta cell number
|
J:54534
|
Cdk4tm1.1Bbd/Cdk4+ Krastm1Bbd/Kras+ Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
increased pituitary adenoma incidence
|
J:86101
|
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
increased pancreatic beta cell number
|
J:54534
|
Cdk4tm1Bbd/Cdk4tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal pancreatic islet morphology
|
J:54534
|
small pancreatic islets
|
J:54534
|
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:57854
|
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv)
|
adenohypophysis hypoplasia
|
J:111333
|
decreased lactotroph cell number
|
J:111333
|
Cdk4tm1Kiyo/Cdk4tm1Kiyo Lin9tm1Orc/Lin9tm1Orc
(involves: 129S1/Sv)
|
adenohypophysis hypoplasia
|
J:111333
|
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal thymus morphology
|
J:92529
|
thymus cortex atrophy
|
J:92529
|
thymus hypoplasia
|
J:92529
|
Cdk6tm1Phin/Cdk6+ Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae)
|
increased T cell derived lymphoma incidence
|
J:144975
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae)
|
decreased thymocyte number
|
J:144975
|
thymus atrophy
|
J:144975
|
thymus hypoplasia
|
J:144975
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae * C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
decreased DN2 thymocyte number
|
J:174697
|
increased DN3 thymocyte number
|
J:174697
|
Cdk6tm2.1Phin/Cdk6tm2.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
decreased DN2 thymocyte number
|
J:174697
|
decreased DN4 thymocyte number
|
J:174697
|
decreased thymocyte number
|
J:174697
|
increased DN3 thymocyte number
|
J:174697
|
small thymus
|
J:174697
|
Cdk6tm3.1Phin/Cdk6tm3.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
enlarged thymus
|
J:174697
|
increased DN1 thymic pro-T cell number
|
J:174697
|
increased thymocyte number
|
J:174697
|
Cdk6tm4.1Phin/Cdk6tm4.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
decreased DN2 thymocyte number
|
J:174697
|
decreased DN4 thymocyte number
|
J:174697
|
decreased thymocyte number
|
J:174697
|
increased DN3 thymocyte number
|
J:174697
|
small thymus
|
J:174697
|
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased pancreatic beta cell mass
|
J:281075
|
Cdkal1tm1.1Tomik/Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn)
|
abnormal pancreatic islet morphology
|
J:178248
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:70894
|
Cdkn1btm1Ako/Cdkn1b+ Ptentm2.1Ppp/Ptentm2.1Ppp Tg(TPO-cre)1Shk/0
(129S1.Cg-Cdkn1btm1Ako Tg(TPO-cre)1Shk Ptentm2.1Ppp)
|
increased thyroid adenoma incidence
|
J:165293
|
increased thyroid carcinoma incidence
|
J:165293
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6)
|
abnormal pituitary intermediate lobe morphology
|
J:50053
|
increased pituitary gland tumor incidence
|
J:50053
|
increased thymocyte number
|
J:33401
|
increased thymus weight
|
J:33401
|
pituitary intermediate lobe hyperplasia
|
J:50053,
J:33401
|
Cdkn1btm1Ako/Cdkn1btm1Ako Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2)
|
enlarged adrenal glands
|
J:50053
|
enlarged pituitary gland
|
J:50053
|
enlarged thymus
|
J:50053
|
increased pituitary adenoma incidence
|
J:50053
|
pituitary intermediate lobe hyperplasia
|
J:50053
|
Cdkn1btm1Ako/Cdkn1btm1Ako Men1tm1.1Ctre/Men1+
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
increased adrenal gland tumor incidence
|
J:120835
|
increased parathyroid gland tumor incidence
|
J:120835
|
increased pituitary gland tumor incidence
|
J:120835
|
increased thyroid tumor incidence
|
J:120835
|
Cdkn1btm1Ako/Cdkn1btm1Ako Ptentm2.1Ppp/Ptentm2.1Ppp Tg(TPO-cre)1Shk/0
(129S1.Cg-Cdkn1btm1Ako Tg(TPO-cre)1Shk Ptentm2.1Ppp)
|
thyroid gland hyperplasia
|
J:165293
|
Cdkn1btm1Kin/Cdkn1b+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enlarged pancreatic islets
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn1btm1Kin/Cdkn1b+ Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
abnormal pancreatic islet morphology
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pituitary intermediate lobe morphology
|
J:33402
|
adrenal medulla hyperplasia
|
J:33402
|
enlarged adrenal glands
|
J:33402
|
enlarged thymus
|
J:33402
|
increased pituitary adenoma incidence
|
J:33402
|
increased pituitary gland weight
|
J:33402
|
pituitary intermediate lobe hyperplasia
|
J:33402
|
thymus hyperplasia
|
J:33402
|
Cdkn1btm1Kin/Cdkn1btm1Kin Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enlarged pancreatic islets
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn1btm1Kin/Cdkn1btm1Kin Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J)
|
abnormal pancreatic islet morphology
|
J:96047
|
increased pancreatic beta cell number
|
J:96047
|
Cdkn1btm1Mlf/Cdkn1b+ Crebbptm1Jvd/Crebbptm1Jvd Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * CBA * FVB)
|
increased T cell derived lymphoma incidence
|
J:88323
|
Cdkn1btm1Mlf/Cdkn1b+ Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J)
|
increased thyroid carcinoma incidence
|
J:210015
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal thymus morphology
|
J:33400
|
enlarged pituitary gland
|
J:33400
|
enlarged thymus
|
J:33400
|
increased pituitary adenoma incidence
|
J:33400
|
pituitary gland hyperplasia
|
J:33400
|
thymus hyperplasia
|
J:33400
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
enlarged thymus
|
J:107588
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Tg(KRT5-CDK4)2303Mlrp/0
(involves: 129S4/SvJae * C57BL/6 * FVB * SENCAR * SSIN)
|
enlarged thymus
|
J:107588
|
thymus hyperplasia
|
J:107588
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J)
|
increased thyroid carcinoma incidence
|
J:210015
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Trp53tm1Brd/Trp53tm1Brd
(involves: C3H * C57BL/6J * NIH)
|
increased T cell derived lymphoma incidence
|
J:87536
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Trp53tm1Brd/Trp53tm1Brd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:87536
|
Cdkn1btm2Mlf/Cdkn1btm2Mlf Tg(Pomc1-cre)1Mlf/0
(involves: 129S4/SvJaeSor)
|
increased pituitary gland tumor incidence
|
J:107588
|
Cdkn1btm3Jro/Cdkn1btm3Jro
(involves: 129S4/SvJaeSor)
|
enlarged thymus
|
J:103819
|
Cdkn1btm3Mlf/Cdkn1btm3Mlf
(involves: 129S4/SvJaeSor)
|
increased pituitary gland tumor incidence
|
J:107588
|
Cdkn1ctm1.1(Cdkn1b*)Kei/Cdkn1c+
(involves: 129P2/OlaHsd * C57BL/6J)
|
enlarged adrenal glands
|
J:147145
|
Cdkn1ctm1Kat/Cdkn1c+
(involves: 129P2/OlaHsd * C57BL/6J)
|
enlarged adrenal glands
|
J:147145
|
Cdkn1ctm1Sje/Cdkn1c+
(involves: 129S7/SvEvBrd * C57BL/6)
|
enlarged adrenal glands
|
J:40203
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:44427
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs Nop53tm2.1Asuz/Nop53tm2.1Asuz Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased thymus weight
|
J:71394
|
thymus hyperplasia
|
J:71394
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
increased pituitary adenoma incidence
|
J:63299
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
increased pheochromocytoma incidence
|
J:63299
|
increased pituitary adenoma incidence
|
J:63299
|
increased T cell derived lymphoma incidence
|
J:63299
|
pituitary gland hyperplasia
|
J:63299
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased pheochromocytoma incidence
|
J:68829
|
increased pituitary adenoma incidence
|
J:68829
|
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal pituitary intermediate lobe morphology
|
J:50053
|
abnormal thymus size
|
J:50053
|
enlarged adrenal glands
|
J:50053
|
enlarged pituitary gland
|
J:50053
|
increased pituitary adenoma incidence
|
J:50053
|
pituitary gland hyperplasia
|
J:50053
|
thymus hyperplasia
|
J:50053
|
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi Men1tm1.1Ctre/Men1+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6)
|
increased adrenal gland tumor incidence
|
J:120835
|
increased parathyroid gland tumor incidence
|
J:120835
|
increased thyroid tumor incidence
|
J:120835
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Ins2Akita/Ins2Akita Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J)
|
abnormal pancreatic beta cell mass
|
J:156725
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Leprdb/Leprdb Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J)
|
increased pancreatic beta cell mass
|
J:156725
|
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cenpjtm1a(EUCOMM)Wtsi/Wtsi)
|
retention of the adrenal gland x-zone
|
J:194085
|
Cer1em1(IMPC)Ccpcz/Cer1em1(IMPC)Ccpcz
(C57BL/6NCrl-Cer1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ces1dtm1Reli/Ces1dtm1Reli
(involves: 129S6/SvEvTac)
|
small pancreatic islets
|
J:158743
|
Cfap53em1(IMPC)Wtsi/Cfap53em1(IMPC)Wtsi
(C57BL/6N-Cfap53em1(IMPC)Wtsi/Wtsi)
|
abnormal thymus topology
|
J:239583
|
Cfap161em1(IMPC)Ccpcz/Cfap161em1(IMPC)Ccpcz
(C57BL/6NCrl-Cfap161em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thyroid gland morphology
|
J:211773
|
enlarged thyroid gland
|
J:211773
|
Cfdem1(IMPC)Mbp/Cfdem1(IMPC)Mbp
(C57BL/6NCrl-Cfdem1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
small adrenal glands
|
J:211773
|
Cflartm1.1Pope/Cflartm1.2Pope Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal thymus corticomedullary boundary morphology
|
J:167430
|
abnormal thymus morphology
|
J:167430
|
Cgatm1Sac/Cgatm1Sac
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal thyroid follicle morphology
|
J:28450
|
absent lactotrophs
|
J:28450
|
decreased lactotroph cell number
|
J:28450
|
decreased somatotroph cell number
|
J:28450
|
increased thyrotroph cell number
|
J:28450
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:146176
|
Chd4tm1.1Kge/Chd4tm1.2Kge Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL)
|
thymus hypoplasia
|
J:109547
|
Chd4tm1.2Kge/Chd4tm1.2Kge Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
thymus hypoplasia
|
J:109547
|
Chd7Gt(RRR136)Byg/Chd7+
(involves: 129P2/OlaHsd * C57BL/6)
|
ectopic thymus
|
J:154590
|
small thymus
|
J:154590
|
thymus hypoplasia
|
J:154590
|
Chd7Gt(S20-7E1)Sor/Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor)
|
abnormal neurohypophysis median eminence morphology
|
J:174086
|
Chd7Gt(S20-7E1)Sor/Chd7Gt(S20-7E1)Sor
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J)
|
Rathke's pouch hypoplasia
|
J:119812
|
Chd7Gt(XK403)Byg/Chd7+ Tbx1tm1Bld/Tbx1+
(either: (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CD-1))
|
ectopic thymus
|
J:154590
|
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi)
|
abnormal neurohypophysis median eminence morphology
|
J:161880
|
Chgbtm1Ribo/Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal adrenal chromaffin cell morphology
|
J:157697
|
Chrdtm1Emdr/Chrdtm1Emdr
(either: B6SJL.129-Chrdtm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))
|
abnormal thyroid gland morphology
|
J:83662
|
absent parathyroid glands
|
J:83662
|
athymia
|
J:83662
|
thyroid gland hypoplasia
|
J:83662
|
Chrdtm1Emdr/Chrdtm1Emdr
(129S6.129-Chrdtm1Emdr)
|
athymia
|
J:146769
|
Chrdtm1Emdr/Chrdtm1Emdr Tbx1m1Jlk/Tbx1m1Jlk
(129/Sv-Tbx1m1Jlk Chrdtm1Emdr)
|
athymia
|
J:146769
|
Chst2em1(IMPC)Mbp/Chst2em1(IMPC)Mbp
(C57BL/6N-Chst2em1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Chst11tm1a(KOMP)Wtsi/Chst11tm1a(KOMP)Wtsi
(C57BL/6N-Chst11tm1a(KOMP)Wtsi/Wtsi)
|
abnormal thymus morphology
|
J:239583
|
Chtoptm1a(EUCOMM)Wtsi/Chtoptm1a(EUCOMM)Wtsi
(C57BL/6N-Chtoptm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
abnormal neurohypophysis morphology
|
J:239583
|
abnormal pineal gland morphology
|
J:239583
|
abnormal thyroid gland morphology
|
J:239583
|
thyroid gland hypoplasia
|
J:239583
|
Chukem1(IMPC)Ccpcz/Chuk+
(C57BL/6NCrl-Chukem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Churc1tm1b(EUCOMM)Wtsi/Churc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Churc1tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Cimap1bem1(IMPC)Ccpcz/Cimap1bem1(IMPC)Ccpcz
(C57BL/6NCrl-Cimap1bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Cir1tm3a(KOMP)Wtsi/Cir1tm3a(KOMP)Wtsi
(C57BL/6N-Cir1tm3a(KOMP)Wtsi/Wtsi)
|
abnormal thyroid gland morphology
|
J:239583
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
thymus hyperplasia
|
J:204829
|
Cited2tm1Bha/Cited2tm1Bha
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent adrenal gland
|
J:76593
|
Cited2tm1Bha/Cited2tm1Bha
(involves: 129P2/OlaHsd)
|
absent adrenal gland
|
J:192202,
J:102098
|
Cited2tm1Bha/Cited2tm2Bha Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129 * C57BL/6 * CBA * SJL)
|
absent adrenal gland
|
J:137951
|
Cited2tm1Bha/Cited2tm2Bha Tg(T-cre)1Lwd/0
(involves: 129 * C3H * C57BL/6 * SJL)
|
absent adrenal gland
|
J:137951
|
Ciz1tm1.1Homy/Ciz1tm1.1Homy
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
thymus hyperplasia
|
J:198470
|
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus morphology
|
J:203159
|
Clec5aem1(IMPC)Mbp/Clec5aem1(IMPC)Mbp
(C57BL/6NCrl-Clec5aem1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Clec16atm1.1Hhak/Clec16atm1.1Hhak Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL)
|
abnormal pancreatic alpha cell morphology
|
J:214528
|
abnormal pancreatic beta cell morphology
|
J:214528
|
Clnkem1(IMPC)Ccpcz/Clnkem1(IMPC)Ccpcz
(C57BL/6NCrl-Clnkem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Clockem1(IMPC)Ccpcz/Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:162641
|
small pancreatic islets
|
J:162641
|
Clptq1NZB/BlNJ/Clptq1NZB/BlNJ
(B6.NZB-(D4Mit193-D4Mit33))
|
enlarged thymus
|
J:143646
|
Cmiptm1a(EUCOMM)Wtsi/Cmiptm1a(EUCOMM)Wtsi
(C57BL/6N-Cmiptm1a(EUCOMM)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
small thyroid gland
|
J:239583
|
Cngb3em1(IMPC)Ccpcz/Cngb3em1(IMPC)Ccpcz
(C57BL/6NCrl-Cngb3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Coa5tm1b(KOMP)Wtsi/Coa5+
(C57BL/6N-Coa5tm1b(KOMP)Wtsi/Tcp)
|
small adrenal glands
|
J:211773
|
Coblem1(IMPC)Ccpcz/Coblem1(IMPC)Ccpcz
(C57BL/6NCrl-Coblem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Cobll1em1(IMPC)Ccpcz/Cobll1em1(IMPC)Ccpcz
(C57BL/6NCrl-Cobll1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Col1a1tm1(CAG-Mir22)Ppp/Col1a1tm1(CAG-Mir22)Ppp Tg(Mx1-cre)1Cgn/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:199366
|
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
small pancreatic islets
|
J:166568
|
Col1a1tm2(tetO-Pou5f1)Jae/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
thymus atrophy
|
J:98920
|
Col1a1tm3(tetO-GFP/RNAi:Apc)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:171191
|
Col1a1tm4(tetO-GFP/RNAi:Apc)Slowe/Col1a1+ Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:171191
|
Col4a2em1(IMPC)Wtsi/Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu)
|
abnormal thymus topology
|
J:239583
|
abnormal thyroid gland isthmus morphology
|
J:239583
|
abnormal thyroid gland morphology
|
J:239583
|
absent thyroid gland isthmus
|
J:239583
|
small thymus
|
J:239583
|
small thyroid gland
|
J:239583
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased pancreatic beta cell mass
|
J:171817
|
decreased pancreatic beta cell number
|
J:171817
|
Col10a1tm1Bhr/Col10a1tm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased thymocyte number
|
J:62230
|
decreased thymus weight
|
J:62230
|
small thymus
|
J:62230
|
thymus hypoplasia
|
J:62230
|
Cop1Gt(XR0653)1.1Wtsi/Cop1Gt(XR0653)1.1Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:178271
|
Cops5tm1Rpar/Cops5tm1Rpar Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:132114
|
thymus medulla hypoplasia
|
J:132114
|
Cops5tm1Rpar/Cops5tm1Rpar Tg(Lck-cre)548Jxm/0 Tg(TcraTcrb)425Cbn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:132114
|
Cops5tm1Rpar/Cops5tm1Rpar Tg(Lck-cre)548Jxm/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:132114
|
Cops8em1(IMPC)Ccpcz/Cops8+
(C57BL/6NCrl-Cops8em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Coro1akoy/Coro1akoy
(C57BL/6-Coro1akoy)
|
decreased thymocyte number
|
J:141431
|
Coro1aptcd/Coro1aptcd
(B6.CTS-Coro1aptcd)
|
increased thymocyte number
|
J:141431
|
Coro1aptcd/Coro1atm1Achn
(B6.Cg-Coro1aptcd Coro1atm1Achn)
|
increased thymocyte number
|
J:141431
|
Coro1atm1Achn/Coro1atm1Achn
(B6.129X1-Coro1atm1Achn)
|
decreased thymocyte number
|
J:141431
|
Coro1ctm1a(KOMP)Wtsi/Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Cox6b1em1(IMPC)Tcp/Cox6b1+
(C57BL/6NCrl-Cox6b1em1(IMPC)Tcp/Tcp)
|
absent adrenal gland
|
J:211773
|
Cpa3tm3(icre)Hrr/Cpa3+ Notch1tm1Agt/Notch1tm1Agt
(involves: 129 * C57BL/6)
|
thymus hypoplasia
|
J:143731
|
Cpefat/Cpefat
(involves: HRS/J)
|
abnormal pancreatic beta cell morphology
|
J:10872
|
degranulated pancreatic beta cells
|
J:13651
|
increased pancreatic islet number
|
J:13651
|
pancreatic islet hyperplasia
|
J:10872
|
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J)
|
abnormal pancreatic beta cell morphology
|
J:24436
|
degranulated pancreatic beta cells
|
J:10872
|
pancreatic islet hyperplasia
|
J:10872
|
Cplane2b2b2827Clo/Cplane2b2b2827Clo
(C57BL/6J-Cplane2b2b2827Clo)
|
thymus hypoplasia
|
J:175213
|
Crb1rd8+em1Boc/Crb1rd8+em1Boc Jak3m1J/Jak3m1J
(B6.Cg-Crb1rd8+em1Boc Jak3m1J/Boc)
|
small thymus
|
J:265859
|
Crb1rd8/Crb1rd8 Jak3m1J/Jak3m1J
(B6.Cg-Crb1rd8 Jak3m1J/BocJ)
|
small thymus
|
J:265859
|
Crebbptm1Few/Crebbp+
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:91133
|
Crebbptm1Few/Crebbptm1Few
(Not Specified)
|
abnormal pancreatic beta cell morphology
|
J:91133
|
Crebbptm1Jvd/Crebbptm1Jvd Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:105505
|
increased T cell derived lymphoma incidence
|
J:105505
|
small thymus
|
J:105505
|
Crebbptm1Jvd/Crebbptm1Jvd Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB)
|
increased T cell derived lymphoma incidence
|
J:88323
|
Crebbptm1Pkb/Crebbptm1Pkb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J)
|
increased adrenal gland weight
|
J:208708
|
increased adrenal gland zona fasciculata size
|
J:208708
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal adrenal gland morphology
|
J:23082
|
decreased adrenal gland zona fasciculata size
|
J:23082
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal solitary pulmonary neuroendocrine cell morphology
|
J:53721
|
Crhtm2.1Maj/Crhtm2.1Maj Tg(Sim1-cre)1Lowl/?
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
adrenal gland atrophy
|
J:238330
|
decreased adrenal gland weight
|
J:238330
|
Crhtm2.2Maj/Crhtm2.2Maj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
adrenal gland atrophy
|
J:238330
|
Crhr1tm1Klee/Crhr1tm1Klee
(involves: 129S4/SvJae * C57BL/6)
|
adrenal gland atrophy
|
J:77641
|
adrenal gland hypoplasia
|
J:48280
|
decreased adrenal gland zona fasciculata size
|
J:48280
|
Crhr1tm1Klee/Crhr1tm1Klee Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6)
|
adrenal gland atrophy
|
J:77641
|
decreased adrenal gland zona fasciculata size
|
J:77641
|
Crhr1tm1Wrst/Crhr1tm1Wrst
(either: (involves: 129P2/OlaHsd * 129P/Ola) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal adrenal medulla morphology
|
J:76022
|
Crip3tm1Mjb/Crip3tm1Mjb
(either: (involves: 129S/Sv) or (involves: 129S/Sv * C57BL/6))
|
decreased thymocyte number
|
J:72942
|
small thymus
|
J:72942
|
thymus hypoplasia
|
J:72942
|
Crkltm1Imo/Crkltm1Imo
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal parathyroid gland development
|
J:67826
|
abnormal thymus development
|
J:67826
|
abnormal thyroid gland development
|
J:67826
|
Crxem1(IMPC)Ccpcz/Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
small thymus
|
J:211773
|
Csf1op/Csf1op
(C57BL/6J-Csf1op)
|
abnormal thyroid parafollicular C-cell morphology
|
J:5634
|
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J)
|
thymus cortex hypoplasia
|
J:26978
|
thymus medulla atrophy
|
J:26978
|
Csf1op/Csf1op
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal thyroid parafollicular C-cell morphology
|
J:5634
|
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg)
|
abnormal pancreatic islet morphology
|
J:145518
|
Csf2tm1Mlg/Csf2tm1Mlg Ifngtm1Ts/Ifngtm1Ts Il3tm1Glli/Il3tm1Glli
(B6.129S-Csf2tm1Mlg Il3tm1Glli Ifngtm1TsIfngtm1Ts)
|
increased pituitary adenoma incidence
|
J:145518
|
Csf2tm1Mlg/Csf2tm1Mlg Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Mlg Il3tm1Glli)
|
abnormal pancreatic islet morphology
|
J:145518
|
decreased pancreatic beta cell number
|
J:145518
|
Csktm1Sor/Csk+ Ptprcltng/Ptprcltng
(involves: 129S7/SvEvBrd * C57BL/6)
|
thymus hypoplasia
|
J:158876
|
Csktm1Sor/Csk+ Ptprcltng/Ptprctm1Mak
(involves: 129S7/SvEvBrd * C57BL/6)
|
thymus hypoplasia
|
J:158876
|
Csktm1Tara/Csktm1Tara Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA)
|
enlarged thymus
|
J:49654
|
Ctc1tm1.1Schg/Ctc1tm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6)
|
small thymus
|
J:184809
|
Ctcftm2Gal/Ctcf+ Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hypoplasia
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hypoplasia
|
J:143271
|
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd)
|
enlarged pancreatic islets
|
J:176727
|
increased pancreatic islet number
|
J:176727
|
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal thymus morphology
|
J:42481
|
Ctnnb1tm1Mmt/Ctnnb1+ Sox2tm1.1(cre/ERT2)Jpmb/Sox2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal adenohypophysis morphology
|
J:201265
|
increased pituitary gland tumor incidence
|
J:201265
|
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt Tg(Pitx1-cre)7Rsd/0
(involves: 129X1/SvJ * BALB/c * C57BL/6)
|
absent pituitary gland
|
J:114817
|
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem Gt(ROSA)26Sortm1(Ctnnb1)Kem/Gt(ROSA)26Sortm1(Ctnnb1)Kem Tg(Cdx1-cre)23Kem/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB)
|
small adrenal glands
|
J:187739
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Tg(Pitx1-cre)7Rsd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal adenohypophysis morphology
|
J:114817
|
absent lactotrophs
|
J:114817
|
absent somatotrophs
|
J:114817
|
absent thyrotrophs
|
J:114817
|
decreased gonadotroph cell number
|
J:114817
|
increased corticotroph cell number
|
J:114817
|
small adenohypophysis
|
J:114817
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio/0
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio)
|
small thymus
|
J:348981
|
thymus hypoplasia
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj)
|
small thymus
|
J:348981
|
thymus hypoplasia
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Tg(Cd4-cre)1Cwi/0 Foxp3sf/Y Rag1tm1Mom/Rag1+
(mixed)
|
thymus hypoplasia
|
J:348981
|
Ctsbtm1Jde/Ctsbtm1Jde
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal thyroid gland morphology
|
J:83877
|
Ctsbtm1Jde/Ctsbtm1Jde Ctsktm1Psa/Ctsktm1Psa
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal thyroid follicle morphology
|
J:83877
|
abnormal thyroid follicular cell morphology
|
J:83877
|
Ctsdm1J/Ctsdm1J
(C3HeB/FeJ-Ctsdm1J/GrsrJ)
|
thymus atrophy
|
J:229377
|
Ctsdtm1.1Thre/Ctsdtm1.1Thre Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
thymus atrophy
|
J:227618
|
Ctsdtm1.1Thre/Ctsdtm1.1Thre Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal thymus morphology
|
J:227618
|
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))
|
thymus hypoplasia
|
J:28201
|
Ctsktm1Psa/Ctsktm1Psa Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal thyroid follicle morphology
|
J:83877
|
abnormal thyroid gland morphology
|
J:83877
|
Ctslnkt/Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))
|
thymus atrophy
|
J:54856
|
Ctslnkt/Ctslnkt
(C.Cg-Ctslnkt)
|
abnormal thymus corticomedullary boundary morphology
|
J:99009
|
abnormal thymus lobule morphology
|
J:99009
|
abnormal thymus morphology
|
J:99009
|
enlarged thymus cortex
|
J:99009
|
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal thyroid gland morphology
|
J:83877
|
Cul4a/Pcid2tm2Ktc/Cul4a/Pcid2tm2Ktc Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
small thymus
|
J:138468
|
Cul4a/Pcid2tm2Ktc/Cul4a/Pcid2tm2Ktc Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
small thymus
|
J:138468
|
Cul9em1(IMPC)Ccpcz/Cul9em1(IMPC)Ccpcz
(C57BL/6N-Cul9em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Cul9tm1.2Yxi/Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased pituitary gland tumor incidence
|
J:170976
|
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased pituitary gland tumor incidence
|
J:170976
|
Cux1tm1Rhsc/Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J)
|
decreased thymocyte number
|
J:100055
|
small thymus
|
J:100055
|
thymus cortex hypoplasia
|
J:100055
|
thymus hypoplasia
|
J:100055
|
Cxadrtm1.1Ics/Cxadrtm1.1Ics Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
enlarged thymus
|
J:174138
|
increased thymocyte number
|
J:174138
|
Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
(involves: 129S2/SvPas * C57BL/6)
|
small adrenal glands
|
J:113489
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * BALB/c)
|
decreased thymus weight
|
J:113489
|
Cxcr4tm1.1Bala/Cxcr4+
(B6.129S2-Cxcr4tm1.1Bala)
|
abnormal thymus morphology
|
J:186735
|
Cxcr4tm1Yiw/Cxcr4tm1Yiw Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:164872
|
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN)
|
abnormal pancreatic islet morphology
|
J:91486
|
decreased pancreatic beta cell number
|
J:91486
|
Cycstm1Mak/Cycstm1Mak
(involves: C57BL/6)
|
abnormal pituitary gland morphology
|
J:98949
|
thymus atrophy
|
J:98949
|
thymus hypoplasia
|
J:98949
|
Cyldtm1Lex/Cyldtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
thymus hyperplasia
|
J:114972
|
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn)
|
decreased thymus weight
|
J:163973
|
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(involves: 129P2/OlaHsd * C57BL/6)
|
small thymus
|
J:122409
|
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn)
|
decreased thymus weight
|
J:163973
|
Cyp1atm1Dwn/Cyp1atm1Dwn
(B6.129-Cyp1atm1Dwn)
|
small thymus
|
J:122409
|
Cyp11a1tm1.1Bcc/Cyp11a1tm1.1Bcc
(B6.129(FVB)-Cyp11a1tm1.1Bcc)
|
abnormal adrenal gland morphology
|
J:191801
|
abnormal adrenocortical cell morphology
|
J:191801
|
absent adrenal chromaffin cells
|
J:191801
|
Cyp11a1tm1Bcc/Cyp11a1tm1Bcc
(involves: 129 * C57BL/6)
|
abnormal adrenal cortex morphology
|
J:78062
|
enlarged adrenocortical cells
|
J:78062
|
small adrenal glands
|
J:78062
|
Cyp11a1tm2Bcc/Cyp11a1tm2Bcc
(Not Specified)
|
abnormal adrenal cortex morphology
|
J:133007
|
abnormal adrenal gland morphology
|
J:133007
|
abnormal adrenal gland zona fasciculata morphology
|
J:133007
|
abnormal adrenal gland zona glomerulosa morphology
|
J:133007
|
enlarged adrenal glands
|
J:133007
|
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J)
|
adrenal gland hyperplasia
|
J:147610
|
decreased thymus weight
|
J:147610
|
enlarged adrenal glands
|
J:147610
|
increased adrenal gland zona fasciculata size
|
J:147610
|
pituitary gland hyperplasia
|
J:147610
|
Cyp11b2tm1.1(cre)Brlt/Cyp11b2+ Nr5a1tm2Klp/Nr5a1tm2Klp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal adrenal gland zona glomerulosa morphology
|
J:204614
|
Cyp11b2tm1Hsk/Cyp11b2tm1Hsk
(involves: 129S6/SvEvTac)
|
abnormal adrenal cortex morphology
|
J:99269
|
abnormal adrenal gland zona glomerulosa morphology
|
J:99269
|
abnormal adrenocortical cell morphology
|
J:99269
|
Cyp27a1tm1Elt/Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J)
|
enlarged adrenal glands
|
J:115373
|
enlarged adrenocortical cells
|
J:115373
|
increased adrenal gland weight
|
J:115373
|
Cyp27b1tm1Star/Cyp27b1tm1Star
(involves: 129S1/Sv * 129X1/SvJ)
|
enlarged parathyroid gland
|
J:71928
|
Cys1cpk/Cys1cpk
(involves: C57BL/6J * CD-1)
|
thymus hypoplasia
|
J:33739
|
Cys1cpk/Cys1cpk
(C.B6(Cg)-Cys1cpk)
|
absent pancreatic islets
|
J:99616
|
Cys1cpk/Cys1cpk
(D2J.B6(Cg)-Cys1cpk)
|
absent pancreatic islets
|
J:99620
|
Dab1scm-4J/Dab1scm-4J
(CBA/J-Dab1scm-4J/GrsrJ)
|
thymus atrophy
|
J:153275
|
Dach1tm1Krs/Dach1tm1Krs
(involves: 129P2/OlaHsd)
|
decreased pancreatic alpha cell number
|
J:166952
|
decreased pancreatic beta cell number
|
J:166952
|
small pancreatic islets
|
J:166952
|
Dad1tm1Kni/Dad1+
(involves: 129S/SvEv)
|
decreased thymus weight
|
J:99897
|
Daglatm1a(EUCOMM)Wtsi/Daglatm1a(EUCOMM)Wtsi
(C57BL/6N-Daglatm1a(EUCOMM)Wtsi/Nju)
|
small thymus
|
J:211773
|
Dcaf15tm1a(EUCOMM)Hmgu/Dcaf15tm1a(EUCOMM)Hmgu
(C57BL/6NCrl-Dcaf15tm1a(EUCOMM)Hmgu/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Dckmemi/Dckmemi
(C57BL/6J-Dckmemi)
|
small thymus
|
J:184080
|
thymus hypoplasia
|
J:184080
|
Dcktm1.1Radu/Dcktm1.1Radu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J)
|
abnormal thymus morphology
|
J:158373
|
thymus hypoplasia
|
J:158373
|
Dclre1atm1Rleg/Dclre1atm1Rleg Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd)
|
increased T cell derived lymphoma incidence
|
J:102381
|
Dclre1cm1Brck/Dclre1cm1Brck
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:207533
|
decreased DN4 thymocyte number
|
J:207533
|
Dclre1ctm1Fwa/Dclre1ctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte number
|
J:80995
|
Dclre1ctm1Fwa/Dclre1ctm1Fwa
(involves: 129S6/SvEvTac)
|
decreased thymocyte number
|
J:147864
|
Dclre1ctm1Jsek/Dclre1ctm1Jsek
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased thymocyte number
|
J:147864
|
Dclre1ctm2.2Jpdv/Dclre1ctm2.2Jpdv
(B6.129S2-Dclre1ctm2.2Jpdv)
|
decreased thymocyte number
|
J:153841
|
Dclre1ctm2Mcow/Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6)
|
absent thymus cortex
|
J:96535
|
decreased thymocyte number
|
J:96535
|
decreased thymus weight
|
J:96535
|
Dcntm1Ioz/Dcn+ Trp53tm1Brd/Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:53511
|
Dcntm1Ioz/Dcntm1Ioz Trp53tm1Brd/Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6)
|
enlarged thymus
|
J:53511
|
increased T cell derived lymphoma incidence
|
J:53511
|
thymus hyperplasia
|
J:53511
|
Ddb1em1(IMPC)Ccpcz/Ddb1+
(C57BL/6N-Ddb1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
dde/dde
(CByJ(Cg)-dde/GrsrJ)
|
thyroid gland cyst
|
J:159016
|
Ddosttm1.1(KOMP)Vlcg/Ddost+
(C57BL/6N-Ddosttm1.1(KOMP)Vlcg/Ucd)
|
small adrenal glands
|
J:211773
|
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng)
|
small pituitary gland
|
J:134371
|
Ddx24em1(IMPC)Mbp/Ddx24+
(C57BL/6NCrl-Ddx24em1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Del(2Duoxa2-Duoxa1)1Sref/Del(2Duoxa2-Duoxa1)1Sref
(involves: 129S6/SvEvTac * C57BL/6J)
|
enlarged adenohypophysis
|
J:205165
|
enlarged thyroid gland
|
J:205165
|
thyroid gland hyperplasia
|
J:205165
|
Del(7)Tyrc-3H/Del(7)Tyrc-3H
(involves: 101/H * C3H/HeH)
|
abnormal thymus morphology
|
J:5063
|
Del(9Cd3g-Cd3d)1Cpt/Del(9Cd3g-Cd3d)1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
thymus hypoplasia
|
J:76991
|
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6)
|
abnormal thymus development
|
J:90288
|
thymus hypoplasia
|
J:90288
|
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
small thymus
|
J:122463
|
Del(16Dgcr2-Hira)1Rak/+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
absent parathyroid glands
|
J:67796
|
Del(16Pi4ka-Hira)1Atai/+
(C57BL/6N-Del(16Pi4ka-Hira)1Atai)
|
thymus hypoplasia
|
J:285407
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
increased pancreatic alpha cell number
|
J:92536
|
increased pancreatic beta cell number
|
J:92536
|
pancreatic islet hyperplasia
|
J:92536
|
Dffbtm1Osa/Dffbtm1Osa Dnase2atm1Osa/Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thymus morphology
|
J:81474
|
small thymus
|
J:81474
|
thymus hypoplasia
|
J:81474
|
Dh/Dh+ Foxn1nu/Foxn1nu
(involves: N:NIH(S))
|
athymia
|
J:6062
|
Dhrs7bGt(OST255410)Lex/Dhrs7bGt(OST255410)Lex
(B6;129S5-Dhrs7bGt(OST255410)Lex/Mmucd)
|
thymus atrophy
|
J:171883
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
abnormal pancreatic islet morphology
|
J:267178
|
Dhx8em1(IMPC)Mbp/Dhx8+
(C57BL/6NCrl-Dhx8em1(IMPC)Mbp/Mmucd)
|
enlarged thymus
|
J:211773
|
Dhx35tm1b(EUCOMM)Wtsi/Dhx35tm1b(EUCOMM)Wtsi
(C57BL/6N-Dhx35tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
Dhx36tm1.2Pmt/Dhx36tm1.2Pmt Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca)
|
thymus hypoplasia
|
J:185179
|
Dicer1tm1Bdh/Dicer1+ H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129 * C57BL/6 * CBA/J)
|
abnormal thymus development
|
J:166758
|
Dicer1tm1Bdh/Dicer1tm1Bdh H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129 * C57BL/6 * CBA/J)
|
athymia
|
J:166758
|
Dicer1tm1Mmk/Dicer1tm1Mmk Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:98192
|
Dicer1tm1Tara/Dicer1tm1Tara Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
abnormal thymus cortex morphology
|
J:180783
|
abnormal thymus epithelium morphology
|
J:180783
|
abnormal thymus medulla morphology
|
J:180783
|
abnormal thymus morphology
|
J:180783
|
Dip2cem1(IMPC)Tcp/Dip2c+
(C57BL/6N-Dip2cem1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Dip2cem1(IMPC)Tcp/Dip2cem1(IMPC)Tcp
(C57BL/6N-Dip2cem1(IMPC)Tcp/Tcp)
|
enlarged adrenal glands
|
J:211773
|
Disp1icb/Disp1tm1Amc
(involves: 129X1/SvJ * C57BL/6J)
|
absent pituitary gland
|
J:92058
|
Disp1tm1Amc/Disp1tm1Amc
(involves: 129X1/SvJ)
|
pituitary gland hypoplasia
|
J:92058
|
Dkc1tm1Ppp/Y
(involves: 129S1/Sv)
|
increased pheochromocytoma incidence
|
J:81054
|
Dlgap1em1(IMPC)Tcp/Dlgap1em1(IMPC)Tcp
(C57BL/6NCrl-Dlgap1em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Dll4tm1Frad/Dll4tm1Frad Foxn1tm3(cre)Nrm/Foxn1+
(B6.Cg-Dll4tm1Frad Foxn1tm3(cre)Nrm)
|
abnormal thymus cell ratio
|
J:143472
|
decreased thymocyte number
|
J:143472
|
Dll4tm1Kaho/Dll4tm1Kaho Tg(Foxn1-cre)8Ghr/0
(involves: C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:143473
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx)
|
abnormal corticotroph morphology
|
J:18080
|
increased somatotroph cell size
|
J:18080
|
Dmtf1tm1Cjs/Dmtf1+ Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:126002
|
Dmtf1tm1Cjs/Dmtf1+ Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:126002
|
Dmtf1tm1Cjs/Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:63444
|
Dmtf1tm1Cjs/Dmtf1tm1Cjs Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:126002
|
Dmtf1tm1Cjs/Dmtf1tm1Cjs Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:126002
|
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg)
|
abnormal pancreatic alpha cell morphology
|
J:226674
|
abnormal pancreatic beta cell morphology
|
J:226674
|
increased pancreatic alpha cell number
|
J:226674
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg Tg(CAG-XBP1*/Venus)#Miur/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic alpha cell morphology
|
J:226674
|
abnormal pancreatic beta cell morphology
|
J:226674
|
decreased pancreatic beta cell number
|
J:226674
|
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh)
|
abnormal pancreatic beta cell morphology
|
J:98194
|
decreased pancreatic beta cell mass
|
J:98194
|
decreased pancreatic beta cell number
|
J:98194
|
Dnajc11spc/Dnajc11spc
(B6.Cg-Dnajc11spc)
|
decreased thymus weight
|
J:221543
|
enlarged thymus medulla
|
J:221543
|
increased DN1 thymic pro-T cell number
|
J:221543
|
thymus cortex atrophy
|
J:221543
|
thymus hypoplasia
|
J:221543
|
Dnase2atm1Osa/Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thymus morphology
|
J:81474
|
small thymus
|
J:81474
|
thymus hypoplasia
|
J:81474
|
Dnmt3atm1Jae/Dnmt3atm1Jae Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: 129S/Sv * Black Swiss * C57BL/6 * CBA/J * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:177838
|
Dnmt3atm1Jae/Dnmt3atm1Jae Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Tg(Ins2-cre)23Herr/0
(involves: Black Swiss * C57BL/6 * CBA/J * SJL)
|
decreased pancreatic beta cell number
|
J:177838
|
increased pancreatic alpha cell number
|
J:177838
|
Dnmt3btm1Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
small thymus
|
J:106540
|
Dnmt3btm1Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
small thymus
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
small thymus
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
Dnmt3btm7Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
small thymus
|
J:106540
|
Dock1b2b3190Clo/Dock1b2b3190Clo
(C57BL/6J-Dock1b2b3190Clo)
|
thymus hypoplasia
|
J:175213
|
Dock10tm1a(EUCOMM)Hmgu/Dock10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dock10tm1a(EUCOMM)Hmgu/Ieg)
|
abnormal thymus cell ratio
|
J:238172
|
Dock11tm1.1Mmar/Dock11tm1.1Mmar
(Not Specified)
|
abnormal thymus cell ratio
|
J:238172
|
Dok1tm1Yyam/Dok1tm1Yyam Dok2tm1Yyam/Dok2tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6)
|
enlarged thymus
|
J:95335
|
Dok1tm1Yyam/Dok1tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6)
|
enlarged thymus
|
J:95335
|
Dok2tm1Yyam/Dok2tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6)
|
enlarged thymus
|
J:95335
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub Tg(Nes-cre)1Kln/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased somatotroph cell number
|
J:194227
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
abnormal adrenal gland zona fasciculata morphology
|
J:110599
|
abnormal adrenal gland zona reticularis morphology
|
J:110599
|
abnormal melanotroph morphology
|
J:110599
|
adenohypophysis hyperplasia
|
J:41857
|
adrenal cortical hyperplasia
|
J:110599
|
decreased lactotroph cell size
|
J:41857
|
decreased somatotroph cell number
|
J:41857
|
enlarged adrenocortical cells
|
J:110599
|
enlarged pituitary gland
|
J:41857
|
increased lactotroph cell number
|
J:41857
|
increased pituitary adenoma incidence
|
J:41857
|
increased thyrotroph cell number
|
J:41857
|
pituitary gland hyperplasia
|
J:41857
|
pituitary intermediate lobe hyperplasia
|
J:110599,
J:41857
|
Drd2tm1Low/Drd2tm1Low
(either: B6.129S2-Drd2tm1Low or (involves: 129S2/SvPas * C57BL/6))
|
abnormal adenohypophysis morphology
|
J:41858
|
abnormal pituitary gland morphology
|
J:41858
|
adenohypophysis hyperplasia
|
J:41858
|
adenohypophysis hypertrophy
|
J:41858
|
adenohypophysis peliosis
|
J:41858
|
decreased gonadotroph cell number
|
J:41858
|
enlarged pituitary gland
|
J:41858
|
increased lactotroph cell number
|
J:41858
|
increased pituitary gland weight
|
J:41858
|
Drd2tm1Mok/Drd2tm1Mok
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
|
enlarged pituitary intermediate lobe
|
J:97838
|
Drgxem1(IMPC)Mbp/Drgx+
(C57BL/6N-Drgxem1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Droshatm1Litt/Droshatm1.1Litt Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
decreased thymocyte number
|
J:138683
|
Dtx4em1(IMPC)Ccpcz/Dtx4+
(C57BL/6N-Dtx4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Duox2thyd/Duox2thyd
(B6(129)-Duox2thyd/J)
|
abnormal adenohypophysis morphology
|
J:121821
|
abnormal thyroid follicle morphology
|
J:121821
|
thyroid gland hyperplasia
|
J:121821
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn
(involves: C57BL/6NCrl)
|
increased thymocyte number
|
J:218203
|
Dusp12em1(IMPC)Mbp/Dusp12+
(C57BL/6N-Dusp12em1(IMPC)Mbp/Ucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Dvl3b2b2866Clo/Dvl3b2b2866Clo
(C57BL/6J-Dvl3b2b2866Clo)
|
thymus hypoplasia
|
J:175213
|
dwt/dwt
(TAIII)
|
decreased somatotroph cell number
|
J:14660
|
decreased somatotroph cell size
|
J:14660
|
Dyrk1atm1Jdc/Dyrk1atm1Jdc Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)
|
decreased thymocyte number
|
J:223138
|
E2f1Tg(Wnt1-cre)2Sor/E2f1+ Snrpbem1Lajm/Snrpb+
(involves: C3H * C57BL/6 * C57BL/6J * CD1)
|
athymia
|
J:326544
|
E2f1tm1Meg/E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
|
enlarged thymus
|
J:33100
|
increased T cell derived lymphoma incidence
|
J:33100
|
increased thymocyte number
|
J:33100
|
increased thymus weight
|
J:33100
|
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
abnormal pancreatic islet morphology
|
J:93708
|
enlarged thymus
|
J:93708
|
increased thymocyte number
|
J:93708
|
E2f1tm1Meg/E2f1tm1Meg E2f3tm2.1Gle/E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal adrenal cortex morphology
|
J:138289
|
E2f1tm1Njd/E2f1+ Rb1tm1Tyj/Rb1+
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
increased thyroid adenoma incidence
|
J:47108
|
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:89720
|
abnormal pancreatic islet morphology
|
J:89720
|
decreased pancreatic islet number
|
J:89720
|
small pancreatic islets
|
J:89720
|
E2f1tm1Njd/E2f1tm1Njd Rb1tm1Tyj/Rb1+
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
abnormal thyroid gland morphology
|
J:47108
|
adrenal medulla hyperplasia
|
J:47108
|
increased pituitary gland tumor incidence
|
J:47108
|
increased thyroid adenoma incidence
|
J:47108
|
E2f2tm1Zubi/E2f2tm1Zubi Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
|
thymus hypoplasia
|
J:76318
|
E2f4tm1Jrn/E2f4tm1Jrn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:64192
|
thymus hypoplasia
|
J:64192
|
E2f4tm1Lees/E2f4+ Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:81082
|
increased thyroid tumor incidence
|
J:81082
|
Ece1tm1Reh/Ece1tm1Reh
(involves: 129S6/SvEvTac * C57BL/6)
|
parathyroid hypoplasia
|
J:46640
|
persistent cervical thymus
|
J:46640
|
thyroid gland hypoplasia
|
J:46640
|
Ecscrtm1.1(KOMP)Vlcg/Ecscrtm1.1(KOMP)Vlcg
(C57BL/6N-Ecscrtm1.1(KOMP)Vlcg/Ucd)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Ednratm1Ywa/Ednratm1Ywa
(129S/SvEv-Ednratm1Ywa)
|
ectopic thymus
|
J:46639
|
thymus hypoplasia
|
J:46639
|
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J)
|
decreased thymus weight
|
J:6766
|
Eef1a2wst/Eef1a2wst
(Not Specified)
|
thymus atrophy
|
J:50410
|
Efna5tm1b(EUCOMM)Wtsi/Efna5tm1b(EUCOMM)Wtsi
(C57BL/6N-Efna5tm1b(EUCOMM)Wtsi/Ieg)
|
enlarged adrenal glands
|
J:211773
|
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu Efnb2tm1.1Jwu/Efnb2tm1.1Jwu Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
decreased DN4 thymocyte number
|
J:178148
|
decreased thymus weight
|
J:178148
|
increased DN3 thymocyte number
|
J:178148
|
small thymus
|
J:178148
|
thymus hypoplasia
|
J:178148
|
Egfrtm1Rdk/Egfrtm1Rdk
(involves: 129X1/SvJ * Black Swiss)
|
abnormal pancreatic beta cell morphology
|
J:62160
|
disorganized pancreatic islets
|
J:62160
|
Egln3tm1Pjr/Egln3tm1Pjr
(involves: 129S/SvEv * Swiss)
|
abnormal adrenal chromaffin cell morphology
|
J:136034
|
abnormal adrenal medulla morphology
|
J:136034
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:123870
|
Egr1tm1Pch/Egr1tm1Pch
(involves: 129S2/SvPas * C57BL/6J)
|
adenohypophysis hypoplasia
|
J:45064
|
decreased somatotroph cell number
|
J:45064
|
Ehd4tm1.1Haba/Ehd4tm1.1Haba
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
abnormal pancreatic islet morphology
|
J:160188
|
pancreatic islet hyperplasia
|
J:160188
|
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac)
|
abnormal pancreatic alpha cell morphology
|
J:76661
|
absent pancreatic alpha cells
|
J:76661
|
absent pancreatic beta cells
|
J:76661
|
decreased pancreatic beta cell number
|
J:76661,
J:129974
|
small pancreatic islets
|
J:76661
|
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster)
|
abnormal pancreatic islet morphology
|
J:70005
|
decreased pancreatic beta cell number
|
J:70005
|
increased pancreatic alpha cell number
|
J:70005
|
Eif4btm1.1Smoc/Eif4btm1.1Smoc Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6)
|
small thymus
|
J:311140
|
Elavl1tm1.1Thla/Elavl1+
(involves: 129S1/Sv)
|
thymus hypoplasia
|
J:155109
|
Elavl1tm1Dkon/Elavl1tm1Dkon Tg(Lck-cre)I57Jxm/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo)
|
increased thymocyte number
|
J:148866
|
Elavl1tm1Thla/Elavl1tm1Thla Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129)
|
thymus hypoplasia
|
J:155109
|
Elk4tm1Rtr/Elk4tm1Rtr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
decreased thymocyte number
|
J:88515
|
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:130031
|
Emv30b/Emv30b Prkdcscid/Prkdcscid
(NOD.Cg-Emv30b Prkdcscid/Dvs)
|
increased T cell derived lymphoma incidence
|
J:29951
|
Emx1tm1(cre)Ito/Emx1+ Hes1tm1Fgu/Hes1tm1Hojo Hes5tm1Fgu/Hes5tm1Fgu
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal neurohypophysis morphology
|
J:121843
|
abnormal pituitary diverticulum morphology
|
J:121843
|
abnormal pituitary gland development
|
J:121843
|
abnormal pituitary gland morphology
|
J:121843
|
abnormal pituitary infundibular stalk morphology
|
J:121843
|
absent pituitary intermediate lobe
|
J:121843
|
increased somatotroph cell number
|
J:121843
|
pituitary gland hypoplasia
|
J:121843
|
Emx2tm1Sia/Emx2tm1Sia Otx2tm1Sia/Otx2+
(involves: C57BL/6 * CBA)
|
abnormal adenohypophysis morphology
|
J:70745
|
Enpp1em1(IMPC)Ccpcz/Enpp1em1(IMPC)Ccpcz
(C57BL/6NCrl-Enpp1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Ep300tm1Pkb/Ep300+ Mybtm1Ssp/Myb+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
Ep300tm1Pkb/Ep300tm1Pkb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
Ep300tm2Pkb/Ep300tm2Pkb Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:105505
|
small thymus
|
J:105505
|
Epm2aTg(TcraK,TcrbK)TG-BFlv/Epm2a+
(involves: C57BL/6 * C57BL/10 * C57BR/cd * CBA/J)
|
increased T cell derived lymphoma incidence
|
J:112696
|
Erap1tm1Dgen/Erap1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hyperplasia
|
J:101679
|
Erbb3tm1Gne/Erbb3tm1Gne
(involves: 129S2/SvPas * C57BL/6)
|
absent adrenergic chromaffin cells
|
J:45302
|
Erbb3tm2Cbm/Erbb3tm2Cbm
(involves: 129P2/OlaHsd)
|
abnormal adrenal gland morphology
|
J:48515
|
absent adrenergic chromaffin cells
|
J:48515
|
Erlin1em1(IMPC)Tcp/Erlin1em1(IMPC)Tcp
(C57BL/6N-Erlin1em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Ero1bGt(P077G11)Wrst/Ero1b+ Ins2Akita/Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc)
|
small pancreatic islets
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
disorganized pancreatic islets
|
J:158805
|
Errfi1tm1Gvw/Errfi1tm1Gvw
(Not Specified)
|
enlarged thymus
|
J:100927
|
Esr1tm1.2Awo/Esr1tm1.2Awo Tg(Cga-cre)1Awo/0
(involves: C57BL/6 * SJL)
|
decreased gonadotroph cell number
|
J:152925
|
Esr1tm1.2Mma/Esr1tm1.2Mma Tg(Cyp17a1-icre)AJako/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
increased gonadotroph cell number
|
J:151908
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
thymus hypoplasia
|
J:110416
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
decreased lactotroph cell number
|
J:40607
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6N)
|
decreased thymocyte number
|
J:111590
|
decreased thymus weight
|
J:111590
|
Esr1tm1Ksk/Esr1tm1Ksk Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
thymus hypoplasia
|
J:110416
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
enlarged pancreatic islets
|
J:151012
|
Ets1tm1.1Dds/Ets1+
(129S6/SvEvTac-Ets1tm1.1Dds)
|
abnormal thymus morphology
|
J:121460
|
enlarged thymus
|
J:121460
|
increased thymus weight
|
J:121460
|
Ets1tm1.1Dds/Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
abnormal thymus cortex morphology
|
J:121460
|
abnormal thymus morphology
|
J:121460
|
abnormal thymus subcapsular epithelium morphology
|
J:121460
|
enlarged thymus
|
J:121460
|
increased thymus weight
|
J:121460
|
Ets1tm1Jml/Ets1tm1Jml
(involves: 129S/SvEv * C57BL/6)
|
thymus hypoplasia
|
J:125056
|
Ets1tm2Jml/Ets1tm2Jml
(involves: 129X1/SvJ * C57BL/6)
|
decreased thymocyte number
|
J:50627
|
Ewsr1tm1(ERG)Thr/Ewsr1+ Rag1tm1(cre)Thr/Rag1+
(involves: 129S/SvEv)
|
increased T cell derived lymphoma incidence
|
J:98679
|
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
|
thymus hypoplasia
|
J:122058
|
Extl3tm1.1Okam/Extl3tm1Okam Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR)
|
decreased pancreatic beta cell mass
|
J:148348
|
decreased pancreatic beta cell number
|
J:148348
|
disorganized pancreatic islets
|
J:148348
|
Exz1BALB/c/Exz1BALB/c
(involves: BALB/c * C57BL/6)
|
early degeneration of the adrenal gland x-zone
|
J:8718
|
Exz1BALB/c/Exz1C57BL/6
(involves: BALB/c * C57BL/6)
|
early degeneration of the adrenal gland x-zone
|
J:8718
|
Exz2BALB/c/Exz2BALB/c
(involves: BALB/c * C57BL/6)
|
early degeneration of the adrenal gland x-zone
|
J:8718
|
Exz2BALB/c/Exz2C57BL/6
(involves: BALB/c * C57BL/6)
|
early degeneration of the adrenal gland x-zone
|
J:8718
|
Eya1tm1Rilm/Eya1tm1Rilm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
absent parathyroid glands
|
J:57313
|
absent thyroid gland isthmus
|
J:79848
|
athymia
|
J:79848,
J:57313
|
persistent ultimobranchial bodies
|
J:79848
|
thyroid gland hypoplasia
|
J:79848
|
Eya1tm1Rilm/Eya1tm1Rilm Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
pituitary gland hypoplasia
|
J:86619
|
small pituitary gland
|
J:86619
|
Eya2tm2Px/Eya2tm2Px
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
small thymus
|
J:311538
|
Eya4tm1b(KOMP)Wtsi/Eya4+
(C57BL/6N-Eya4tm1b(KOMP)Wtsi/Tcp)
|
small adrenal glands
|
J:211773
|
Ezh2tm2Sho/Ezh2tm2.1Sho Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:182211
|
Ezh2tm2Sho/Ezh2tm2Sho Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:182211
|
Faddtm1Wnt/Faddtm1Wnt Tg(Fadd)33Wnt/0 Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA * ICR)
|
thymus hypoplasia
|
J:69617
|
Faddtm1Wnt/Faddtm1Wnt Tg(Fadd)33Wnt/0 Tg(Lck-cre)I57Jxm/0 Tg(Tcra2C,Tcrb2C)1Dlo/0
(involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL)
|
thymus hypoplasia
|
J:69617
|
Faddtm1Wnt/Faddtm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:168722
|
Fads2tm1Mtna/Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal thymus cortex morphology
|
J:153293
|
small thymus
|
J:153293
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL)
|
increased pancreatic alpha cell number
|
J:27735
|
Fam32aem1(IMPC)Mbp/Fam32a+
(C57BL/6N-Fam32aem1(IMPC)Mbp/Ucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Fam53aem1(IMPC)Ccpcz/Fam53aem1(IMPC)Ccpcz
(C57BL/6N-Fam53aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam81aem1(IMPC)Ccpcz/Fam81aem1(IMPC)Ccpcz
(C57BL/6N-Fam81aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam83dem1(IMPC)Ccpcz/Fam83dem1(IMPC)Ccpcz
(C57BL/6N-Fam83dem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam120cem1(IMPC)Ccpcz/Fam120cem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam120cem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam124aem1(IMPC)Ccpcz/Fam124aem1(IMPC)Ccpcz
(C57BL/6N-Fam124aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam161bem1(IMPC)Ccpcz/Fam161bem1(IMPC)Ccpcz
(C57BL/6N-Fam161bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam167aem1(IMPC)Ccpcz/Fam167aem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam167aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam185aem1(IMPC)Ccpcz/Fam185aem1(IMPC)Ccpcz
(C57BL/6N-Fam185aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam219aem1(IMPC)Ccpcz/Fam219aem1(IMPC)Ccpcz
(C57BL/6N-Fam219aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fam227bem1(IMPC)Ccpcz/Fam227bem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam227bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
abnormal thymus medulla morphology
|
J:28885
|
abnormal thyroid follicle morphology
|
J:28171
|
abnormal thyroid gland morphology
|
J:28171
|
enlarged thymus
|
J:13757
|
increased thymus weight
|
J:28885
|
thymus atrophy
|
J:27634
|
thymus cortex atrophy
|
J:13757,
J:28885
|
Faslpr/Faslpr
(MRL/Mp-Agtpbp1atms Faslpr)
|
enlarged thymus
|
J:103944
|
Fasldel1Hong/Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6))
|
abnormal thymus cell ratio
|
J:112563
|
enlarged thymus
|
J:112563
|
Fat3em1(IMPC)Ccpcz/Fat3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fat3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fbln1Gt(XST011)Byg/Fbln1Gt(XST011)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hypoplasia
|
J:137690
|
thyroid gland hypoplasia
|
J:137690
|
Fbln1tm1Tmpl/Fbln1tm1Tmpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thymus hypoplasia
|
J:137690
|
Fbn1tm1Rmz/Fbn1tm1Rmz
(involves: 129S4/SvJae * C57BL/6J)
|
increased solitary pulmonary neuroendocrine cell number
|
J:137934
|
Fbrsl1em1(IMPC)Tcp/Fbrsl1em1(IMPC)Tcp
(C57BL/6N-Fbrsl1em1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Fbxo7tm1a(EUCOMM)Wtsi/Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
thymus atrophy
|
J:272313
|
thymus hypoplasia
|
J:272313
|
Fbxo9tm1b(EUCOMM)Hmgu/Fbxo9tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxo9tm1b(EUCOMM)Hmgu/Tcp)
|
small adrenal glands
|
J:211773
|
Fbxo25em1(IMPC)Ccpcz/Fbxo25em1(IMPC)Ccpcz
(C57BL/6N-Fbxo25em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fbxw7tm1Iaai/Fbxw7tm1Iaai Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:137138
|
Fbxw7tm1Iaai/Fbxw7tm1Iaai Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:137138
|
Fbxw7tm1Kei/Fbxw7tm1Kei Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
enlarged thymus
|
J:128523
|
Fbxw7tm1Kei/Fbxw7tm1Kei Trp53tm1Tyj/Trp53tm1Tyj Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:128523
|
Fbxw9tm1a(EUCOMM)Wtsi/Fbxw9tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbxw9tm1a(EUCOMM)Wtsi/Bay)
|
abnormal thyroid gland morphology
|
J:211773
|
Fbxw16em1(IMPC)Ccpcz/Fbxw16+
(C57BL/6N-Fbxw16em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
small thymus
|
J:211773
|
Fbxw18em1(IMPC)Ccpcz/Fbxw18+
(C57BL/6N-Fbxw18em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fbxw20em1(IMPC)Ccpcz/Fbxw20em1(IMPC)Ccpcz
(C57BL/6N-Fbxw20em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fbxw25em1(IMPC)Ccpcz/Fbxw25em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxw25em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fcmrtm1b(KOMP)Wtsi/Fcmrtm1b(KOMP)Wtsi
(C57BL/6N-Fcmrtm1b(KOMP)Wtsi/Ucd)
|
enlarged adrenal glands
|
J:211773
|
Fdxrtm1Xch/Fdxr+
(B6.Cg-Fdxrtm1Xch)
|
increased T cell derived lymphoma incidence
|
J:244082
|
Fen1tm1Rak/Fen1+
(involves: 129/Sv * C57BL/6 * SJL/J)
|
thymus atrophy
|
J:77962
|
Fen1tm2.1Bhsh/Fen1tm2.1Bhsh
(involves: 129S1/Sv)
|
increased thymus tumor incidence
|
J:218627
|
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ)
|
thymus hypoplasia
|
J:64748
|
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6)
|
enlarged pancreatic islets
|
J:182599
|
Fgd1em1(IMPC)Tcp/Fgd1+
(C57BL/6NCrl-Fgd1em1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
Fgf8tm1.1Mrt/Fgf8tm1.2Mrt
(involves: 129P2/OlaHsd)
|
abnormal pituitary gland morphology
|
J:178252
|
Fgf8tm1.3Mrt/Fgf8tm1.4Mrt Tg(Tbx1-cre)1Joe/0
(involves: 129P2/OlaHsd)
|
abnormal thymus morphology
|
J:88814
|
small thymus
|
J:88814
|
Fgf8tm1.4Mrt/Fgf8+ Tbx1tm1Bld/Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * ICR)
|
thymus hypoplasia
|
J:78686
|
Fgf8tm1Mrc/Fgf8tm1Moon Hoxa3tm1(cre)Moon/Hoxa3+
(involves: 129/Sv * C57BL/6)
|
abnormal parathyroid gland morphology
|
J:87304
|
absent parathyroid glands
|
J:87304
|
ectopic parathyroid gland
|
J:87304
|
ectopic thymus
|
J:87304
|
parathyroid hypoplasia
|
J:87304
|
thymus hypoplasia
|
J:87304
|
Fgf8tm1Mrc/Fgf8tm2Mrc Hoxa3tm1(cre)Moon/Hoxa3+
(involves: 129/Sv * C57BL/6)
|
abnormal parathyroid gland morphology
|
J:87304
|
absent parathyroid glands
|
J:87304
|
ectopic parathyroid gland
|
J:87304
|
ectopic thymus
|
J:87304
|
parathyroid hypoplasia
|
J:87304
|
thymus hypoplasia
|
J:87304
|
Fgf10tm1Ska/Fgf10tm1Ska
(involves: C57BL/6 * CBA)
|
abnormal neurohypophysis development
|
J:114183
|
abnormal Rathke's pouch apoptosis
|
J:114183
|
absent adenohypophysis
|
J:114183
|
absent pituitary gland
|
J:114183
|
absent Rathke's pouch
|
J:114183
|
absent thyroid gland
|
J:114183
|
decreased pancreatic beta cell number
|
J:114183
|
small thymus
|
J:114183
|
Fgf14em1(IMPC)Ccpcz/Fgf14em1(IMPC)Ccpcz
(C57BL/6N-Fgf14em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thyroid gland morphology
|
J:211773
|
enlarged thyroid gland
|
J:211773
|
Fgf20em1(IMPC)Ccpcz/Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA)
|
thymus atrophy
|
J:88172
|
Fgfr2tm1.1Dsn/Fgfr2tm1.1Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pituitary gland development
|
J:59285
|
abnormal Rathke's pouch apoptosis
|
J:59285
|
abnormal Rathke's pouch development
|
J:59285
|
absent adenohypophysis
|
J:59285
|
absent Rathke's pouch
|
J:59285
|
Fgfr2tm1Ewj/Fgfr2+ Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal thymus morphology
|
J:101174
|
Fgfr2tm3Dsn/Fgfr2tm3Dsn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal adrenal gland development
|
J:67731
|
abnormal thymus development
|
J:67731
|
absent adenohypophysis
|
J:67731
|
absent thyroid gland
|
J:67731
|
Fhip2bem1(IMPC)Ccpcz/Fhip2bem1(IMPC)Ccpcz
(C57BL/6N-Fhip2bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fli1tm1Ber/Fli1tm1Ber
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))
|
decreased thymocyte number
|
J:33052
|
Flt3tm1Irl/Flt3tm1Irl KitW/KitW-v
(involves: 129S/SvEv * C57BL/6)
|
thymus hypoplasia
|
J:27238
|
fm/fm
(involves: CBA/H)
|
abnormal thymus morphology
|
J:275
|
Fmo3em1(IMPC)Mbp/Fmo3em1(IMPC)Mbp
(C57BL/6N-Fmo3em1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fnip1em1(IMPC)Ccpcz/Fnip1+
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Fnip1em1(IMPC)Ccpcz/Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Fostm1Wag/Fostm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus size
|
J:3493
|
decreased thymocyte number
|
J:3493
|
Foxa1tm1Khk/Foxa1+ Foxa2tm1Khk/Foxa2tm1Khk Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased pancreatic beta cell number
|
J:143476
|
pancreatic islet hypoplasia
|
J:143476
|
Foxa1tm1Khk/Foxa1tm1Khk Foxa2tm1Khk/Foxa2tm1Khk Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased pancreatic beta cell number
|
J:143476
|
pancreatic islet hypoplasia
|
J:143476
|
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:70409
|
disorganized pancreatic islets
|
J:70409
|
Foxa2tm1Khk/Foxa2tm1Khk Tg(Foxa3-cre)1Khk/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
decreased pancreatic alpha cell number
|
J:96332
|
disorganized pancreatic islets
|
J:96332
|
Foxc1ch/Foxc1ch
(involves: CBA * STOCK Tyrc f)
|
abnormal pituitary diverticulum morphology
|
J:5191
|
abnormal pituitary gland development
|
J:75733
|
Foxd1tm1Lai/Foxd1tm1Lai
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))
|
abnormal adrenal gland morphology
|
J:33767
|
small adrenal glands
|
J:33767
|
Foxe1tm1Rdl/Foxe1tm1Rdl
(B6.129-Foxe1tm1Rdl)
|
abnormal thyroid gland development
|
J:95017
|
Foxe1tm1Rdl/Foxe1tm1Rdl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thyroid gland development
|
J:48970
|
absent thyroid gland
|
J:48970
|
Foxh1b2b2662Clo/Foxh1b2b2662Clo
(C57BL/6J-Foxh1b2b2662Clo)
|
thymus hypoplasia
|
J:175213
|
Foxi3em3Akg/Foxi3tm1.2Akg
(involves: 129X1/SvJ * C57BL/6)
|
athymia
|
J:336768
|
Foxm1tm1Rhc/Foxm1tm1Rhc Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal pancreatic beta cell morphology
|
J:111026
|
abnormal pancreatic islet morphology
|
J:111026
|
decreased pancreatic beta cell mass
|
J:111026
|
decreased pancreatic beta cell number
|
J:111026
|
increased pancreatic alpha cell number
|
J:111026
|
small pancreatic islets
|
J:111026
|
Foxn1nu-2J/Foxn1nu-2J
(B6(SJL)-Foxn1nu-2J/GrsrJ)
|
athymia
|
J:192383
|
Foxn1nu-StL/Foxn1nu-StL
(involves: C57BL/6)
|
athymia
|
J:63313
|
Foxn1nu-StL/Foxn1tm1Tbo
(involves: 129S1/Sv * C57BL/6)
|
abnormal thymus development
|
J:63313
|
athymia
|
J:63313
|
Foxn1nu-str/Foxn1nu-str
(AKR/J-Foxn1nu-str/J)
|
athymia
|
J:24755
|
Foxn1nu-Y/Foxn1nu-Y
(101/HY-Foxn1nu-Y)
|
abnormal thymus development
|
J:4060
|
athymia
|
J:4060,
J:29022
|
Foxn1nu/Foxn1+
(C.Cg-Foxn1nu)
|
small thymus
|
J:7330
|
Foxn1nu/Foxn1+
(NFS.Cg-Foxn1nu)
|
abnormal thymus morphology
|
J:7330
|
small thymus
|
J:7330
|
Foxn1nu/Foxn1+
(B6N.Cg-Foxn1nu)
|
small thymus
|
J:7330
|
Foxn1nu/Foxn1+
(C3N.Cg-Foxn1nu)
|
small thymus
|
J:7330
|
Foxn1nu/Foxn1nu
(involves: NMRI)
|
abnormal thymus development
|
J:6363
|
Foxn1nu/Foxn1nu
(Not Specified)
|
abnormal thymus morphology
|
J:202297
|
athymia
|
J:202296,
J:5059
|
Foxn1nu/Foxn1nu
(involves: C57BL/10Sn * C57BR/cd)
|
abnormal thymus development
|
J:7898
|
Foxn1nu/Foxn1nu
(involves: CD-1)
|
athymia
|
J:106251
|
Foxn1nu/Foxn1nu Map3k14aly/Map3k14aly
(involves: BALB/cAJcl * C57BL/6J)
|
athymia
|
J:96579
|
Foxn1nu/Foxn1nu Tg(Foxn1)E1Hon/0
(involves: CD-1)
|
athymia
|
J:33866
|
Foxn1nu/Foxn1tm1.1Dmsu Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
abnormal thymus epithelium morphology
|
J:159773
|
decreased thymocyte number
|
J:159773
|
Foxn1sepe/Foxn1sepe
(BALB/c-Foxn1sepe)
|
athymia
|
J:227974
|
Foxn1tm1.1(KOMP)Vlcg/Foxn1tm1.1(KOMP)Vlcg
(C57BL/6N-Foxn1tm1.1(KOMP)Vlcg/Tcp)
|
abnormal thymus morphology
|
J:211773
|
athymia
|
J:211773
|
Foxn1tm1.1Cbln/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hyperplasia
|
J:177992
|
Foxn1tm1.1Cbln/Foxn1tm1.1Cbln
(involves: 129P2/OlaHsd * C57BL/6)
|
increased DN1 thymic pro-T cell number
|
J:177992
|
thymus hypoplasia
|
J:177992
|
Foxn1tm1.1Cbln/Foxn1tm1Tbo
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
small thymus
|
J:177992
|
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
abnormal thymus morphology
|
J:159773
|
decreased thymocyte number
|
J:159773
|
small thymus
|
J:159773
|
thymus atrophy
|
J:159773
|
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu Tg(KRT5-cre/ERT2)2Ipc/0
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal thymus corticomedullary boundary morphology
|
J:159773
|
abnormal thymus medulla morphology
|
J:159773
|
decreased thymocyte number
|
J:159773
|
small thymus
|
J:159773
|
thymus atrophy
|
J:159773
|
Foxn1tm1Dmsu/Foxn1tm1Dmsu
(involves: 129/Sv * C57BL/6)
|
athymia
|
J:159773
|
Foxn1tm1Nrm/Foxn1tm1Nrm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal thymus development
|
J:86255
|
abnormal thymus epithelium morphology
|
J:86255
|
absent thymus cortex
|
J:86255
|
absent thymus medulla
|
J:86255
|
decreased thymocyte number
|
J:86255
|
small thymus
|
J:86255
|
thymus cyst
|
J:86255
|
Foxn1tm1Tbo/Foxn1tm1Tbo
(involves: 129S1/Sv)
|
abnormal thymus development
|
J:33796
|
abnormal thymus epithelium morphology
|
J:177992
|
abnormal thymus morphology
|
J:33796
|
athymia
|
J:33796
|
Foxn1tm3(cre)Nrm/Foxn1+ Gt(ROSA)26Sortm1(Tbx1)Rche/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NHsd)
|
abnormal thymus development
|
J:214094
|
abnormal thymus epithelium morphology
|
J:214094
|
decreased thymocyte number
|
J:214094
|
thymus hypoplasia
|
J:214094
|
Foxn1tm3(cre)Nrm/Foxn1+ Mir205hgtm1Oers/Mir205hgtm1Oers
(B6(Cg)-Mir205hgtm1Oers Foxn1tm3(cre)Nrm)
|
decreased thymocyte number
|
J:278363
|
decreased thymus weight
|
J:278363
|
thymus hypoplasia
|
J:278363
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo3tm1Rdp/Foxo3tm1Rdp Foxo4tm1Rdp/Foxo4tm1Rdp Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell differentiation
|
J:215526
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo3tm1Rdp/Foxo3tm1Rdp Foxo4tm1Rdp/Foxo4tm1Rdp Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
|
increased T cell derived lymphoma incidence
|
J:118179
|
Foxo1tm1Whb/Foxo1+ Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
increased pancreatic beta cell number
|
J:109010
|
Foxo3tm1.1Rdp/Foxo3+ Foxo4tm1.1Rdp/Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N)
|
increased pituitary adenoma incidence
|
J:118179
|
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased prolactinoma incidence
|
J:118179
|
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp Foxo4tm1.1Rdp/Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N)
|
increased pituitary adenoma incidence
|
J:118179
|
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
|
abnormal thymus cortex morphology
|
J:11262
|
abnormal thymus morphology
|
J:11262
|
small thymus
|
J:11262
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thymus hypoplasia
|
J:125405
|
Foxp3tm1.1Mal/Foxp3tm1.1Mal Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
thymus hypoplasia
|
J:131351
|
Foxp3tm1Ayr/Foxp3tm1Ayr Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:125405
|
Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch)
|
thymus hypoplasia
|
J:120636
|
Foxp3tm3Tch/Foxp3+
(C.129X1-Foxp3tm3Tch)
|
decreased thymocyte number
|
J:120636
|
Fshrtm1Saco/Fshrtm1Saco
(involves: C57BL/6)
|
adenohypophysis hyperplasia
|
J:50933
|
increased gonadotroph cell number
|
J:50933
|
increased thyrotroph cell number
|
J:50933
|
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:119526
|
abnormal pancreatic islet morphology
|
J:119526
|
enlarged pancreatic islets
|
J:119526
|
increased pancreatic beta cell number
|
J:119526
|
Ftotm1Urt/Ftotm1Urt Lepob/Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enlarged pancreatic islets
|
J:219118
|
Fts/Fts+
(involves: C57BL/6 * SJL)
|
thymus hyperplasia
|
J:20159
|
Fts/Fts+
(B6.Cg-Fts)
|
increased thymocyte number
|
J:108193
|
thymus hyperplasia
|
J:108193
|
Fubp1tm1.1Dlev/Fubp1tm1.1Dlev
(involves: 129 * C57BL/6)
|
thymus hypoplasia
|
J:229985
|
FusGt(U3NeoSV1)HO14Ggh/FusGt(U3NeoSV1)HO14Ggh
(B6.129S2-FusGt(U3NeoSV1)HO14Ggh)
|
small thymus
|
J:60213
|
FuzGt(OSTGST001398)Lex/FuzGt(OSTGST001398)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal pituitary diverticulum morphology
|
J:177881
|
Fyb1tm1Gak/Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte number
|
J:111368
|
Fyntm1Rmp/Fyntm1Rmp Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
thymus hypoplasia
|
J:37062,
J:37940
|
Fyntm1Yik/Fyntm1Yik Ptk2tm1Lfr/Ptk2+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:110771
|
thymus cortex atrophy
|
J:110771
|
Fzd9tm1Uta/Fzd9tm1Uta
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
thymus atrophy
|
J:98133
|
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased pancreatic alpha cell number
|
J:117664
|
GabpaGt(XH074)Byg/GabpaGt(XH074)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:92671
|
small thymus
|
J:92671
|
Gabra5em1(IMPC)Ccpcz/Gabra5em1(IMPC)Ccpcz
(C57BL/6N-Gabra5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
increased thymocyte number
|
J:57882
|
increased thymus weight
|
J:57882
|
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:220742
|
abnormal pancreatic islet morphology
|
J:220742
|
decreased pancreatic beta cell mass
|
J:220742
|
decreased pancreatic beta cell number
|
J:220742
|
Gakem1(IMPC)Ccpcz/Gak+
(C57BL/6NCrl-Gakem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn)
|
decreased lactotroph cell number
|
J:78046
|
Garin1aem1(IMPC)Ccpcz/Garin1aem1(IMPC)Ccpcz
(C57BL/6N-Garin1aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Garin1bem1(IMPC)Ccpcz/Garin1bem1(IMPC)Ccpcz
(C57BL/6N-Garin1bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Garin2em1(IMPC)Ccpcz/Garin2em1(IMPC)Ccpcz
(C57BL/6N-Garin2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Gas2l2tm1a(KOMP)Wtsi/Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi)
|
abnormal thymus topology
|
J:239583
|
Gata2tm1Sac/Gata2tm1Sac Tg(Cga-cre)3Sac/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
abnormal pituitary gland development
|
J:108963
|
Gata3tm1Iho/Gata3tm1Iho Tg(DO11.10)10Dlo/0 Tg(Lck-cre)1Cwi/0
(involves: BALB/c * C3H * C57BL/6)
|
small thymus
|
J:86996
|
Gata3tm1Iho/Gata3tm1Iho Tg(Lck-cre)1Cwi/0
(involves: BALB/c)
|
decreased thymocyte number
|
J:86996
|
small thymus
|
J:86996
|
Gata3tm2Jeng/Gata3tm2Jeng
(Not Specified)
|
decreased thymocyte number
|
J:155686
|
Gba1tm1.1Pmis/Gba1tm1.1Pmis Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal thymus morphology
|
J:167081
|
Gba1tm1.1Pmis/Gba1tm1.2Pmis Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal thymus morphology
|
J:167081
|
Gbx2tm1.1Mrt/Gbx2tm1.1Mrt Fgf8tm1.4Mrt/Fgf8+
(B6.129-Gbx2tm1.1Mrt Fgf8tm1.4Mrt)
|
abnormal thymus development
|
J:100584
|
Gcgtm1Yhys/Gcgtm1Yhys
(B6.129S6-Gcgtm1Yhys)
|
abnormal pancreatic alpha cell morphology
|
J:154694
|
increased pancreatic islet number
|
J:154694
|
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc)
|
abnormal pancreatic alpha cell morphology
|
J:300368
|
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
|
abnormal pancreatic alpha cell differentiation
|
J:176507
|
abnormal pancreatic alpha cell morphology
|
J:176507
|
abnormal pancreatic islet morphology
|
J:176507
|
enlarged pancreatic islets
|
J:176507
|
pancreatic islet hyperplasia
|
J:176507
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal pancreatic alpha cell morphology
|
J:251829
|
increased pancreatic alpha cell number
|
J:251829
|
pancreatic islet hyperplasia
|
J:251829,
J:81772
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL)
|
increased pancreatic alpha cell mass
|
J:208604
|
increased pancreatic alpha cell number
|
J:208604
|
increased pancreatic beta cell mass
|
J:208604
|
Gcgrtm1Mjch/Gcgrtm1Mjch Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
|
abnormal pancreatic alpha cell morphology
|
J:251829
|
pancreatic islet hyperplasia
|
J:251829
|
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
increased pancreatic alpha cell number
|
J:208604
|
increased pancreatic beta cell mass
|
J:208604
|
GckGls006/Gck+
(C3HeB/FeJ-GckGls006)
|
decreased pancreatic beta cell mass
|
J:189544
|
small pancreatic islets
|
J:189544
|
GckGls006/GckGls006
(C3HeB/FeJ-GckGls006)
|
abnormal pancreatic beta cell morphology
|
J:189544
|
abnormal pancreatic islet morphology
|
J:189544
|
decreased pancreatic beta cell mass
|
J:189544
|
small pancreatic islets
|
J:189544
|
Gckm1Rge/Gck+
(involves: C3HeB/FeJ)
|
decreased pancreatic beta cell mass
|
J:162903
|
small pancreatic islets
|
J:162903
|
Gcktm1Tka/Gck+ Irs1tm1Tka/Irs1tm1Tka
(involves: 129X1/SvJ * C57BL/6 * CBA * ICR)
|
increased pancreatic beta cell mass
|
J:38899
|
pancreatic islet hyperplasia
|
J:38899
|
Gcktm1Ydor/Gck+ Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6 * C57BL/6J * CD-1)
|
increased pancreatic beta cell mass
|
J:302600
|
Gcktm1Ydor/Gck+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
decreased pancreatic beta cell mass
|
J:302600
|
increased pancreatic beta cell mass
|
J:302600
|
Gcm2tm1.2Malx/Gcm2tm1.2Malx
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6N)
|
parathyroid hypoplasia
|
J:213334
|
Gcm2tm1Kry/Gcm2tm1Kry
(involves: 129S7/SvEvBrd)
|
absent parathyroid glands
|
J:63291
|
Gcm2tm1Kry/Gcm2tm1Kry
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal parathyroid gland development
|
J:121311
|
absent parathyroid glands
|
J:121311
|
Gdap1tm2b(KOMP)Wtsi/Gdap1tm2b(KOMP)Wtsi
(C57BL/6N-Gdap1tm2b(KOMP)Wtsi/Ucd)
|
abnormal adrenal gland morphology
|
J:211773
|
abnormal thymus morphology
|
J:211773
|
small adrenal glands
|
J:211773
|
small thymus
|
J:211773
|
Gdf6em1(IMPC)Ccpcz/Gdf6+
(C57BL/6NCrl-Gdf6em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Gdf11tm1Sjl/Gdf11+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased pancreatic alpha cell mass
|
J:94455
|
increased pancreatic islet number
|
J:94455
|
small pancreatic islets
|
J:94455
|
Gdf11tm1Sjl/Gdf11tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pancreatic beta cell differentiation
|
J:94455
|
decreased pancreatic beta cell mass
|
J:94455
|
increased pancreatic alpha cell mass
|
J:94455
|
pancreatic islet hyperplasia
|
J:94455
|
small pancreatic islets
|
J:94455
|
Gfi1tm1.1Wep/Gfi1tm1.1Wep
(B6.129-Gfi1tm1.1Wep)
|
small thymus
|
J:117105
|
thymus hypoplasia
|
J:117105
|
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased thymocyte number
|
J:75143
|
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte number
|
J:192927
|
Gfi1tm2Tmo/Gfi1tm2Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased thymocyte number
|
J:93337
|
Gfi1tm4Tmo/Gfi1tm4Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte number
|
J:116870
|
Gfm2em1(IMPC)Mbp/Gfm2+
(C57BL/6N-Gfm2em1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
GhSma1/Gh+
(C3HeB/FeJ-GhSma1)
|
abnormal adenohypophysis morphology
|
J:89518
|
absent lactotrophs
|
J:89518
|
absent somatotrophs
|
J:89518
|
decreased pituitary gland weight
|
J:89518
|
small adenohypophysis
|
J:89518
|
small pituitary gland
|
J:89518
|
GhSma1/GhSma1
(C3HeB/FeJ-GhSma1)
|
abnormal adenohypophysis morphology
|
J:89518
|
absent lactotrophs
|
J:89518
|
absent somatotrophs
|
J:89518
|
decreased pituitary gland weight
|
J:89518
|
small adenohypophysis
|
J:89518
|
small pituitary gland
|
J:89518
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:173909
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c)
|
decreased pituitary gland weight
|
J:53777
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:107763
|
small pancreatic islets
|
J:107763
|
Ghrhtm1Salv/Ghrhtm1Salv
(involves: 129 * C57BL/6)
|
pituitary gland hypoplasia
|
J:91828
|
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit)
|
abnormal somatotroph morphology
|
J:7211
|
absent somatotroph secretory granules
|
J:7211
|
decreased somatotroph cell number
|
J:7211
|
decreased somatotroph cell size
|
J:7211
|
decreased somatotroph secretory granule number
|
J:7211
|
small pituitary gland
|
J:5647
|
Gimap1tm1.1Gwb/Gimap1tm1.1Gwb Tg(CD2-icre)4Kio/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased thymocyte number
|
J:160782
|
Gimap3tm1.1Yout/Gimap3tm1.1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased thymocyte number
|
J:209926
|
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
|
thymus atrophy
|
J:160090
|
Gimap5m1Btlr/Gimap5m1Btlr Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:160090
|
Gin1em1(IMPC)Mbp/Gin1em1(IMPC)Mbp
(C57BL/6N-Gin1em1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Gli1tm1Alj/Gli1tm1Alj Gli2tm1Alj/Gli2tm1Alj
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent pituitary gland
|
J:60986
|
Gli3Pdn/Gli3Pdn
(involves: Jcl:ICR)
|
absent pineal gland
|
J:17581
|
Gli3tm1Urt/Gli3tm1Urt
(involves: 129P2/OlaHsd * C57BL/6)
|
absent adrenal gland
|
J:76496
|
Gli3Xt/Gli3Xt
(involves: 101/H * C3H/HeH * CBA/H)
|
absent pineal gland
|
J:5049
|
ectopic adrenal gland
|
J:5049
|
Glis3tm1.2Chan/Glis3tm1.2Chan
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
absent pancreatic alpha cells
|
J:177082
|
absent pancreatic beta cells
|
J:177082
|
decreased pancreatic alpha cell number
|
J:177082
|
decreased pancreatic beta cell number
|
J:177082
|
decreased pancreatic delta cell number
|
J:177082
|
decreased pancreatic epsilon cell number
|
J:177082
|
disorganized pancreatic islets
|
J:177082
|
small pancreatic islets
|
J:177082
|
Glis3tm1Hiha/Glis3tm1Hiha
(involves: C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:150077
|
decreased pancreatic alpha cell number
|
J:150077
|
decreased pancreatic beta cell number
|
J:150077
|
decreased pancreatic delta cell number
|
J:150077
|
small pancreatic islets
|
J:150077
|
Glra1nmf11/Glra1nmf11
(C57BL/6J-Glra1nmf11/J)
|
thymus atrophy
|
J:78134
|
Glrbspa/Glrbspa
(Not Specified)
|
abnormal adrenal cortex morphology
|
J:5196
|
enlarged adrenal glands
|
J:5196
|
Gls2em1Xen/Gls2em1Xen
(involves: C57BL/6NTac)
|
increased pancreatic alpha cell number
|
J:271619
|
Glud1tm1.1Pma/Glud1tm1.1Pma Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/J * SJL)
|
disorganized pancreatic islets
|
J:145558
|
Gm5148em1(IMPC)Ccpcz/Gm5148+
(C57BL/6NCrl-Gm5148em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Gm26330em1Liuq/Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq)
|
enlarged pancreatic islets
|
J:341056
|
Gmnntm1.1Kio/Gmnntm1.2Kio Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
decreased DN1 thymic pro-T cell number
|
J:159657
|
decreased DN4 thymocyte number
|
J:159657
|
decreased thymocyte number
|
J:159657
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(PTH-cre)4167Slib/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal parathyroid gland morphology
|
J:116986
|
small thyroid gland
|
J:116986
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(Tg-cre)1Soff/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal thyroid follicular cell morphology
|
J:127484
|
abnormal thyroid gland morphology
|
J:127484
|
Gna12tm1Citb/Gna12tm1Citb Gna13tm2.1Soff/Gna13tm2.1Soff Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
thymus hyperplasia
|
J:149560
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased thymocyte number
|
J:24434
|
Gnao1tm4Lbi/Gnao1tm4Lbi Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell mass
|
J:169627
|
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1)
|
thymus cortex atrophy
|
J:49340
|
Gnastm5.1Lsw/Gnastm5.1Lsw Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
|
pancreatic islet hyperplasia
|
J:102504
|
Golph3em1(IMPC)Tcp/Golph3em1(IMPC)Tcp
(C57BL/6NCrl-Golph3em1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
Golt1btm1b(EUCOMM)Wtsi/Golt1btm1b(EUCOMM)Wtsi
(C57BL/6N-Golt1btm1b(EUCOMM)Wtsi/Ieg)
|
enlarged thymus
|
J:211773
|
Gp2em1(IMPC)Mbp/Gp2em1(IMPC)Mbp
(C57BL/6N-Gp2em1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Gpc2tm1.1(KOMP)Vlcg/Gpc2tm1.1(KOMP)Vlcg
(C57BL/6N-Gpc2tm1.1(KOMP)Vlcg/Ucd)
|
small adrenal glands
|
J:211773
|
Gpr39tm1Dgen/Gpr39tm1Dgen
(B6.129P2-Gpr39tm1Dgen)
|
abnormal pancreatic islet morphology
|
J:151806
|
Gpr83em1(IMPC)Ccpcz/Gpr83em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpr83em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Gprc6atm1.1(KOMP)Vlcg/Gprc6atm1.1(KOMP)Vlcg
(C57BL/6N-Gprc6atm1.1(KOMP)Vlcg/Ucd)
|
increased thymus weight
|
J:211773
|
Gramd1bem1Pton/Gramd1bem1Pton
(involves: C57BL/6N)
|
abnormal adrenal cortex morphology
|
J:266462
|
abnormal adrenal gland morphology
|
J:266462
|
abnormal adrenal gland zona fasciculata morphology
|
J:266462
|
Grap2tm1Amch/Grap2tm1Amch
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte number
|
J:76696
|
Grap2tm1Eac/Grap2tm1Eac
(involves: C57BL/6)
|
decreased thymocyte number
|
J:92023
|
Grb2tm1.1Hua/Grb2tm1.1Hua Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:161294
|
Grb2tm1Paw/Grb2+ Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased adrenal gland tumor incidence
|
J:93530
|
Grb2tm1Paw/Grb2+ Ptentm2Mak/Ptentm2Mak Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:93530
|
Grb10tm1.1Fliu/Grb10tm1.1Fliu Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:208498
|
increased pancreatic beta cell mass
|
J:208498
|
Gsdma3Ae/Gsdma3+
(involves: C57BL/6J * CAST/Ei)
|
enlarged thymus
|
J:180149
|
Gsk3btm1Jrw/Gsk3b+ Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J)
|
decreased pancreatic beta cell mass
|
J:135659
|
Gsx1tm1Ssp/Gsx1tm1Ssp
(involves: 129P2/OlaHsd)
|
decreased lactotroph cell number
|
J:31764
|
decreased somatotroph cell number
|
J:31764
|
small adenohypophysis
|
J:31764
|
small pituitary gland
|
J:31764
|
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+ Rb1tm2Brn/Rb1tm2Brn Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N))
|
increased pituitary gland tumor incidence
|
J:187257
|
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+ Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N))
|
increased pituitary gland tumor incidence
|
J:187257
|
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+ Tg(Gfap-cre)2Brn/0
(either: (involves: 129P2/OlaHsd * FVB/N) or (involves: 129P2/OlaHsd * C57BL/6 * FVB/N))
|
increased pituitary gland tumor incidence
|
J:187257
|
Gt(ROSA)26Sortm1(CAG-Foxo1*)Jcbr/Gt(ROSA)26Sor+ Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N)
|
decreased corticotroph cell number
|
J:134336
|
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6 * CBA/J)
|
abnormal pancreatic alpha cell morphology
|
J:146650
|
abnormal pancreatic islet morphology
|
J:146650
|
decreased pancreatic alpha cell number
|
J:146650
|
decreased pancreatic beta cell number
|
J:146650
|
decreased pancreatic islet number
|
J:146650
|
small pancreatic islets
|
J:146650
|
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+ Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
adrenal medulla hyperplasia
|
J:222527
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+ Tacc3tm1.1Tno/Tacc3+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:179414
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+ Tacc3tm1.1Tno/Tacc3tm1.2Tno Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:179414
|
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+ Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129S4/SvJae * BALB/c * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:130367
|
Gt(ROSA)26Sortm1(CTNNB1)Nerl/Gt(ROSA)26Sortm1(CTNNB1)Nerl Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:112660
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+ Tg(LHX3-cre)#Sjr/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
abnormal adenohypophysis morphology
|
J:211401
|
decreased gonadotroph cell number
|
J:211401
|
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N)
|
decreased pancreatic beta cell mass
|
J:201507
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Hprt1tm1(Ins2-HBEGF)Herr/Y Tg(Gcg-rtTA)#Herr/0 Tg(tetO-cre)1Jaw/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal pancreatic alpha cell differentiation
|
J:159291
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Hprt1tm1(Ins2-HBEGF)Herr/Y Tg(Ins2-cre/ERT)1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:159291
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:210493
|
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/Gt(ROSA)26Sor+ Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * C57BL/6NTac)
|
increased thyroid adenoma incidence
|
J:170965
|
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+ Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N)
|
decreased somatotroph cell number
|
J:169459
|
small adenohypophysis
|
J:169459
|
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+ Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:160931
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal pancreatic alpha cell morphology
|
J:144715
|
abnormal pancreatic beta cell morphology
|
J:144715
|
abnormal pancreatic islet morphology
|
J:144715
|
decreased pancreatic beta cell number
|
J:144715
|
increased pancreatic alpha cell number
|
J:144715
|
Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe/? Krt19tm1(cre/ERT)Ggu/?
(B6.Cg-Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe Krt19tm1(cre/ERT)Ggu)
|
increased pancreatic beta cell number
|
J:215154
|
Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe/? Tg(Pdx1-cre)6Tuv/?
(B6.Cg-Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe Tg(Pdx1-cre)6Tuv)
|
increased pancreatic beta cell number
|
J:215154
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Neurod1-cre)1Able/0
(involves: 129S4/SvJaeSor * C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:190530
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Neurog3-cre)C1Able/0
(involves: 129S4/SvJaeSor)
|
absent pancreatic islets
|
J:190530
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Neurog3-cre/Esr1*)1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
absent pancreatic alpha cells
|
J:86975
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
abnormal endocrine pancreas morphology
|
J:86975
|
decreased pancreatic alpha cell number
|
J:86975
|
decreased pancreatic beta cell number
|
J:86975
|
Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu/Gt(ROSA)26Sor+ Tg(Lck-cre)548Jxm/0
(B6.Cg-Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu Tg(Lck-cre)548Jxm)
|
increased T cell derived lymphoma incidence
|
J:185287
|
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ Tg(MMTV-cre)#Tfln/0 Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased T cell derived lymphoma incidence
|
J:170898
|
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+ Trp53tm1Brn/Trp53tm1Brn Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased T cell derived lymphoma incidence
|
J:170898
|
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sortm1(rtTA)Awu Xisttm1Awu/Y
(involves: 129S4/SvJae)
|
abnormal thymus morphology
|
J:112954
|
decreased thymocyte number
|
J:112954
|
small thymus
|
J:112954
|
thymus hypoplasia
|
J:112954
|
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sortm1(rtTA)Awu Xisttm1Awu/Xisttm1Awu
(involves: 129S4/SvJae)
|
small thymus
|
J:112954
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+ Tg(CAG-cre)1Nagy/0 Tg(tetO-Vegfa)90Ala/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)
|
thymus atrophy
|
J:99607
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:102234
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:102234
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6113Njen/0
(involves: C3H * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:102234
|
pituitary gland hyperplasia
|
J:102234
|
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J)
|
increased pheochromocytoma incidence
|
J:153656
|
increased T cell derived lymphoma incidence
|
J:153656
|
Gt(ROSA)26Sortm1(Tbx1/GFP)Bem/Gt(ROSA)26Sor+ Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
athymia
|
J:204435
|
Gt(ROSA)26Sortm1(tTA,tetO-Mir21)Fjsl/Gt(ROSA)26Sor+ Tg(Nes-cre)1Wmz/0
(involves: C57BL/6 * C57BL/6J * SJL/J)
|
abnormal thymus corticomedullary boundary morphology
|
J:163919
|
abnormal thymus morphology
|
J:163919
|
enlarged thymus
|
J:163919
|
Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/Gt(ROSA)26Sor+ Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J)
|
thymus hyperplasia
|
J:185598
|
Gt(ROSA)26Sortm1.1(Maml1/EGFP)Hri/? Foxa2tm3.1(icre)Heli/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:184814
|
Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/?
(involves: 129 * C57BL/6)
|
increased pancreatic islet number
|
J:201964
|
Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:286108
|
small pancreatic islets
|
J:286108
|
Gt(ROSA)26Sortm1Fia/Gt(ROSA)26Sor+ Hprt1tm1(CMV-cre)Brd/Hprt1+ Nf1tm1Fcr/Nf1tm1Fcr
(involves: 129S/SvEv * 129S/SvEvBrd)
|
adrenal medulla hyperplasia
|
J:114455
|
Gt(ROSA)26Sortm1Fia/Gt(ROSA)26Sor+ Nf1tm1Par/Nf1tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
small adenohypophysis
|
J:138868
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
enlarged thymus
|
J:202090
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
enlarged thymus
|
J:202090
|
Gt(ROSA)26Sortm2(myc*T58A)Rcse/Gt(ROSA)26Sortm2(myc*T58A)Rcse Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL)
|
increased pituitary gland tumor incidence
|
J:169403
|
Gt(ROSA)26Sortm2.1(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:153656
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/? Tnfaip3tm1Homy/Tnfaip3tm1Homy
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
thymus atrophy
|
J:212681
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ Ripk3tm1Arte/Ripk3tm1Arte
(involves: C57BL/6NTac)
|
thymus atrophy
|
J:209137
|
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sor+ Tg(Tek-cre)1Ywa/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)
|
increased T cell derived lymphoma incidence
|
J:263520
|
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sortm18(Zeb2)Jhai Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * CD-1 * SJL)
|
increased thymus tumor incidence
|
J:263520
|
Gt(ROSA)26Sortm18(Zeb2)Jhai/Gt(ROSA)26Sortm18(Zeb2)Jhai Tg(Tek-cre)1Ywa/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)
|
increased T cell derived lymphoma incidence
|
J:263520
|
Gulosfx/Gulosfx
(BALB/cBy-Gulosfx/J)
|
small thymus
|
J:66648
|
H1f0tm1Ais/H1f0tm1Ais H1f2tm2Ais/H1f2tm2Ais H1f4tm2Ais/H1f4tm2Ais
(involves: 129/Sv * C57BL/6 * SJL)
|
small thymus
|
J:83954
|
H1f2tm2Ais/H1f2tm2Ais H1f3tm2Ais/H1f3+ H1f4tm2Ais/H1f4tm2Ais
(involves: 129/Sv * C57BL/6 * SJL)
|
small thymus
|
J:83954
|
H2-Aab-tm1Blt/H2-Aab-tm1Blt
(C57BL/6-H2-Aab-tm1Blt)
|
enlarged thymus
|
J:16372
|
thymus hyperplasia
|
J:16372
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell)
|
enlarged thyroid gland
|
J:113509
|
H2b/H2b Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:131357
|
H2b/H2b Ptcratm1Vbo/Ptcratm1Vbo Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:131357
|
H2b/H2b Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:131357
|
H2b/H2d Tg(TcraTcrb)1100Mjb/?
(involves: BALB/c * C57BL/6)
|
small thymus
|
J:133645
|
H2b/H2k Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
|
small thymus
|
J:133645
|
H2b/H2s Tg(TcraTcrb)1100Mjb/?
(involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss)
|
small thymus
|
J:133645
|
H2d/H2d Tcra/Tcrdtm1.1(Tcra)Rsky/Tcra/Tcrdtm1.1(Tcra)Rsky Tg(Tcrb)93Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:131357
|
H2u/H2u Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J)
|
abnormal thymus cell ratio
|
J:92992
|
decreased thymocyte number
|
J:92992
|
increased T cell derived lymphoma incidence
|
J:92992
|
H2u/H2u Tg(TCRA)B1Jg/0 Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg)
|
abnormal thymus cell ratio
|
J:92992
|
increased T cell derived lymphoma incidence
|
J:92992
|
H2axtm1Fwa/H2ax+ Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:84879
|
H2axtm1Fwa/H2axtm1Fwa
(involves: 129S6/SvEvTac)
|
increased T cell derived lymphoma incidence
|
J:84879
|
H2axtm1Fwa/H2axtm1Fwa Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:84879
|
H4c16em1(IMPC)Mbp/H4c16em1(IMPC)Mbp
(C57BL/6N-H4c16em1(IMPC)Mbp/MbpMmucd)
|
enlarged thymus
|
J:211773
|
H6pdtm1Pmst/H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6)
|
enlarged adrenal glands
|
J:189132,
J:108281
|
H6pdtm1Pmst/H6pdtm1Pmst Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
enlarged adrenal glands
|
J:189132
|
H13tm1b(KOMP)Wtsi/H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi)
|
abnormal thymus topology
|
J:239583
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
small thyroid gland
|
J:239583
|
Hace1tm1Pngr/Hace1tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:125183
|
Hadhtm1Csta/Hadhtm1Csta
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)
|
abnormal pancreatic alpha cell morphology
|
J:166803
|
Hand2tm1Cse/Hand2+ H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J)
|
abnormal thymus development
|
J:155265
|
Hax1tm1.1Gach/Hax1tm1.1Gach
(involves: BALB/c)
|
decreased thymocyte number
|
J:174159
|
thymus hypoplasia
|
J:174159
|
Hcktm1Hev/Hcktm1Hev Srctm1Sor/Srctm1Sor
(involves: 129S7/SvEvBrd * C57BL/6J)
|
thymus hypoplasia
|
J:31647
|
Hcls1em1(IMPC)Ccpcz/Hcls1em1(IMPC)Ccpcz
(C57BL/6NCrl-Hcls1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc Hdac2tm1.1Shmc/Hdac2+ Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
enlarged thymus
|
J:194769
|
thymus hypoplasia
|
J:194769
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc Hdac2tm1.1Shmc/Hdac2tm1.1Shmc Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
abnormal thymus corticomedullary boundary morphology
|
J:194769
|
decreased thymocyte number
|
J:194769
|
enlarged thymus
|
J:194769
|
increased T cell derived lymphoma incidence
|
J:194769
|
increased thymocyte number
|
J:194769
|
Hectd3tm1(NCOM)Cmhd/Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju)
|
small thymus
|
J:211773
|
Hellstm1Kmu/Hellstm1Kmu
(involves: 129S1/Sv)
|
small thymus
|
J:61948
|
Hellstm1Rarc/Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J)
|
small thymus
|
J:107145
|
thymus hypoplasia
|
J:107145
|
HelqGt(RRF112)Byg/Helq+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:206104
|
HelqGt(RRF112)Byg/HelqGt(RRF112)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:206104
|
Hephl1cw/Hephl1cw
(CWD/LeJ)
|
enlarged thymus
|
J:24875
|
Hes1tm1.1Frad/Hes1tm1.1Frad Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased DN1 thymic pro-T cell number
|
J:167000
|
decreased DN2 thymocyte number
|
J:167000
|
decreased DN3 thymocyte number
|
J:167000
|
decreased DN4 thymocyte number
|
J:167000
|
increased DN1 thymic pro-T cell number
|
J:167000
|
thymus hypoplasia
|
J:167000
|
Hes1tm1Fgu/Hes1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased solitary pulmonary neuroendocrine cell number
|
J:64088
|
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased solitary pulmonary neuroendocrine cell number
|
J:64088
|
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pituitary gland development
|
J:121843
|
pituitary gland hypoplasia
|
J:121843
|
Hes1tm1Kag/Hes1tm1Kag Foxa2tm3.1(icre)Heli/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic beta cell differentiation
|
J:184814
|
Hesx1tm1Icar/Hesx1tm1Icar
(involves: 129P2/OlaHsd * C57BL/6)
|
absent pituitary infundibular stalk
|
J:47920
|
absent Rathke's pouch
|
J:47920
|
bifurcated Rathke's pouch
|
J:47920
|
small adenohypophysis
|
J:47920
|
Hesx1tm2Jpmb/Hesx1tm2Jpmb
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
abnormal adenohypophysis morphology
|
J:142649
|
ectopic pituitary gland
|
J:142649
|
Hesx1tm3Jpmb/Hesx1tm3Jpmb
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
abnormal adenohypophysis morphology
|
J:142649
|
abnormal pituitary gland morphology
|
J:142649
|
abnormal Rathke's pouch development
|
J:142649
|
ectopic adenohypophysis
|
J:142649
|
ectopic pituitary gland
|
J:142649
|
Hhatem1(IMPC)Ccpcz/Hhat+
(C57BL/6NCrl-Hhatem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Hhextm1Cwb/Hhextm1Cwb
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal thyroid gland development
|
J:93580
|
Hhextm1Rbe/Hhextm1Rbe
(B6.129P2-Hhextm1Rbe)
|
abnormal thyroid gland development
|
J:95017
|
Hhextm1Rbe/Hhextm1Rbe
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thyroid gland development
|
J:62027
|
abnormal thyroid gland morphology
|
J:62027
|
absent Rathke's pouch
|
J:62027
|
Hhiptm1Amc/Hhiptm1Amc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreatic islet morphology
|
J:85472
|
disorganized pancreatic islets
|
J:85472
|
small pancreatic islets
|
J:85472
|
Hip1tm4Tsr/Hip1+ Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:151974
|
Hipk3Gt(OST51087)Lex/Hipk3Gt(OST51087)Lex
(involves: 129S5/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:194563
|
small pancreatic islets
|
J:194563
|
Hivep2tm1Sis/Hivep2tm1Sis
(involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal thymus cortex morphology
|
J:72249
|
abnormal thymus lobule morphology
|
J:72249
|
abnormal thymus medulla morphology
|
J:72249
|
enlarged thymus cortex
|
J:72249
|
Hk3em1(IMPC)Tcp/Hk3em1(IMPC)Tcp
(C57BL/6N-Hk3em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Hmga1tm1Brun/Hmga1tm1Brun
(Not Specified)
|
abnormal pancreatic islet morphology
|
J:99652
|
small pancreatic islets
|
J:99652
|
Hmga2pg-Tg40ACha/Hmga2+
(involves: C57BL/6J * CBA/J)
|
small adrenal glands
|
J:21153
|
Hmga2pg-Tg40ACha/Hmga2pg-Tg40ACha
(involves: C57BL/6J * CBA/J)
|
small adrenal glands
|
J:21153
|
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ)
|
increased pheochromocytoma incidence
|
J:100773
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
small adenohypophysis
|
J:92940
|
small pituitary gland
|
J:92940
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
small adenohypophysis
|
J:92940
|
small pituitary gland
|
J:92940
|
Hnf1atm1.1Ylee/Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:47008
|
decreased pancreatic beta cell number
|
J:47008
|
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
|
decreased pancreatic beta cell mass
|
J:48230
|
small pancreatic islets
|
J:48230
|
Hnf1btm2Ics/Hnf1b+
(involves: 129 * C57BL/6N)
|
decreased pancreatic islet number
|
J:306082
|
small pancreatic islets
|
J:306082
|
Hnf4atm1b(EUCOMM)Hmgu/Hnf4a+
(C57BL/6N-Hnf4atm1b(EUCOMM)Hmgu/Ieg)
|
enlarged thyroid gland
|
J:211773
|
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm)
|
thymus hypoplasia
|
J:188749
|
Hormad2em1(IMPC)Ccpcz/Hormad2em1(IMPC)Ccpcz
(C57BL/6NCrl-Hormad2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Hoxa1tm3.1Mrc/Hoxa1tm3.1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
absent parathyroid glands
|
J:178887
|
parathyroid hypoplasia
|
J:178887
|
thymus hypoplasia
|
J:178887
|
Hoxa1tm3.1Mrc/Hoxa1tm3.1Mrc Hoxb1tm3Mrc/Hoxb1+
(involves: 129S1/Sv * 129X1/SvJ)
|
absent parathyroid glands
|
J:41540
|
small thymus
|
J:41540
|
Hoxa1tm3.1Mrc/Hoxa1tm3.1Mrc Hoxb1tm3Mrc/Hoxb1tm3Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
absent parathyroid glands
|
J:41540
|
athymia
|
J:41540
|
Hoxa3tm1Kth/Hoxa3tm1Kth
(involves: 129S1/Sv * 129X1/SvJ)
|
athymia
|
J:60296
|
Hoxa3tm1Kth/Hoxa3tm1Kth Hoxd3tm3(Hoxa3)Mrc/Hoxd3+
(involves: 129S1/Sv * 129X1/SvJ)
|
athymia
|
J:60296
|
Hoxa3tm1Mrc/Hoxa3+ Hoxb3tm1Mrc/Hoxb3tm1Mrc
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
ectopic parathyroid gland
|
J:46523
|
ectopic thymus
|
J:46523
|
Hoxa3tm1Mrc/Hoxa3+ Hoxd3tm1Mrc/Hoxd3tm1Mrc
(involves: 129S7/SvEvBrd * C57BL/6J)
|
ectopic parathyroid gland
|
J:46523
|
ectopic thymus
|
J:46523
|
Hoxa3tm1Mrc/Hoxa3tm1Mrc
(involves: 129S7/SvEvBrd)
|
abnormal thyroid gland isthmus morphology
|
J:161296
|
abnormal thyroid gland morphology
|
J:161296
|
abnormal ultimobranchial body morphology
|
J:161296
|
absent parathyroid glands
|
J:17753,
J:161296
|
absent thyroid gland isthmus
|
J:161296
|
athymia
|
J:17753,
J:161296
|
small thyroid gland
|
J:17753
|
Hoxa3tm1Mrc/Hoxa3tm1Mrc Hoxb3tm1Mrc/Hoxb3tm1Mrc
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
abnormal thyroid gland isthmus morphology
|
J:46523
|
abnormal ultimobranchial body morphology
|
J:46523
|
absent thyroid gland isthmus
|
J:46523
|
absent ultimobranchial body
|
J:46523
|
persistent ultimobranchial bodies
|
J:46523
|
Hoxa3tm1Mrc/Hoxa3tm1Mrc Hoxd3tm1Mrc/Hoxd3tm1Mrc
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal thyroid gland morphology
|
J:46523
|
athymia
|
J:19447
|
persistent ultimobranchial bodies
|
J:46523
|
Hoxa3tm1Mrc/Hoxa3tm2Nrm
(involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd)
|
absent parathyroid glands
|
J:161296
|
athymia
|
J:161296
|
Hoxa3tm1Mrc/Hoxa3tm3.1Nrm H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)
|
ectopic parathyroid gland
|
J:161296
|
ectopic thymus
|
J:161296
|
Hoxa3tm1Nrm/Hoxa3tm1Mrc
(involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd)
|
absent parathyroid glands
|
J:161296
|
athymia
|
J:161296
|
Hoxa3tm1Nrm/Hoxa3tm1Nrm
(involves: C3H * C57BL/6 * C57BL/6NHsd)
|
absent parathyroid glands
|
J:161296
|
athymia
|
J:161296
|
Hoxa3tm2Nrm/Hoxa3tm2Nrm
(involves: C3H * C57BL/6 * C57BL/6NHsd)
|
absent parathyroid glands
|
J:161296
|
athymia
|
J:161296
|
Hoxa3tm2Nrm/Hoxa3tm3.1Nrm H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C3H * C57BL/6 * CBA/J)
|
ectopic parathyroid gland
|
J:161296
|
ectopic thymus
|
J:161296
|
Hoxa5tm1Rob/Hoxa5tm1Rob
(129S(Cg)-Hoxa5tm1Rob)
|
abnormal thyroid gland development
|
J:84449
|
Hoxa7tm1Mrc/Hoxa7tm1Mrc Hoxb7tm1Mrc/Hoxb7tm1Mrc
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
small thymus
|
J:50942
|
Hoxb3tm1Mrc/Hoxb3tm1Mrc Hoxd3tm1Mrc/Hoxd3tm1Mrc
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
abnormal ultimobranchial body morphology
|
J:46523
|
Hoxb9tm1Mrc/Hoxb9tm1Mrc
(involves: 129S7/SvEvBrd)
|
small thymus
|
J:37847
|
Hprt1tm1(Ins2-HBEGF)Herr/Y
(involves: 129 * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:159291
|
decreased pancreatic beta cell mass
|
J:159291
|
decreased pancreatic beta cell number
|
J:159291
|
increased pancreatic beta cell mass
|
J:159291
|
Hps6em1(IMPC)Tcp/Hps6em1(IMPC)Tcp
(C57BL/6N-Hps6em1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Hrrh-R/Hrrh-R
(involves: 101 * C3H/Rl * C57BL/RlEl * C57BL/10Rl * SEC/El)
|
decreased thymus weight
|
J:156542
|
Hrrh/Hrrh
(RHJ/LeJ)
|
thymus atrophy
|
J:57947
|
Hrrhsl/Hrrhsl
(involves: BALB/c)
|
thymus atrophy
|
J:98859
|
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))
|
thymus cortex atrophy
|
J:21316
|
Hrastm1Jaf/Hrastm1Jaf Nf2tm2Gth/Nf2tm2Gth Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr)
|
increased thyroid tumor incidence
|
J:231492
|
Hrastm1Jaf/Hrastm1Jaf Ptentm2.1Ppp/Ptentm2.1Ppp Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/NCr)
|
increased thyroid tumor incidence
|
J:231492
|
Hrastm1Jaf/Hrastm1Jaf Trp53tm1Brn/Trp53tm1Brn Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr)
|
increased thyroid tumor incidence
|
J:231492
|
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd)
|
enlarged adrenal glands
|
J:189059
|
Hsd11b1tm1.1Ggla/Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
enlarged adrenal glands
|
J:189132
|
Hsd11b1tm1Ggla/Hsd11b1tm1Ggla Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
enlarged adrenal glands
|
J:189059
|
Hsd11b1tm1Yko/Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
enlarged adrenal glands
|
J:37960,
J:45085
|
Hsd17b3tm1.2Mpo/Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl)
|
decreased pituitary gland weight
|
J:301756
|
Hsd17b4em1(IMPC)Tcp/Hsd17b4em1(IMPC)Tcp
(C57BL/6NCrl-Hsd17b4em1(IMPC)Tcp/Tcp)
|
enlarged adrenal glands
|
J:211773
|
htd/htd
(C3H/HeJ-htd/J)
|
abnormal thyroid follicular cell morphology
|
J:68094
|
Htr2btm1Kry/Htr2btm1Kry Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
Htra2mnd2/Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei)
|
abnormal thymus morphology
|
J:12780
|
Htra2tm1.1Hohj/Htra2tm1.1Hohj Tg(Nes-cre)1Kln/0
(involves: C57BL/6J)
|
thymus atrophy
|
J:225666
|
Htra2tm1.2Hohj/Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J)
|
thymus atrophy
|
J:225666
|
Htra2tm1Jdo/Htra2tm1Jdo
(involves: 129P/Ola * C57BL/6)
|
small thymus
|
J:94227
|
Huwe1tm1Wgu/Y Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased pancreatic beta cell number
|
J:182446
|
disorganized pancreatic islets
|
J:182446
|
Hycc1em1(IMPC)Ccpcz/Hycc1em1(IMPC)Ccpcz
(C57BL/6N-Hycc1em1(IMPC)Ccpcz/Ccpcz)
|
enlarged thymus
|
J:211773
|
Hydinhyrh/Hydinhyrh
(involves: C57BL/6J * C57BL/10J * RIII)
|
thymus atrophy
|
J:137815
|
Icostm1Flv/Icos+
(NOD.129S1-Icostm1Flv)
|
decreased pancreatic islet number
|
J:131529
|
Icostm1Flv/Icostm1Flv Rc3h1san/Rc3h1+
(involves: 129S1/Sv * C57BL/6 * C57BL/6JSfdAnu)
|
increased T cell derived lymphoma incidence
|
J:189087
|
Id1tm1Zhu/Id1tm1Zhu Tcf3tm1Wein/Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal thymus corticomedullary boundary morphology
|
J:44278
|
increased T cell derived lymphoma incidence
|
J:44278
|
Id3tm2.1Cmu/Id3tm2.1Cmu
(Not Specified)
|
decreased thymocyte number
|
J:176462
|
Id3tm2.1Cmu/Id3tm2.1Cmu Tcf3tm4Zhu/Tcf3tm4Zhu Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:176462
|
Idstm1Muen/Y
(involves: C57BL/6)
|
increased thyroid gland weight
|
J:259752
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1)
|
abnormal pancreatic beta cell differentiation
|
J:336782
|
abnormal pancreatic beta cell morphology
|
J:336782
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
abnormal pancreatic beta cell differentiation
|
J:336782
|
abnormal pancreatic beta cell morphology
|
J:336782
|
decreased pancreatic beta cell mass
|
J:336782
|
small pancreatic islets
|
J:336782
|
Ifngtm1.1Hayg/Ifngtm1.1Hayg
(Not Specified)
|
thymus atrophy
|
J:220784
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts)
|
increased T cell derived lymphoma incidence
|
J:77491
|
Ifngtm1Ts/Ifngtm1Ts Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
enlarged thymus medulla
|
J:57474
|
Igbp1tm1Cbt/Y Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:93221
|
Igbp1tm1Cbt/Igbp1+ Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:93221
|
Igbp1tm1Imku/Y Tg(Lck-cre)I57Jxm/?
(involves: 129P2/OlaHsd * ICR)
|
abnormal thymus cortex morphology
|
J:84395
|
abnormal thymus corticomedullary boundary morphology
|
J:84395
|
decreased thymocyte number
|
J:84395
|
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * C57BL/6J)
|
adrenal gland cyst
|
J:77413
|
Igfbp3tm1Jep/Igfbp3tm1Jep Igfbp4tm1Jep/Igfbp4tm1Jep Igfbp5tm1Jep/Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:112029
|
Igh-Vtm1(Igh-Vx24)Hmb/Igh-Vtm1(Igh-Vx24)Hmb
(involves: 129/Sv * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:54380
|
Ightm1(PAX5)Mbu/Igh+
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal thymus morphology
|
J:118111
|
enlarged thymus
|
J:118111
|
increased T cell derived lymphoma incidence
|
J:118111
|
thymus hypoplasia
|
J:118111
|
Ightm1(PAX5)Mbu/Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal thymus morphology
|
J:118111
|
enlarged thymus
|
J:118111
|
increased T cell derived lymphoma incidence
|
J:118111
|
thymus hypoplasia
|
J:118111
|
Ighmtm1Cgn/Ighm+ Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * C57BL/6 * CF-1)
|
thymus hypoplasia
|
J:99033
|
Ighmtm1Cgn/Ighmtm1Cgn Tg(Ins2-Cxcl13)1Cys/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:110548
|
Ighmtm1Cgn/Ighmtm1Cgn Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * C57BL/6 * CF-1)
|
thymus hypoplasia
|
J:99033
|
Igs2em5(CAG-Mir802)Gpt/Igs2em5(CAG-Mir802)Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
abnormal pancreatic beta cell differentiation
|
J:287584
|
decreased pancreatic beta cell mass
|
J:287584
|
decreased pancreatic beta cell number
|
J:287584
|
Igsf1tm1Zuk/Y
(either: (involves: 129S6/SvEv * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal pituitary gland morphology
|
J:190867
|
Ikbkgtm1Mka/Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
small thymus
|
J:63054
|
Ikzf1plstc/Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc)
|
decreased thymocyte number
|
J:84569
|
increased T cell derived lymphoma incidence
|
J:84569
|
Ikzf1plstc/Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc)
|
thymus hypoplasia
|
J:84569
|
Ikzf1tm1(Pax5)Mbu/Ikzf1+ Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:118111
|
Ikzf1tm1(Pax5)Mbu/Ikzf1tm1(Pax5)Mbu Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:80815
|
Ikzf1tm1.1(Pax5)Mbu/Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
enlarged thymus
|
J:118111
|
increased T cell derived lymphoma incidence
|
J:118111
|
thymus hypoplasia
|
J:118111
|
Ikzf1tm1.1Smale/Ikzf1tm1.1Smale
(B6.Cg-Ikzf1tm1.1Smale)
|
decreased DN1 thymic pro-T cell number
|
J:208211
|
thymus hypoplasia
|
J:208211
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymus lobule morphology
|
J:29355
|
abnormal thymus medulla morphology
|
J:29355
|
enlarged thymus
|
J:29355
|
thymus cortex hypoplasia
|
J:29355
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
abnormal thymus lobule morphology
|
J:29355
|
abnormal thymus medulla morphology
|
J:29355
|
enlarged thymus
|
J:29355
|
thymus cortex hypoplasia
|
J:29355
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymus cortex morphology
|
J:20671
|
abnormal thymus morphology
|
J:20671
|
thymus hypoplasia
|
J:20671
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c)
|
abnormal thymus cortex morphology
|
J:20671
|
abnormal thymus morphology
|
J:20671
|
thymus hypoplasia
|
J:20671
|
Ikzf1tm2.1Smale/Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale)
|
decreased DN2 thymocyte number
|
J:208211
|
decreased DN3 thymocyte number
|
J:208211
|
thymus cortex hypoplasia
|
J:208211
|
thymus hypoplasia
|
J:208211
|
Ikzf1tm2Kge/Ikzf1tm2Kge
(involves: 129S4/SvJae)
|
abnormal thymus development
|
J:37317
|
thymus hypoplasia
|
J:37317
|
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu Il7rtm1.1(icre)Hrr/Il7r+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased T cell derived lymphoma incidence
|
J:209928
|
Ikzf1tm3Kge/Ikzf1tm3Kge Tg(CD2-icre)4Kio/?
(involves: C57BL/10 * CBA/Ca)
|
increased T cell derived lymphoma incidence
|
J:209927
|
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
|
thymus hypoplasia
|
J:25940
|
Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
thymus hypoplasia
|
J:111821,
J:22521
|
Il2rgtm1Cgn/Il2rgtm1Cgn
(involves: 129 * CB20)
|
thymus hypoplasia
|
J:22521
|
Il2rgtm1Krf/Il2rgtm1Krf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))
|
decreased thymocyte number
|
J:114561
|
Il2rgtm1Krf/Il2rgtm1Krf Tg(BCL2/IGH)1Tjd/0
(either: (involves: 129P2/OlaHsd * C3H/He * C57BL/6) or (involves: 129P2/OlaHsd * C3H/He * C57BL/6 * FVB/N))
|
decreased thymocyte number
|
J:114561
|
Il2rgtm1Krf/Il2rgtm1Krf Tg(Igh-Pim1)1Brn/0
(either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N))
|
decreased thymocyte number
|
J:114561
|
Il2rgtm1Sug/Y
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased thymocyte number
|
J:31167
|
small thymus
|
J:31167
|
thymus cortex hypoplasia
|
J:31167
|
thymus hypoplasia
|
J:31167
|
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
small thymus
|
J:24117
|
small thymus cortex
|
J:24117
|
thymus hyperplasia
|
J:108209
|
Il2rgtm1Wjl/Y Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: 129S4/SvJae * C57BL/6)
|
thymus hypoplasia
|
J:108209
|
Il2rgtm1Wjl/Y Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
abnormal thymus morphology
|
J:109833
|
Il2rgtm1Wjl/Y Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ)
|
abnormal thymus morphology
|
J:140388
|
absent thymus cortex
|
J:140388
|
absent thymus medulla
|
J:140388
|
thymus cyst
|
J:140388
|
Il2rgtm1Wjl/Il2rgtm1Wjl Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
abnormal thymus morphology
|
J:109833
|
thymus cyst
|
J:109833
|
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Il3tm1Glli)
|
abnormal pancreatic islet morphology
|
J:145518
|
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
abnormal pancreatic alpha cell mass
|
J:139138
|
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hypoplasia
|
J:75419
|
Il6sttm1Wme/Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:67677
|
Il7hlb368/Il7hlb368
(C57BL/6J-Il7hlb368/J)
|
small thymus
|
J:118450
|
thymus hypoplasia
|
J:118450
|
Il7m1Jyen/Il7m1Jyen
(involves: C3H * C57BL/6)
|
thymus hypoplasia
|
J:136470
|
Il7tm1.1Mysl/Il7tm1.1Mysl
(B6.129P2(Cg)-Il7tm1.1Mysl)
|
decreased thymocyte number
|
J:200544
|
thymus hypoplasia
|
J:200544
|
Il7tm1Dnax/Il7tm1Dnax
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymus weight
|
J:24165
|
small thymus
|
J:24165
|
thymus hypoplasia
|
J:24165
|
Il7tm1Dnax/Il7tm1Dnax
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:64861
|
Il7tm1Hms/Il7tm1Hms
(involves: 129S6/SvEvTac)
|
thymus hypoplasia
|
J:43971
|
Il7rtm1Abra/Il7rtm1Abra
(B6.129S4-Il7rtm1Abra)
|
decreased thymocyte number
|
J:125360
|
Il7rtm1Iku/Il7rtm1Iku
(involves: 129P2/OlaHsd * C57BL/6J)
|
small thymus
|
J:34658
|
thymus hypoplasia
|
J:34658
|
Il7rtm1Imx/Il7rtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd)
|
thymus hypoplasia
|
J:21135
|
Il7rtm1Imx/Il7rtm1Imx
(B6.129S7-Il7rtm1Imx)
|
decreased thymocyte number
|
J:125360
|
Il7rtm1Imx/Il7rtm1Imx
(involves: 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:64861
|
Il7rtm1Imx/Il7rtm1Imx Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
decreased thymocyte number
|
J:66400
|
Il7rtm2Iku/Il7rtm2Iku Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased thymocyte number
|
J:193283
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymus weight
|
J:107077
|
thymus hyperplasia
|
J:107077
|
Il10tm1Cgn/Il10tm1Cgn Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal thymus corticomedullary boundary morphology
|
J:107077
|
thymus hypoplasia
|
J:107077
|
Il13ra1tm1Zagh/Il13ra1tm1Zagh
(involves: BALB/c * C57BL/6)
|
abnormal thymus development
|
J:183111
|
Il15tm1Imx/Il15tm1Imx
(C57BL/6-Il15tm1Imx/Tac)
|
abnormal thymus cell ratio
|
J:111786
|
Il15tm1Imx/Il15tm1Imx Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymus cell ratio
|
J:111786
|
Ildr2Dbsm1-DBA/2J/Ildr2Dbsm1-DBA/2J Lepob/Lepob
(B6.Cg-Ildr2Dbsm1-DBA/2J Lepob)
|
decreased pancreatic beta cell mass
|
J:138216
|
Ildr2W87*/Ildr2W87*
(involves: C3HeB/FeJ)
|
abnormal pancreatic beta cell differentiation
|
J:138216
|
decreased pancreatic beta cell mass
|
J:138216
|
decreased pancreatic beta cell number
|
J:138216
|
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased thymocyte number
|
J:118602
|
Inhatm1Bay/Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased adrenal gland tumor incidence
|
J:125349,
J:20450
|
Inhatm1Bay/Inhatm1Bay Smad3tm1Par/Smad3+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/Sv * C57BL/6)
|
increased adrenal gland tumor incidence
|
J:125349
|
Ino80tm1.1Schg/Ino80+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:221224
|
Inpp5del20/Inpp5del20
(B6.129-Inpp5del20)
|
decreased thymocyte number
|
J:173266
|
small thymus
|
J:173266
|
Inpp5dm1Btlr/Inpp5dm1Btlr
(C57BL/6J-Inpp5dm1Btlr)
|
enlarged thymus
|
J:140987
|
Ins1tm1Jja/Ins1tm1Jja
(involves: 129S2/SvPas)
|
increased pancreatic beta cell mass
|
J:77595
|
increased pancreatic beta cell number
|
J:77595
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2+
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreatic alpha cell mass
|
J:106827
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas)
|
enlarged pancreatic islets
|
J:40377
|
increased pancreatic beta cell number
|
J:77595
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas * C57BL/6)
|
enlarged pancreatic islets
|
J:106827
|
increased pancreatic alpha cell mass
|
J:106827
|
increased pancreatic beta cell mass
|
J:106827
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Mnt/Ins2tm1Mnt Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased pancreatic beta cell number
|
J:152798
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita)
|
abnormal pancreatic beta cell morphology
|
J:47883
|
degranulated pancreatic beta cells
|
J:47883
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita/J)
|
abnormal pancreatic islet morphology
|
J:321591
|
decreased pancreatic beta cell number
|
J:321591
|
Ins2Akita/Ins2+
(involves: C57BL/6NSlc)
|
abnormal pancreatic islet morphology
|
J:200802
|
Ins2Akita/Ins2+ Or12d17em1Cya/Or12d17em1Cya
(C57BL/6-Ins2Akita Or12d17em1Cya)
|
abnormal pancreatic islet morphology
|
J:321591
|
Ins2Akita/Ins2+ Prf1tm1Sdz/Prf1tm1Sdz Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz)
|
abnormal pancreatic islet morphology
|
J:138005
|
Ins2Akita/Ins2+ Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N * C57BL/6NSlc)
|
abnormal pancreatic islet morphology
|
J:200802
|
decreased pancreatic beta cell number
|
J:200802
|
Ins2Akita/Ins2Akita
(C57BL/6-Ins2Akita)
|
abnormal pancreatic alpha cell morphology
|
J:47883
|
abnormal pancreatic beta cell morphology
|
J:47883
|
small pancreatic islets
|
J:47883
|
Ins2Akita/Ins2Akita
(involves: C57BL/6NSlc)
|
decreased pancreatic beta cell mass
|
J:156725
|
Ins2Akita/Ins2Akita Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J)
|
decreased pancreatic beta cell mass
|
J:303318
|
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S)
|
abnormal pancreatic beta cell morphology
|
J:122098
|
abnormal pancreatic islet morphology
|
J:122098
|
decreased pancreatic beta cell number
|
J:122098
|
disorganized pancreatic islets
|
J:122098
|
increased pancreatic alpha cell number
|
J:122098
|
Ins2em#Arak/Ins2+
(C.129-Rag2tm1Fwa Ins2em#Arak Jak3tm1Tks/Arak)
|
abnormal pancreatic beta cell morphology
|
J:294041
|
abnormal pancreatic islet morphology
|
J:294041
|
small pancreatic islets
|
J:294041
|
Ins2tm1Delt/Ins2+
(involves: 129S2/SvPas * Black Swiss)
|
absent pancreatic beta cells
|
J:94589
|
decreased pancreatic alpha cell number
|
J:94589
|
small pancreatic islets
|
J:94589
|
Ins2tm1Delt/Ins2tm1Jja
(involves: 129S2/SvPas)
|
decreased pancreatic beta cell number
|
J:94589
|
Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas)
|
increased pancreatic beta cell mass
|
J:77595
|
increased pancreatic beta cell number
|
J:77595
|
Insl5tm1Imad/Insl5tm1Imad
(129(B6)-Insl5tm1Imad)
|
decreased pancreatic beta cell number
|
J:189146
|
small pancreatic islets
|
J:189146
|
Insm1tm1.1(GFP/cre)Mgn/Insm1tm1.1(GFP/cre)Mgn
(involves: 129S6/SvEvTac * CD-1 * SJL)
|
abnormal endocrine pancreas morphology
|
J:214095
|
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
absent PP cells
|
J:112173
|
decreased pancreatic alpha cell number
|
J:112173
|
decreased pancreatic beta cell number
|
J:112173
|
decreased pancreatic delta cell number
|
J:112173
|
decreased pancreatic epsilon cell number
|
J:112173
|
increased PP cell number
|
J:112173
|
pancreatic islet hypoplasia
|
J:112173
|
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic beta cell number
|
J:112173
|
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd)
|
abnormal pituitary gland development
|
J:206319
|
absent somatotrophs
|
J:206319
|
absent thyrotrophs
|
J:206319
|
small pituitary gland
|
J:206319
|
Insrtm1Dac/Insr+
(involves: 129 * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:135659
|
Insrtm1Dac/Insr+
(B6.129S4-Insrtm1Dac/J)
|
increased pancreatic beta cell mass
|
J:246319
|
Insrtm1Dac/Insr+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
absent pancreatic beta cells
|
J:80826
|
Insrtm1Dac/Insr+ Ppp2r2aigt10/Ppp2r2a+
(involves: 129S4/SvJae * C3H/HeH * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:246319
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L1Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased pancreatic beta cell mass
|
J:91350
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
abnormal pancreatic islet morphology
|
J:91350
|
increased pancreatic beta cell mass
|
J:91350
|
Insrtm1Dac/Insrtm1Dac Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
abnormal pancreatic islet morphology
|
J:91350
|
increased pancreatic beta cell mass
|
J:91350
|
Insrtm1Khn/Insrtm1Khn Pdx1tm1Ted/Pdx1+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased pancreatic beta cell mass
|
J:92861
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB)
|
increased pancreatic beta cell mass
|
J:63878,
J:92861
|
pancreatic islet hyperplasia
|
J:92861
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased pancreatic beta cell mass
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased pancreatic beta cell mass
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB)
|
abnormal pancreatic beta cell morphology
|
J:169404
|
abnormal pancreatic islet morphology
|
J:169404
|
decreased pancreatic beta cell number
|
J:169404
|
Invsinv/Invsinv
(involves: FVB/N)
|
abnormal pancreatic islet morphology
|
J:50117
|
disorganized pancreatic islets
|
J:50117
|
pancreatic islet hyperplasia
|
J:50117
|
Iqcmem1(IMPC)Tcp/Iqcmem1(IMPC)Tcp
(C57BL/6NCrl-Iqcmem1(IMPC)Tcp/Cmmr)
|
enlarged adrenal glands
|
J:211773
|
Irak4em1(IMPC)Ccpcz/Irak4em1(IMPC)Ccpcz
(C57BL/6NCrl-Irak4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
|
abnormal thymus cell ratio
|
J:36025
|
Irf4em1(IMPC)Mbp/Irf4em1(IMPC)Mbp
(C57BL/6N-Irf4em1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Irs1tm1Jos/Irs1+ Irs2tm2Mfw/Irs2tm2Mfw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:93415
|
Irs1tm1Jos/Irs1tm1Jos Irs3tm1Lhd/Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased pancreatic beta cell mass
|
J:80976
|
pancreatic islet hyperplasia
|
J:80976
|
Irs1tm2.1Mfw/Irs1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:156999
|
Irs1tm2.1Mfw/Irs1tm2.1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:156999
|
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:96047
|
decreased gonadotroph cell number
|
J:64791
|
decreased pancreatic beta cell mass
|
J:135659,
J:46134
|
decreased pancreatic beta cell number
|
J:94000
|
small pancreatic islets
|
J:96047
|
small pituitary gland
|
J:64791
|
small pituitary intermediate lobe
|
J:74303
|
Irs2tm1Mfw/Irs2tm1Mfw Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:87249
|
pancreatic islet hyperplasia
|
J:87249
|
Irs2tm1Mfw/Irs2tm1Mfw Tg(Ins2-Irs2)13Mfw/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:94000
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell morphology
|
J:65485
|
decreased pancreatic beta cell mass
|
J:65485
|
Irs2tm1With/Irs2tm1With Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased pancreatic beta cell number
|
J:97406
|
Irs2tm1With/Irs2tm1With Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:97406
|
Irs2tm2Mfw/Irs2tm2Mfw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:93415
|
Irs2tm2Tka/Irs2tm2Tka Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:93416
|
Isl1tm1(cre)Sev/Isl1+ Pax9tm1Rbal/Pax9tm1.1Hpt
(involves: 129 * C57BL/6J)
|
ectopic thymus
|
J:311535
|
thymus hypoplasia
|
J:311535
|
Isl1tm1Tmj/Isl1tm1Tmj
(involves: 129S1/Sv)
|
abnormal pancreatic islet morphology
|
J:37641
|
abnormal Rathke's pouch development
|
J:50517
|
absent pancreatic alpha cells
|
J:37641
|
small Rathke's pouch
|
J:50517
|
Ism1em1(IMPC)Ccpcz/Ism1em1(IMPC)Ccpcz
(C57BL/6NCrl-Ism1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Itgb1tm1Ref/Itgb1tm1Ref Tg(Ins2-cre)1Heed/?
(involves: 129 * C57BL/6 * CBA)
|
disorganized pancreatic islets
|
J:122649
|
increased pancreatic alpha cell number
|
J:122649
|
Itgb6em1(IMPC)Ccpcz/Itgb6em1(IMPC)Ccpcz
(C57BL/6NCrl-Itgb6em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymus cell ratio
|
J:111786
|
Itktm1Litt/Itktm1Litt Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd)
|
decreased thymocyte number
|
J:141390
|
Itpkbtm1Ssch/Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent thymus medulla
|
J:86257
|
Jag2tm1Grid/Jag2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal thymus medulla morphology
|
J:46930
|
abnormal thymus morphology
|
J:46930
|
Jak1tm1Rds/Jak1tm1Rds
(involves: 129)
|
decreased thymocyte number
|
J:47300
|
small thymus
|
J:47300
|
Jak3bfy/Jak3bfy
(C57BL/6JSfdAnu-Jak3bfy/AnuApb)
|
decreased thymocyte number
|
J:104190
|
small thymus
|
J:104190
|
Jak3m1J/Jak3m1J
(B6.Cg-Crb1+ Jak3m1J/Boc)
|
decreased thymus weight
|
J:265859
|
small thymus
|
J:265859
|
Jak3M1Pgrs/Jak3M1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
small thymus
|
J:185217
|
Jak3tm1Flv/Jak3tm1Flv
(involves: 129S1/Sv)
|
thymus hypoplasia
|
J:95794
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
small thymus
|
J:29722
|
thymus hypoplasia
|
J:29722
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae)
|
abnormal thymus cell ratio
|
J:128694
|
decreased thymocyte number
|
J:64861
|
thymus hypoplasia
|
J:128694
|
Jak3tm1Tks/Jak3tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus cortex morphology
|
J:31231
|
abnormal thymus corticomedullary boundary morphology
|
J:31231
|
abnormal thymus medulla morphology
|
J:31231
|
absent Hassall's corpuscle
|
J:31231
|
decreased thymocyte number
|
J:31231
|
small thymus medulla
|
J:31231
|
thymus cortex hypoplasia
|
J:31231
|
thymus hypoplasia
|
J:31231
|
Jak3X887Y/Jak3X887Y
(Not Specified)
|
abnormal thymus morphology
|
J:112658
|
Jarid2jumonji/Jarid2jumonji
(C.129P2-Jarid2jumonji)
|
abnormal thymus cell ratio
|
J:42772
|
thymus hypoplasia
|
J:42772
|
Jarid2jumonji/Jarid2jumonji
(either: B6.129P2-Jarid2jumonji or D2.129P2-Jarid2jumonji)
|
thymus hypoplasia
|
J:42772
|
Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA/J)
|
decreased pancreatic beta cell mass
|
J:303318
|
Jmjd6tm1Gbf/Jmjd6tm1Gbf
(C57BL/6-Ptdsrtm1Gbf)
|
small thymus
|
J:102098
|
thymus hypoplasia
|
J:102098
|
Kat6atm1.1Glac/Kat6atm1.1Glac
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymus weight
|
J:148955
|
thymus hypoplasia
|
J:148955
|
Kat6atm1Avo/Kat6a+
(involves: 129 * BALB/c * FVB/N)
|
small thymus
|
J:188772
|
Kat6atm1Avo/Kat6atm1Avo
(involves: 129/Sv * BALB/c * FVB/N)
|
abnormal thymus development
|
J:108453
|
athymia
|
J:188772
|
small thymus
|
J:108453,
J:188772
|
thymus hypoplasia
|
J:108453
|
Kat6atm2.2Avo/Kat6a+ Tbx1tm1Bld/Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
small thymus
|
J:188772
|
Katnipem1(IMPC)Mbp/Katnip+
(C57BL/6NCrl-Katnipem1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Kbtbd3em1(IMPC)Ccpcz/Kbtbd3em1(IMPC)Ccpcz
(C57BL/6NCrl-Kbtbd3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Kcne3tm1Gwab/Kcne3tm1Gwab
(involves: C57BL/6)
|
abnormal adrenal gland morphology
|
J:210381
|
Kcnh6em1Jkya/Kcnh6em1Jkya
(involves: C57BL/6N)
|
decreased pancreatic beta cell mass
|
J:271003
|
decreased pancreatic beta cell number
|
J:271003
|
increased pancreatic alpha cell number
|
J:271003
|
Kcnn4em1(IMPC)Ccpcz/Kcnn4em1(IMPC)Ccpcz
(C57BL/6NCrl-Kcnn4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
small thymus
|
J:211773
|
Kdelr1m1Btlr/Kdelr1m1Btlr
(C57BL/6J-Kdelr1m1Btlr)
|
thymus hypoplasia
|
J:158794
|
Kdm1atm1.1Rsd/Kdm1atm1.1Rsd Tg(Pitx1-cre)7Rsd/0
(involves: BALB/c * C57BL/6)
|
abnormal pituitary gland development
|
J:121427
|
Kdm5atm1.1Kael/Kdm5a+ Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
increased pituitary gland tumor incidence
|
J:175625
|
increased thyroid tumor incidence
|
J:175625
|
Kdm5atm1.1Kael/Kdm5atm1.1Kael Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
increased pituitary gland tumor incidence
|
J:175625
|
increased thyroid tumor incidence
|
J:175625
|
Kdm5atm1Kael/Kdm5atm1Kael Men1tm2.1Mmey/Men1tm2.1Mmey Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA/J * FVB/N)
|
abnormal pancreatic islet morphology
|
J:175625
|
pancreatic islet hyperplasia
|
J:175625
|
Kif5btm1Njen/Kif5btm1.1Njen Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL)
|
abnormal pancreatic beta cell morphology
|
J:170198
|
increased pancreatic beta cell number
|
J:170198
|
small pancreatic islets
|
J:170198
|
Kif16bem1(IMPC)Ccpcz/Kif16bem1(IMPC)Ccpcz
(C57BL/6NCrl-Kif16bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Kifbptm1a(KOMP)Wtsi/Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
Kiss1tm1Coll/Kiss1tm1Coll
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal adrenal gland morphology
|
J:122381
|
retention of the adrenal gland x-zone
|
J:122381
|
Kiss1rtm1.1(KOMP)Vlcg/Kiss1rtm1.1(KOMP)Vlcg
(C57BL/6N-Kiss1rtm1.1(KOMP)Vlcg/Ucd)
|
increased thymus weight
|
J:211773
|
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae)
|
decreased adrenal gland weight
|
J:181650
|
increased thymus weight
|
J:181650
|
Kiss1rtm1Coll/Kiss1rtm1Coll
(involves: 129S6/SvEvTac)
|
abnormal adrenal cortex morphology
|
J:96442
|
retention of the adrenal gland x-zone
|
J:96442
|
Kiss1rtm1Gstn/Kiss1rtm1Gstn
(involves: 129P2/OlaHsd)
|
increased thymus weight
|
J:102113
|
KitW-vkd/KitW-vkd
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB)
|
decreased thymocyte number
|
J:79128
|
KitW/KitW Tg(PDGFB-EPO)321Zbz/?
(involves: C3H * C57BL/6)
|
decreased thymocyte number
|
J:79128
|
KitlSl/KitlSl-d
(involves: C57BL/6 * WC)
|
thymus atrophy
|
J:5758
|
Kitltm3.1Pbes/Kitltm3.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased thymocyte number
|
J:157170
|
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J))
|
abnormal adenohypophysis morphology
|
J:44109
|
abnormal gonadotroph morphology
|
J:44109
|
decreased somatotroph cell size
|
J:44109
|
decreased somatotroph secretory granule number
|
J:44109
|
thymus atrophy
|
J:44109
|
Klkl/Klkl
(involves: C3H/J * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:66078
|
small pancreatic islets
|
J:66078
|
Klf13tm1Kren/Klf13tm1Kren
(B6.129-Klf13tm1Kren)
|
decreased thymocyte number
|
J:145839
|
increased thymocyte number
|
J:145839
|
thymus hyperplasia
|
J:145839
|
Klhl1em1(IMPC)Ccpcz/Klhl1em1(IMPC)Ccpcz
(C57BL/6N-Klhl1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Klhl6em1(IMPC)Ccpcz/Klhl6em1(IMPC)Ccpcz
(C57BL/6NCrl-Klhl6em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Klhl12em1(IMPC)Tcp/Klhl12em1(IMPC)Tcp
(C57BL/6N-Klhl12em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Klk10em1(IMPC)Ccpcz/Klk10em1(IMPC)Ccpcz
(C57BL/6NCrl-Klk10em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Klk11em1(IMPC)Ccpcz/Klk11em1(IMPC)Ccpcz
(C57BL/6N-Klk11em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Kmt2atm1Thr/Kmt2a+ Mllt3tm2Thr/Mllt3+ Tg(Lck-cre)1Thr/?
(involves: 129S/SvEv)
|
increased T cell derived lymphoma incidence
|
J:100794
|
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH)
|
enlarged pancreatic islets
|
J:203736
|
Kmt2etm1.1Hjf/Kmt2e+
(B6.129P2-Kmtetm1.1Hjf)
|
decreased thymocyte number
|
J:145579
|
thymus hypoplasia
|
J:145579
|
Kmt2etm1.1Hjf/Kmt2etm1.1Hjf
(B6.129P2-Kmtetm1.1Hjf)
|
decreased thymocyte number
|
J:145579
|
small thymus
|
J:145579
|
thymus hypoplasia
|
J:145579
|
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:68981
|
Krastm2Tyj/Kras+
(involves: 129S2/SvPas)
|
increased T cell derived lymphoma incidence
|
J:68981
|
Krastm2Tyj/Kras+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:68981
|
Krastm2Tyj/Kras+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:68981
|
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:68981
|
Krastm3Tyj/Kras+
(involves: 129S4/SvJae)
|
increased T cell derived lymphoma incidence
|
J:68981
|
Krastm3Tyj/Kras+ Mir21atm1.1Eno/Mir21atm1.1Eno
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:164198
|
Krastm3Tyj/Krastm3Tyj
(involves: 129S4/SvJae)
|
increased T cell derived lymphoma incidence
|
J:237900
|
Krastm4Tyj/Kras+ Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
thymus atrophy
|
J:247853
|
Krastm4Tyj/Kras+ Ptentm2.1Ppp/Ptentm2.1Ppp Tg(TPO-cre)1Shk/0
(129.Cg-Krastm4Tyj Tg(Tpo-cre)1Shk Ptentm2.1Ppp)
|
enlarged thyroid gland
|
J:147732
|
increased thyroid carcinoma incidence
|
J:147732
|
Krastm4Tyj/Kras+ Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA)
|
increased lymphoblastic lymphoma incidence
|
J:88163
|
Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
enlarged pancreatic islets
|
J:87196
|
Krastm4Tyj/Kras+ Trp53tm2Tyj/Trp53+ Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased T cell derived lymphoma incidence
|
J:98936
|
Krastm4Tyj/Krastm4Tyj Trim33tm1Los/Trim33tm1Los Tg(Pdx1-cre)89.1Dam/0
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * DBA/2)
|
disorganized pancreatic islets
|
J:151781
|
Krt1em1(IMPC)Ccpcz/Krt1em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Krt27em1(IMPC)Ccpcz/Krt27em1(IMPC)Ccpcz
(C57BL/6N-Krt27em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Krt33aem1(IMPC)Ccpcz/Krt33aem1(IMPC)Ccpcz
(C57BL/6N-Krt33aem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Krt33bem1(IMPC)Ccpcz/Krt33bem1(IMPC)Ccpcz
(C57BL/6N-Krt33bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Krt34em1(IMPC)Ccpcz/Krt34em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt34em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Krt72em1(IMPC)Ccpcz/Krt72em1(IMPC)Ccpcz
(C57BL/6N-Krt72em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Krtap7-1em1(IMPC)Ccpcz/Krtap7-1em1(IMPC)Ccpcz
(C57BL/6NCrl-Krtap7-1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Krtap9-5em1(IMPC)Ccpcz/Krtap9-5em1(IMPC)Ccpcz
(C57BL/6N-Krtap9-5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Lair1tm1.1Jco/Lair1tm1.1Jco
(involves: C57BL/6)
|
decreased thymocyte number
|
J:180203
|
Lama2tm1Stk/Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal thymus corticomedullary boundary morphology
|
J:61802
|
thymus cortex hypoplasia
|
J:61802
|
Lama5b2b2966.1Clo/Lama5b2b2966.1Clo
(C57BL/6J-Lama5b2b2966.1Clo)
|
thymus hypoplasia
|
J:175213
|
Lamp1em1(IMPC)Mbp/Lamp1em1(IMPC)Mbp
(C57BL/6N-Lamp1em1(IMPC)Mbp/MbpMmucd)
|
small adrenal glands
|
J:211773
|
Lamp2tm1Psa/Lamp2tm1Psa
(either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))
|
abnormal thymus morphology
|
J:64151
|
Lamtor4em1(IMPC)Ccpcz/Lamtor4+
(C57BL/6N-Lamtor4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thyroid gland morphology
|
J:211773
|
enlarged thyroid gland
|
J:211773
|
Lamtor5tm1Lye/Lamtor5tm1Lye Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
abnormal pancreatic islet morphology
|
J:258406
|
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased thymocyte number
|
J:77099
|
small thymus
|
J:77099
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
thymus hypoplasia
|
J:77098
|
Lattm1Bpay/Lattm1Bpay
(involves: 129S2/SvPas)
|
decreased thymocyte number
|
J:103904
|
small thymus
|
J:103904
|
Lattm1Les/Lattm1.1Wz Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:147946
|
small thymus
|
J:147946
|
Lattm1Les/Lattm1Les
(Not Specified)
|
decreased thymocyte number
|
J:54059
|
small thymus
|
J:54059
|
Lattm1Les/Lattm1Les Tg(CD2-LAT2)1Wz/0
(Not Specified)
|
small thymus
|
J:116964
|
Lattm2.1Lov/Lattm2.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
small thymus
|
J:77695
|
Lattm2.1Mal/Lattm2.1Mal
(involves: 129S2/SvPas)
|
thymus hypoplasia
|
J:94074
|
Lattm3.1Mal/Lattm3.1Mal
(involves: 129S2/SvPas)
|
abnormal thymus cell ratio
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal thymus cell ratio
|
J:94074
|
Lats1tm1Tx/Lats1tm1Tx
(involves: 129S2/SvPas * C57BL/6J)
|
adenohypophysis hyperplasia
|
J:52536
|
Lbrlym3/Lbrlym3
(C57BL/6-Lbrlym3)
|
thymus hypoplasia
|
J:180355
|
Lcattm1Hgc/Lcattm1Hgc
(involves: C57BL/6 * DBA)
|
abnormal adrenal gland morphology
|
J:41208
|
Lckm1Btlr/Lckm1Btlr
(C57BL/6J-Lckm1Btlr)
|
thymus atrophy
|
J:144695
|
thymus hypoplasia
|
J:144695
|
Lcktm1.1Litt/Lcktm1.1Litt
(Not Specified)
|
abnormal thymus morphology
|
J:152472
|
Lcktm1Dbs/Lcktm1Dbs
(involves: C3H * C57BL/6)
|
decreased thymocyte number
|
J:114660
|
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
decreased thymocyte number
|
J:1119
|
thymus atrophy
|
J:1119
|
thymus hypoplasia
|
J:37062,
J:37940
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
thymus hyperplasia
|
J:173490
|
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz)
|
decreased thymocyte number
|
J:150304
|
small thymus
|
J:150304
|
Lcp2tm2Gak/Lcp2tm2Gak Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:107467
|
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
thymus hypoplasia
|
J:147721
|
Lcp2twm/Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu)
|
decreased thymocyte number
|
J:104190
|
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J)
|
abnormal adrenal gland morphology
|
J:85174
|
Lepob/Lepob
(involves: C57BL/6J)
|
enlarged pancreatic islets
|
J:219118
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
enlarged pancreatic islets
|
J:5400
|
Lepob/Lepob
(D2.Cg-Lepob/Chua)
|
abnormal pancreatic islet morphology
|
J:78850
|
decreased pancreatic beta cell number
|
J:78850
|
increased pancreatic beta cell number
|
J:78850
|
Lepob/Lepob
(involves: 129 * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:121534
|
enlarged pancreatic islets
|
J:121534
|
increased pancreatic islet number
|
J:121534
|
Lepob/Lepob
(BKS.Cg-Lepob/J)
|
small pancreatic islets
|
J:5400
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
abnormal pancreatic beta cell morphology
|
J:7702
|
increased pancreatic beta cell mass
|
J:7702
|
increased pancreatic beta cell number
|
J:7702
|
Lepob/Lepob
(involves: BTBR * C57BL/6 * V stock)
|
decreased pancreatic beta cell number
|
J:65486
|
disorganized pancreatic islets
|
J:65486
|
pancreatic islet hyperplasia
|
J:65486
|
Lepob/Lepob
(BTBR.Cg-Lepob/WiscJ)
|
abnormal pancreatic islet morphology
|
J:106121
|
decreased pancreatic beta cell mass
|
J:106121
|
small pancreatic islets
|
J:106121
|
Lepob/Lepob Mir375tm1Stf/Mir375tm1Stf
(B6.Cg-Mir375tm1Stf Lepob)
|
decreased pancreatic beta cell mass
|
J:147572
|
decreased pancreatic beta cell number
|
J:147572
|
increased pancreatic alpha cell number
|
J:147572
|
Lepob/Lepob Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:121534
|
disorganized pancreatic islets
|
J:121534
|
Lepob/Lepob Tg(Ins2-Mir184)4Mnpy/0
(involves: C57BL/10J)
|
decreased pancreatic beta cell mass
|
J:210552
|
Leptm1.2Gvcao/Leptm1.2Gvcao
(involves: 129S4/SvJaeSor * FVB/NJ * FVB/NTac)
|
decreased somatotroph cell number
|
J:218720
|
Leprdb-3J/Leprdb-3J
(129P3/J-Leprdb-3J/J)
|
increased pancreatic alpha cell number
|
J:6337
|
increased pancreatic beta cell number
|
J:6337
|
pancreatic islet hyperplasia
|
J:6337
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLtJ-Leprdb-5J/LtJ)
|
degranulated pancreatic beta cells
|
J:87061
|
pancreatic islet hyperplasia
|
J:87061
|
Leprdb-5J/Leprdb-5J
(NOD/ShiLt-Leprdb-5J)
|
abnormal pancreatic islet morphology
|
J:118305
|
degranulated pancreatic beta cells
|
J:118305
|
Leprdb-9J/Leprdb-9J
(involves: C57BL/6 * CBA * SWR)
|
abnormal adrenal gland zona reticularis morphology
|
J:129982
|
abnormal pancreatic beta cell morphology
|
J:129982
|
absent adrenal medulla
|
J:129982
|
degranulated pancreatic beta cells
|
J:129982
|
enlarged adrenal glands
|
J:129982
|
Leprdb-dmpg/Leprdb-dmpg
(involves: B10.D2-H8b/Sn * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:83762
|
Leprdb-rlpy/Leprdb-rlpy
(involves: NU/J)
|
abnormal pancreatic beta cell morphology
|
J:83762
|
Leprdb-rtnd/Leprdb-rtnd
(involves: C57BL/6 * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:83762
|
Leprdb/Lepr+ Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H * C57BL/6 * C57BLKS/J)
|
increased pancreatic beta cell mass
|
J:186924
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
abnormal pancreatic beta cell morphology
|
J:96047
|
abnormal pancreatic islet morphology
|
J:96047
|
Leprdb/Leprdb
(FVB.BKS-Leprdb)
|
increased pancreatic beta cell number
|
J:78850
|
pancreatic islet hyperplasia
|
J:78850
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/Jcl)
|
increased pancreatic beta cell mass
|
J:156725
|
Leprdb/Leprdb Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BLKS/J * DBA)
|
abnormal pancreatic islet morphology
|
J:170206
|
Leprm1Clo/Leprm1Clo
(STOCK Leprm1Clo/GrsrJ)
|
pancreatic islet hyperplasia
|
J:232775
|
Leprtm1.1Chua/Lepr+ Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB)
|
decreased somatotroph cell number
|
J:173444
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB)
|
decreased somatotroph cell number
|
J:173444
|
Lgals9tm1.1Cfg/Lgals9tm1.1Cfg
(involves: C57BL/6)
|
thymus hyperplasia
|
J:217719
|
Lgr6em1(IMPC)Ccpcz/Lgr6em1(IMPC)Ccpcz
(C57BL/6NCrl-Lgr6em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Lhcgrtm1(KOMP)Vlcg/Lhcgrtm1(KOMP)Vlcg
(C57BL/6N-Lhcgrtm1(KOMP)Vlcg/Nju)
|
small thymus
|
J:211773
|
Lhcgrtm1Hht/Lhcgrtm1Hht
(involves: 129S7/SvEvBrd * C57BL/6J)
|
enlarged adrenal glands
|
J:105533
|
increased adrenal gland weight
|
J:105533
|
Lhx3tm1(cre)Slp/Lhx3tm1(cre)Slp
(involves: 129S1/Sv)
|
abnormal Rathke's pouch apoptosis
|
J:119270
|
abnormal Rathke's pouch development
|
J:119270
|
absent adenohypophysis
|
J:119270
|
small pituitary intermediate lobe
|
J:119270
|
Lhx3tm1.1Sjr/Lhx3tm1.1Sjr
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
abnormal pituitary gland morphology
|
J:169035
|
abnormal thyroid follicle morphology
|
J:169035
|
adenohypophysis hypoplasia
|
J:169035
|
decreased gonadotroph cell number
|
J:169035
|
decreased lactotroph cell number
|
J:169035
|
Lhx3tm1Lmgd/Lhx3tm1Lmgd
(involves: 129S4/SvJae)
|
abnormal corticotroph morphology
|
J:33050
|
abnormal pituitary gland development
|
J:33050
|
abnormal Rathke's pouch development
|
J:33050
|
absent adenohypophysis
|
J:33050,
J:51420
|
absent lactotrophs
|
J:33050
|
absent pituitary intermediate lobe
|
J:33050,
J:51420
|
absent somatotrophs
|
J:33050
|
absent thyrotrophs
|
J:33050
|
adrenal cortical hyperplasia
|
J:33050
|
decreased gonadotroph cell number
|
J:33050
|
Lhx4tm1Ssp/Lhx4tm1Ssp
(involves: 129S2/SvPas * CF-1)
|
abnormal Rathke's pouch development
|
J:79850
|
decreased gonadotroph cell number
|
J:79850
|
small adenohypophysis
|
J:79850
|
small Rathke's pouch
|
J:79850
|
Lhx4tm1Ssp/Lhx4tm1Ssp Prop1df/Prop1df
(involves: 129S2/SvPas * C57BL/6 * CF-1 * Goodale large mice * pink-eyed stock)
|
abnormal Rathke's pouch apoptosis
|
J:79850
|
abnormal Rathke's pouch development
|
J:79850
|
absent adenohypophysis
|
J:79850
|
absent gonadotrophs
|
J:79850
|
small Rathke's pouch
|
J:79850
|
Lhx5em1(IMPC)Ccpcz/Lhx5+
(C57BL/6N-Lhx5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte number
|
J:63078
|
small thymus
|
J:50865
|
Lig4tm1Fwa/Lig4tm1Fwa Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:63078
|
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal thymus morphology
|
J:157574
|
decreased thymocyte number
|
J:157574
|
decreased thymus weight
|
J:157574
|
increased T cell derived lymphoma incidence
|
J:157574
|
small thymus
|
J:157574
|
Lipatm1Hodu/Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1)
|
abnormal adrenal gland morphology
|
J:49674
|
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:85540
|
pancreatic islet hyperplasia
|
J:85540
|
Lipetm2Rze/Lipetm2Rze Tg(Ins2-cre)25Mgn/?
(involves: 129 * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:144744
|
increased pancreatic beta cell mass
|
J:144744
|
ll/ll X/Yaa
(BXSB/MpJScr-ll)
|
increased T cell derived lymphoma incidence
|
J:10973
|
Lmnatm1.1Otin/Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6)
|
small thymus
|
J:177632
|
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv)
|
thymus atrophy
|
J:58702
|
Lmod3em1(IMPC)Mbp/Lmod3+
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
enlarged thymus
|
J:211773
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA)
|
abnormal thymus cortex morphology
|
J:126456
|
abnormal thymus medulla morphology
|
J:126456
|
small thymus
|
J:126456
|
Lrig3em1(IMPC)Ccpcz/Lrig3em1(IMPC)Ccpcz
(C57BL/6NCrl-Lrig3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Lrp2b2b2671Clo/Lrp2b2b2671Clo
(C57BL/6J-Lrp2b2b2671Clo)
|
thymus hypoplasia
|
J:175213
|
Lrpap1tm1Her/Lrpap1tm1Her
(B6.129S7-Lrpap1tm1Her)
|
abnormal thyroid gland morphology
|
J:107358
|
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal thymus medulla morphology
|
J:211308
|
abnormal thymus morphology
|
J:211308
|
absent thymus corticomedullary boundary
|
J:211308
|
decreased DN2 thymocyte number
|
J:211308
|
decreased DN3 thymocyte number
|
J:211308
|
decreased DN4 thymocyte number
|
J:211308
|
decreased thymocyte number
|
J:211308
|
small thymus
|
J:211308
|
small thymus cortex
|
J:211308
|
thymus hypoplasia
|
J:211308
|
Lrrc17em1(IMPC)Ccpcz/Lrrc17em1(IMPC)Ccpcz
(C57BL/6N-Lrrc17em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ltatm1Dch/Ltatm1Dch
(involves: 129S2/SvPas)
|
abnormal thymus epithelium morphology
|
J:173115
|
abnormal thymus medulla morphology
|
J:173115
|
small thymus medulla
|
J:173115
|
Ltatm1Dch/Ltatm1Dch Tg(Ins2-Cxcl13)1Cys/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:110548
|
Ltatm1Dch/Ltatm1Dch Tnfsf14tm1Lpc/Tnfsf14tm1Lpc
(involves: 129S2/SvPas * 129X1/SvJ)
|
abnormal thymus epithelium morphology
|
J:173115
|
small thymus medulla
|
J:173115
|
Ltatm1Jods/Ltatm1Jods
(involves: C57BL/6)
|
abnormal thymus epithelium morphology
|
J:125864
|
Ltbrtm1Mmat/Ltbrtm1Mmat
(involves: C57BL/6 * CBA)
|
abnormal thymus epithelium morphology
|
J:173115
|
abnormal thymus medulla morphology
|
J:173115
|
small thymus medulla
|
J:173115
|
Ltbrtm1Mmat/Ltbrtm1Mmat Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal thymus epithelium morphology
|
J:173115
|
Ly6etm1Zmt/Ly6etm1Zmt
(involves: 129S1/Sv)
|
abnormal adrenal cortex morphology
|
J:73972
|
LyarGt(RRG292)Byg/LyarGt(RRG292)Byg Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:263530
|
Lyntm1b(EUCOMM)Hmgu/Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H)
|
small thymus
|
J:211773
|
Lystbg-J/Lystbg-J Prkdcscid/Prkdcscid
(B6.Cg-Lystbg-J Prkdcscid/Sz)
|
abnormal thymus morphology
|
J:34814
|
small thymus
|
J:34814
|
thymus cyst
|
J:34814
|
Lztfl1tm1.2Zpl/Lztfl1tm1.2Zpl Tg(Camk2a-cre)#Stl/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL * C57BL/6 * C57BL/6N)
|
pancreatic islet hyperplasia
|
J:287261
|
Lztfl1tm1.3Zpl/Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N)
|
pancreatic islet hyperplasia
|
J:287261
|
Macroh2a2em1(IMPC)Hmgu/Macroh2a2em1(IMPC)Hmgu
(C57BL/6NCrl-Macroh2a2em1(IMPC)Hmgu/Ieg)
|
abnormal thymus morphology
|
J:211773
|
Maddtm1Bpra/Maddtm1Bpra Tg(Ins2-cre/ERT)1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic beta cell morphology
|
J:225256
|
abnormal pancreatic islet morphology
|
J:225256
|
Mafatm1Staka/Mafatm1Staka
(involves: ICR)
|
abnormal pancreatic islet morphology
|
J:99126
|
Maml1tm1Mkit/Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:122286
|
Man2b2tm1b(KOMP)Wtsi/Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Tcp)
|
small adrenal glands
|
J:211773
|
Manbatm1Khf/Manbatm1Khf
(B6.129-Manbatm1Khf)
|
abnormal thyroid follicle morphology
|
J:105427
|
Manftm1a(KOMP)Wtsi/Manftm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * ICR)
|
abnormal pancreatic beta cell differentiation
|
J:211812
|
decreased pancreatic beta cell mass
|
J:211812
|
decreased pancreatic beta cell number
|
J:211812
|
decreased pancreatic islet number
|
J:211812
|
Map2k6tm1Ina/Map2k6tm1Ina Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal thymus cell ratio
|
J:100093
|
Map3k3tm1Kuro/Map3k3tm1Kuro Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:147103
|
Map3k14aly/Map3k14aly
(involves: C57BL/6J)
|
abnormal thymus corticomedullary boundary morphology
|
J:87993
|
abnormal thymus medulla morphology
|
J:87993
|
small thymus
|
J:147681
|
thymus cyst
|
J:147681
|
Map3k14aly/Map3k14aly
(involves: AEJ/GnRk * C57BL/6J)
|
absent thymus corticomedullary boundary
|
J:16865,
J:54529
|
Map3k14tm1.2Gne/Map3k14tm1.2Gne
(B6(Cg)-Map3k14tm1.2Gne)
|
abnormal thymus cell ratio
|
J:240453
|
Map3k14tm1Rds/Map3k14tm1Rds
(involves: 129/Sv * C57BL/6)
|
abnormal thymus morphology
|
J:68125
|
Mapk1tm1Gela/Mapk1tm1Gela H2az2Tg(Wnt1-cre)11Rth/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal thymus morphology
|
J:144862
|
abnormal thyroid gland morphology
|
J:144862
|
Mapk1tm1Gela/Mapk1tm1Gela Mapk3tm1Gela/Mapk3+ H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal thymus morphology
|
J:144862
|
abnormal thyroid gland morphology
|
J:144862
|
Mapk1tm1Gela/Mapk1tm1Gela Mapk3tm1Gela/Mapk3tm1Gela H2az2Tg(Wnt1-cre)11Rth/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal thyroid gland morphology
|
J:144862
|
athymia
|
J:144862
|
Mapk1tm1Hed/Mapk1tm1Hed Mapk3tm1Gpg/Mapk3tm1Gpg Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:113280
|
small thymus
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed Mapk3tm1Gpg/Mapk3tm1Gpg Tg(TcraTcrb)1100Mjb/0
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:113280
|
Mapk8tm1Rjd/Mapk8tm1Rjd Mapk9tm2.1Rjd/Mapk9tm2.1Rjd Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
small pancreatic islets
|
J:192551
|
Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal pancreatic beta cell morphology
|
J:152617
|
Mapkapk3em1(IMPC)Ccpcz/Mapkapk3em1(IMPC)Ccpcz
(C57BL/6N-Mapkapk3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Marchf3tm1b(EUCOMM)Hmgu/Marchf3tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf3tm1b(EUCOMM)Hmgu/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Mark2Gt(pSABetageo)38Bss/Mark2Gt(pSABetageo)38Bss
(involves: 129S2/SvPas * MF1)
|
small pituitary gland
|
J:57958
|
Marveld2tm1.1Sria/Marveld2tm1.1Sria
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal thyroid follicle morphology
|
J:201580
|
Marveld3em1(IMPC)Ccpcz/Marveld3em1(IMPC)Ccpcz
(C57BL/6NCrl-Marveld3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Mb21d2em1(IMPC)Mbp/Mb21d2em1(IMPC)Mbp
(C57BL/6N-Mb21d2em1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
abnormal pancreatic islet morphology
|
J:323838
|
Mbd5tm1.2Gxu/Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J)
|
small pituitary gland
|
J:192212
|
Mc2rtm1Dchi/Mc2rtm1Dchi
(B6.129P2-Mc2rtm1Dchi)
|
abnormal adrenal gland capsule morphology
|
J:127445
|
abnormal adrenal gland zona fasciculata morphology
|
J:127445
|
adrenal gland hypoplasia
|
J:127445
|
increased thymus weight
|
J:127445
|
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
adrenal cortical hyperplasia
|
J:82809
|
adrenal gland hypoplasia
|
J:82809
|
Mcl1tm1Ywh/Mcl1tm1Ywh Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:137400
|
Mcl1tm2Sjk/Mcl1tm3Sjk Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:86906
|
MclrRF/J/MclrSWR/J
(involves: RF/J * SWR/J)
|
increased T cell derived lymphoma incidence
|
J:9614
|
MclrSWR/J/MclrSWR/J
(involves: RF/J * SWR/J)
|
increased T cell derived lymphoma incidence
|
J:9614
|
Mcm2Gt(AB0178)Wtsi/Mcm2+ Mcm4chaos3/Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:165667
|
Mcm4chaos3/Mcm4chaos3
(involves: C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:165667
|
Mcm4Sdla/Mcm4+
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:194117
|
Mdc1Gt(OST441263)Lex/Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
small thymus
|
J:137341
|
Mdm2tm1.1Ypz/Mdm2tm1.1Ypz Tg(IghMyc)22Bri/0
(B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri)
|
enlarged thymus
|
J:164200
|
Mdm2tm1Bay/Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased thymocyte number
|
J:81065
|
decreased thymus weight
|
J:81065
|
thymus hypoplasia
|
J:81065
|
Mdm2tm1Glo/Mdm2+ Mdm4tm1Glo/Mdm4+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
thymus atrophy
|
J:123661
|
thymus hypoplasia
|
J:123661
|
Mdm2tm1Glo/Mdm2+ Trp53tm2Wahl/Trp53tm2Wahl
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
small thymus
|
J:174375
|
Mdm2tm1Mep/Mdm2tm1.1Mep
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
decreased thymus weight
|
J:81065
|
Mdm2tm2.1Snj/Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:189297
|
Megf8b2b1702.2Clo/Megf8b2b1702.2Clo
(C57BL/6J-Megf8b2b1702.2Clo)
|
thymus hypoplasia
|
J:175213
|
Meis3tm1b(EUCOMM)Hmgu/Meis3tm1b(EUCOMM)Hmgu
(C57BL/6N-Meis3tm1b(EUCOMM)Hmgu/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Men1tm1.1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))
|
pancreatic islet hyperplasia
|
J:67128
|
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * FVB/N)
|
increased adrenal gland tumor incidence
|
J:133299
|
increased parathyroid adenoma incidence
|
J:133299
|
increased pheochromocytoma incidence
|
J:133299
|
increased pituitary adenohypophysis tumor incidence
|
J:133299
|
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased adrenal gland tumor incidence
|
J:120835
|
increased parathyroid gland tumor incidence
|
J:120835
|
increased pituitary gland tumor incidence
|
J:120835
|
increased thyroid tumor incidence
|
J:120835
|
Men1tm1.1Ctre/Men1+ Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
increased adrenal gland tumor incidence
|
J:133299
|
increased parathyroid gland tumor incidence
|
J:133299
|
increased pheochromocytoma incidence
|
J:133299
|
increased pituitary adenohypophysis tumor incidence
|
J:133299
|
increased pituitary melanotroph tumor incidence
|
J:133299
|
increased thyroid C-cell carcinoma incidence
|
J:133299
|
Men1tm1.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6)
|
abnormal pituitary gland morphology
|
J:116086
|
increased adrenal gland adenoma incidence
|
J:116086
|
increased parathyroid adenoma incidence
|
J:116086
|
increased pituitary adenoma incidence
|
J:116086
|
increased prolactinoma incidence
|
J:116086
|
pancreatic islet hyperplasia
|
J:116086
|
parathyroid gland hyperplasia
|
J:116086
|
thyroid gland hyperplasia
|
J:116086
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
pancreatic islet hyperplasia
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)1Heed/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
pancreatic islet hyperplasia
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
pancreatic islet hyperplasia
|
J:85042
|
Men1tm1.2Ctre/Men1tm1.2Ctre Tg(PTH-cre)4167Slib/0
(Not Specified)
|
enlarged parathyroid gland
|
J:86642
|
Men1tm1.2Zqw/Men1tm1.2Zqw Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
pancreatic islet hyperplasia
|
J:85133
|
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))
|
increased adrenal gland tumor incidence
|
J:67128
|
increased parathyroid adenoma incidence
|
J:67128
|
increased pheochromocytoma incidence
|
J:67128
|
increased pituitary adenoma incidence
|
J:67128
|
increased prolactinoma incidence
|
J:67128
|
increased thyroid adenoma incidence
|
J:67128
|
pancreatic islet hyperplasia
|
J:67128
|
thyroid gland cyst
|
J:67128
|
Men1tm1Ctre/Men1tm1Ctre Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)
|
abnormal pancreatic islet morphology
|
J:146440
|
enlarged pancreatic islets
|
J:146440
|
pancreatic islet hyperplasia
|
J:146440
|
Men1tm1Gfk/Men1tm1Gfk Tg(Ins2-cre)25Mgn/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * DBA)
|
increased prolactinoma incidence
|
J:89898
|
pancreatic islet hyperplasia
|
J:89898
|
Men1tm1Mmey/Men1+
(involves: 129S6/SvEvTac * FVB/N)
|
increased pancreatic beta cell number
|
J:102494
|
Men1tm1Rvt/Men1+
(involves: 129 * C57BL/6)
|
increased adrenal cortical tumor incidence
|
J:191261
|
increased parathyroid adenoma incidence
|
J:191261
|
increased parathyroid gland tumor incidence
|
J:191261
|
increased pituitary adenohypophysis tumor incidence
|
J:191261
|
increased pituitary gland tumor incidence
|
J:191261
|
increased thyroid tumor incidence
|
J:191261
|
pancreatic islet hyperplasia
|
J:191261
|
parathyroid gland hyperplasia
|
J:191261
|
Men1tm1Zqw/Men1+
(involves: 129/Sv * 129P2/OlaHsd)
|
enlarged adrenal glands
|
J:85302
|
enlarged pituitary gland
|
J:85302
|
increased adrenal cortical tumor incidence
|
J:85302
|
increased adrenal gland adenoma incidence
|
J:85302
|
increased adrenal gland tumor incidence
|
J:85302
|
increased adrenocortical adenoma incidence
|
J:85302
|
increased parathyroid adenoma incidence
|
J:85302
|
increased pituitary adenohypophysis tumor incidence
|
J:85302
|
increased prolactinoma incidence
|
J:85302
|
increased thyroid carcinoma incidence
|
J:85302
|
increased thyroid tumor incidence
|
J:85302
|
thyroid gland hyperplasia
|
J:85302
|
Men1tm2.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6)
|
abnormal pituitary gland morphology
|
J:116086
|
increased parathyroid adenoma incidence
|
J:116086
|
increased pituitary adenoma incidence
|
J:116086
|
thyroid gland hyperplasia
|
J:116086
|
Men1tm2.1Mmey/Men1tm2.1Mmey Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA/J * FVB/N)
|
abnormal pancreatic islet morphology
|
J:175625
|
pancreatic islet hyperplasia
|
J:175625
|
Mesp1tm2(cre)Ysa/Mesp1+ Tbx1tm1Bld/Tbx1tm3Bld
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
athymia
|
J:112457
|
thymus hypoplasia
|
J:112457
|
Mesp1tm2(cre)Ysa/Mesp1+ Tbx1tm1Bld/Tbx1tm5Bld
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
athymia
|
J:112457
|
Mettm1Sst/Mettm1Sst Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:196854
|
decreased pancreatic beta cell mass
|
J:196854
|
Mfngem1(IMPC)Ccpcz/Mfngem1(IMPC)Ccpcz
(C57BL/6NCrl-Mfngem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Mgmttm1Lds/Mgmttm1Lds
(involves: 129P2/OlaHsd * C57BL/6)
|
small pancreatic islets
|
J:118148
|
Mgmttm1Mse/Mgmttm1Mse
(involves: 129S/SvEv)
|
increased T cell derived lymphoma incidence
|
J:47642
|
Mgmttm1Mse/Mgmttm1Mse Mlh1tm1Mse/Mlh1tm1Mse
(involves: 129S/SvEv)
|
increased T cell derived lymphoma incidence
|
J:47642
|
Mib1tm2Kong/Mib1tm2Kong Foxa2tm3.1(icre)Heli/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:184814
|
Mief1em1(IMPC)Mbp/Mief1em1(IMPC)Mbp
(C57BL/6N-Mief1em1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Minar1em1(IMPC)Tcp/Minar1em1(IMPC)Tcp
(C57BL/6NCrl-Minar1em1(IMPC)Tcp/Tcp)
|
abnormal thymus morphology
|
J:211773
|
Mir26a-1em1Xfu/Mir26a-1em1Xfu Mir26a-2em1Xfu/Mir26a-2em1Xfu
(involves: C57BL/6)
|
abnormal pancreatic alpha cell morphology
|
J:286108
|
decreased pancreatic islet number
|
J:286108
|
enlarged pancreatic islets
|
J:286108
|
pancreatic islet hyperplasia
|
J:286108
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:173230
|
Mir184tm1Ics/Mir184tm1Ics
(Not Specified)
|
increased pancreatic beta cell mass
|
J:210552
|
Mir205hgtm1.1Oers/Mir205hgtm1.1Oers
(B6(Cg)-Mir205hgtm1.1Oers)
|
small thymus
|
J:278363
|
Mir375tm1Stf/Mir375tm1Stf
(B6.129-Mir375tm1Stf)
|
abnormal pancreatic islet morphology
|
J:147572
|
decreased pancreatic beta cell mass
|
J:147572
|
decreased pancreatic beta cell number
|
J:147572
|
disorganized pancreatic islets
|
J:147572
|
increased pancreatic alpha cell number
|
J:147572
|
Mir802em3Gpt/Mir802em3Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
abnormal pancreatic beta cell differentiation
|
J:287584
|
increased pancreatic beta cell number
|
J:287584
|
Mirc14tm1.1Czc/Mirc14tm1.1Czc Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6))
|
thymus hypoplasia
|
J:188125
|
Mirc14tm1.2Czc/Mirc14tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))
|
decreased DN3 thymocyte number
|
J:188125
|
decreased thymocyte number
|
J:188125
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased DN1 thymic pro-T cell number
|
J:203157
|
decreased thymocyte number
|
J:203157
|
Mirc33tm1.1Cwh/Mirc33tm1.1Cwh
(involves: 129X1/SvJ)
|
thymus hypoplasia
|
J:189763
|
Mlh1tm1Mse/Mlh1tm1Mse
(involves: 129S/SvEv)
|
increased T cell derived lymphoma incidence
|
J:47642
|
Mlh1tm1Rak/Mlh1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:53451
|
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:53451
|
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:153684
|
Mllt6em1(IMPC)Tcp/Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Mmp13em1(IMPC)Ccpcz/Mmp13em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp13em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Mmp15tm1b(KOMP)Wtsi/Mmp15tm1b(KOMP)Wtsi
(C57BL/6N-Mmp15tm1b(KOMP)Wtsi/Bay)
|
abnormal thyroid gland morphology
|
J:211773
|
athymia
|
J:211773
|
Mmp20em1(IMPC)Ccpcz/Mmp20em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp20em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Mmuttm1Cpv/Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:147313
|
Mnx1tm1Jhk/Mnx1tm1Jhk
(involves: 129P2/OlaHsd)
|
abnormal pancreatic delta cell morphology
|
J:57314
|
abnormal pancreatic islet morphology
|
J:57314
|
decreased pancreatic beta cell number
|
J:57314
|
small pancreatic islets
|
J:57314
|
Mnx1tm1Tmj/Mnx1tm1Tmj
(involves: 129S1/Sv)
|
abnormal pancreatic islet morphology
|
J:57317
|
decreased pancreatic beta cell number
|
J:57317
|
decreased pancreatic delta cell number
|
J:57317
|
Mogstm1(KOMP)Vlcg/Mogs+
(C57BL/6N-Mogstm1(KOMP)Vlcg/Bay)
|
abnormal thyroid gland morphology
|
J:211773
|
absent adrenal gland
|
J:211773
|
enlarged thymus
|
J:211773
|
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
abnormal adrenal gland morphology
|
J:239583
|
abnormal pineal gland morphology
|
J:239583
|
abnormal pituitary gland morphology
|
J:239583
|
abnormal thymus topology
|
J:239583
|
abnormal thyroid gland morphology
|
J:239583
|
absent pituitary gland
|
J:239583
|
athymia
|
J:239583
|
small adrenal glands
|
J:239583
|
small thymus
|
J:239583
|
small thyroid gland
|
J:239583
|
Mpgtm1Lds/Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6)
|
small pancreatic islets
|
J:118148
|
Mplem1(IMPC)Ccpcz/Mplem1(IMPC)Ccpcz
(C57BL/6NCrl-Mplem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Mpv17lem1Riida/Mpv17lem1Riida
(C57BL/6N-Mpv17lem1Riida)
|
enlarged pancreatic islets
|
J:319850
|
Mraptm1.2Geno/Mraptm1.2Geno
(involves: C57BL/6)
|
abnormal adrenal gland capsule morphology
|
J:278935
|
abnormal adrenal gland development
|
J:278935
|
small adrenal glands
|
J:278935
|
Mrgprb2em1(IMPC)Tcp/Mrgprb2em1(IMPC)Tcp
(C57BL/6NCrl-Mrgprb2em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Msh2tm1Htr/Msh2tm1Htr
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
increased T cell derived lymphoma incidence
|
J:27469
|
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd)
|
increased T cell derived lymphoma incidence
|
J:45433
|
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd * FVB)
|
increased T cell derived lymphoma incidence
|
J:45433
|
Msh2tm1Whl/Msh2tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased lymphoblastic lymphoma incidence
|
J:79016
|
Msh2tm1Whl/Msh2tm1Whl Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased lymphoblastic lymphoma incidence
|
J:79016
|
increased pheochromocytoma incidence
|
J:79016
|
increased pituitary adenohypophysis tumor incidence
|
J:79016
|
increased pituitary melanotroph tumor incidence
|
J:79016
|
increased thyroid C-cell carcinoma incidence
|
J:79016
|
Msi2Gt(E035H03)Wrst/Msi2Gt(E035H03)Wrst
(B6.129P2-Msi2Gt(E035H03)Wrst)
|
decreased DN2 thymocyte number
|
J:174870
|
decreased DN3 thymocyte number
|
J:174870
|
small thymus
|
J:174870
|
thymus hypoplasia
|
J:174870
|
Msx1tm1Bero/Msx1tm1Bero
(B6.129P2-Msx1tm1Bero)
|
abnormal subcommissural organ morphology
|
J:84975
|
Msx1tm1Rilm/Msx1+ Pax9tm1Rbal/Pax9tm1Rbal
(involves: 129 * CD-1)
|
ectopic thymus
|
J:311535
|
thymus hypoplasia
|
J:311535
|
Mtapem1(IMPC)Mbp/Mtap+
(C57BL/6N-Mtapem1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Mtf1Thyls-BALB/c/Mtf1Thyls-BALB/c
(involves: BALB/c * MSM)
|
increased T cell derived lymphoma incidence
|
J:71358
|
Mtf1Thyls-BALB/c/Mtf1Thyls-MSM
(involves: BALB/c * MSM)
|
increased T cell derived lymphoma incidence
|
J:85264,
J:71358
|
Mtortm1.2Koz/Mtortm1.2Koz Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal thymus cell ratio
|
J:150108
|
Mtortm1Lgm/Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6)
|
decreased thymocyte number
|
J:168600
|
MybM303V/MybM303V
(involves: 129S1/SvlmJ * C57BL/6)
|
decreased thymocyte number
|
J:96507
|
Mybtm1Cgn/Mybtm1.1Cgn Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:91122
|
Mybtm1Cgn/Mybtm1Cgn Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:91122
|
Mybtm1Cgn/Mybtm1Cgn Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:91122
|
Mybtm1Epr/Mybtm1Epr Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:93481
|
Mybtm1Epr/Mybtm1Epr Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:93481
|
Mybtm1Jof/Mybtm1Jof
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:85344
|
Mybtm1Jof/Mybtm1Ssp
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:85344
|
Mybphltm1b(KOMP)Wtsi/Mybphltm1b(KOMP)Wtsi
(C57BL/6N-Mybphltm1b(KOMP)Wtsi/Wtsi)
|
abnormal thymus morphology
|
J:239583
|
abnormal thyroid gland morphology
|
J:239583
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal pancreatic beta cell morphology
|
J:148283
|
decreased pancreatic beta cell mass
|
J:148283
|
small pancreatic islets
|
J:148283
|
Myriptm1Tiz/Myriptm1Tiz
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal pancreatic beta cell morphology
|
J:258210
|
abnormal pancreatic islet morphology
|
J:258210
|
Naa10em1(IMPC)Mbp/Y
(C57BL/6NCrl-Naa10em1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Naa25em1(IMPC)Tcp/Naa25+
(C57BL/6NCrl-Naa25em1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
Naa38em1(IMPC)Ccpcz/Naa38+
(C57BL/6N-Naa38em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased T cell derived lymphoma incidence
|
J:195140
|
Nampttm1Oleo/Nampttm1Oleo Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca)
|
thymus hypoplasia
|
J:141448
|
NbeaTg(GH1)240BNec/Nbea+
(involves: C57BL/6 * SJL)
|
abnormal pituitary gland development
|
J:128767
|
Nbnem7Jpt/Nbntm2Zqw Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:277750
|
increased T cell derived lymphoma incidence
|
J:277750
|
Nbntm1Xu/Nbntm1Xu
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:75272
|
thymus hypoplasia
|
J:75272
|
Nbntm1Zqw/Nbn+
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:86563
|
increased thyroid adenoma incidence
|
J:86563
|
Ncaph2nes/Ncaph2nes
(C57BL/6JSfdAnu-Ncaph2nes/Anu)
|
abnormal thymus cell ratio
|
J:123300
|
abnormal thymus cortex morphology
|
J:123300
|
abnormal thymus corticomedullary boundary morphology
|
J:123300
|
decreased thymocyte number
|
J:123300
|
thymus hypoplasia
|
J:123300
|
Ncaph2nes/Ncaph2nes Tg(TcrHEL3A9)1Mmd/0
(C57BL/6-Ncaph2nes Tg(TcrHEL3A9)1Mmd)
|
abnormal thymus cell ratio
|
J:123300
|
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6)
|
abnormal thymus lobule morphology
|
J:141377
|
thymus hypoplasia
|
J:141377
|
Ncoa5tm1Hxia/Ncoa5+
(involves: 129 * C57BL/6)
|
decreased pancreatic islet number
|
J:207622
|
small pancreatic islets
|
J:207622
|
Ncor1tm1Rsd/Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
small thymus
|
J:65417
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+ Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N)
|
decreased thymus weight
|
J:267519
|
thymus atrophy
|
J:267519
|
thymus cortex atrophy
|
J:267519
|
thymus medulla atrophy
|
J:267519
|
Ndrg2tm1Kmori/Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased T cell derived lymphoma incidence
|
J:210264
|
Ndrg2tm1Kmori/Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
increased T cell derived lymphoma incidence
|
J:210264
|
Ndst1b2b2230Clo/Ndst1b2b2230Clo
(C57BL/6J-Ndst1b2b2230Clo)
|
thymus hypoplasia
|
J:175213
|
Ndst1tm1.1Grob/Ndst1tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
pituitary gland hypoplasia
|
J:100425
|
Nell1em1(IMPC)Mbp/Nell1em1(IMPC)Mbp
(C57BL/6N-Nell1em1(IMPC)Mbp/MbpMmucd)
|
small adrenal glands
|
J:211773
|
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:43010
|
absent pancreatic islets
|
J:43010
|
decreased pancreatic alpha cell number
|
J:43010
|
decreased pancreatic beta cell number
|
J:43010
|
decreased pancreatic delta cell number
|
J:43010
|
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129X1/SvJ)
|
decreased solitary pulmonary neuroendocrine cell number
|
J:137934
|
Neurog3tm1(EGFP)Khk/Neurog3tm1(EGFP)Khk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pancreatic alpha cell morphology
|
J:77398
|
abnormal pancreatic beta cell morphology
|
J:77398
|
abnormal pancreatic delta cell morphology
|
J:77398
|
Neurog3tm1.1(cre/ERT)Ggu/Neurog3+ Pdx1tm1Macd/Pdx1+ Tg(tetO-Myt1)2Ggu/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
abnormal pancreatic islet morphology
|
J:136131
|
Neurog3tm1Fgu/Neurog3tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent pancreatic alpha cells
|
J:60642
|
absent pancreatic beta cells
|
J:60642
|
absent pancreatic islets
|
J:60642
|
Neurog3tm1Fgu/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
abnormal pancreatic islet morphology
|
J:161480
|
small pancreatic islets
|
J:161480
|
Neurog3tm1Heed/Neurog3tm1Heed
(Not Specified)
|
abnormal endocrine pancreas morphology
|
J:147764
|
Neurog3tm3.1Ggr/Neurog3tm3.1Ggr Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL)
|
abnormal pancreatic islet morphology
|
J:161480
|
small pancreatic islets
|
J:161480
|
Nf1tm1Fcr/Nf1tm1Par Pax3tm1(cre)Joe/Pax3+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
adrenal medulla hyperplasia
|
J:114455
|
Nf1tm1Par/Nf1tm1Par H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal adrenal cortex morphology
|
J:80323
|
abnormal adrenal gland morphology
|
J:80323
|
abnormal adrenergic chromaffin cell morphology
|
J:80323
|
enlarged adrenal glands
|
J:80323
|
increased pheochromocytoma incidence
|
J:80323
|
thin adrenal cortex
|
J:80323
|
Nf1tm1Par/Nf1tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal pituitary gland development
|
J:138868
|
abnormal pituitary gland morphology
|
J:138868
|
small adenohypophysis
|
J:138868
|
small pituitary gland
|
J:138868
|
Nf1tm1Par/Nf1tm1Par Tg(Mpz-cre)94Imeg/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal adrenal cortex morphology
|
J:80323
|
abnormal adrenal gland morphology
|
J:80323
|
abnormal adrenergic chromaffin cell morphology
|
J:80323
|
enlarged adrenal glands
|
J:80323
|
increased pheochromocytoma incidence
|
J:80323
|
thin adrenal cortex
|
J:80323
|
Nf1tm1Par/Nf1tm1Par Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal adrenal cortex morphology
|
J:80323
|
abnormal adrenal gland morphology
|
J:80323
|
abnormal adrenergic chromaffin cell morphology
|
J:80323
|
enlarged adrenal glands
|
J:80323
|
increased pheochromocytoma incidence
|
J:80323
|
thin adrenal cortex
|
J:80323
|
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas * C57BL/6)
|
increased adrenal gland tumor incidence
|
J:18542
|
increased pheochromocytoma incidence
|
J:18542
|
Nf2tm2Gth/Nf2tm2Gth Ptgdstm1.1(cre)Gvn/Ptgds+
(involves: 129P2/OlaHsd * FVB/N)
|
increased pituitary adenoma incidence
|
J:173718
|
Nf2tm2Gth/Nf2tm2Gth Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * FVB/NCr)
|
abnormal thyroid gland morphology
|
J:231492
|
Nf2tm2Gth/Nf2tm2Gth Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased T cell derived lymphoma incidence
|
J:132943
|
Nfam1em1(IMPC)Ccpcz/Nfam1em1(IMPC)Ccpcz
(C57BL/6N-Nfam1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Nfat5tm1Snh/Nfat5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thymus hypoplasia
|
J:91482
|
Nfatc2tm1Srf/Nfatc2tm1Srf
(involves: 129P2/OlaHsd * C57BL/6)
|
enlarged thymus
|
J:110686
|
thymus hyperplasia
|
J:110686
|
Nfatc3tm1Glm/Nfatc3tm1Glm Tg(DO11.10)10Dlo/?
(involves: 129S2/SvPas * BALB/c * C3H * C57BL/6)
|
small thymus
|
J:50124
|
Nfatc3tm1Grc/Nfatc3tm1Grc Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
decreased thymocyte number
|
J:141917
|
thymus hypoplasia
|
J:141917
|
Nfe2l2em1(IMPC)Ccpcz/Nfe2l2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nfe2l2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Nfil3tm1.1(KOMP)Vlcg/Nfil3tm1.1(KOMP)Vlcg
(C57BL/6N-Nfil3tm1.1(KOMP)Vlcg/Ucd)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Nfkb1tm1Bal/Nfkb1tm1Bal Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal thymus cortex morphology
|
J:45119
|
abnormal thymus medulla morphology
|
J:45119
|
thymus hypoplasia
|
J:45119
|
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
|
abnormal thymus cell ratio
|
J:154812
|
abnormal thymus size
|
J:154812
|
Nfkb2tm1Brv/Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
abnormal thymus corticomedullary boundary morphology
|
J:43469
|
thymus atrophy
|
J:43469
|
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
increased thymocyte number
|
J:163686
|
Nfkbiatm1Bal/Nfkbiatm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
thymus atrophy
|
J:30058
|
Nfkbiatm1Fey/Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte number
|
J:110817
|
thymus atrophy
|
J:110817
|
Nhej1tm1.1Ics/Nhej1+
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:194422
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:194422
|
Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129)
|
thymus hypoplasia
|
J:138774
|
Nhej1tm1Fwa/Nhej1tm1Fwa Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129)
|
increased T cell derived lymphoma incidence
|
J:138774
|
Nhej1tm1Fwa/Nhej1tm1Fwa Xrcc5tm1Nus/Xrcc5tm1Nus
(involves: 129S6/SvEvTac * C57BL/6)
|
athymia
|
J:236776
|
Niban3em1(IMPC)Mbp/Niban3em1(IMPC)Mbp
(C57BL/6N-Niban3em1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Nidd5BALB/cA/Nidd5TSOD
(involves: BALB/cA * TSOD)
|
abnormal pancreatic beta cell morphology
|
J:55285
|
Nidd5TSOD/Nidd5TSOD
(involves: BALB/cA * TSOD)
|
abnormal pancreatic beta cell morphology
|
J:55285
|
NiddsSJL/NBom/?
(involves: NZO/HlBom * SJL/NBom)
|
abnormal pancreatic beta cell morphology
|
J:78920
|
Nkaptm1.1Viss/Y Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased DN4 thymocyte number
|
J:165961
|
decreased thymocyte number
|
J:165961
|
increased DN3 thymocyte number
|
J:165961
|
thymus hypoplasia
|
J:165961
|
Nkx2-1tm1Jaw/Nkx2-1tm1Jaw
(B6.129-Nkx2-1tm1Jaw)
|
abnormal thyroid gland development
|
J:169693
|
Nkx2-1tm1Shk/Nkx2-1tm1Shk
(B6.129S4-Nkx2-1tm1Shk)
|
abnormal thyroid gland development
|
J:169693
|
absent pituitary gland
|
J:169693
|
absent thyroid gland
|
J:169693
|
small thyroid gland
|
J:95017
|
Nkx2-1tm1Shk/Nkx2-1tm1Shk
(involves: 129S4/SvJae)
|
abnormal adenohypophysis development
|
J:50517
|
abnormal adrenal cortex morphology
|
J:30559
|
abnormal Rathke's pouch apoptosis
|
J:50517
|
abnormal Rathke's pouch development
|
J:50517
|
abnormal thyroid gland development
|
J:110629
|
absent pituitary gland
|
J:30559
|
absent pituitary infundibular stalk
|
J:50517
|
absent thyroid gland
|
J:30559
|
Nkx2-1tm2Rdl/Nkx2-1tm2Rdl
(B6.129-Nkx2-1tm2Rdl)
|
abnormal pituitary gland development
|
J:169693
|
abnormal Rathke's pouch development
|
J:169693
|
abnormal thyroid gland development
|
J:169693
|
absent infundibular recess of third ventricle
|
J:169693
|
absent pituitary gland
|
J:169693
|
absent thyroid gland
|
J:169693
|
Nkx2-1tm2Shk/Nkx2-1tm2Shk
(involves: 129S4/SvJae * 129X1/SvJ)
|
abnormal thyroid follicle morphology
|
J:111027
|
Nkx2-1tm2Shk/Nkx2-1tm2Shk Tg(TPO-cre)1Shk/0
(involves: 129X1/SvJ * FVB/NCr)
|
abnormal thyroid follicle morphology
|
J:111027
|
small thyroid gland
|
J:111027
|
Nkx2-1tm3Rdl/Nkx2-1tm3Rdl
(B6.129-Nkx2-1tm3Rdl)
|
abnormal thyroid gland development
|
J:169693
|
absent thyroid gland
|
J:169693
|
Nkx2-2tm1Jlr/Nkx2-2tm1Jlr
(involves: 129X1/SvJ)
|
abnormal pancreatic beta cell differentiation
|
J:48576
|
abnormal pancreatic islet morphology
|
J:48576
|
absent pancreatic beta cells
|
J:48576
|
decreased pancreatic alpha cell number
|
J:48576
|
decreased PP cell number
|
J:48576
|
Nkx2-2tm1Jlr/Nkx2-2tm1Jlr Nkx6-1tm1Jlr/Nkx6-1tm1Jlr
(involves: 129 * 129X1/SvJ * C57BL/6J)
|
decreased pancreatic alpha cell number
|
J:65594
|
decreased pancreatic beta cell number
|
J:65594
|
decreased PP cell number
|
J:65594
|
disorganized pancreatic islets
|
J:65594
|
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * C57BL/6J * SJL)
|
decreased pancreatic beta cell number
|
J:177838
|
disorganized pancreatic islets
|
J:177838
|
increased pancreatic alpha cell number
|
J:177838
|
increased pancreatic epsilon cell number
|
J:177838
|
small pancreatic islets
|
J:177838
|
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA/J * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:177838
|
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+ Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:177838
|
Nkx2-2tm5.1Suss/Nkx2-2tm5.1Suss Tg(Pdx1-cre)6Tuv/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * NTac:NIHBS * SJL)
|
decreased pancreatic alpha cell number
|
J:204869
|
decreased pancreatic beta cell number
|
J:204869
|
increased pancreatic epsilon cell number
|
J:204869
|
Nkx2-5tm1(cre)Rjs/Nkx2-5+ Tbx1tm1Bld/Tbx1tm3Bld
(involves: 129S7/SvEvBrd * C57BL/6)
|
small thymus
|
J:91013
|
Nkx6-1tm1.1Msan/Nkx6-1+ Pdx1tm1Cvw/Pdx1+ Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal pancreatic islet morphology
|
J:195153
|
decreased pancreatic beta cell number
|
J:195153
|
increased pancreatic alpha cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1.1Msan Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: 129 * C57BL/6 * DBA * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:195153
|
decreased pancreatic beta cell number
|
J:195153
|
increased pancreatic delta cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1.1Msan Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal pancreatic beta cell differentiation
|
J:195153
|
decreased pancreatic beta cell number
|
J:195153
|
increased pancreatic alpha cell number
|
J:195153
|
increased pancreatic delta cell number
|
J:195153
|
increased pancreatic epsilon cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1.2Msan
(involves: 129S6/SvEvTac * C57BL * DBA * SJL)
|
decreased pancreatic beta cell number
|
J:195153
|
Nkx6-1tm1Jlr/Nkx6-1tm1Jlr
(involves: 129 * C57BL/6J)
|
decreased pancreatic beta cell number
|
J:65594
|
small pancreatic islets
|
J:65594
|
Nle1tm1Cba/Nle1tm1.1Cota Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
thymus hypoplasia
|
J:204063
|
Nlktm1Tbo/Nlktm1Tbo
(129S1/Sv-Nlktm1Tbo)
|
decreased thymocyte number
|
J:73353
|
thymus hypoplasia
|
J:73353
|
nmf4/nmf4
(C57BL/6J-nmf4/J)
|
thymus cortex atrophy
|
J:78134
|
Nmf15/Nmf15+
(C57BL/6J-Nmf15/J)
|
enlarged pancreatic islets
|
J:82238
|
nmf356/nmf356
(C57BL/6J-nmf356/J)
|
pancreatic islet hyperplasia
|
J:87349
|
thymus atrophy
|
J:87349
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru Nmt2tm1.1Poru/Nmt2tm1.1Poru Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased DN4 thymocyte number
|
J:226234
|
small thymus medulla
|
J:226234
|
Nnattm1.2Geno/Nnat+
(either: 129S2(Cg)-Nnattm1.2Geno or B6.129S2(Cg)-Nnattm1.2Geno)
|
abnormal pancreatic beta cell morphology
|
J:265677
|
abnormal pancreatic islet morphology
|
J:265677
|
NntC57BL/6J/NntC57BL/6J
(C57BL/6J)
|
abnormal adrenocortical cell morphology
|
J:185986
|
disorganized adrenal gland zona fasciculata
|
J:185986
|
Noc2ltm1.1Arte/Noc2ltm1.1Arte Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal thymus cell ratio
|
J:216490
|
abnormal thymus morphology
|
J:216490
|
decreased DN3 thymocyte number
|
J:216490
|
decreased DN4 thymocyte number
|
J:216490
|
small thymus
|
J:216490
|
thymus hypoplasia
|
J:216490
|
Nogtm1Amc/Nogtm1Amc
(either: (involves: 129S1/Sv * CD-1) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal pituitary gland development
|
J:121318
|
abnormal Rathke's pouch apoptosis
|
J:121318
|
abnormal Rathke's pouch development
|
J:121318
|
absent adenohypophysis
|
J:121318
|
absent pituitary gland
|
J:121318
|
absent pituitary infundibular stalk
|
J:121318
|
absent Rathke's pouch
|
J:121318
|
Nop53tm2.1Asuz/Nop53tm2.1Asuz Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
Nop53tm2.1Asuz/Nop53tm2.1Asuz Trp53tm1Tyj/Trp53tm1Tyj Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
Notch1tm1Agt/Notch1tm1Agt Notch2tm1Frad/Notch2tm1Frad Ptf1atm1(cre)Hnak/Ptf1a+
(involves: 129 * BALB/cJ)
|
abnormal endocrine pancreas morphology
|
J:139250
|
decreased pancreatic islet number
|
J:139250
|
Notch1tm1Agt/Notch1tm1Agt Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal thymus cell ratio
|
J:55400,
J:143472
|
abnormal thymus morphology
|
J:55400
|
decreased thymocyte number
|
J:55400
|
small thymus
|
J:55400
|
Notch1tm2Pst/Notch1tm2Pst
(B6.Cg-Notch1tm2Pst)
|
decreased thymocyte number
|
J:131563
|
Notch2tm3Grid/Notch2tm3Grid Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
small pituitary gland
|
J:130929
|
Notch3tm1Khan/Notch3tm1Khan
(involves: C57BL/6 * CBA)
|
decreased thymocyte number
|
J:98284
|
small thymus
|
J:98284
|
Noxa1em1(IMPC)Ccpcz/Noxa1em1(IMPC)Ccpcz
(C57BL/6NCrl-Noxa1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Npattm1b(EUCOMM)Wtsi/Npattm1b(EUCOMM)Wtsi
(C57BL/6N-Npattm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal adrenal gland morphology
|
J:239583
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Npc1m1N/Npc1m1N
(involves: BALB/c)
|
abnormal adenohypophysis morphology
|
J:91430
|
adenohypophysis hypoplasia
|
J:91430
|
decreased lactotroph cell number
|
J:91430
|
Npc2tm1e.1(EUCOMM)Wtsi/Npc2+
(C57BL/6N-Npc2tm1e.1(EUCOMM)Wtsi/Tcp)
|
small adrenal glands
|
J:211773
|
Nr0b1tm1.1Lja/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
retention of the adrenal gland x-zone
|
J:51292
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neurohypophysis median eminence morphology
|
J:81790
|
Nr3c1Gt(ESKN92)Hgs/Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs)
|
abnormal adrenal gland morphology
|
J:141205
|
abnormal adrenal gland zona fasciculata morphology
|
J:141205
|
abnormal adrenal gland zona glomerulosa morphology
|
J:141205
|
enlarged adrenal glands
|
J:141205
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
thymus hypoplasia
|
J:189951
|
Nr3c1tm1Dage/Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased adrenal gland zona fasciculata size
|
J:147914
|
small adrenal glands
|
J:147914
|
thin adrenal cortex
|
J:147914
|
Nr3c1tm1Dage/Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased adrenal gland zona fasciculata size
|
J:147914
|
small adrenal glands
|
J:147914
|
thin adrenal cortex
|
J:147914
|
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal adrenal chromaffin cell morphology
|
J:27441
|
abnormal adrenal cortex morphology
|
J:27441
|
abnormal adrenal gland morphology
|
J:27441
|
abnormal adrenal gland zona reticularis morphology
|
J:27441
|
absent adrenal medulla
|
J:27441
|
absent adrenergic chromaffin cells
|
J:27441
|
enlarged adrenal glands
|
J:27441
|
enlarged adrenocortical cell nuclei
|
J:27441
|
enlarged adrenocortical cells
|
J:27441
|
increased adrenal gland zona fasciculata size
|
J:27441
|
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd)
|
abnormal adrenal chromaffin cell morphology
|
J:54931
|
Nr3c1tm2.1Gsc/Nr3c1tm2.1Gsc
(involves: 129P2/OlaHsd)
|
abnormal adrenal chromaffin cell morphology
|
J:54931
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal thymus morphology
|
J:121903
|
Nr5a1em1Kemi/Nr5a1+
(involves: C57BL/6 * DBA/2)
|
small adrenal glands
|
J:277036
|
Nr5a1em1Kemi/Nr5a1em1Kemi
(involves: C57BL/6 * DBA/2)
|
absent adrenal gland
|
J:277036
|
Nr5a1tm1.1Hain/Nr5a1+
(Not Specified)
|
retention of the adrenal gland x-zone
|
J:175843
|
Nr5a1tm1.1Hain/Nr5a1tm1.1Hain
(Not Specified)
|
retention of the adrenal gland x-zone
|
J:175843
|
small adrenal glands
|
J:175843
|
Nr5a1tm1Enl/Nr5a1tm1Enl
(involves: 129S4/SvJae)
|
abnormal pituitary gland morphology
|
J:28971
|
absent adrenal gland
|
J:28971
|
decreased gonadotroph cell number
|
J:28971
|
Nr5a1tm1Jmi/Nr5a1tm1Jmi
(involves: 129X1/SvJ)
|
absent adrenal gland
|
J:35577
|
Nr5a1tm1Klp/Nr5a1tm1Klp
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
absent adrenal gland
|
J:35576
|
Nr5a1tm2.1Klp/Nr5a1tm2.1Klp
(involves: 129P2/OlaHsd)
|
absent adrenal gland
|
J:66593
|
Nr5a1tm3Klp/Nr5a1tm3Klp
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
absent adrenal gland
|
J:28763
|
Nrastm1.1Emfu/Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N)
|
abnormal thymus morphology
|
J:189834
|
Nsmftm1a(KOMP)Wtsi/Nsmftm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased gonadotroph cell number
|
J:222116
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal thymus capsule morphology
|
J:239583
|
Ntrk2tm1Mini/Ntrk2+
(involves: 129P2/OlaHsd * C57BL/6)
|
adrenal cortical hyperplasia
|
J:210229
|
increased adrenal gland zona fasciculata size
|
J:210229
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
adrenal cortical hyperplasia
|
J:210229
|
increased adrenal gland zona fasciculata size
|
J:210229
|
Nudcd3em1(IMPC)Wtsi/Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi)
|
increased DN3 thymocyte number
|
J:351330
|
thymus hypoplasia
|
J:351330
|
Nuggcem1(IMPC)Ccpcz/Nuggcem1(IMPC)Ccpcz
(C57BL/6NCrl-Nuggcem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Nxntm1b(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ucd)
|
small adrenal glands
|
J:211773
|
Nxnl2em1(IMPC)Ccpcz/Nxnl2+
(C57BL/6NCrl-Nxnl2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Nxnl2em1(IMPC)Ccpcz/Nxnl2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nxnl2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Oas1cem1(IMPC)Ccpcz/Oas1cem1(IMPC)Ccpcz
(C57BL/6N-Oas1cem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Odad3b2b1885Clo/Odad3b2b1885Clo
(C57BL/6J-Odad3b2b1885Clo)
|
abnormal adrenal gland morphology
|
J:175213
|
Odaphem1(IMPC)Ccpcz/Odaphem1(IMPC)Ccpcz
(C57BL/6NCrl-Odaphem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ogttm1Gwh/Y Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:93112
|
Onecut1tm1.1Mga/Onecut1tm1.1Mga Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
absent pancreatic islets
|
J:155058
|
decreased pancreatic alpha cell number
|
J:155058
|
decreased pancreatic beta cell number
|
J:155058
|
Onecut1tm1Flem/Onecut1tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal pancreatic islet morphology
|
J:62595
|
absent pancreatic alpha cells
|
J:121610
|
absent pancreatic beta cells
|
J:121610
|
decreased pancreatic alpha cell number
|
J:62595
|
decreased pancreatic beta cell number
|
J:62595
|
decreased pancreatic delta cell number
|
J:62595
|
disorganized pancreatic islets
|
J:62595
|
Opa1tm1.1Hise/Opa1tm1.2Hise Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL)
|
abnormal pancreatic beta cell morphology
|
J:183074
|
decreased pancreatic beta cell number
|
J:183074
|
small pancreatic islets
|
J:183074
|
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep)
|
enlarged pancreatic islets
|
J:147786
|
Or1e32em1(IMPC)Mbp/Or1e32em1(IMPC)Mbp
(C57BL/6NCrl-Or1e32em1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan)
|
increased pancreatic beta cell number
|
J:214124
|
Osr1tm1Jian/Osr1tm1Jian
(either: (involves: 129S1/Sv * C57BL/6J) or (involves: 129S1/Sv * ICR))
|
absent adrenal gland
|
J:104942
|
Otcem1(IMPC)Tcp/Otc+
(C57BL/6NCrl-Otcem1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
Otop1em1(IMPC)Ccpcz/Otop1em1(IMPC)Ccpcz
(C57BL/6NCrl-Otop1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Otptm1Tlu/Otptm1Tlu
(either: 129/Sv-Otptm1Tlu or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal neurohypophysis median eminence morphology
|
J:65759
|
abnormal neurohypophysis morphology
|
J:65759
|
Otud5tm1Vmd/Otud5tm1Vmd Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:219495
|
Otx2tm1Pas/Otx2+
(involves: C57BL/6 * FVB/N)
|
abnormal gonadotroph morphology
|
J:210118
|
decreased gonadotroph cell number
|
J:210118
|
Otx2tm1Sia/Otx2+
(involves: C57BL/6 * CBA)
|
abnormal adenohypophysis morphology
|
J:29682
|
Otx2tm2(Otx1)Sia/Otx2tm2(Otx1)Sia
(involves: C57BL/6 * CBA)
|
absent pituitary gland
|
J:51989
|
Pabir2em1(IMPC)Ccpcz/Y
(C57BL/6NCrl-Pabir2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Pabir2em1(IMPC)Ccpcz/Pabir2em1(IMPC)Ccpcz
(C57BL/6NCrl-Pabir2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Pag1tm1Kplm/Pag1tm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte number
|
J:101365
|
Pahem1(IMPC)Tcp/Pahem1(IMPC)Tcp
(C57BL/6NCrl-Pahem1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:92244
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
thymus atrophy
|
J:116017
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd)
|
thymus atrophy
|
J:269785
|
Parltm1Bdes/Parltm1Bdes Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
thymus atrophy
|
J:269785
|
Patz1tm1.1Welm/Patz1tm1.1Welm
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:158947
|
Pax1un-i/Pax1+
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased thymocyte number
|
J:100951
|
Pax1un-i/Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased thymocyte number
|
J:100951
|
Pax21Neu/Pax21Neu
(involves: 102)
|
increased pancreatic beta cell mass
|
J:89465
|
increased pancreatic islet number
|
J:89465
|
pancreatic islet hyperplasia
|
J:89465
|
Pax21Neu/Pax2+
(involves: 102)
|
increased pancreatic beta cell mass
|
J:89465
|
increased pancreatic islet number
|
J:89465
|
pancreatic islet hyperplasia
|
J:89465
|
Pax3Sp-1H/Pax3Sp-1H
(involves: 101/H * C3H/HeH * C57BL/6)
|
abnormal thymus morphology
|
J:88412
|
abnormal thyroid gland morphology
|
J:88412
|
absent thyroid gland
|
J:88412
|
absent ultimobranchial body
|
J:88412
|
small thyroid gland
|
J:88412
|
Pax3tm1(FOXO1A)Gcg/Pax3+
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))
|
abnormal thymus lobule morphology
|
J:79365
|
ectopic thymus
|
J:79365
|
Pax4tm1(cre/ERT2)Sosa/Pax4tm1(cre/ERT2)Sosa
(Not Specified)
|
absent pancreatic beta cells
|
J:130423
|
absent pancreatic delta cells
|
J:130423
|
Pax4tm1Pgr/Pax4tm1.1Aman Tg(CMV-cre)1Cgn/0
(involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)
|
absent pancreatic beta cells
|
J:192683
|
absent pancreatic delta cells
|
J:192683
|
increased pancreatic alpha cell number
|
J:192683
|
Pax4tm1Pgr/Pax4tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * NMRI))
|
abnormal pancreatic islet morphology
|
J:40439
|
absent pancreatic delta cells
|
J:39028
|
decreased pancreatic beta cell number
|
J:39208
|
Pax4tm1Pgr/Pax4tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ)
|
absent pancreatic beta cells
|
J:130423
|
absent pancreatic delta cells
|
J:130423
|
Pax6Sey-Neu/Pax6Sey-Neu
(involves: 102 * C3H * CD-1)
|
absent pancreatic alpha cells
|
J:41624
|
absent pancreatic beta cells
|
J:41624
|
Pax6tm1Pgr/Pax6tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
absent pancreatic alpha cells
|
J:40439
|
disorganized pancreatic islets
|
J:40439
|
Pax6tm1Pgr/Pax6tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S1/Sv * 129X1/SvJ * FVB * NMRI)
|
decreased pancreatic alpha cell number
|
J:90642
|
decreased pancreatic beta cell number
|
J:90642
|
Pax6tm2Pgr/Pax6tm2Pgr Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB * NMRI)
|
decreased pancreatic alpha cell number
|
J:90642
|
decreased pancreatic beta cell number
|
J:90642
|
Pax6tm2Pgr/Pax6tm2Pgr Tg(Pdx1-cre)6Cvw/0
(involves: FVB * NMRI)
|
decreased pancreatic alpha cell number
|
J:90642
|
decreased pancreatic beta cell number
|
J:90642
|
Pax8tm1(cre)Mbu/Pax8tm1(cre)Mbu
(involves: 129P2/OlaHsd * C3H/He * C57BL/6)
|
absent thyroid gland
|
J:80208
|
Pax8tm1Pgr/Pax8tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal adenohypophysis morphology
|
J:117324
|
abnormal thyroid diverticulum morphology
|
J:47310
|
abnormal thyroid gland development
|
J:47310
|
abnormal thyroid gland morphology
|
J:47310
|
absent thyroid follicular cells
|
J:47310
|
decreased lactotroph cell number
|
J:117324
|
decreased somatotroph cell number
|
J:117324
|
increased thyrotroph cell number
|
J:117324
|
small thyroid gland
|
J:47310
|
Pax8tm1Rdl/Pax8tm1.1(cre)Mbu
(B6.129(Cg)-Pax8tm1Rdl Pax8tm1.1(cre)Mbu)
|
abnormal thyroid follicle morphology
|
J:220108
|
abnormal thyroid follicular cell morphology
|
J:220108
|
abnormal thyroid gland morphology
|
J:220108
|
small thyroid gland
|
J:220108
|
Pax9tm1.1Hpt/Pax9tm1.1Hpt Tg(Pgk1-cre)1Lni/?
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal thymus lobule morphology
|
J:125026
|
absent parathyroid glands
|
J:125026
|
Pax9tm1Rbal/Pax9tm1Rbal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent parathyroid glands
|
J:49857
|
absent ultimobranchial body
|
J:49857
|
athymia
|
J:49857
|
Pax9tm1Rbal/Pax9tm1Rbal
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
ectopic thymus
|
J:311535
|
thymus hypoplasia
|
J:311535
|
Paxxem1Spj/Paxxem1Spj Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
athymia
|
J:236776
|
Pbx1em1Dunw/Pbx1em1Dunw
(C57BL/6J-Pbx1em1Dunw)
|
adrenal gland hypoplasia
|
J:320934
|
ectopic thymus
|
J:320934
|
thymus hypoplasia
|
J:320934
|
Pbx1tm1.1Febe/Pbx1+
(involves: C57BL/6)
|
decreased adrenal gland zona fasciculata size
|
J:129552
|
small adrenal glands
|
J:129552
|
Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:75811
|
Pbx1tm1Mlc/Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6)
|
absent adrenal gland
|
J:87270
|
absent pancreatic islets
|
J:75811
|
ectopic thymus
|
J:71996
|
Pbx1tm1Mlc/Pbx1tm3.1Mlc Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal thymus morphology
|
J:149799
|
small thymus
|
J:149799
|
thymus hypoplasia
|
J:149799
|
Pcgf2tm1Hko/Pcgf2tm1Hko
(involves: BALB/c * C57BL/6)
|
decreased thymocyte number
|
J:71268
|
Pclaftm1.1Lkd/Pclaftm1.1Lkd
(involves: C57BL/6)
|
thymus hypoplasia
|
J:177782
|
Pcsk1em2Irli/Pcsk1em2Irli
(C57BL/6J-Pcsk1em2Irli)
|
abnormal pancreatic islet morphology
|
J:324309
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell differentiation
|
J:85590
|
abnormal pancreatic islet morphology
|
J:41505
|
decreased pancreatic beta cell number
|
J:41505
|
increased pancreatic alpha cell mass
|
J:41505
|
increased pancreatic delta cell number
|
J:41505
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J)
|
abnormal pancreatic alpha cell differentiation
|
J:236905
|
abnormal pancreatic alpha cell morphology
|
J:236905
|
enlarged pancreatic islets
|
J:236905
|
increased pancreatic alpha cell number
|
J:236905
|
pancreatic islet hyperplasia
|
J:236905
|
Pcsk5vcc/Pcsk5vcc
(involves: C57BL/6J)
|
abnormal thymus lobule morphology
|
J:136243
|
small thymus
|
J:136243
|
Pdgfratm8Sor/Pdgfratm8Sor H2az2Tg(Wnt1-cre)11Rth/H2az2+
(Not Specified)
|
small thymus
|
J:81153
|
Pdgfratm8Sor/Pdgfratm8Sor Pdgfrbtm1Mdt/Pdgfrbtm1Mdt H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6 * CBA)
|
abnormal thymus development
|
J:122584
|
thymus hypoplasia
|
J:122584
|
Pdgfratm8Sor/Pdgfratm8Sor Pdgfrbtm11Sor/Pdgfrbtm11Sor Tg(Nr5a1-cre)2Klp/0
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal adrenal cortex morphology
|
J:142042
|
abnormal adrenal gland morphology
|
J:142042
|
small adrenal glands
|
J:142042
|
Pdgfrbb2b2903Clo/Pdgfrbb2b2903Clo
(C57BL/6J-Pdgfrbb2b2903Clo)
|
thymus hypoplasia
|
J:175213
|
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J)
|
thymus hypoplasia
|
J:288824
|
Pdia6tm1b(EUCOMM)Hmgu/Pdia6+
(C57BL/6N-Pdia6tm1b(EUCOMM)Hmgu/Ieg)
|
enlarged thyroid gland
|
J:211773
|
Pdik1lem1(IMPC)Mbp/Pdik1lem1(IMPC)Mbp
(C57BL/6NCrl-Pdik1lem1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Pdpk1tm1Dral/Pdpk1tm1Dral
(B6.129P2-Pdpk1tm1Dral)
|
decreased adrenal gland zona fasciculata size
|
J:136089
|
pancreatic islet hyperplasia
|
J:136089
|
pancreatic islet hypoplasia
|
J:136089
|
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N)
|
abnormal melanotroph morphology
|
J:134336
|
decreased corticotroph cell number
|
J:134336
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(CAG-cat,-lacZ)11Miya/0 Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
|
abnormal pituitary intermediate lobe morphology
|
J:162892
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:109010
|
small pancreatic islets
|
J:109010
|
Pdss1em1(IMPC)Mbp/Pdss1+
(C57BL/6NCrl-Pdss1em1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Pdx1tm1.1Stof/Pdx1+
(involves: 129/Sv * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:152582
|
Pdx1tm1.1Stof/Pdx1tm1.1Stof
(involves: 129/Sv * C57BL/6)
|
abnormal pancreatic delta cell morphology
|
J:152582
|
abnormal pancreatic epsilon cell morphology
|
J:152582
|
abnormal PP cell morphology
|
J:152582
|
decreased pancreatic alpha cell mass
|
J:152582
|
decreased pancreatic beta cell mass
|
J:152582
|
pancreatic islet hypoplasia
|
J:152582
|
Pdx1tm1Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic islet size
|
J:165268
|
decreased pancreatic beta cell number
|
J:165268
|
disorganized pancreatic islets
|
J:165268
|
small pancreatic islets
|
J:165268
|
Pdx1tm1Cvw/Pdx1+ Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
disorganized pancreatic islets
|
J:75811
|
Pdx1tm1Cvw/Pdx1+ SpopGt(BGB118)Byg/Spop+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:165268
|
disorganized pancreatic islets
|
J:165268
|
Pdx1tm1Cvw/Pdx1tm1Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pancreatic beta cell differentiation
|
J:32017
|
abnormal pancreatic islet morphology
|
J:32017
|
Pdx1tm1Cvw/Pdx1tm4Cvw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA)
|
decreased pancreatic beta cell number
|
J:130389
|
disorganized pancreatic islets
|
J:130389
|
increased pancreatic alpha cell number
|
J:130389
|
increased pancreatic delta cell number
|
J:130389
|
Pdx1tm1Heed/Pdx1tm1Heed Tg(Ins2-cre)1Heed/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:48516
|
decreased pancreatic beta cell number
|
J:48516
|
disorganized pancreatic islets
|
J:48516
|
increased pancreatic alpha cell number
|
J:48516
|
Pdx1tm1Macd/Pdx1+ Tg(tetO-Sox17,-EGFP)1Jaw/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal endocrine pancreas morphology
|
J:151981
|
Pdx1tm1Macd/Pdx1tm1Macd Tg(tetO-Ipf1,EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal pancreatic beta cell morphology
|
J:101742
|
small pancreatic islets
|
J:101742
|
Pdx1tm1Ted/Pdx1+
(involves: 129P2/OlaHsd)
|
abnormal pancreatic islet morphology
|
J:82969
|
decreased pancreatic beta cell mass
|
J:82969
|
decreased pancreatic islet number
|
J:82969
|
small pancreatic islets
|
J:82969
|
Pdx1tm2Cvw/Pdx1+ Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL)
|
pancreatic islet hyperplasia
|
J:97234
|
Pdx1tm2Cvw/Pdx1tm2Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pancreatic beta cell differentiation
|
J:32017
|
abnormal pancreatic islet morphology
|
J:32017
|
Pdx1tm3Cvw/Pdx1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
disorganized pancreatic islets
|
J:104617
|
increased pancreatic alpha cell number
|
J:104617
|
increased PP cell number
|
J:104617
|
Pex2tm1Plf/Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal adrenal cortex morphology
|
J:44975
|
Pex7tm1Nbra/Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6)
|
abnormal adrenal gland morphology
|
J:158845
|
Pex13tm1.1Crne/Pex13tm1.1Crne
(involves: 129T2/SvEms * C57BL/6J)
|
abnormal adrenocortical cell morphology
|
J:84795
|
Pfdn1Gt(GTR1.3)1Rul/Pfdn1Gt(GTR1.3)1Rul
(involves: 129)
|
abnormal thymus cell ratio
|
J:137415
|
abnormal thymus morphology
|
J:137415
|
decreased thymus weight
|
J:137415
|
thymus hypoplasia
|
J:137415
|
Pgap1oto/Pgap1oto
(involves: STOCK In(1)1Rk/J)
|
absent Rathke's pouch
|
J:41878
|
Pgbd1em1(IMPC)Tcp/Pgbd1em1(IMPC)Tcp
(C57BL/6NCrl-Pgbd1em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Pgcem1(IMPC)Ccpcz/Pgcem1(IMPC)Ccpcz
(C57BL/6NCrl-Pgcem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Pglyrp4em1(IMPC)Ccpcz/Pglyrp4em1(IMPC)Ccpcz
(C57BL/6NCrl-Pglyrp4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
small thymus
|
J:211773
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased pancreatic beta cell number
|
J:125584
|
pancreatic islet hyperplasia
|
J:125584
|
Phc1tm1Os/Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6)
|
decreased thymus weight
|
J:43764
|
parathyroid hypoplasia
|
J:43764
|
Phf6em1Wencc/Y Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
abnormal thymus cell ratio
|
J:278804
|
Phf6em1Wencc/Phf6em1Wencc Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
abnormal thymus cell ratio
|
J:278804
|
Phf6tm1.1Avo/Y Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased DN2 thymocyte number
|
J:276228
|
Phf6tm1.2Avo/Y
(involves: BALB/c * BALB/cJ * C57BL/6 * FVB/N)
|
small pituitary gland
|
J:299742
|
Phf20Gt(XN131)Byg/Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:228714
|
small thymus
|
J:228714
|
thymus hypoplasia
|
J:228714
|
Pigvb2b2859Clo/Pigvb2b2859Clo
(C57BL/6J-Pigvb2b2859Clo)
|
thymus hypoplasia
|
J:175213
|
Pik3catm1Bvan/Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic beta cell number
|
J:109024
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi)
|
pancreatic islet hyperplasia
|
J:152332
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal thymus lobule morphology
|
J:125791
|
small thymus
|
J:125791
|
thymus hypoplasia
|
J:125791
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:60347
|
thymus hypoplasia
|
J:60347
|
Pik3r1tm1.1Geno/Pik3r1+
(involves: C57BL/6 * C57BL/6J)
|
pancreatic islet hyperplasia
|
J:234657
|
PikfyveGt(AT0926)Wtsi/PikfyveGt(AT0926)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus morphology
|
J:190368
|
thymus hypoplasia
|
J:190368
|
Piptm1Myal/Piptm1Myal
(involves: 129S/SvEv * C57BL/6)
|
abnormal thymus corticomedullary boundary morphology
|
J:202016
|
enlarged thymus
|
J:202016
|
enlarged thymus medulla
|
J:202016
|
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:85204
|
decreased pancreatic islet number
|
J:85204
|
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd)
|
abnormal pancreatic islet morphology
|
J:85204
|
decreased pancreatic islet number
|
J:85204
|
Pitx1tm1Jdr/Pitx1+ Pitx2tm1Sac/Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ)
|
small Rathke's pouch
|
J:73774
|
Pitx1tm1Jdr/Pitx1tm1Jdr Pitx2tm1Sac/Pitx2+
(involves: 129S1/Sv * 129X1/SvJ)
|
small Rathke's pouch
|
J:73774
|
Pitx1tm1Jdr/Pitx1tm1Jdr Pitx2tm1Sac/Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal Rathke's pouch development
|
J:73774
|
Pitx1tm1Rsd/Pitx1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pituitary gland morphology
|
J:53310
|
decreased gonadotroph cell number
|
J:53310
|
decreased thyrotroph cell number
|
J:53310
|
Pitx2tm1.1Dmm/Pitx2tm2Sac
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
pituitary gland hypoplasia
|
J:181058
|
Pitx2tm1.1Sac/Pitx2tm2Sac Tg(Tshb-cre)4Sac/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
small thyroid gland
|
J:197591
|
Pitx2tm1Rsd/Pitx2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pituitary gland development
|
J:57673
|
pituitary gland hypoplasia
|
J:57673
|
Pitx2tm1Sac/Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal adenohypophysis morphology
|
J:73774
|
absent gonadotrophs
|
J:73774
|
decreased somatotroph cell number
|
J:73774
|
decreased thyrotroph cell number
|
J:73774
|
Pitx2tm1Sac/Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ)
|
small Rathke's pouch
|
J:73774
|
Pitx2tm2Sac/Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal adenohypophysis development
|
J:51160
|
abnormal Rathke's pouch apoptosis
|
J:99227
|
abnormal Rathke's pouch development
|
J:99227,
J:51160
|
Pitx2tm2Sac/Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ)
|
adenohypophysis hypoplasia
|
J:73774
|
Pkd1tm1Jzh/Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))
|
decreased pancreatic islet number
|
J:72627
|
Pkd1tm1Jzh/Pkd1tm1Jzh
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))
|
decreased pancreatic islet number
|
J:43193
|
Pkn3tm1.1Mrl/Pkn3+ Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
enlarged thymus
|
J:216983
|
Pkn3tm1.1Mrl/Pkn3tm1.1Mrl Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
enlarged thymus
|
J:216983
|
Pknox1Gt(OST71835)Lex/Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
thymus hypoplasia
|
J:103769
|
Pla2g5em1(IMPC)Ccpcz/Pla2g5em1(IMPC)Ccpcz
(C57BL/6NCrl-Pla2g5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
thymus hyperplasia
|
J:157757
|
Plppr5em1(IMPC)Ccpcz/Plppr5em1(IMPC)Ccpcz
(C57BL/6NCrl-Plppr5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
plt/plt
(B6.DDD-plt)
|
abnormal thymus cortex morphology
|
J:93960
|
small thymus medulla
|
J:93960
|
Plxnd1b2b1863Clo/Plxnd1b2b1863Clo
(C57BL/6J-Plxnd1b2b1863Clo)
|
thymus hypoplasia
|
J:175213
|
Plxnd1b2b3150Clo/Plxnd1b2b3150Clo
(C57BL/6J-Plxnd1b2b3150Clo)
|
thymus hypoplasia
|
J:175213
|
Pmltm1.1Ews/Pmltm1.1Ews
(involves: 129 * 129P2/OlaHsd)
|
increased T cell derived lymphoma incidence
|
J:262172
|
Pmltm1Ppp/Pml+ Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo)
|
increased T cell derived lymphoma incidence
|
J:317504
|
Pmltm1Ppp/Pmltm1Ppp Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo)
|
increased T cell derived lymphoma incidence
|
J:317504
|
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
increased T cell derived lymphoma incidence
|
J:162378
|
Pnpe/Pnpe
(C57BL/6J-Pnpe)
|
thymus hypoplasia
|
J:39328
|
Pnpf/Pnpf
(C57BL/6J-Pnpf)
|
thymus hypoplasia
|
J:39328
|
Pnpg/Pnpg
(involves: C57BL/6 * DBA/2J)
|
thymus hypoplasia
|
J:39328
|
Poats1C57BL/6JCrl/Poats1C57BL/6JCrl
(involves: C57BL/6JCrl * DBA/2JCrl)
|
increased adrenal gland tumor incidence
|
J:131752
|
Pofut1tm2Pst/Pofut1tm1Pst Shhtm2(cre/ERT2)Cjt/Shh+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
increased solitary pulmonary neuroendocrine cell number
|
J:150051
|
Polbtm1a(KOMP)Wtsi/Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi)
|
adrenal gland hypoplasia
|
J:239583
|
small thyroid gland
|
J:239583
|
Pold1tm1.1Bdp/Pold1tm1.1Bdp
(B6.129-Pold1tm1.1Bdp)
|
increased T cell derived lymphoma incidence
|
J:153684
|
Pold1tm1.1Bdp/Pold1tm1.1Bdp Poletm1.1Bdp/Poletm1.1Bdp
(B6.129-Poletm1.1Bdp Pold1tm1.1Bdp)
|
increased T cell derived lymphoma incidence
|
J:153684
|
Pold1tm1.1Uchi/Pold1tm1.1Uchi
(C57BL/6-Pold1tm1.1Uchi)
|
enlarged thymus
|
J:144992
|
Pold1tm1Bdp/Pold1tm1Bdp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:100685
|
Pold1tm1Uchi/Pold1tm1.1Uchi
(C57BL/6-Pold1tm1Uchi/Pold1tm1.1Uchi)
|
enlarged thymus
|
J:144992
|
Pole3em1Tbo/Pole3em1Tbo
(FVB-Pole3em1Tbo)
|
decreased thymocyte number
|
J:298827
|
Pole3em2Tbo/Pole3em2Tbo
(FVB-Pole3em2Tbo)
|
decreased thymocyte number
|
J:298827
|
Pole3em3Tbo/Pole3em3Tbo
(FVB-Pole3em3Tbo)
|
decreased DN4 thymocyte number
|
J:298827
|
decreased thymocyte number
|
J:298827
|
increased DN3 thymocyte number
|
J:298827
|
small thymus
|
J:298827
|
Pole3em4Tbo/Pole3em4Tbo
(FVB-Pole3em4Tbo)
|
decreased DN4 thymocyte number
|
J:298827
|
decreased thymocyte number
|
J:298827
|
increased DN3 thymocyte number
|
J:298827
|
Pole3tm1(KOMP)Vlcg/Pole3tm1(KOMP)Vlcg
(involves: C57BL/6NTac * FVB)
|
decreased DN4 thymocyte number
|
J:298827
|
increased DN3 thymocyte number
|
J:298827
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
abnormal thymus morphology
|
J:261973
|
absent thymus cortex
|
J:261973
|
athymia
|
J:261973
|
increased T cell derived lymphoma incidence
|
J:261973
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg Trp53tm1Brd/Trp53+
(involves: C57BL/6J * C57BL/6NTac)
|
increased T cell derived lymphoma incidence
|
J:261973
|
Polgtm1Prol/Polgtm1Prol
(B6J.129S7-Polgtm1Prol)
|
decreased thymocyte number
|
J:154187
|
Polr1bem1(IMPC)Tcp/Polr1b+
(C57BL/6NCrl-Polr1bem1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
Pomctm1Low/Pomc+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased pituitary adenoma incidence
|
J:119240
|
Pomctm1Low/Pomc+ Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
increased pituitary adenoma incidence
|
J:119240
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased adrenal gland zona fasciculata size
|
J:119240
|
disorganized adrenal gland zona fasciculata
|
J:119240
|
increased pituitary adenoma incidence
|
J:119240
|
small adrenal glands
|
J:119240
|
Pomctm1Low/Pomctm1Low Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster)
|
enlarged adrenal glands
|
J:119240
|
increased adrenal gland zona fasciculata size
|
J:119240
|
increased pituitary adenoma incidence
|
J:119240
|
Pomctm2Ute/Pomctm2Ute
(involves: 129S1/Sv * 129X1/SvJ)
|
absent adrenal gland
|
J:57503
|
Pou1f1dw/Pou1f1dw
(Not Specified)
|
absent lactotrophs
|
J:6754
|
absent somatotrophs
|
J:7211
|
decreased thyrotroph cell number
|
J:12161
|
Pou1f1dw/Pou1f1dw
(DW/J Pou1f1dw)
|
abnormal adenohypophysis morphology
|
J:108961
|
absent lactotrophs
|
J:7211
|
absent somatotrophs
|
J:7211
|
adenohypophysis hypoplasia
|
J:108961
|
Pou2f1tm1Shrp/Pou2f1tm1Shrp Sox2tm1.1Vep/Sox2+
(involves: 129S4/SvJae * C3H/HeN * C57BL/6)
|
abnormal adenohypophysis morphology
|
J:119175
|
abnormal pituitary diverticulum morphology
|
J:119175
|
Pou3f2tm1Rsd/Pou3f2tm1Rsd
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neurohypophysis morphology
|
J:30430
|
abnormal pituicyte morphology
|
J:30430
|
abnormal pituitary gland morphology
|
J:30430
|
Pou3f2tm1Tno/Pou3f2tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal neurohypophysis morphology
|
J:30429
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz Tg(Ins2-cre)25Mgn/0
(involves: 129 * C57 * FVB)
|
pancreatic islet hyperplasia
|
J:89959
|
Ppargtm1Mae/Pparg+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal endocrine pancreas morphology
|
J:91362
|
Ppargtm2(tTA)Yba/Pparg+
(involves: 129S1/SvImJ * C57BL/6)
|
pancreatic islet hyperplasia
|
J:125992
|
Ppargtm2Avp/Ppargtm2Avp
(involves: 129/Sv * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:121534
|
Ppargc1atm1Aztc/Ppargc1a+
(C57BL/6-Ppargc1atm1Aztc)
|
increased adrenal gland weight
|
J:82809
|
increased thymus weight
|
J:82809
|
Ppargc1atm1Brsp/Ppargc1atm2Brsp Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell morphology
|
J:127403
|
enlarged pancreatic islets
|
J:127403
|
increased pancreatic beta cell mass
|
J:127403
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
small thymus
|
J:74284
|
Ppp2r2aigt10/Ppp2r2a+
(involves: C3H/HeH * C57BL/6J)
|
increased pancreatic beta cell mass
|
J:246319
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymus weight
|
J:75775
|
thymus hypoplasia
|
J:77729
|
Ppp3r1tm2Grc/Ppp3r1tm2Grc Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:89771
|
thymus hypoplasia
|
J:89771
|
Ppp4r3btm1b(EUCOMM)Hmgu/Ppp4r3btm1b(EUCOMM)Hmgu
(C57BL/6N-Ppp4r3btm1b(EUCOMM)Hmgu/Ieg)
|
abnormal thymus morphology
|
J:211773
|
Prdm2tm1Shg/Prdm2+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary adenoma incidence
|
J:71406
|
Prdm2tm1Shg/Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary adenoma incidence
|
J:71406
|
Prdm8em1(IMPC)Wtsi/Prdm8+
(C57BL/6N-Prdm8em1(IMPC)Wtsi/Wtsi)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prdm8em1(IMPC)Wtsi/Prdm8em1(IMPC)Wtsi
(C57BL/6N-Prdm8em1(IMPC)Wtsi/Wtsi)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:84677
|
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz)
|
decreased pancreatic beta cell number
|
J:43468
|
Prf1tm1Sdz/Prf1tm1Sdz
(C.B6-Prf1tm1Sdz)
|
increased T cell derived lymphoma incidence
|
J:77491
|
Prkab1em2(IMPC)Mbp/Prkab1em2(IMPC)Mbp
(C57BL/6N-Prkab1em2(IMPC)Mbp/Ucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prkar1atm1.1Lsk/Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased thyroid tumor incidence
|
J:98799
|
Prkar1atm1.1Lsk/Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased thyroid tumor incidence
|
J:160299
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Ptentm1.1Mwst/Ptentm1.1Mwst Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)
|
enlarged thyroid gland
|
J:225245
|
increased thyroid carcinoma incidence
|
J:225245
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Tg(Ghrhr-cre)3242Lsk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased pituitary gland tumor incidence
|
J:130264
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)
|
abnormal thyroid gland morphology
|
J:241066
|
enlarged thyroid gland
|
J:241066
|
increased thyroid carcinoma incidence
|
J:225245,
J:241066
|
Prkar1atm1Lsk/Prkar1atm1Lsk Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal adrenal cortex morphology
|
J:161521
|
abnormal adrenal gland zona glomerulosa morphology
|
J:161521
|
adrenal cortical hyperplasia
|
J:161521
|
decreased adrenal gland zona fasciculata size
|
J:161521
|
disorganized adrenal gland zona fasciculata
|
J:161521
|
retention of the adrenal gland x-zone
|
J:161521
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:120293
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL)
|
decreased DN1 thymic pro-T cell number
|
J:186080
|
decreased DN4 thymocyte number
|
J:186080
|
thymus hypoplasia
|
J:186080
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased DN1 thymic pro-T cell number
|
J:186080
|
decreased DN4 thymocyte number
|
J:186080
|
Prkcitm1Rfar/Prkci+ Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
pancreatic islet hyperplasia
|
J:123964
|
Prkcitm1Rfar/Prkcitm1Rfar Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
pancreatic islet hyperplasia
|
J:123964
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:186080
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy Prkd3tm1.1Shoy/Prkd3tm1.1Shoy Tg(BCL2)25Wehi/0 Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6 * C57BL/6JWehi * SJL/JWehi)
|
decreased thymocyte number
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy Prkd3tm1.1Shoy/Prkd3tm1.1Shoy Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
small thymus medulla
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy Prkd3tm1.1Shoy/Prkd3tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy Prkd3tm1.1Shoy/Prkd3tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraTcrb)425Cbn/0
(involves: 129 * BALB/c * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy Prkd3tm1.1Shoy/Prkd3tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
Prkdcscid/Prkdcscid
(C.BKa-Prkdcscid)
|
abnormal thymus morphology
|
J:6958
|
absent thymus cortex
|
J:6958
|
increased T cell derived lymphoma incidence
|
J:6958
|
small thymus
|
J:6958
|
thymus cyst
|
J:6958
|
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid)
|
abnormal thymus corticomedullary boundary morphology
|
J:22026
|
abnormal thymus lobule morphology
|
J:22026
|
increased T cell derived lymphoma incidence
|
J:109833,
J:22026
|
thymus cyst
|
J:22026
|
Prkdcscid/Prkdcscid
(B6.Cg-Prkdcscid/Sz)
|
abnormal thymus morphology
|
J:34814
|
small thymus
|
J:34814
|
thymus cyst
|
J:34814
|
Prkdcscid/Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin/0
(C.BKa-Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin)
|
abnormal pancreatic islet morphology
|
J:204420
|
decreased pancreatic beta cell number
|
J:204420
|
PrkdcTg(INS-PDE2)5-1Lmb/?
(involves: FVB/N)
|
abnormal thymus morphology
|
J:108405
|
Prkdctm1Fwa/Prkdctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte number
|
J:50221
|
Prkdctm1Gcl/Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
absent thymus corticomedullary boundary
|
J:53765
|
increased T cell derived lymphoma incidence
|
J:53765
|
small thymus
|
J:53765
|
thymus hypoplasia
|
J:53765
|
Prkdctm1Get/Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss)
|
abnormal thymus corticomedullary boundary morphology
|
J:50222
|
thymus hypoplasia
|
J:50222
|
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas)
|
abnormal gonadotroph morphology
|
J:79661
|
abnormal pituitary gland morphology
|
J:79661
|
decreased lactotroph cell number
|
J:45243
|
enlarged pituitary gland
|
J:79661,
J:83246
|
increased pituitary adenoma incidence
|
J:79661
|
increased pituitary gland weight
|
J:83246
|
pituitary gland hyperplasia
|
J:79661
|
pituitary gland hypertrophy
|
J:79661
|
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:106829
|
decreased pancreatic beta cell mass
|
J:106829
|
small pancreatic islets
|
J:106829
|
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129/Sv * 129P2/OlaHsd)
|
abnormal thyroid gland morphology
|
J:101609
|
increased thyroid carcinoma incidence
|
J:101609
|
Prmt7tm1a(EUCOMM)Wtsi/Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal thymus topology
|
J:239583
|
Prnptm1Cwe/Prnptm1Cwe Tg(Lck-Prnp)33Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
thymus hypoplasia
|
J:129512
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp)a20Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased DN2 thymocyte number
|
J:129512
|
decreased DN4 thymocyte number
|
J:129512
|
decreased thymocyte number
|
J:129512
|
increased DN3 thymocyte number
|
J:129512
|
thymus atrophy
|
J:129512
|
Prop1df/Prop1df
(STOCK Prop1df)
|
absent somatotrophs
|
J:7211
|
decreased thyrotroph cell number
|
J:12169
|
small adenohypophysis
|
J:12169
|
small thyroid gland
|
J:12169
|
Prop1df/Prop1df
(DF)
|
abnormal pituitary gland development
|
J:108961
|
abnormal pituitary gland morphology
|
J:108961
|
pituitary gland hypoplasia
|
J:108961
|
Prop1tm1Rsd/Prop1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal adenohypophysis development
|
J:114817
|
Prop1tm1Sac/Prop1+
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
abnormal pituitary gland morphology
|
J:94409
|
Prop1tm1Sac/Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
abnormal neurohypophysis morphology
|
J:94409
|
adenohypophysis hypoplasia
|
J:94409
|
pituitary gland hypoplasia
|
J:94409
|
small thyroid gland
|
J:94409
|
Proser2em1(IMPC)Ccpcz/Proser2em1(IMPC)Ccpcz
(C57BL/6NCrl-Proser2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prox1tm1Gco/Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
abnormal endocrine pancreas morphology
|
J:103538
|
Prrc2btm1a(EUCOMM)Wtsi/Prrc2btm1a(EUCOMM)Wtsi
(C57BL/6N-Prrc2btm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal thyroid gland morphology
|
J:239583
|
Prss3btm1.1Satom/Prss3b+
(B6(FVB)-Prss3btm1.1Satom)
|
enlarged pancreatic islets
|
J:267764
|
Prss8tm1.1Hum/Prss8tm1.2Hum Tg(KRT14-cre)1Ipc/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL)
|
thymus medulla hypoplasia
|
J:100139
|
Prss12em1(IMPC)Ccpcz/Prss12em1(IMPC)Ccpcz
(C57BL/6N-Prss12em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss16tm1.1Mal/Prss16tm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus cortex morphology
|
J:148034
|
Prss16tm1.1Mal/Prss16tm1.1Mal Rag2tm1Fwa/Rag2tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
thymus hypoplasia
|
J:148034
|
Prss21em1(IMPC)Ccpcz/Prss21+
(C57BL/6N-Prss21em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss33em1(IMPC)Ccpcz/Prss33em1(IMPC)Ccpcz
(C57BL/6N-Prss33em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss35em1(IMPC)Ccpcz/Prss35em1(IMPC)Ccpcz
(C57BL/6N-Prss35em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss47em1(IMPC)Ccpcz/Prss47em1(IMPC)Ccpcz
(C57BL/6N-Prss47em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss48em1(IMPC)Ccpcz/Prss48em1(IMPC)Ccpcz
(C57BL/6NCrl-Prss48em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss54em1(IMPC)Ccpcz/Prss54em1(IMPC)Ccpcz
(C57BL/6N-Prss54em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss55em1(IMPC)Ccpcz/Prss55em1(IMPC)Ccpcz
(C57BL/6NCrl-Prss55em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Prss57em1(IMPC)Ccpcz/Prss57em1(IMPC)Ccpcz
(C57BL/6N-Prss57em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Psen2em1(IMPC)Ccpcz/Psen2em1(IMPC)Ccpcz
(C57BL/6NCrl-Psen2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Psma8em1(IMPC)Tcp/Psma8em1(IMPC)Tcp
(C57BL/6N-Psma8em1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
|
athymia
|
J:261081
|
Psmb11em1(IMPC)Ccpcz/Psmb11em1(IMPC)Ccpcz
(C57BL/6NCrl-Psmb11em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Psme4b2b1508Clo/Psme4b2b1508Clo
(C57BL/6J-Psme4b2b1508Clo)
|
thymus hypoplasia
|
J:175213
|
Psphtm1.1(KOMP)Vlcg/Psph+
(C57BL/6N-Psphtm1.1(KOMP)Vlcg/Ucd)
|
small adrenal glands
|
J:211773
|
Psphtm1a(EUCOMM)Hmgu/Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
abnormal neurohypophysis morphology
|
J:239583
|
abnormal pineal gland morphology
|
J:239583
|
abnormal thymus morphology
|
J:239583
|
abnormal thymus topology
|
J:239583
|
abnormal thyroid gland morphology
|
J:239583
|
absent neurohypophysis
|
J:239583
|
absent pineal gland
|
J:239583
|
athymia
|
J:239583
|
Pstpip1em1(IMPC)Ccpcz/Pstpip1em1(IMPC)Ccpcz
(C57BL/6N-Pstpip1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
pta/pta
(C57BL/6J-pta)
|
thymus hypoplasia
|
J:94456
|
Ptch1tm1Bjw/Ptch1tm1Bjw Tg(KRT14-cre)8Brn/0
(involves: 129T2/SvEms * FVB/N)
|
thymus hypoplasia
|
J:231264
|
Ptch1tm1Hahn/Ptch1tm1Hahn Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thymus lobule morphology
|
J:127207
|
thymus hypoplasia
|
J:127207
|
Ptcratm1(icre)Hjf/Ptcratm1(icre)Hjf
(B6.129P2-Ptcratm1(icre)Hjf)
|
decreased DN4 thymocyte number
|
J:197923
|
decreased thymocyte number
|
J:197923
|
Ptcratm1.1Shoy/Ptcratm1.1Shoy
(involves: C57BL/6)
|
decreased thymocyte number
|
J:166147
|
increased DN3 thymocyte number
|
J:166147
|
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
decreased DN4 thymocyte number
|
J:123569
|
increased DN3 thymocyte number
|
J:123569
|
thymus hypoplasia
|
J:123569
|
Ptentm1.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
|
increased adrenal gland tumor incidence
|
J:158751
|
increased T cell derived lymphoma incidence
|
J:158751
|
increased thyroid tumor incidence
|
J:158751
|
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * C57BL/6NTac)
|
increased thyroid adenoma incidence
|
J:170965
|
Ptentm1.1Mro/Pten+
(Not Specified)
|
increased pheochromocytoma incidence
|
J:236514
|
Ptentm1.1Mro/Pten+ Sdhbtm1.2Ics/Sdhb+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
increased pheochromocytoma incidence
|
J:236514
|
Ptentm1.1Mwst/Ptentm1.1Mwst Tg(TPO-cre)1Shk/0
(involves: 129 * FVB/NCr)
|
abnormal thyroid follicular cell morphology
|
J:225245
|
Ptentm1.2Mwst/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
|
increased adrenal gland tumor incidence
|
J:158751
|
increased T cell derived lymphoma incidence
|
J:158751
|
increased thyroid tumor incidence
|
J:158751
|
Ptentm1Hwu/Pten+ Tg(Nkx2-1-cre)2Sand/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal thyroid follicle morphology
|
J:197590
|
enlarged thyroid gland
|
J:197590
|
thyroid gland hyperplasia
|
J:197590
|
Ptentm1Hwu/Pten+ Tg(Nkx2-1-cre)2Sand/0
(B6.Cg-Ptentm1Hwu Tg(Nkx2-1-cre)2Sand)
|
abnormal thyroid gland morphology
|
J:197590
|
increased thyroid tumor incidence
|
J:197590
|
Ptentm1Hwu/Ptentm1Hwu Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:170129
|
decreased pancreatic beta cell mass
|
J:170129
|
Ptentm1Hwu/Ptentm1Hwu Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)
|
enlarged thymus
|
J:169097
|
Ptentm1Hwu/Ptentm1Hwu Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0 Tg(TPO-cre)1Shk/0
(involves: 129S4/SvJae * FVB/NCr * FVB/NJ)
|
abnormal thyroid gland morphology
|
J:177181
|
enlarged thyroid gland
|
J:177181
|
increased thyroid carcinoma incidence
|
J:177181
|
Ptentm1Hwu/Ptentm1Hwu Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)
|
enlarged thymus
|
J:216983
|
Ptentm1Hwu/Ptentm1Hwu Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N)
|
enlarged thymus
|
J:135172
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:170206
|
enlarged pancreatic islets
|
J:106937
|
increased pancreatic beta cell mass
|
J:170206
|
increased pancreatic beta cell number
|
J:106937
|
increased pancreatic islet number
|
J:106937
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)
|
abnormal pancreatic beta cell morphology
|
J:170129
|
increased pancreatic beta cell mass
|
J:170129
|
Ptentm1Hwu/Ptentm1Hwu Tg(KRT14-cre)#Smr/0
(involves: 129S4/SvJae * C57BL/6J * SJL/J)
|
enlarged thyroid gland
|
J:138927
|
increased thyroid tumor incidence
|
J:138927
|
Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
enlarged thymus
|
J:169097
|
Ptentm1Hwu/Ptentm1Hwu Tg(Mx1-cre)1Cgn/0
(BKS.Cg-Ptprcb Thy1a Tg(Mx1-cre)1Cgn Ptentm1Hwu)
|
enlarged thymus
|
J:109085
|
Ptentm1Hwu/Ptentm1Hwu Tg(Nkx2-1-cre)2Sand/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal thyroid gland morphology
|
J:197590
|
enlarged thyroid gland
|
J:197590
|
thyroid gland hyperplasia
|
J:197590
|
Ptentm1Hwu/Ptentm1Hwu Tg(Nkx2-1-cre)2Sand/0
(B6.Cg-Ptentm1Hwu Tg(Nkx2-1-cre)2Sand)
|
abnormal thyroid follicle morphology
|
J:197590
|
abnormal thyroid gland morphology
|
J:197590
|
enlarged thyroid gland
|
J:197590
|
increased thyroid adenoma incidence
|
J:197590
|
thyroid gland hyperplasia
|
J:197590
|
Ptentm1Hwu/Ptentm1Hwu Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
enlarged pancreatic islets
|
J:102226
|
pancreatic islet hyperplasia
|
J:102226
|
Ptentm1Hwu/Ptentm1Hwu Tg(Pdx1-cre/Esr1*)35.10Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
pancreatic islet hyperplasia
|
J:102226
|
Ptentm1Hwu/Ptentm1Hwu Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased solitary pulmonary neuroendocrine cell number
|
J:146355
|
Ptentm1Hwu/Ptentm1Hwu Tg(TPO-cre)1Shk/0
(involves: 129S4/SvJae * FVB/NCr)
|
enlarged thyroid gland
|
J:177181
|
Ptentm1Mak/Pten+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased adrenal gland tumor incidence
|
J:63478
|
increased T cell derived lymphoma incidence
|
J:50437
|
Ptentm1Mak/Pten+
(B6.129P2-Ptentm1Mak)
|
increased adrenal gland tumor incidence
|
J:93530
|
Ptentm1Mro/Pten+ Sdhbtm1.1Ics/Sdhb+ Tg(KLK3-cre)D4Trp/0
(involves: 129S2/SvPas * FVB)
|
increased pheochromocytoma incidence
|
J:236514
|
Ptentm1Mro/Ptentm1Mro Sdhbtm1.1Ics/Sdhb+ Tg(KLK3-cre)D4Trp/0
(involves: 129S2/SvPas * FVB)
|
increased pheochromocytoma incidence
|
J:236514
|
Ptentm1Mro/Ptentm1Mro Sdhbtm1.1Ics/Sdhbtm1.2Ics Tg(KLK3-cre)D4Trp/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * FVB)
|
increased pheochromocytoma incidence
|
J:236514
|
Ptentm1Rps/Pten+
(involves: 129S1/Sv * C57BL/6J)
|
abnormal thyroid gland morphology
|
J:53065
|
enlarged thymus
|
J:53065
|
increased thyroid carcinoma incidence
|
J:53065
|
Ptentm2.1Gle/Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N)
|
abnormal thyroid follicular cell morphology
|
J:158751
|
increased adrenal gland tumor incidence
|
J:158751
|
increased T cell derived lymphoma incidence
|
J:158751
|
increased thyroid tumor incidence
|
J:158751
|
Ptentm2.1Ppp/Ptentm2.1Ppp Tg(TPO-cre)1Shk/0
(129S1.Cg-Ptentm2.1Ppp Tg(TPO-cre)1Shk)
|
increased thyroid adenoma incidence
|
J:165293
|
increased thyroid carcinoma incidence
|
J:165293
|
thyroid gland hyperplasia
|
J:165293
|
Ptentm2.1Ppp/Ptentm2.1Ppp Trp53tm1Brn/Trp53tm1Brn Tg(TPO-cre)1Shk/0
(129.Cg-Tg(TPO-cre)1Shk Trp53tm1Brn Ptentm2.1Ppp)
|
enlarged thyroid gland
|
J:211100
|
increased thyroid carcinoma incidence
|
J:211100
|
Ptf1atm1(cre)Hnak/Ptf1a+ Rbpjtm1Rsch/Rbpjtm1Rsch
(involves: 129X1/SvJ)
|
abnormal pancreatic alpha cell differentiation
|
J:139250
|
decreased pancreatic islet number
|
J:139250
|
disorganized pancreatic islets
|
J:139250
|
increased pancreatic alpha cell number
|
J:139250
|
Ptf1atm1Pkwe/Ptf1atm1Pkwe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic alpha cell number
|
J:51571
|
Ptgisem1(IMPC)Mbp/Ptgisem1(IMPC)Mbp
(C57BL/6N-Ptgisem1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Pth1rtm1a(EUCOMM)Hmgu/Pth1rtm1a(EUCOMM)Hmgu
(C57BL/6N-Pth1rtm1a(EUCOMM)Hmgu/Wtsi)
|
abnormal thymus morphology
|
J:239583
|
Pthtm1Dgo/Pthtm1Dgo
(involves: 129S2/SvPas * C57BL/6J)
|
enlarged parathyroid gland
|
J:76407
|
Pthtm1Dgo/Pthtm1Dgo Pthlhtm1Hmk/Pthlhtm1Hmk
(involves: 129S2/SvPas * C57BL/6J)
|
enlarged parathyroid gland
|
J:76407
|
Pthlhtm1Hmk/Pthlhtm1Hmk
(involves: 129S2/SvPas * C57BL/6J)
|
enlarged parathyroid gland
|
J:76407
|
Ptpmt1tm2.1Ckq/Ptpmt1tm2.1Ckq Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL)
|
small thymus
|
J:194929
|
Ptpn1tm1Bbk/Ptpn1tm1Bbk
(involves: 129/Sv * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:87249
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr)
|
decreased thymocyte number
|
J:186843
|
thymus atrophy
|
J:186843
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr)
|
decreased thymocyte number
|
J:186843
|
thymus atrophy
|
J:186843
|
Ptpn2tm2.1Ttig/Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig)
|
decreased thymocyte number
|
J:186843
|
thymus atrophy
|
J:186843
|
Ptpn6em1.1Shoy/Ptpn6em1.1Shoy
(involves: C57BL/6)
|
decreased thymocyte number
|
J:236298
|
Ptpn6me-B2/Ptpn6me-B2
(involves: BALB/c)
|
small thymus
|
J:169850
|
Ptpn6me-v/Ptpn6me-v
(C57BL/6J-Ptpn6me-v)
|
abnormal thymus development
|
J:16613
|
Ptpn6me/Ptpn6me
(C57BL/6J-Ptpn6me/J)
|
abnormal thymus morphology
|
J:5579
|
small thymus
|
J:5579
|
Ptpn6me/Ptpn6me
(either: (involves: C3H * C57BL/6J) or (involves: C57BL/6J * C57BL/6N))
|
thymus atrophy
|
J:5999
|
Ptpn11tm1Ckq/Ptpn11+ Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased lymphoblastic lymphoma incidence
|
J:177285
|
Ptpn11tm1Ckq/Ptpn11+ Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
increased lymphoblastic lymphoma incidence
|
J:177285
|
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6)
|
abnormal thymus morphology
|
J:201448
|
thymus hyperplasia
|
J:201448
|
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
abnormal thymus morphology
|
J:201448
|
thymus hyperplasia
|
J:201448
|
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas
(involves: C57BL/6)
|
enlarged thymus
|
J:176519
|
Ptprcltng/Ptprcltng
(C57BL/6-Ptprcltng)
|
thymus hypoplasia
|
J:158876
|
Ptprcltng/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
thymus hypoplasia
|
J:158876
|
Ptprcltng/Ptprctm1Mak Tg(TcraTcrb)425Cbn/0
(involves: 129/Sv * BALB/c * C57BL/6)
|
thymus hypoplasia
|
J:158876
|
Ptprcm1Smv/Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
decreased DN4 thymocyte number
|
J:214487
|
increased DN3 thymocyte number
|
J:214487
|
Ptprctm1Holm/Ptprctm1Holm
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:33466
|
Ptprctm1Holm/Ptprctm1Holm Tg(Lck*F505)2964Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:64671
|
thymus hyperplasia
|
J:64671
|
Ptprctm1Holm/Ptprctm1Holm Tg(Lck*F505)3073Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:64671
|
thymus hyperplasia
|
J:64671
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:13163
|
Ptprctm1Tyb/Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb)
|
thymus hypoplasia
|
J:57681
|
Ptprstm1Mtr/Ptprstm1Mtr
(involves: 129/Sv * BALB/c)
|
small pituitary gland
|
J:53434
|
Ptprvtm1Kry/Ptprvtm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
abnormal pancreatic islet morphology
|
J:126780
|
increased pancreatic beta cell mass
|
J:126780
|
increased pancreatic islet number
|
J:126780
|
pancreatic islet hyperplasia
|
J:126780
|
Ptprz1em1(IMPC)Ccpcz/Ptprz1em1(IMPC)Ccpcz
(C57BL/6NCrl-Ptprz1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:82724
|
decreased pancreatic beta cell mass
|
J:82724
|
thymus hyperplasia
|
J:72267
|
Puf60tm1.1Kmtsu/Puf60+ Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj)
|
increased T cell derived lymphoma incidence
|
J:233347
|
increased thymus weight
|
J:233347
|
Puratm1Kkh/Puratm1Kkh
(involves: 129)
|
abnormal thymus morphology
|
J:85759
|
Pwwp3aem1(IMPC)Tcp/Pwwp3aem1(IMPC)Tcp
(C57BL/6NCrl-Pwwp3aem1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Qrich1b2b2404Clo/Qrich1b2b2404Clo
(C57BL/6J-Qrich1b2b2404Clo)
|
thymus hypoplasia
|
J:175213
|
Rab27aash/Rab27aash Rab27btm1Tiz/Rab27btm1Tiz
(involves: 129P2/OlaHsd * C3H/He * C3H/HeSn)
|
abnormal corticotroph morphology
|
J:145238
|
Rabl3xm/Rabl3em1Btlr
(C57BL/6J-Rabl3xm Rabl3em1Btlr)
|
thymus hypoplasia
|
J:287198
|
Rad50tm2Jpt/Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
abnormal thymus morphology
|
J:78820
|
increased T cell derived lymphoma incidence
|
J:78820
|
Rad50tm2Jpt/Rad50tm2Jpt Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:78820
|
Rag1tm1.1Sadu/Rag1tm1.1Sadu Trdctm1Mal/Trdctm1Mal Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
small thymus
|
J:187400
|
Rag1tm1Fwa/Rag1tm1Fwa
(involves: 129)
|
thymus hypoplasia
|
J:86464
|
Rag1tm1Jsek/Rag1tm1Jsek
(involves: 129S6/SvEvTac)
|
thymus hypoplasia
|
J:146912
|
Rag1tm1Jsek/Rag1tm1Jsek Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased T cell derived lymphoma incidence
|
J:146912
|
Rag1tm1Mom/Rag1+ Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag1tm1Mom/Rag1+ Tg(LPV-TAg1135)11Tvd/0 Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * CD-1)
|
thymus hypoplasia
|
J:1934
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
small thymus
|
J:111874
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
abnormal thymus epithelium morphology
|
J:125864
|
Rag1tm1Mom/Rag1tm1Mom Prf1tm1Sdz/Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz)
|
abnormal thymus cortex morphology
|
J:109843
|
increased T cell derived lymphoma incidence
|
J:109843
|
thymus hypoplasia
|
J:109843
|
Rag1tm1Mom/Rag1tm1Mom Slc46a2tm1Moki/Slc46a2+ Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6)
|
thymus hypoplasia
|
J:140121
|
Rag1tm1Mom/Rag1tm1Mom Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S7/SvEvBrd * C3H/He * C57BL/6)
|
increased thymocyte number
|
J:135903
|
Rag1tm1Mom/Rag1tm1Mom Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag1tm1Mom/Rag1tm1Mom Tg(LPV-TAg1135)11Tvd/0 Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag1tm1Mom/Rag1tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
decreased pancreatic beta cell number
|
J:111874
|
decreased thymus weight
|
J:111874
|
Rag1tm1Mom/Rag1tm1Mom Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL)
|
increased pituitary adenoma incidence
|
J:141515
|
increased T cell derived lymphoma incidence
|
J:141515
|
Rag1tm1Mom/Rag1tm1Mom Trp53tm1Brd/Trp53tm1Brd Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL)
|
increased T cell derived lymphoma incidence
|
J:141515
|
Rag2tm1.1Desi/Rag2tm1.1Desi Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:168974
|
Rag2tm1.1Mss/Rag2tm1.1Mss
(involves: 129S6/SvEvTac)
|
increased DN3 thymocyte number
|
J:171970
|
Rag2tm1.1Mss/Rag2tm1.1Mss Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased T cell derived lymphoma incidence
|
J:170462
|
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
abnormal thymus morphology
|
J:122108
|
absent Hassall's corpuscle
|
J:122108
|
Rag2tm1Fwa/Rag2+ Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag2tm1Fwa/Rag2+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * MF1)
|
thymus hypoplasia
|
J:1935
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
decreased thymocyte number
|
J:114561
|
Rag2tm1Fwa/Rag2tm1Fwa Tbatatm1Faf/Tbatatm1Faf
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased thymocyte number
|
J:166065
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster)
|
increased DN3 thymocyte number
|
J:235890
|
increased T cell derived lymphoma incidence
|
J:235890
|
increased thymus tumor incidence
|
J:235890
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(Igh-Pim1)1Brn/0
(involves: 129S/SvEv * C57BL/6LiA * CBA)
|
decreased thymocyte number
|
J:114561
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2)
|
thymus hyperplasia
|
J:125548
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal thymus cell ratio
|
J:78309
|
Rag2tm1Fwa/Rag2tm1Fwa Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:47667
|
Rag2tm1Fwa/Rag2tm1Mao
(involves: 129S/SvEv * C57BL/6)
|
thymus hypoplasia
|
J:81837
|
Rag2tm1Mao/Rag2tm1Mao
(involves: 129 * C57BL/6)
|
thymus hypoplasia
|
J:81837
|
Rag2tm1Tgi/Rag2tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte number
|
J:113641
|
Rag2tm2.1Desi/Rag2tm2.1Desi Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:168974
|
Ralatm1a(EUCOMM)Wtsi/Ralatm1a(EUCOMM)Wtsi
(C57BL/6N-Ralatm1a(EUCOMM)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal thymus morphology
|
J:62244
|
decreased thymocyte number
|
J:62244
|
small thymus
|
J:62244
|
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified)
|
enlarged pancreatic islets
|
J:201171
|
increased pancreatic alpha cell number
|
J:201171
|
pancreatic islet hyperplasia
|
J:201171
|
Raratm1Ipc/Raratm1Ipc Rarbtm1Ipc/Rarbtm1Ipc
(involves: 129S2/SvPas)
|
ectopic parathyroid gland
|
J:21034
|
persistent cervical thymus
|
J:21034
|
Raratm1Ipc/Raratm1Ipc Rarbtm1Mma/Rarbtm1Mma
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus morphology
|
J:43344
|
persistent cervical thymus
|
J:43344
|
Raratm1Ipc/Raratm1Ipc Rargtm1Ipc/Rargtm1Ipc
(involves: 129S2/SvPas)
|
abnormal pituitary gland development
|
J:21009
|
ectopic parathyroid gland
|
J:21034
|
ectopic thyroid gland
|
J:21034
|
persistent cervical thymus
|
J:21034
|
Raratm1Ipc/Raratm1Ipc Rargtm2Ipc/Rargtm2Ipc
(involves: 129S2/SvPas)
|
ectopic thymus
|
J:42773
|
Raratm2Ipc/Raratm2Ipc Raratm1Ipc/Rara+ Rargtm1Ipc/Rargtm1Ipc
(involves: 129S2/SvPas)
|
ectopic parathyroid gland
|
J:21034
|
Raratm2Ipc/Raratm2Ipc Rarbtm1Ipc/Rarbtm1Ipc
(involves: 129S2/SvPas)
|
ectopic parathyroid gland
|
J:21034
|
Rasgrf1tm1Esn/Rasgrf1tm1Esn
(involves: 129/Sv * C57BL/6N)
|
decreased pancreatic beta cell number
|
J:83950
|
small pancreatic islets
|
J:83950
|
Rasgrp1tm1Jstn/Rasgrp1tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased thymocyte number
|
J:108677
|
Rassf2tm1Dlim/Rassf2tm1Dlim
(B6.Cg-Rassf2tm1Dlim)
|
abnormal thymus epithelium morphology
|
J:181952
|
decreased thymus weight
|
J:181952
|
thymus hypoplasia
|
J:181952
|
Rassf5tm1Kina/Rassf5tm1Kina
(involves: C57BL/6 * CBA * ICR)
|
abnormal thymus cell ratio
|
J:92670
|
abnormal thymus corticomedullary boundary morphology
|
J:92670
|
abnormal thymus medulla morphology
|
J:92670
|
decreased thymocyte number
|
J:92670
|
Rb1tm1Brd/Rb1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal neuroendocrine gland morphology
|
J:17434
|
increased pituitary adenoma incidence
|
J:17434
|
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased pheochromocytoma incidence
|
J:79016
|
increased pituitary adenohypophysis tumor incidence
|
J:79016
|
increased pituitary melanotroph tumor incidence
|
J:79016
|
increased thyroid C-cell carcinoma incidence
|
J:79016
|
Rb1tm1Brn/Rb1+ Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal pituitary intermediate lobe morphology
|
J:48860
|
increased pituitary adenoma incidence
|
J:48860
|
Rb1tm1Brn/Rb1+ X/Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N)
|
pituitary intermediate lobe hyperplasia
|
J:48860
|
Rb1tm1Brn/Rb1tm1Brn Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased pituitary adenoma incidence
|
J:48860
|
Rb1tm1Brn/Rb1tm1Brn X/Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N)
|
increased pituitary adenoma incidence
|
J:48860
|
pituitary intermediate lobe hyperplasia
|
J:48860
|
Rb1tm1Mlh/Rb1+
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
increased pituitary melanotroph tumor incidence
|
J:20542
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:81082,
J:2511
|
increased thyroid tumor incidence
|
J:81082
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6J)
|
increased pheochromocytoma incidence
|
J:133299
|
increased pituitary adenohypophysis tumor incidence
|
J:133299
|
increased pituitary melanotroph tumor incidence
|
J:133299
|
increased thyroid C-cell carcinoma incidence
|
J:133299
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
increased pituitary gland tumor incidence
|
J:175625
|
increased thyroid tumor incidence
|
J:175625
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas)
|
increased pituitary gland tumor incidence
|
J:215358
|
Rb1tm1Tyj/Rb1+ Rbl1tm1Tyj/Rbl1+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:34058
|
Rb1tm1Tyj/Rb1+ Rbl1tm1Tyj/Rbl1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:34058
|
Rb1tm1Tyj/Rb1+ Smarca4tm1Mag/Smarca4+
(involves: 129S/Sv * 129S2/SvPas * C57BL/6J * CD-1)
|
increased pituitary gland tumor incidence
|
J:132091
|
Rb1tm1Tyj/Rb1+ Trim27Gt(XP0484)Wtsi/Trim27Gt(XP0484)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pituitary gland tumor incidence
|
J:189317
|
increased thyroid tumor incidence
|
J:189317
|
Rb1tm1Tyj/Rb1+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased pituitary melanotroph tumor incidence
|
J:19542
|
increased thyroid tumor incidence
|
J:19542
|
Rb1tm1Tyj/Rb1tm2Tyj
(chimera involves: 129S2/SvPas * C57BL/6)
|
increased pituitary adenoma incidence
|
J:59268
|
Rb1tm2Brn/Rb1tm2Brn Tg(Gfap-cre)2Brn/0
(involves: 129 * FVB/N)
|
increased pituitary gland tumor incidence
|
J:187257
|
Rb1tm2Brn/Rb1tm2Brn Tg(Rbp3-cre)1Brn/0
(involves: 129 * FVB/N)
|
increased pituitary adenohypophysis tumor incidence
|
J:77982
|
increased pituitary melanotroph tumor incidence
|
J:77982
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53+
(involves: 129P2/OlaHsd)
|
increased thyroid carcinoma incidence
|
J:86077,
J:157319
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd)
|
increased thyroid carcinoma incidence
|
J:86077,
J:157319
|
Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(Gfap-cre)2Brn/0
(involves: 129 * 129P2/OlaHsd * FVB/N)
|
increased pituitary gland tumor incidence
|
J:187257
|
Rb1tm2Mlh/Rb1+
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
increased pituitary melanotroph tumor incidence
|
J:20542
|
Rb1tm3Tyj/Rb1tm3Tyj Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N)
|
increased pituitary gland tumor incidence
|
J:91406
|
Rb1tm3Tyj/Rb1tm3Tyj Trp53tm1Tyj/Trp53tm1Tyj Tg(Nes-cre)1Atp/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N)
|
increased pituitary gland tumor incidence
|
J:91406
|
Rbm4tm1Wtarn/Rbm4tm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
small pancreatic islets
|
J:192831
|
Rbm4btm1Wtarn/Rbm4btm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
small pancreatic islets
|
J:192831
|
Rbpjtm1Hon/Rbpjtm1Hon Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:99747
|
small thymus
|
J:99747
|
Rc3h1san/Rc3h1+
(involves: C57BL/6JSfdAnu)
|
increased T cell derived lymphoma incidence
|
J:189087
|
Rc3h1tm1.2Mass/Rc3h1tm1.2Mass
(involves: C57BL/6 * CBA * NZB * SJL)
|
abnormal thymus development
|
J:177784
|
Recql4tm1Abe/Recql4tm1Abe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thymus corticomedullary boundary morphology
|
J:85574
|
small thymus
|
J:85574
|
Relatm1Bal/Relatm1Bal Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymus morphology
|
J:60742
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri)
|
absent thymus medulla
|
J:23081,
J:76450
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
thymus atrophy
|
J:22675
|
thymus hypoplasia
|
J:22675
|
Rettm1Giro/Ret+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
adrenal cortical hyperplasia
|
J:141658
|
Rettm1Giro/Ret+
(129.129P2-Rettm1Giro)
|
abnormal thyroid gland morphology
|
J:141658
|
adrenal cortical hyperplasia
|
J:141658
|
increased thyroid adenoma incidence
|
J:141658
|
Rettm2.1Cos/Ret+
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
adrenergic chromaffin cell hyperplasia
|
J:60659
|
thyroid gland hyperplasia
|
J:60659
|
Rettm2.1Cos/Rettm2.1Cos
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
abnormal adrenal gland morphology
|
J:60659
|
abnormal adrenal medulla morphology
|
J:60659
|
adrenergic chromaffin cell hyperplasia
|
J:60659
|
increased pheochromocytoma incidence
|
J:60659
|
thyroid gland hyperplasia
|
J:60659
|
Rettm2.1Cos/Rettm2.1Cos
(involves: 129S1/Sv * C57BL/6J)
|
increased pheochromocytoma incidence
|
J:148708
|
Rev3ltm1Rwd/Rev3ltm2.1Rwd Trp53tm1Brd/Trp53tm1Brd Tg(MMTV-cre)1Mam/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
increased T cell derived lymphoma incidence
|
J:158922
|
Rfflem1(IMPC)Ccpcz/Rfflem1(IMPC)Ccpcz
(C57BL/6N-Rfflem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rfx4Tg(Myh6-CYP2J2)Tr5Dcz/Rfx4+
(involves: C57BL/6NTac)
|
absent subcommissural organ
|
J:84751
|
Rfx5tm1.1Ifo/Rfx5tm1.1Ifo
(involves: 129 * C57BL/6)
|
abnormal thymus cortex morphology
|
J:67941
|
Rgsc142/Rgsc142+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased T cell derived lymphoma incidence
|
J:133634
|
Rgsc1033/Rgsc1033+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased pituitary adenoma incidence
|
J:133634
|
increased thyroid carcinoma incidence
|
J:133634
|
Rgsc1324/Rgsc1324+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased pheochromocytoma incidence
|
J:133634
|
Rgsc1328/Rgsc1328+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased pheochromocytoma incidence
|
J:133634
|
Rhagem1(IMPC)Ccpcz/Rhagem1(IMPC)Ccpcz
(C57BL/6NCrl-Rhagem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rhbdf1tm1.1Mfm/Rhbdf1tm1.1Mfm
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J)
|
small thymus
|
J:203951
|
Rhobtb1em2(IMPC)Ccpcz/Rhobtb1em2(IMPC)Ccpcz
(C57BL/6N-Rhobtb1em2(IMPC)Ccpcz/Ccpcz)
|
abnormal thyroid gland morphology
|
J:211773
|
enlarged thyroid gland
|
J:211773
|
Rhohtm1Brak/Rhohtm1Brak
(involves: 129/Sv * C57BL/6)
|
thymus hypoplasia
|
J:143161
|
Rhohtm1Daw/Rhohtm1Daw
(involves: 129 * C57BL/6)
|
thymus hypoplasia
|
J:113565
|
Rictortm1.1Klg/Rictortm1.1Klg Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn)
|
decreased DN1 thymic pro-T cell number
|
J:189736
|
decreased DN2 thymocyte number
|
J:189736
|
decreased DN3 thymocyte number
|
J:189736
|
decreased DN4 thymocyte number
|
J:189736
|
decreased thymus weight
|
J:189736
|
thymus hypoplasia
|
J:189736
|
Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
decreased pancreatic beta cell mass
|
J:170129
|
Rictortm1.1Mnh/Rictortm1.1Mnh Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev)
|
enlarged pancreatic islets
|
J:150064
|
Rims2tm1Sse/Rims2tm1Sse
(B6.Cg-Rims2tm1Sse)
|
increased pancreatic alpha cell number
|
J:163080
|
pancreatic islet hyperplasia
|
J:163080
|
Rint1tm1Whl/Rint1+
(Not Specified)
|
increased pituitary adenoma incidence
|
J:122805
|
Ripk1tm1Led/Ripk1tm1Led
(involves: 129S6/SvEvTac)
|
abnormal thymus morphology
|
J:46522
|
decreased thymocyte number
|
J:46522
|
Ripply3tm1Sjt/Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6)
|
abnormal parathyroid gland morphology
|
J:167713
|
abnormal thymus development
|
J:167713
|
abnormal ultimobranchial body morphology
|
J:167713
|
ectopic thymus
|
J:167713
|
increased pancreatic alpha cell mass
|
J:214095
|
increased pancreatic beta cell mass
|
J:214095
|
small thymus
|
J:167713
|
Rlimem1(IMPC)Rbrc/Rlim+
(C57BL/6NJcl-Rlimem1(IMPC)Rbrc/Rbrc)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rnaseh2btm1a(EUCOMM)Wtsi/Rnaseh2btm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
thymus hypoplasia
|
J:186986
|
Rnaseltm1Slvm/Rnaseltm1Slvm
(involves: 129P2/OlaHsd)
|
abnormal thymus morphology
|
J:44292
|
enlarged thymus
|
J:44292
|
thymus hyperplasia
|
J:44292
|
Rnf5tm1.1(KOMP)Vlcg/Rnf5+
(C57BL/6N-Rnf5tm1.1(KOMP)Vlcg/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:161240
|
increased T cell derived lymphoma incidence
|
J:161240
|
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:161240
|
increased T cell derived lymphoma incidence
|
J:161240
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1)
|
decreased pancreatic islet number
|
J:244583
|
small pancreatic islets
|
J:244583
|
Rnf148em1(IMPC)Ccpcz/Rnf148em1(IMPC)Ccpcz
(C57BL/6N-Rnf148em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rnf168Gt(156B6)Cmhd/Rnf168Gt(156B6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased DN3 thymocyte number
|
J:198260
|
Rnf168Gt(405F11)Cmhd/Rnf168Gt(405F11)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased DN3 thymocyte number
|
J:198260
|
Rnf168tm2b(EUCOMM)Hmgu/Rnf168tm2b(EUCOMM)Hmgu
(C57BL/6N-Rnf168tm2b(EUCOMM)Hmgu/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rnf208em1(IMPC)Ccpcz/Rnf208em1(IMPC)Ccpcz
(C57BL/6N-Rnf208em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rnf223em1(IMPC)Ccpcz/Rnf223em1(IMPC)Ccpcz
(C57BL/6N-Rnf223em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ror1em1(IMPC)Ccpcz/Ror1+
(C57BL/6NCrl-Ror1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rorasg/Rorasg
(involves: C57BL/6)
|
thymus atrophy
|
J:2228
|
Rorctm1Amj/Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))
|
decreased thymus weight
|
J:64381
|
thymus hypoplasia
|
J:64381
|
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:248565
|
Rpap3em1(IMPC)Mbp/Rpap3+
(C57BL/6N-Rpap3em1(IMPC)Mbp/Ucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rpgrip1ltm1a(EUCOMM)Wtsi/Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal pineal gland morphology
|
J:239583
|
absent adenohypophysis
|
J:239583
|
Rpgrip1ltm1Urt/Rpgrip1ltm1Urt
(involves: 129S1/Sv * 129X1/SvJ)
|
absent Rathke's pouch
|
J:123018
|
small Rathke's pouch
|
J:123018
|
Rpl22Gt(GST000137)Lex/Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd)
|
thymus hypoplasia
|
J:123569
|
Rpl22Gt(YHB332)Byg/Rpl22Gt(YHB332)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus development
|
J:201164
|
Rpl27aSfa/Rpl27a+
(C57BL/6J-Rpl27aSfa)
|
small thymus
|
J:174216
|
Rplp1tm1.1Melt/Rplp1tm1.2Melt
(Not Specified)
|
small thymus
|
J:218949
|
Rps6tm1Om/Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal pancreatic beta cell morphology
|
J:100952
|
abnormal pancreatic islet morphology
|
J:100952
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic beta cell mass
|
J:66406
|
small pancreatic islets
|
J:66406
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(B6.129P2-Rps6kb1tm1Gtho)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
decreased pancreatic beta cell mass
|
J:144599
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Rps6kb2tm1Gtho/Rps6kb2tm1Gtho Tg(Ins2-Akt1*)3Mbb/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
(C57BL/6-Rps27lGt(IST11658B7)Tigm)
|
decreased thymus weight
|
J:223276
|
thymus cortex hypoplasia
|
J:223276
|
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
(involves: 129 * C57BL/6N)
|
thymus hypoplasia
|
J:223276
|
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6N)
|
increased T cell derived lymphoma incidence
|
J:223276
|
Rpsatm1Ells/Rpsa+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:138267
|
Rr28tm1Tilg/Rr28+ Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
adrenal gland cyst
|
J:77413
|
Rr38tm1.2Aafo/Rr38+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased thymocyte number
|
J:227747
|
Rr38tm1.2Aafo/Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased thymocyte number
|
J:227747
|
decreased thymus weight
|
J:227747
|
increased DN3 thymocyte number
|
J:227747
|
small thymus
|
J:227747
|
thymus hypoplasia
|
J:227747
|
Rr115em1Bobh/Rr115+ Shhtm1Chg/Shh+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal adenohypophysis development
|
J:306254
|
abnormal magnocellular neurosecretory cell morphology
|
J:306254
|
abnormal neurohypophysis development
|
J:306254
|
abnormal parvocellular neurosecretory cell morphology
|
J:306254
|
abnormal Rathke's pouch development
|
J:306254
|
ectopic neurohypophysis
|
J:306254
|
Rr344em1Jfer/Rr344em1Jfer
(B6.Cg-Rr344em1Jfer)
|
decreased pancreatic alpha cell mass
|
J:328047
|
decreased pancreatic beta cell mass
|
J:328047
|
Rr394em1Bhao/Rr394em1Bhao
(Not Specified)
|
decreased thymocyte number
|
J:333961
|
increased DN3 thymocyte number
|
J:333961
|
Rr395em1Bhao/Rr395em1Bhao
(Not Specified)
|
decreased thymocyte number
|
J:333961
|
increased DN4 thymocyte number
|
J:333961
|
Rr149356tm1.1Pf/Rr149356tm1.1Pf
(either: 129P2/OlaHsd-Rr149356tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal thymus cortex morphology
|
J:34311
|
abnormal thymus medulla morphology
|
J:34311
|
abnormal thymus morphology
|
J:34311
|
decreased thymocyte number
|
J:34311
|
Rr149356tm1Abnd/Rr149356tm1Abnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal thymus morphology
|
J:137580
|
thymus hypoplasia
|
J:137580
|
Rr149356tm1Che/Rr149356tm1Che Tcrdtm1Mom/Tcrdtm1Mom Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:106246
|
Rr149356tm1Che/Rr149356tm1Che Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:106246
|
Rr299391tm1.1Fwa/Rr299391+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased thymocyte number
|
J:55401
|
Rr299391tm1.1Fwa/Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * FVB/N)
|
decreased thymocyte number
|
J:55401
|
Rras2em1(IMPC)Ccpcz/Rras2em1(IMPC)Ccpcz
(C57BL/6NCrl-Rras2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
thymus atrophy
|
J:186071
|
Rrm2btm1Ynak/Rrm2btm1Ynak
(involves: 129 * C57BL/6J)
|
thymus cortex hypoplasia
|
J:84841
|
Rsad1tm1.1(KOMP)Vlcg/Rsad1+
(C57BL/6N-Rsad1tm1.1(KOMP)Vlcg/Ucd)
|
small thymus
|
J:211773
|
Rsad1tm1.1(KOMP)Vlcg/Rsad1tm1.1(KOMP)Vlcg
(C57BL/6N-Rsad1tm1.1(KOMP)Vlcg/Ucd)
|
small adrenal glands
|
J:211773
|
Runx1tm1(RUNX1)Gcg/Runx1tm1(RUNX1)Gcg Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:106800
|
Runx1tm1Spe/Runx1+
(either: (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA/Ca) or (involves: 129S4/SvJae * C57BL/6 * CBA/Ca))
|
increased T cell derived lymphoma incidence
|
J:80829
|
Runx1tm1Tani/Runx1tm1Tani Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:125959
|
Runx1tm1Toku/Runx1tm1Toku
(involves: 129P2/OlaHsd * C57BL/6)
|
small thymus
|
J:87697
|
thymus hypoplasia
|
J:87697
|
Runx1tm1Yg/Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal thymus corticomedullary boundary morphology
|
J:125830
|
abnormal thymus lobule morphology
|
J:125830
|
decreased thymocyte number
|
J:125830
|
small thymus
|
J:125830
|
thymus cyst
|
J:125830
|
thymus hypoplasia
|
J:125830
|
Runx1tm2Buch/Runx1tm2Buch Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal thymus lobule morphology
|
J:105709
|
decreased thymus weight
|
J:105709
|
increased T cell derived lymphoma incidence
|
J:105709
|
Runx1tm3(Runx3)Toku/Runx1tm3(Runx3)Toku
(involves: 129P2/OlaHsd)
|
abnormal thymus medulla morphology
|
J:98965
|
decreased thymocyte number
|
J:98965
|
small thymus
|
J:98965
|
thymus hypoplasia
|
J:98965
|
Runx1tm3Dow/Runx1+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:77129
|
Runx1tm3Itan/Runx1tm3Itan
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:168918
|
Runx1tm3Spe/Runx1tm3Spe Spi1tm2.1Dgt/Spi1tm2.1Dgt Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased thymus weight
|
J:131217
|
Runx1tm3Spe/Runx1tm3Spe Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased thymus weight
|
J:131217
|
Runx1tm3Spe/Runx1tm3Spe Tg(VAV1-cre)1Graf/0
(involves: 129S4/SvJae)
|
decreased thymocyte number
|
J:145700
|
Runx2tm1Kish/Runx2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thyroid follicle morphology
|
J:162258
|
abnormal thyroid gland morphology
|
J:162258
|
enlarged thymus
|
J:162258
|
Runx2tm1Kish/Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:40783
|
Ruvbl2M1Btlr/Ruvbl2+
(involves: C57BL/6J)
|
increased thymocyte number
|
J:185495
|
Ryr2tm1.1Hnis/Ryr2tm1.1Hnis
(involves: C57BL/6)
|
increased thymus weight
|
J:228787
|
thymus cortex hyperplasia
|
J:228787
|
Sac3d1tm1Hnaka/Sac3d1tm1Hnaka
(involves: 129P2/OlaHsd)
|
thymus hyperplasia
|
J:144601
|
Sall3tm1.1(KOMP)Mbp/Sall3+
(C57BL/6NCrl-Sall3tm1.1(KOMP)Mbp/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Satb1tm1Kos/Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:61085
|
small thymus
|
J:61085
|
Sbdstm1Jrom/Sbdstm3.1Jrom Ptf1atm1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreatic islet size
|
J:189357
|
Sbdstm2.1Jrom/Sbdstm3.1Jrom Ptf1atm1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal pancreatic islet size
|
J:189357
|
Scelem1(IMPC)Ccpcz/Scelem1(IMPC)Ccpcz
(C57BL/6NCrl-Scelem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal adrenal gland morphology
|
J:53349
|
abnormal pancreatic islet morphology
|
J:53349
|
adrenal cortical hyperplasia
|
J:53349
|
increased pancreatic beta cell mass
|
J:53349
|
pancreatic islet hyperplasia
|
J:53349
|
small adenohypophysis
|
J:77510
|
Scr/Scr
(involves: 101/H * C3H/HeH)
|
small thymus
|
J:3458
|
Sdhbtm1c(EUCOMM)Hmgu/Sdhbtm1c(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic islet morphology
|
J:326592
|
decreased pancreatic beta cell mass
|
J:326592
|
Sdhdtm1Jlob/Sdhdtm2Jlob Thtm1(cre)Te/Th+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal adrenal chromaffin cell morphology
|
J:186713
|
Sec23bGt(AD0407)Wtsi/Sec23bGt(AD0407)Wtsi
(B6J.129P2-Sec23bGt(AD0407)Wtsi)
|
abnormal endocrine pancreas morphology
|
J:186391
|
decreased pancreatic alpha cell number
|
J:186391
|
decreased pancreatic beta cell number
|
J:186391
|
decreased pancreatic islet number
|
J:186391
|
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
abnormal pancreatic beta cell morphology
|
J:164159
|
abnormal pancreatic delta cell morphology
|
J:164159
|
decreased pancreatic beta cell number
|
J:164159
|
increased pancreatic alpha cell number
|
J:164159
|
increased pancreatic delta cell number
|
J:164159
|
Sec61a1m1Gek/Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek/0
(C57BL/6-Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek)
|
abnormal pancreatic beta cell morphology
|
J:164159
|
Sel1lGt(CA0017)Wtsi/Sel1lGt(CA0017)Wtsi
(involves: 129P2/OlaHsd)
|
abnormal pancreatic alpha cell differentiation
|
J:158780
|
abnormal pancreatic beta cell differentiation
|
J:158780
|
Selenbp1tm1Hyama/Selenbp1tm1Hyama
(C57BL/6-Selenbp1tm1Hyama)
|
increased thymus weight
|
J:202420
|
Selenottm1.1Ics/Selenottm1.1Ics Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA)
|
increased pancreatic islet number
|
J:203279
|
small pancreatic islets
|
J:203279
|
Senp1tm1Wami/Senp1tm1Wami Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Senp1tm1Wami Tg(Adipoq-cre)1Evdr)
|
abnormal pancreatic islet morphology
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
|
abnormal pancreatic islet morphology
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Pdgfra-cre)1Clc/0
(B6.Cg-Senp1tm1Wami Tg(Pdgfra-cre)1Clc)
|
abnormal pancreatic islet morphology
|
J:228009
|
Septin9tm2.1Emfu/Septin9tm2.1Emfu Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased DN4 thymocyte number
|
J:205027
|
increased DN3 thymocyte number
|
J:205027
|
Serp1tm1Hori/Serp1tm1Hori
(involves: 129X1/SvJ * C57BL/6)
|
small adenohypophysis
|
J:109619
|
small adrenal glands
|
J:109619
|
small pituitary gland
|
J:109619
|
small thyroid gland
|
J:109619
|
Serpini2pq/Serpini2pq
(involves: C57BL/6J)
|
decreased thymocyte number
|
J:115744
|
small thymus
|
J:115744
|
thymus hypoplasia
|
J:115744
|
Sertad1tm1Srn/Sertad1tm1Srn
(B6.129-Sertad1tm1Srn)
|
decreased pancreatic beta cell mass
|
J:157231
|
decreased pancreatic islet number
|
J:157231
|
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal pineal gland morphology
|
J:239583
|
abnormal thymus morphology
|
J:239583
|
small thymus
|
J:239583
|
small thyroid gland
|
J:239583
|
sevr/sevr
(C3H/HeJ-sevr/GrsrJ)
|
thymus atrophy
|
J:109437
|
Sgms1tm1Kenw/Sgms1tm1Kenw
(involves: 129S2/SvPas * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:168726
|
Sgpl1Gt(OST58278)Lex/Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
thymus cortex hypoplasia
|
J:145159
|
thymus hypoplasia
|
J:145159
|
thymus medulla hyperplasia
|
J:145159
|
Sgpl1Gt(OST58278)Lex/Sgpl1tm1(SGPL1)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
thymus cortex hypoplasia
|
J:145159
|
thymus medulla hyperplasia
|
J:145159
|
Sgpl1tm1(SGPL1)Lex/Sgpl1tm1(SGPL1)Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6J)
|
abnormal thymus lobule morphology
|
J:145159
|
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp)
|
decreased pancreatic beta cell mass
|
J:235035
|
small pancreatic islets
|
J:235035
|
Sh2b1tm1Lr/Sh2b1tm1Lr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
pancreatic islet hyperplasia
|
J:92794
|
Sh2b1tm2.1Lr/Sh2b1tm2.1Lr Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased pancreatic beta cell mass
|
J:209019
|
small pancreatic islets
|
J:209019
|
Sh3pxd2atm1b(EUCOMM)Wtsi/Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal adenohypophysis morphology
|
J:239583
|
abnormal pineal gland morphology
|
J:239583
|
abnormal thymus topology
|
J:239583
|
small thyroid gland
|
J:239583
|
Shc1tm1Ravi/Shc1tm1Ravi Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
thymus hypoplasia
|
J:78180
|
Shhtm2Amc/Shhtm2.1Amc Tg(Nr5a1-cre)2Klp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal adrenal gland morphology
|
J:168522
|
abnormal adrenocortical cell morphology
|
J:168522
|
enlarged adrenocortical cells
|
J:168522
|
small adrenal glands
|
J:168522
|
thin adrenal cortex
|
J:168522
|
Shisal1em1(IMPC)Ccpcz/Shisal1em1(IMPC)Ccpcz
(C57BL/6N-Shisal1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
sho/sho
(Not Specified)
|
small thymus
|
J:255
|
Shprhem1(IMPC)Tcp/Shprhem1(IMPC)Tcp
(C57BL/6NCrl-Shprhem1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:204228
|
increased pancreatic beta cell number
|
J:204228
|
Sim1tm1Fan/Sim1tm1Fan
(involves: 129/Sv * C57BL/6)
|
abnormal pituicyte morphology
|
J:50772
|
absent magnocellular neurosecretory cells
|
J:50772
|
pituitary gland hypoplasia
|
J:50772
|
Sirt1tm3Fwa/Sirt1tm3Fwa Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased pituitary gland weight
|
J:155802
|
small pituitary gland
|
J:155802
|
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
thymus hyperplasia
|
J:100408
|
Sit1tm1Lsmn/Sit1tm1Lsmn Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6)
|
thymus hypoplasia
|
J:100408
|
Six1tm1Kwk/Six1tm1Kwk
(involves: 129P2/OlaHsd * C57BL/6)
|
athymia
|
J:104488
|
Six1tm1Mair/Six1tm1Mair
(involves: 129S2/SvPas)
|
athymia
|
J:84417
|
Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
small adenohypophysis
|
J:86619
|
Six6tm1Rsd/Six6tm1Rsd
(either: 129 or (involves: 129S1/Sv * 129X1/SvJ))
|
pituitary gland hypoplasia
|
J:104339
|
Six6tm1Rsd/Six6tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal neuroendocrine cell morphology
|
J:168233
|
Skida1tm1.1(KOMP)Wtsi/Skida1+
(C57BL/6N-Skida1tm1.1(KOMP)Wtsi/Ucd)
|
enlarged thymus
|
J:211773
|
Skida1tm1.1(KOMP)Wtsi/Skida1tm1.1(KOMP)Wtsi
(C57BL/6N-Skida1tm1.1(KOMP)Wtsi/Ucd)
|
enlarged thymus
|
J:211773
|
Skiltm1Sis/Skil+
(involves: C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:62174
|
skp/skp
(CXB5/ByJ-skp/GrsrJ)
|
thymus atrophy
|
J:153578
|
Slc2a2tm1Thor/Slc2a2tm1Thor
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:43839
|
decreased pancreatic beta cell mass
|
J:43839
|
increased pancreatic alpha cell mass
|
J:43839
|
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6 * SJL)
|
pancreatic islet hyperplasia
|
J:97234
|
Slc5a5tm1d(KOMP)Wtsi/Slc5a5tm1d(KOMP)Wtsi
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal thyroid gland morphology
|
J:250121
|
enlarged thyroid gland
|
J:250121
|
Slc6a3tm1Mca/Slc6a3tm1Mca
(involves: 129P2/OlaHsd)
|
abnormal adenohypophysis morphology
|
J:41856
|
adenohypophysis hypoplasia
|
J:41856
|
decreased lactotroph cell number
|
J:41856
|
decreased somatotroph cell number
|
J:41856
|
pituitary intermediate lobe hypoplasia
|
J:41856
|
Slc6a3tm1Mca/Slc6a3tm1Mca
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal adenohypophysis morphology
|
J:93114
|
small pituitary gland
|
J:93114
|
Slc6a3tm1Mca/Slc6a3tm1Mca Slc6a4tm1Kpl/Slc6a4tm1Kpl
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal adenohypophysis morphology
|
J:93114
|
small pituitary gland
|
J:93114
|
Slc8a1tm1Herc/Slc8a1+
(involves: 129 * CD-1)
|
increased pancreatic beta cell mass
|
J:186743
|
Slc17a8em1(IMPC)Mbp/Slc17a8em1(IMPC)Mbp
(C57BL/6N-Slc17a8em1(IMPC)Mbp/MbpMmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Slc19a1tm1Gold/Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL)
|
small thymus
|
J:68666
|
Slc20a2tm1a(EUCOMM)Wtsi/Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc20a2tm1a(EUCOMM)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Slc22a6tm1Dgen/Slc22a6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymus weight
|
J:101679
|
Slc23a2tm1Nbm/Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm)
|
abnormal adrenergic chromaffin cell morphology
|
J:85988
|
abnormal adrenocortical cell morphology
|
J:85988
|
Slc24a4tm1b(KOMP)Wtsi/Slc24a4+
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H)
|
enlarged thymus
|
J:211773
|
Slc25a20tm1a(EUCOMM)Wtsi/Slc25a20tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a20tm1a(EUCOMM)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Slc25a46atc/Slc25a46atc
(B6.Cg-Slc25a46atc)
|
decreased thymus weight
|
J:242350
|
thymus hypoplasia
|
J:242350
|
Slc26a4loop/Slc26a4loop
(C3HeB/FeJ-Slc26a4loop)
|
abnormal thyroid follicle morphology
|
J:216847
|
abnormal thyroid gland morphology
|
J:216847
|
Slc26a7tm1Sole/Slc26a7tm1Sole
(involves: 129)
|
abnormal thyroid follicle morphology
|
J:325346
|
enlarged thyroid gland
|
J:325346
|
Slc29a3em1(IMPC)Mbp/Slc29a3em1(IMPC)Mbp
(C57BL/6NCrl-Slc29a3em1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Slc30a4em1(IMPC)Tcp/Slc30a4em1(IMPC)Tcp
(C57BL/6NCrl-Slc30a4em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
small thymus
|
J:211773
|
Slc30a8tm1.1Htwt/Slc30a8tm1.1Htwt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * CBA/JNCrlj * DBA)
|
abnormal pancreatic beta cell morphology
|
J:204003
|
Slc30a10tm1.1Sommu/Slc30a10tm1.1Sommu
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)
|
abnormal thyroid follicle morphology
|
J:243657
|
abnormal thyroid follicular cell morphology
|
J:243657
|
abnormal thyroid gland morphology
|
J:243657
|
Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(C57BL/6-Slc38a5tm1(KOMP)Vlcg)
|
abnormal pancreatic alpha cell morphology
|
J:251829
|
Slc38a7em1(IMPC)Ccpcz/Slc38a7em1(IMPC)Ccpcz
(C57BL/6NCrl-Slc38a7em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Slc39a10tm1.1Tfk/Slc39a10tm1.1Tfk Tg(Foxn1-cre)8Ghr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:254216
|
Slc46a2tm1Moki/Slc46a2tm1Moki
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thymus hypoplasia
|
J:140121
|
Slc52a2tm1.1(KOMP)Vlcg/Slc52a2+
(C57BL/6N-Slc52a2tm1.1(KOMP)Vlcg/Ucd)
|
small adrenal glands
|
J:211773
|
Smad2tm1Cxd/Smad2+ Smad3tm1Cxd/Smad3+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
small thyroid gland
|
J:106308
|
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
thymus hypoplasia
|
J:53510
|
Smad4tm1.1Gsu/Smad4tm1.1Gsu Ptf1atm1.1(cre)Cvw/Ptf1a+ Tg(MtTGFA)Lmb/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal pancreatic islet morphology
|
J:229184
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd Tg(Foxn1-cre)8Ghr/0
(B6.Cg-Smad4tm2.1Cxd Tg(Foxn1-cre)8Ghr)
|
small thymus
|
J:138837
|
Smad7Gt(YHC053)Byg/Smad7Gt(YHC053)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal thymus morphology
|
J:212881
|
thymus hypoplasia
|
J:212881
|
Smad7tm1Gkg/Smad7tm1Gkg Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell differentiation
|
J:198451
|
decreased pancreatic alpha cell number
|
J:198451
|
decreased pancreatic beta cell number
|
J:198451
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn Tg(Lck-cre)1Cwi/0 Tg(LCKprBCL2L1)12Sjk/0
(Not Specified)
|
increased thymocyte number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1Mag Tg(Lck-cre)1Cwi/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:85191
|
Smarca4tm1.2Pcn/Smarca4tm1Tich Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased thymocyte number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1Tich Tg(Lck-cre)1Cwi/0 Tg(LCKprBCL2L1)12Sjk/0
(involves: 129)
|
increased thymocyte number
|
J:144072
|
Smarca4tm1Tich/Smarca4+ Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased thymocyte number
|
J:144072
|
Smarcb1tm1Sho/Smarcb1tm3Sho Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:80224
|
Smg9tm1b(EUCOMM)Wtsi/Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal neurohypophysis morphology
|
J:239583
|
abnormal pineal gland morphology
|
J:239583
|
Smpd3tm1Wst/Smpd3tm1Wst
(involves: 129S1/Sv)
|
abnormal adenohypophysis morphology
|
J:97284
|
abnormal pituicyte morphology
|
J:97284
|
decreased corticotroph cell number
|
J:97284
|
decreased gonadotroph cell number
|
J:97284
|
decreased somatotroph cell number
|
J:97284
|
decreased thyrotroph cell number
|
J:97284
|
Snai2tm2Grid/Snai2+ Snai3tm1.2Jhws/Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
abnormal thymus cortex morphology
|
J:204710
|
abnormal thymus medulla morphology
|
J:204710
|
Snai2tm2Grid/Snai2tm2Grid
(involves: 129S1/Sv)
|
small thymus
|
J:78323
|
Snai2tm2Grid/Snai2tm2Grid Snai3tm1.2Jhws/Snai3+
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
abnormal thymus cortex morphology
|
J:204710
|
abnormal thymus medulla morphology
|
J:204710
|
Snai2tm2Grid/Snai2tm2Grid Snai3tm1.2Jhws/Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
abnormal thymus cortex morphology
|
J:204710
|
abnormal thymus medulla morphology
|
J:204710
|
small thymus
|
J:204710
|
thymus fibrosis
|
J:204710
|
Snd1em1(IMPC)Tcp/Snd1+
(C57BL/6NCrl-Snd1em1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Snrnp40em1Btlr/Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
abnormal thymus development
|
J:282417
|
decreased DN1 thymic pro-T cell number
|
J:282417
|
decreased DN4 thymocyte number
|
J:282417
|
small thymus
|
J:282417
|
thymus hypoplasia
|
J:282417
|
Soat1ald/Soat1ald
(AKR/O)
|
abnormal adrenal cortex morphology
|
J:12157,
J:5089
|
abnormal adrenocortical cell morphology
|
J:12157
|
thymus hyperplasia
|
J:12157
|
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6)
|
abnormal adrenal gland morphology
|
J:37049
|
Socs1tm1Jni/Socs1tm1Jni
(Not Specified)
|
decreased thymocyte number
|
J:57475
|
Socs1tm1Kish/Socs1tm1Kish
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent thymus corticomedullary boundary
|
J:51685
|
Socs1tm1Kish/Socs1tm1Kish
(B6.129P2-Socs1tm1Kish)
|
thymus atrophy
|
J:69472
|
Socs1tm1Kish/Socs1tm1Kish Stat1tm1Rds/Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
thymus atrophy
|
J:69472
|
Socs1tm1Kish/Socs1tm1Kish Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus atrophy
|
J:69472
|
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
small thymus
|
J:51281
|
thymus cortex atrophy
|
J:57474,
J:51281
|
Socs1tm1Wehi/Socs1tm3Wehi Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
enlarged thymus medulla
|
J:83009
|
thymus hyperplasia
|
J:83009
|
Socs1tm2Wehi/Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi)
|
thymus atrophy
|
J:72528
|
Socs7tm1Wsa/Socs7tm1Wsa
(involves: C57BL/6)
|
abnormal subcommissural organ morphology
|
J:93449
|
enlarged pancreatic islets
|
J:93449
|
Sos1tm1.1Les/Sos1tm1.1Les Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
decreased DN4 thymocyte number
|
J:174536
|
decreased thymocyte number
|
J:174536
|
Sox2tm1Rlb/Sox2+
(involves: 129S/SvEv * MF1)
|
abnormal adenohypophysis development
|
J:114458
|
abnormal pituitary gland morphology
|
J:114458
|
bifurcated Rathke's pouch
|
J:114458
|
decreased somatotroph cell number
|
J:114458
|
small adenohypophysis
|
J:114458
|
Sox3tm1Pqt/Y
(chimera involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal adenohypophysis development
|
J:195300
|
abnormal pituitary infundibular stalk morphology
|
J:195300
|
absent pituitary infundibular stalk
|
J:195300
|
Sox3tm1Rlb/Y
(involves: 129S7/SvEvBrd * MF1)
|
abnormal pituitary gland morphology
|
J:88507
|
abnormal Rathke's pouch development
|
J:88507
|
bifurcated Rathke's pouch
|
J:88507
|
Sox3tm1Rlb/Sox3tm1Rlb
(involves: 129S7/SvEvBrd * MF1)
|
abnormal pituitary gland morphology
|
J:88507
|
abnormal Rathke's pouch development
|
J:88507
|
bifurcated Rathke's pouch
|
J:88507
|
Sox4Igt4/Del(13)36H
(involves: 101/H * C3H/HeH * C57BL/6)
|
thymus hypoplasia
|
J:141688
|
Sox9tm1.1Gsr/Sox9+
(involves: 129S4/SvJae * CD-1)
|
decreased pancreatic alpha cell mass
|
J:141017
|
decreased pancreatic beta cell mass
|
J:141017
|
decreased pancreatic delta cell number
|
J:141017
|
decreased PP cell number
|
J:141017
|
pancreatic islet hyperplasia
|
J:141017
|
Sox9tm1Gsr/Sox9+ Tg(Pdx1-cre)6Cvw/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * FVB/N)
|
decreased pancreatic alpha cell mass
|
J:141017
|
decreased pancreatic beta cell mass
|
J:141017
|
decreased pancreatic delta cell number
|
J:141017
|
decreased PP cell number
|
J:141017
|
pancreatic islet hyperplasia
|
J:141017
|
Sox9tm2Gsr/Sox9tm2Gsr
(involves: 129P2/OlaHsd * CD-1)
|
pancreatic islet hyperplasia
|
J:141017
|
Sox10tm6(Sox100B)Weg/Sox10tm6(Sox100B)Weg
(involves: 129P2/OlaHsd * C3H)
|
abnormal adrenal medulla morphology
|
J:160023
|
Sox14em1(IMPC)Ccpcz/Sox14+
(C57BL/6N-Sox14em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Sox14em1(IMPC)Ccpcz/Sox14em1(IMPC)Ccpcz
(C57BL/6N-Sox14em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Sox17tm1Sjm/Sox17tm2Sjm Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C3H * C57BL/6 * C57BL/Ka * CBA)
|
thymus hypoplasia
|
J:123050
|
Sp3tm1Sus/Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6)
|
small thymus
|
J:84837
|
Sp4tm1Sus/Sp4tm1Sus
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hypoplasia
|
J:77894
|
Spata31f3em1(IMPC)Ccpcz/Spata31f3em1(IMPC)Ccpcz
(C57BL/6NCrl-Spata31f3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Sphk1tm1.1Cgh/Sphk1tm2Cgh Sphk2tm1.1Cgh/Sphk2tm1.1Cgh Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal thymus cell ratio
|
J:120783
|
Spi1tm1.1Dgt/Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ)
|
increased T cell derived lymphoma incidence
|
J:90331
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
decreased thymocyte number
|
J:106040
|
increased T cell derived lymphoma incidence
|
J:106040
|
small thymus
|
J:106040
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:90331
|
Spi1tm1Ram/Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6)
|
decreased thymocyte number
|
J:36473
|
Spink13em1(IMPC)Ccpcz/Spink13em1(IMPC)Ccpcz
(C57BL/6N-Spink13em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Spns2tm1Tni/Spns2tm1Tni
(B6.Cg-Spns2tm1Tni)
|
abnormal thymus morphology
|
J:225108
|
decreased thymocyte number
|
J:225108
|
SpopGt(BGB118)Byg/SpopGt(BGB118)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic beta cell mass
|
J:165268
|
Spoptm1b(KOMP)Wtsi/Spop+
(C57BL/6N-Spoptm1b(KOMP)Wtsi/Tcp)
|
small adrenal glands
|
J:211773
|
small thymus
|
J:211773
|
Spred1em1(IMPC)Ccpcz/Spred1em1(IMPC)Ccpcz
(C57BL/6N-Spred1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Spryd4em1(IMPC)Ccpcz/Spryd4em1(IMPC)Ccpcz
(C57BL/6N-Spryd4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac)
|
adrenal gland cyst
|
J:166879
|
increased adrenal cortical tumor incidence
|
J:166879
|
increased thyroid carcinoma incidence
|
J:166879
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal thymus morphology
|
J:202954
|
decreased thymus weight
|
J:202954
|
increased adrenal gland weight
|
J:202954
|
Srftm1Rmn/Srftm1Rmn H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
absent thyroid gland
|
J:144862
|
athymia
|
J:144862
|
Srftm2Nor/Srftm2Nor Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:124767
|
srn/srn
(involves: BUA/Hn * SM/J)
|
abnormal adrenal gland morphology
|
J:5150
|
absent adrenal gland
|
J:5150
|
Srpxtm1Hzi/Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:119999
|
Srsf2tm1Xdfu/Srsf2+ Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
decreased thymocyte number
|
J:88668
|
decreased thymus weight
|
J:88668
|
Srsf2tm1Xdfu/Srsf2tm1Xdfu Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
absent thymus corticomedullary boundary
|
J:88668
|
decreased thymocyte number
|
J:88668
|
small thymus
|
J:88668
|
Srsf3tm1Pjln/Srsf3tm1Pjln Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA)
|
abnormal thymus development
|
J:205756
|
Srxn1tm1Sgrh/Srxn1tm1Sgrh Tg(Cyp11a1-cre)16Mchu/?
(involves: C57BL/6J)
|
adrenal gland hyperplasia
|
J:222986
|
Ssbp2tm1Lana/Ssbp2tm1Lana Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * BALB/c * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:162035
|
thymus hypoplasia
|
J:162035
|
Ssr2tm1b(EUCOMM)Wtsi/Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi)
|
abnormal thymus morphology
|
J:239583
|
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129 * C57BL/6J)
|
decreased pancreatic beta cell number
|
J:91762
|
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129)
|
abnormal pancreatic alpha cell morphology
|
J:179577
|
Sstr5tm1Fcb/Sstr5tm2Fcb Tg(Ins2-cre)1Heed/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased pancreatic delta cell number
|
J:99786
|
Startm1Klp/Startm1Klp
(involves: 129P2/OlaHsd)
|
abnormal adrenal cortex morphology
|
J:43589
|
abnormal adrenal gland morphology
|
J:43589
|
adrenal cortical hyperplasia
|
J:43589
|
Stat3tm1Dnl/Stat3tm1Dlv
(involves: C57BL/6)
|
decreased thymocyte number
|
J:87599
|
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru)
|
abnormal pancreatic beta cell morphology
|
J:90600
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
disorganized pancreatic islets
|
J:127051
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
disorganized pancreatic islets
|
J:127051
|
Stat5atm2Mam/Stat5atm2Mam Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
Stat5btm1Hwd/Stat5btm1Hwd
(involves: C57BL/6)
|
decreased thymocyte number
|
J:112035
|
Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
disorganized pancreatic islets
|
J:127051
|
Stat5btm1Mam/Stat5btm1Mam Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
disorganized pancreatic islets
|
J:127051
|
Stk4tm1.1Kina/Stk4tm1.1Kina
(involves: C57BL/6)
|
thymus hyperplasia
|
J:148791
|
Stk4tm1.1Wtao/Stk4tm1.2Wtao Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL/J)
|
increased thymocyte number
|
J:152323
|
Stk4tm1.2Wtao/Stk4tm1.2Wtao
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
increased thymocyte number
|
J:152323
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR)
|
abnormal pancreatic islet morphology
|
J:134078
|
decreased pancreatic alpha cell number
|
J:134078
|
decreased pancreatic beta cell number
|
J:134078
|
decreased pancreatic delta cell number
|
J:134078
|
small pancreatic islets
|
J:134078
|
Stk11tm1.1Sjm/Stk11tm1.1Sjm Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * SJL)
|
thymus hypoplasia
|
J:165090
|
Stk26tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
abnormal thyroid gland morphology
|
J:211773
|
enlarged thyroid gland
|
J:211773
|
Stk26tm1b(EUCOMM)Hmgu/Stk26tm1b(EUCOMM)Hmgu
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
abnormal adrenal gland morphology
|
J:211773
|
enlarged adrenal glands
|
J:211773
|
Stk36tm1Fjs/Stk36tm1Fjs
(involves: 129S1/Sv * C57BL/6)
|
thymus atrophy
|
J:116391
|
Stk38tm1Hem/Stk38+
(involves: 129P2/Ola * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:185408
|
Stk38tm1Hem/Stk38tm1Hem
(involves: 129P2/Ola * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:185408
|
Stub1tm1Cpat/Stub1tm1Cpat
(involves: 129S/SvEv * C57BL/6)
|
thymus atrophy
|
J:86213
|
thymus hypoplasia
|
J:86213
|
Stx1btm1.1Sud/Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal adrenal chromaffin cell morphology
|
J:138035
|
Stx7em1(IMPC)Rbrc/Stx7em1(IMPC)Rbrc
(C57BL/6NJcl-Stx7em1(IMPC)Rbrc/Rbrc)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
sty/sty
(Not Specified)
|
small thymus
|
J:3675
|
Sult1a1em1(IMPC)Ccpcz/Sult1a1em1(IMPC)Ccpcz
(C57BL/6NCrl-Sult1a1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
thymus atrophy
|
J:144991
|
thymus hypoplasia
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus atrophy
|
J:144991
|
thymus hypoplasia
|
J:144991
|
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
decreased DN1 thymic pro-T cell number
|
J:188422
|
increased DN3 thymocyte number
|
J:188422
|
Syngr1em1(IMPC)Ccpcz/Syngr1em1(IMPC)Ccpcz
(C57BL/6NCrl-Syngr1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Syt1tm1a(EUCOMM)Wtsi/Syt1tm1a(EUCOMM)Wtsi
(C57BL/6N-Syt1tm1a(EUCOMM)Wtsi/Wtsi)
|
adrenal gland cyst
|
J:239583
|
thyroid gland cyst
|
J:239583
|
Sytl1tm1Tiz/Sytl1tm1Tiz Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac)
|
abnormal pancreatic beta cell morphology
|
J:200233
|
Sytl4tm1Tiz/Y
(involves: 129P2/OlaHsd)
|
abnormal corticotroph morphology
|
J:145238
|
Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * C3H/He)
|
abnormal pancreatic beta cell morphology
|
J:102610
|
tAE5/tAE5
(Not Specified)
|
abnormal thymus cortex morphology
|
J:83862
|
abnormal thymus morphology
|
J:83862
|
thymus cortex hypoplasia
|
J:83862
|
Tacc3tm1Jni/Tacc3tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:74762
|
small thymus
|
J:74762
|
Taf7tm1.1Dss/Taf7tm1.2Dss Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:185745
|
Taf7tm1.1Dss/Taf7tm1.2Dss Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:185745
|
small thymus
|
J:185745
|
Tas2r102em1(IMPC)Bay/Tas2r102em1(IMPC)Bay
(C57BL/6N-Tas2r102em1(IMPC)Bay/Bay)
|
abnormal adrenal gland morphology
|
J:211773
|
Tasp1tm1Jjdh/Tasp1tm1Jjdh Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:112159
|
decreased thymus weight
|
J:112159
|
tb/tb
(Not Specified)
|
absent lactotrophs
|
J:12166
|
pituitary gland hyperplasia
|
J:12166
|
Tbatatm1Faf/Tbatatm1Faf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus epithelium morphology
|
J:166065
|
enlarged thymus
|
J:166065
|
increased thymocyte number
|
J:166065
|
thymus hyperplasia
|
J:166065
|
Tbx1m1H/Tbx1m1H
(involves: C3H/HeH * C57BL/6J)
|
small thymus
|
J:169366
|
Tbx1m1Jlk/Tbx1m1Jlk
(129/Sv-Tbx1m1Jlk)
|
athymia
|
J:146769
|
Tbx1m1Jlk/Tbx1tm1Bld
(involves: 129)
|
athymia
|
J:146769
|
Tbx1tm1.1Dsr/Tbx1tm1.1Dsr
(either: 129/Sv or (involves: 129/Sv * C57BL/6))
|
athymia
|
J:93588
|
Tbx1tm1Bem/Tbx1tm1Bem
(FVB.Cg-Tbx1tm1Bem)
|
absent parathyroid glands
|
J:91664
|
absent ultimobranchial body
|
J:91664
|
athymia
|
J:91664
|
thymus hypoplasia
|
J:91664
|
Tbx1tm1Bld/Tbx1tm1Bld
(involves: 129S7/SvEvBrd)
|
athymia
|
J:146769
|
Tbx1tm1Bld/Tbx1tm2.1Bem Tfap2atm1(cre)Moon/Tfap2a+
(either: (involves: 129/Sv * C57BL/6 * SJL) or (involves: 129/Sv * C57BL/6J * CBA * SJL))
|
athymia
|
J:154590
|
thymus hypoplasia
|
J:154590
|
Tbx1tm1Bld/Tbx1tm5Bld
(involves: 129S7/SvEvBrd * C57BL/6)
|
athymia
|
J:112457
|
Tbx1tm1Dsr/Tbx1tm1Dsr
(either: 129/Sv or (involves: 129/Sv * C57BL/6))
|
athymia
|
J:93588
|
Tbx1tm1Pa/Tbx1tm1Pa
(either: (involves: 129) or (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * Swiss Webster))
|
abnormal thymus development
|
J:70730
|
absent parathyroid glands
|
J:70730
|
athymia
|
J:70730
|
Tbx1tm2.1Bem/Tbx1tm2.2Bem Foxg1tm1(cre)Skm/Foxg1+
(involves: 129 * C57BL/6J * SJL * Swiss Webster)
|
absent parathyroid glands
|
J:105980
|
athymia
|
J:105980
|
small thyroid gland
|
J:105980
|
Tbx19tm1Jdr/Tbx19tm1Jdr
(either: (involves: 129/Sv) or (involves: BALB/c))
|
adrenal gland hypoplasia
|
J:82562
|
decreased corticotroph cell number
|
J:82562
|
Tcaf2em1(IMPC)Ccpcz/Tcaf2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tcaf2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Tcf3tm1Wein/Tcf3tm1Wein
(involves: 129S4/SvJaeSor * C57BL/6)
|
enlarged thymus
|
J:44278
|
increased T cell derived lymphoma incidence
|
J:44278
|
Tcf3tm1Zhu/Tcf3tm1Zhu
(involves: 129 * C57BL/6J)
|
thymus hypoplasia
|
J:136143
|
Tcf3tm2Wein/Tcf3tm2Wein
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:47671
|
Tcf4tm1Hmb/Tcf4tm1Zhu Tg(Kit-cre)143Hmb/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:65236
|
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd)
|
thymus cortex hypoplasia
|
J:23255
|
thymus hypoplasia
|
J:23255
|
Tcf7tm2Cle/Tcf7tm2Cle
(involves: 129P2/OlaHsd)
|
thymus hypoplasia
|
J:23255
|
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal neurohypophysis morphology
|
J:239583
|
Tcf7l2tm1Cle/Tcf7l2tm1Cle
(involves: 129P2/OlaHsd)
|
abnormal pituitary intermediate lobe morphology
|
J:86317
|
enlarged adenohypophysis
|
J:86317
|
enlarged pituitary gland
|
J:86317
|
Tcf7l2tm1Geno/Tcf7l2tm1Geno Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell mass
|
J:189204
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:120411
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129S7/SvEvBrd * C57BL/6J)
|
thymus hypoplasia
|
J:136143
|
Tcf12tm2Zhu/Tcf12tm2Zhu
(Not Specified)
|
decreased thymocyte number
|
J:120411
|
thymus hypoplasia
|
J:120411
|
Tcf12tm3Zhu/Tcf12tm3Zhu Tcf3tm4Zhu/Tcf3tm4Zhu Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
thymus hypoplasia
|
J:129570
|
Tcf12tm3Zhu/Tcf12tm3Zhu Tg(Lck-cre)#Zhu/0
(involves: C57BL/6 * SJL/J)
|
decreased thymocyte number
|
J:129570
|
Tcirg1oc/Tcirg1oc
(B6C3Fe a/a-Tcirg1oc/J)
|
abnormal thyroid gland morphology
|
J:7870
|
Tcirg1tm1Utku/Tcirg1tm1Utku
(involves: 129X1/SvJ * C57BL/6)
|
thymus atrophy
|
J:92730
|
Tcof1tm1Mjd/Tcof1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal Rathke's pouch development
|
J:62928
|
Tcra-Jtm1Slek/Tcra-Jtm1Slek
(involves: 129P2/OlaHsd)
|
increased thymocyte number
|
J:101398
|
TcraLn1Ogu/Tcra+
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:152041
|
TcraLn3Jae/Tcra+
(B6.Cg-TcraLn3Jae)
|
thymus hypoplasia
|
J:143006
|
TcraLn3Jae/Tcra+ TcrbLn3Jae/Tcrb+
(B6.Cg-TcrbLn3Jae TcraLn3Jae)
|
thymus hypoplasia
|
J:143006
|
Tcratm1Mass/Tcra+ Tg(Nes-cre)Wme/0
(involves: C57BL/6 * CBA)
|
decreased thymocyte number
|
J:201417
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal thymus cortex morphology
|
J:1292
|
absent thymus medulla
|
J:1292
|
enlarged thymus cortex
|
J:1292
|
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky H2b/H2b Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:131357
|
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky H2d/H2d Ptcratm1Vbo/Ptcratm1Vbo Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:131357
|
Tcratm1Mom/Tcratm1Mom Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
thymus hypoplasia
|
J:3206
|
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c)
|
thymus hypoplasia
|
J:3206
|
Tcrbtm1Mom/Tcrbtm1Mom Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
thymus hypoplasia
|
J:3206
|
Tcrgtm1Scar/Tcrgtm1Scar
(B6.Cg-Tcrgtm1Scar)
|
enlarged thymus
|
J:105477
|
thymus hyperplasia
|
J:105477
|
Tdp2tm1.1Huy/Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1)
|
thymus atrophy
|
J:195301
|
Tekt1em1(IMPC)Ccpcz/Tekt1em1(IMPC)Ccpcz
(C57BL/6NCrl-Tekt1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Tenm4em1(IMPC)Tcp/Tenm4em1(IMPC)Tcp
(C57BL/6NCrl-Tenm4em1(IMPC)Tcp/Tcp)
|
small adrenal glands
|
J:211773
|
Terb1tm1b(KOMP)Mbp/Terb1+
(C57BL/6N-Terb1tm1b(KOMP)Mbp/Ucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Tespa1tm1Smoc/Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc)
|
abnormal thymus morphology
|
J:186446
|
small thymus medulla
|
J:186446
|
Tet2Gt(AN0709)Wtsi/Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
increased DN1 thymic pro-T cell number
|
J:174052
|
Tet2tm1Ics/Tet2tm1Ics Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased DN1 thymic pro-T cell number
|
J:174052
|
Tfamtm1Lrsn/Tfamtm1Lrsn Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
absent pancreatic beta cells
|
J:65522
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2m+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased pancreatic beta cell mass
|
J:256448
|
decreased pancreatic islet number
|
J:256448
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2mtm1a(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:256448
|
decreased pancreatic beta cell mass
|
J:256448
|
decreased pancreatic islet number
|
J:256448
|
Tg(ACTB-Artn)1Wss/0
(involves: C57BL/6Crl * DBA/2Crl)
|
abnormal adrenal gland morphology
|
J:90843
|
abnormal adrenal medulla morphology
|
J:90843
|
increased adrenal gland tumor incidence
|
J:90843
|
Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N)
|
abnormal adrenal gland morphology
|
J:160015
|
increased pituitary gland weight
|
J:160015
|
increased prolactinoma incidence
|
J:160015
|
pituitary gland hyperplasia
|
J:160015
|
Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh)
|
thymus cortex hypoplasia
|
J:92579
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2)
|
small pancreatic islets
|
J:57075
|
Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N)
|
small pancreatic islets
|
J:69591
|
Tg(APCS-Tnfsf11*)#aKhs/0
(C57BL/6J-Tg(APCS-Tnfsf11*)#aKhs)
|
enlarged thymus medulla
|
J:264357
|
Tg(APOE-Artn)1Wss/0
(involves: C57BL/6Crl * DBA/2Crl)
|
abnormal adrenal gland morphology
|
J:90843
|
abnormal adrenal medulla morphology
|
J:90843
|
increased adrenal gland tumor incidence
|
J:90843
|
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA)
|
enlarged parathyroid gland
|
J:93981
|
Tg(AZIP/F)1Vsn/0
(involves: FVB/N)
|
pancreatic islet hyperplasia
|
J:50807
|
Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J)
|
increased pancreatic beta cell mass
|
J:145998
|
Tg(BCL2)22Wehi/0 Tg(IghMyc)22Bri/0
(involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi)
|
enlarged thymus
|
J:69571
|
Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
increased T cell derived lymphoma incidence
|
J:93111
|
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0 Tg(Dbh-icre)1Gsc/0
(involves: C57BL/6 * FVB/N)
|
adrenal gland hyperplasia
|
J:186696
|
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0 Thtm1(cre)Te/Th+
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
adrenal gland hyperplasia
|
J:186696
|
Tg(CAG-Bgeo,-Nkx6-1,-EGFP)#Msan/0 Tg(Neurog3-cre)C1Able/0
(involves: BALB/c * C57BL/6)
|
decreased pancreatic alpha cell number
|
J:195153
|
decreased pancreatic delta cell number
|
J:195153
|
decreased pancreatic epsilon cell number
|
J:195153
|
increased pancreatic beta cell number
|
J:195153
|
Tg(CAG-Bgeo/ALPP)1Lbe/0 Tg(Ins2-cre/ERT)1Dam/0 Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased pancreatic beta cell number
|
J:127412
|
Tg(CAG-CYP27A1)23Etl/0
(involves: C57BL/6JOlaHsd * CBA)
|
enlarged adrenal glands
|
J:78951
|
Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0 Tg(TPO-cre)1Shk/0
(involves: FVB/NCr * FVB/NJ)
|
thyroid gland hyperplasia
|
J:177181
|
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB)
|
abnormal adrenal gland morphology
|
J:80609
|
abnormal pituitary gland morphology
|
J:80609
|
thymus atrophy
|
J:80609
|
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB)
|
abnormal adrenal gland morphology
|
J:80609
|
abnormal pituitary gland morphology
|
J:80609
|
thymus atrophy
|
J:80609
|
Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB)
|
abnormal adrenal gland morphology
|
J:80609
|
abnormal pituitary gland morphology
|
J:80609
|
thymus atrophy
|
J:80609
|
Tg(CD2-Lmo2)#Thr/0
(involves: C57BL/6 * CBA)
|
enlarged thymus
|
J:102058
|
Tg(CD2-Mir181d)38Oers/0
(involves: C57BL/6)
|
thymus atrophy
|
J:212571
|
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA)
|
small thymus
|
J:126456
|
Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6)
|
thymus hypoplasia
|
J:80066
|
Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
increased T cell derived lymphoma incidence
|
J:93665
|
Tg(CD3E)26Cpt/Tg(CD3E)26Cpt
(involves: C57BL/6J * CBA/J)
|
abnormal thymus corticomedullary boundary morphology
|
J:81711
|
decreased thymocyte number
|
J:81711
|
thymus hypoplasia
|
J:54756
|
Tg(CD4-HIV)F21380Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(CD4-HIV)F21388Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(CD4-HIV)F21407Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(CD4-HIV)F26605Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(CD4-HIV)F26622Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(CD4-HIV)F26990Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(CD4-HIV)F27011Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(CD4-HIV)F27367Pjo/0
(involves: C3H * C57BL/6)
|
thymus atrophy
|
J:78756
|
Tg(Cd4-NPM/ALK)N1Ingh/0
(either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster))
|
increased lymphoblastic lymphoma incidence
|
J:82127
|
Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: C57BL/6 * Swiss Webster)
|
increased DN3 thymocyte number
|
J:235890
|
increased thymus tumor incidence
|
J:235890
|
Tg(Cd4-NPM/ALK)N1Ingh/0 Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal thymus morphology
|
J:235890
|
increased T cell derived lymphoma incidence
|
J:235890
|
Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:110916
|
Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6)
|
abnormal thymus morphology
|
J:79703
|
Tg(Cga-LHB/CGB)94Jhn/?
(involves: C57BL/6 * SJL)
|
abnormal adrenocortical cell morphology
|
J:125349
|
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr)
|
pancreatic islet hyperplasia
|
J:71205
|
Tg(CMV-cre)1Cgn/0 Trp53tm4Att/Trp53+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
small thymus
|
J:217080
|
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL)
|
abnormal adrenal cortex morphology
|
J:95465
|
abnormal adrenal gland morphology
|
J:94953
|
abnormal adrenal gland x-zone morphology
|
J:95465,
J:94953
|
abnormal adrenocortical cell morphology
|
J:95465
|
abnormal thyroid follicle morphology
|
J:95465,
J:94953
|
adrenal cortical hyperplasia
|
J:95465
|
adrenal gland hyperplasia
|
J:94953
|
increased thyroid adenoma incidence
|
J:95465,
J:94953
|
retention of the adrenal gland x-zone
|
J:95465
|
thyroid gland cyst
|
J:95465
|
thyroid gland hyperplasia
|
J:94953
|
Tg(Col1a1-Ptprv)1Kry/?
(Not Specified)
|
decreased pancreatic beta cell mass
|
J:126780
|
Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL)
|
decreased thymus weight
|
J:92996
|
enlarged adrenal glands
|
J:92996
|
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ)
|
decreased pancreatic beta cell number
|
J:97926
|
Tg(EEF1A1-SHC1*)1Ravi/? Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
thymus hypoplasia
|
J:78180
|
Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * SJL)
|
pancreatic islet hyperplasia
|
J:76995
|
Tg(Ela1-TAg)19Bri/0
(involves: C57BL/6 * SJL)
|
pancreatic islet hyperplasia
|
J:76995
|
Tg(Emu-Pim1)64aBrn/0
(involves: C57BL/6LiA * CBA)
|
enlarged thymus
|
J:79624
|
increased T cell derived lymphoma incidence
|
J:79624
|
Tg(Fli1)1Ber/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased thymocyte number
|
J:33052
|
Tg(Gcg-TAg)25Ddr/?
(involves: CD-1)
|
abnormal pancreatic islet morphology
|
J:91490,
J:101537
|
enlarged pancreatic islets
|
J:101537
|
pancreatic islet hyperplasia
|
J:91490
|
Tg(Ggamma-T)15Cps/0
(involves: C57BL/6J * CBA/J)
|
increased adrenal gland tumor incidence
|
J:38778
|
Tg(Ggamma-T)15Cps/Tg(Ggamma-T)15Cps
(involves: C57BL/6J * CBA/J)
|
increased adrenal gland tumor incidence
|
J:38778
|
Tg(Gh1-rtTA)4-3Jek/0 Tg(tetO-Egfr*)2-9Jek/0
(involves: C57BL/6 * SJL)
|
abnormal gonadotroph morphology
|
J:68692
|
decreased lactotroph cell number
|
J:68692
|
decreased somatotroph cell number
|
J:68692
|
small adenohypophysis
|
J:68692
|
Tg(Gh-Gal)4599Vron/?
(involves: C57BL/6 * CD-1 * SJL)
|
increased pituitary adenoma incidence
|
J:86486
|
pituitary gland hyperplasia
|
J:86486
|
Tg(GHRL-TAg)1-5Hiwa/0
(C57BL/6-Tg(GHRL-TAg)1-5Hiwa)
|
increased thyroid tumor incidence
|
J:152492
|
Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem/0
(either: FVB-Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem or (involves: C57BL/6 * FVB))
|
abnormal thymus development
|
J:67796
|
abnormal thymus lobule morphology
|
J:67796
|
decreased thymocyte number
|
J:67796
|
thymus hypoplasia
|
J:67796
|
Tg(Gpbar1)1Auw/0
(involves: C57BL/6J)
|
abnormal pancreatic islet size
|
J:152388
|
Tg(H2-K-BCL2)1Josd/0
(involves: C57BL/6 * C57BL/Ka * C3H)
|
enlarged thymus
|
J:80894
|
Tg(H2-K-Fosl2,-EGFP)13Wag/0
(either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag)
|
thymus fibrosis
|
J:139032
|
Tg(H2KmPCC)2939Stoe/0 Tg(Tcra2B4)1Mmd/0 Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL)
|
decreased thymocyte number
|
J:50143
|
Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J)
|
abnormal pancreatic alpha cell morphology
|
J:96353
|
abnormal pancreatic beta cell morphology
|
J:96353
|
abnormal pancreatic delta cell morphology
|
J:96353
|
decreased pancreatic beta cell number
|
J:96353
|
Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:178816
|
Tg(Igh-Mir155)8Cro/0
(involves: FVB/N)
|
increased lymphoblastic lymphoma incidence
|
J:109591
|
Tg(Igh-Pim1)1Brn/0
(involves: C57BL/6LiA * CBA)
|
enlarged thymus
|
J:79624
|
increased T cell derived lymphoma incidence
|
J:79624
|
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL)
|
enlarged thymus
|
J:78177
|
Tg(Igk-Eik-H2-Ead)1Flv/0 Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0
(involves: C57BL/6 * SJL)
|
thymus hypoplasia
|
J:124574
|
Tg(Ins1-Cat,Tyr)25Pne/0
(NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne)
|
abnormal pancreatic islet morphology
|
J:108415
|
decreased pancreatic beta cell number
|
J:108415
|
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
absent pancreatic beta cells
|
J:209714
|
Tg(Ins1-EGFP/GH1)14Hara/0
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)
|
decreased pancreatic beta cell number
|
J:127015
|
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)
|
abnormal pancreatic beta cell morphology
|
J:127015
|
Tg(Ins2-Akt1*)3Mbb/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic beta cell morphology
|
J:72216
|
abnormal pancreatic islet morphology
|
J:72216
|
decreased pancreatic beta cell number
|
J:72216
|
enlarged pancreatic islets
|
J:72216
|
increased pancreatic beta cell mass
|
J:72216
|
increased pancreatic islet number
|
J:72216
|
Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Tg(Ins2-Akt1*)3Mbb)
|
abnormal pancreatic beta cell morphology
|
J:144599
|
abnormal pancreatic islet morphology
|
J:144599
|
enlarged pancreatic islets
|
J:144599
|
increased pancreatic beta cell mass
|
J:144599
|
Tg(Ins2-Ccl19)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-Ccl19)2Cys/0 Tg(Ins2-Ccl21b)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-Ccl21b)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
abnormal pancreatic islet morphology
|
J:93555
|
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL)
|
decreased pancreatic beta cell number
|
J:93555
|
Tg(Ins2-CDKN1B)1Maka/0
(involves: C57BL/6J)
|
abnormal pancreatic islet morphology
|
J:96047
|
decreased pancreatic beta cell number
|
J:96047
|
Tg(Ins2-Cebpb)2Maka/0
(involves: C57BL/6)
|
decreased pancreatic beta cell mass
|
J:156725
|
Tg(Ins2-cre)23Herr/0 Tsc2tm1Kido/Tsc2tm1Kido
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal pancreatic islet morphology
|
J:135811
|
decreased pancreatic beta cell number
|
J:135811
|
increased pancreatic beta cell mass
|
J:135811
|
pancreatic islet hyperplasia
|
J:135811
|
Tg(Ins2-Cxcl12)2Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238
|
Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:77238,
J:110548
|
Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fasl)24Ach/J)
|
abnormal pancreatic islet morphology
|
J:78679
|
Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:81287
|
absent pancreatic beta cells
|
J:81287
|
Tg(Ins2-HA)165Bri/0 Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:99756
|
Tg(Ins2-HBEGF)5Rin/?
(C57BL/6-Tg(Ins2-HBEGF)5Rin)
|
abnormal pancreatic islet morphology
|
J:204420
|
decreased pancreatic beta cell number
|
J:204420
|
Tg(Ins2-Hnf1a)#Cbw/0
(involves: C57BL/6 * CBA/J)
|
abnormal pancreatic beta cell morphology
|
J:134757
|
decreased pancreatic beta cell number
|
J:134757
|
disorganized pancreatic islets
|
J:134757
|
increased pancreatic alpha cell number
|
J:134757
|
Tg(Ins2-Iapp)6Soel/Tg(Ins2-Iapp)6Soel
(involves: FVB/N)
|
abnormal pancreatic islet morphology
|
J:130022
|
Tg(Ins2-IAPP)L13Gjsc/0
(FVB/N-Tg(Ins2-IAPP)L13Gjsc)
|
abnormal pancreatic islet morphology
|
J:142009
|
decreased pancreatic beta cell mass
|
J:142009
|
decreased pancreatic beta cell number
|
J:142009
|
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N)
|
abnormal pancreatic islet morphology
|
J:130022
|
decreased pancreatic beta cell mass
|
J:130022
|
Tg(Ins2-Irs2)13Mfw/0
(involves: C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:94000
|
Tg(Ins2-Lta)#Flv/0
(involves: NOD)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins2-Lta)#Flv/0
(involves: C57BL/6)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins2-Mir184)4Mnpy/0
(Not Specified)
|
decreased pancreatic beta cell mass
|
J:210552
|
Tg(Ins2-Mirc13)E4Biat/0
(C57BL/6N-Tg(Ins2-Mirc13)E4Biat)
|
decreased pancreatic beta cell mass
|
J:314874
|
Tg(Ins2-Nos2)31Okam/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:45520
|
decreased pancreatic beta cell mass
|
J:45520
|
Tg(Ins2-Nos2)40Okam/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:45520
|
decreased pancreatic beta cell mass
|
J:45520
|
Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6)
|
abnormal pancreatic islet morphology
|
J:81284,
J:81287
|
Tg(Ins2-OVA)307Wehi/0 Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * C57BL/6JWehi)
|
decreased pancreatic beta cell number
|
J:99451
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA)
|
increased pancreatic beta cell mass
|
J:210552
|
increased pancreatic beta cell number
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell morphology
|
J:127412
|
decreased pancreatic beta cell number
|
J:127412
|
disorganized pancreatic islets
|
J:127412
|
increased pancreatic beta cell number
|
J:127412
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell mass
|
J:210552
|
decreased pancreatic beta cell number
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Sri)10Hhv/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:246708
|
Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic islet morphology
|
J:73760
|
decreased pancreatic beta cell number
|
J:73760
|
disorganized pancreatic islets
|
J:73760
|
small pancreatic islets
|
J:73760
|
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA * NOD)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:91820
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL)
|
disorganized pancreatic islets
|
J:141527
|
increased pancreatic beta cell mass
|
J:141527
|
pancreatic islet hyperplasia
|
J:141527
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL)
|
disorganized pancreatic islets
|
J:141527
|
pancreatic islet hyperplasia
|
J:141527
|
Tg(INS-MT2A,Tyr)1Pne/0
(FVB-Tg(INS-MT2A,Tyr)1Pne)
|
abnormal pancreatic islet morphology
|
J:95089
|
Tg(INS-MT2A,Tyr)1Pne/0
(NOD.FVB-Tg(INS-MT2A,Tyr)1Pne)
|
abnormal pancreatic islet morphology
|
J:108415
|
decreased pancreatic beta cell number
|
J:108415
|
Tg(ITGAL-Hhex)2Hro/0
(C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro)
|
abnormal thymus corticomedullary boundary morphology
|
J:80777
|
thymus hypoplasia
|
J:80777
|
Tg(KRT14-Edn3)1Takk/?
(B6.Cg-Tg(KRT14-Edn3)1Takk)
|
increased thyroid tumor incidence
|
J:104881
|
Tg(KRT19-TAg)7Eps/0
(involves: FVB/N)
|
enlarged adrenal glands
|
J:64395
|
increased adrenal gland tumor incidence
|
J:64395
|
Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2)
|
increased T cell derived lymphoma incidence
|
J:88120
|
Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6)
|
decreased thymocyte number
|
J:73487
|
increased T cell derived lymphoma incidence
|
J:73487
|
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: C3H/He * C57BL/6)
|
decreased thymocyte number
|
J:73487
|
increased T cell derived lymphoma incidence
|
J:73487
|
Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:144975
|
Tg(Lck-Akt2*)#Test/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:153923
|
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:226234
|
Tg(Lck-cre)548Jxm/? Tgfb1tm2.1Doe/Tgfb1tm2.1Doe
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)
|
decreased thymus weight
|
J:150024
|
thymus hypoplasia
|
J:150024
|
Tg(Lck-cre)548Jxm/? Upf2tm1Btp/Upf2tm1Btp
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
thymus hypoplasia
|
J:134765
|
Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6)
|
decreased thymocyte number
|
J:100451
|
Tg(Lck-FADD)1Hed/Tg(Lck-FADD)1Hed
(involves: BALB/c * C57BL/6)
|
decreased thymocyte number
|
J:100451
|
Tg(Lck-Hhex)1Hro/0
(C3HeB/FeJ-Tg(Lck-Hhex)1Hro)
|
thymus hyperplasia
|
J:80777
|
Tg(Lck-Id1)28Xhsu/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:58607
|
Tg(Lck-LMO1)11Sjk/0 Tg(STIL-TAL1)A5(3)Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros)
|
enlarged thymus
|
J:40868
|
increased T cell derived lymphoma incidence
|
J:40868
|
Tg(Lck-Map3k8)3456Ngc/?
(involves: C3H/HeJ * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:39450
|
Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2)
|
increased lymphoblastic lymphoma incidence
|
J:63300
|
increased T cell derived lymphoma incidence
|
J:96010
|
increased thymocyte number
|
J:63300
|
thymus hyperplasia
|
J:63300
|
Tg(Lck-Socs3)1Kubo/0
(Not Specified)
|
decreased thymocyte number
|
J:128797
|
Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:117301
|
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
decreased thymocyte number
|
J:149973
|
Tg(Lck-Stk17b)26.1Wals/? Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/10)
|
decreased thymocyte number
|
J:149973
|
Tg(Lck-Tal1)4709Led/0
(FVB/N-Tg(Lck-Tal1)4709Led)
|
abnormal thymus morphology
|
J:36076
|
increased lymphoblastic lymphoma incidence
|
J:36076
|
Tg(Lck-Tax)53Hall/0
(involves: C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:129531
|
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
abnormal thymus cell ratio
|
J:92453
|
abnormal thymus morphology
|
J:92453
|
thymus cortex hypoplasia
|
J:92453
|
thymus hypoplasia
|
J:92453
|
Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J)
|
abnormal thymus cell ratio
|
J:93005
|
increased T cell derived lymphoma incidence
|
J:93005
|
Tg(LCKprBCL2)36Sjk/?
(involves: C3H * C57BL/6)
|
abnormal thymus cell ratio
|
J:11548
|
increased T cell derived lymphoma incidence
|
J:28635
|
Tg(Mafg-Nfe2l1)1Mym/0
(involves: C57BL/6J * DBA/2)
|
abnormal pancreatic beta cell morphology
|
J:230118
|
enlarged pancreatic islets
|
J:230118
|
Tg(Mafg-Nfe2l1)6Mym/0
(involves: C57BL/6J * DBA/2)
|
abnormal pancreatic beta cell morphology
|
J:230118
|
enlarged pancreatic islets
|
J:230118
|
Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL)
|
increased T cell derived lymphoma incidence
|
J:69755
|
increased thymocyte number
|
J:50604
|
Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased pituitary adenoma incidence
|
J:51661
|
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr)
|
increased pituitary adenoma incidence
|
J:93548
|
Tg(Mt1a-GPHB5)1Sok/0
(involves: C57BL/6)
|
abnormal adrenal cortex morphology
|
J:105176
|
abnormal thyroid follicle morphology
|
J:105176
|
abnormal thyroid follicular cell morphology
|
J:105176
|
Tg(MtTGFA)Lmb/0
(involves: CD-1)
|
abnormal pancreatic islet morphology
|
J:229184
|
Tg(Mx1-cre)1Cgn/0 Zmiz1tm1c(EUCOMM)Hmgu/Zmiz1tm1c(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA/J)
|
thymus hypoplasia
|
J:234445
|
Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL)
|
increased adrenal gland tumor incidence
|
J:54269
|
Tg(Pdx1-Ffar1)AHeed/0
(Not Specified)
|
disorganized pancreatic islets
|
J:129843
|
Tg(Pdx1-Myt1)2Ggu/0
(Not Specified)
|
abnormal pancreatic islet morphology
|
J:136131
|
Tg(PGK1-KITLG*220)441Daw/Tg(PGK1-KITLG*220)441Daw
(C3H/HeJ-Tg(PGK1-KITLG*220)441Daw)
|
abnormal thymus morphology
|
J:32600
|
Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N)
|
increased T cell derived lymphoma incidence
|
J:17848
|
Tg(Pklr-HRAS*G12V)21Ak/0
(involves: C57BL/6 * DBA/2)
|
abnormal thymus morphology
|
J:44803
|
enlarged thymus
|
J:44803
|
Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA)
|
pancreatic islet hyperplasia
|
J:185488
|
Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA)
|
pancreatic islet hyperplasia
|
J:185488
|
Tg(Prl-EGFR)#Sme/0
(Not Specified)
|
increased prolactinoma incidence
|
J:219654
|
Tg(PTH-CCND1)PC2Anar/0
(FVB/N-Tg(PTH-CCND1)PC2Anar)
|
abnormal parathyroid gland morphology
|
J:69423
|
enlarged parathyroid gland
|
J:69423
|
increased parathyroid adenoma incidence
|
J:69423
|
parathyroid gland hyperplasia
|
J:69423
|
Tg(PyLT)1Vb/0
(Not Specified)
|
abnormal adrenal cortex morphology
|
J:55528
|
adrenal medulla hyperplasia
|
J:55528
|
enlarged adrenal glands
|
J:55528
|
increased adrenal gland weight
|
J:55528
|
increased pituitary adenoma incidence
|
J:55528
|
increased pituitary gland tumor incidence
|
J:55528
|
thin adrenal cortex
|
J:55528
|
Tg(Rbp3-SV40)IT-2Jjw/?
(involves: BALB/c * C57BL/6)
|
enlarged pineal gland
|
J:60231
|
increased pineal gland tumor incidence
|
J:60231
|
Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6J * DBA/2J)
|
abnormal pancreatic islet morphology
|
J:50695
|
decreased pancreatic alpha cell number
|
J:50695
|
decreased pancreatic delta cell number
|
J:50695
|
increased pancreatic beta cell number
|
J:50695
|
Tg(RIP1-Tag)5Dh/?
(C3HeB/FeJ-Tg(RIP1-Tag)5Dh)
|
abnormal pancreatic islet morphology
|
J:80168
|
Tg(RIR-Tag)87Dh/0
(involves: C57BL/6J * DBA/2J)
|
abnormal pancreatic islet morphology
|
J:50695
|
decreased pancreatic alpha cell number
|
J:50695
|
decreased pancreatic delta cell number
|
J:50695
|
increased pancreatic beta cell number
|
J:50695
|
Tg(RP3-340H11)29Kel/0
(involves: C57BL/6J * CBA/Ca)
|
decreased pancreatic alpha cell number
|
J:91709
|
decreased pancreatic beta cell mass
|
J:91709
|
decreased pancreatic beta cell number
|
J:91709
|
decreased pancreatic delta cell number
|
J:91709
|
decreased PP cell number
|
J:91709
|
increased pancreatic alpha cell number
|
J:91709
|
increased pancreatic beta cell number
|
J:91709
|
Tg(rTH-Tag)20Dmc/0
(involves: C57BL/6NTac * DBA/2NTac)
|
increased adrenal gland tumor incidence
|
J:90323
|
Tg(Sox3)1Pqt/0 Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA)
|
abnormal subcommissural organ morphology
|
J:184232
|
absent pineal gland
|
J:184232
|
Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA)
|
abnormal subcommissural organ morphology
|
J:184232
|
Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh)
|
increased pancreatic beta cell mass
|
J:100328
|
pancreatic islet hyperplasia
|
J:100328
|
Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA)
|
decreased thymus weight
|
J:77977
|
Tg(SV40-NRAS*G12D)1Sco/?
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:125150
|
Tg(SV)419Bri/Tg(SV)419Bri
(C57BL/6J-Tg(SV)419Bri)
|
increased T cell derived lymphoma incidence
|
J:147031
|
Tg(SV)427Bri/0
(C57BL/6J-Tg(SV)427Bri)
|
enlarged thymus
|
J:79096
|
Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N)
|
decreased thymocyte number
|
J:55022
|
increased T cell derived lymphoma incidence
|
J:55022
|
thymus hypoplasia
|
J:55022
|
Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6)
|
abnormal thymus cell ratio
|
J:92992
|
decreased thymocyte number
|
J:92992
|
Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57L * DBA/2 * SJL)
|
decreased thymocyte number
|
J:95380
|
Tg(TcraDN32D3)#Alhn/0
(involves: NOD)
|
decreased thymocyte number
|
J:201417
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * C57L/J * DBA/2J)
|
decreased thymocyte number
|
J:79738
|
thymus hypoplasia
|
J:79738
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/0 Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal thymus morphology
|
J:84536
|
increased thymocyte number
|
J:84536
|
Tg(Tcrb-TCF3/PBX1)19Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased thymocyte number
|
J:95693
|
Tg(Tcrb-TCF3/PBX1)23Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased thymocyte number
|
J:95693
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal thymus cell ratio
|
J:78309
|
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
thymus hypoplasia
|
J:77696
|
Tg(Tek-cre)1Ywa/0 Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)
|
increased T cell derived lymphoma incidence
|
J:263520
|
Tg(tetO-BRAF*V600E)26Jaf/0 Tg(TG-rtTA)30Jaf/0
(involves: FVB/N)
|
enlarged thyroid gland
|
J:184420
|
increased thyroid carcinoma incidence
|
J:184420
|
increased thyroid tumor incidence
|
J:184420
|
Tg(tetO-TAg)2-5Hiwa/0
(involves: C57BL/6)
|
adrenal medulla hyperplasia
|
J:175962
|
increased adrenal gland tumor incidence
|
J:175962
|
Tg(TG-BRAF*V600E)2Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)2Jaf)
|
enlarged thyroid gland
|
J:98550
|
increased thyroid carcinoma incidence
|
J:98550
|
increased thyroid tumor incidence
|
J:98550
|
Tg(TG-BRAF*V600E)3Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)3Jaf)
|
enlarged thyroid gland
|
J:98550
|
increased thyroid carcinoma incidence
|
J:98550
|
Tg(TG-NRAS*Q61K)#Msnt/0
(Not Specified)
|
abnormal thyroid follicle morphology
|
J:210016
|
increased thyroid adenoma incidence
|
J:210016
|
increased thyroid carcinoma incidence
|
J:210016
|
Tg(TG-RET/CCDC6)1Cled/0
(involves: FVB/N)
|
increased thyroid carcinoma incidence
|
J:55883,
J:93679
|
Tg(TG-RET/CCDC6)42Cled/0
(involves: FVB/N)
|
abnormal thyroid follicle morphology
|
J:55883
|
increased thyroid carcinoma incidence
|
J:55883,
J:93679
|
increased thyrotroph cell number
|
J:93679
|
increased thyrotroph cell size
|
J:93679
|
Tg(TG-RET/NCOA4)3209Rstn/0
(involves: C57BL/6)
|
abnormal thyroid follicular cell morphology
|
J:51366
|
abnormal thyroid gland morphology
|
J:51366
|
enlarged thyroid gland
|
J:51366
|
increased thyroid carcinoma incidence
|
J:51366
|
Tg(TG-SV40)#Cled/0
(involves: C57BL/6J * DBA/2J)
|
enlarged thyroid gland
|
J:209788
|
increased thyroid carcinoma incidence
|
J:209788
|
thymus hypoplasia
|
J:209788
|
thyroid gland cyst
|
J:209788
|
Tg(TG-TPR/NTRK1)5215Rstn/0
(involves: C3H * C57BL/6)
|
abnormal thyroid follicle morphology
|
J:67120
|
increased thyroid carcinoma incidence
|
J:67120
|
thyroid gland hyperplasia
|
J:67120
|
Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J)
|
increased thyroid carcinoma incidence
|
J:210015
|
Tg(Th-TAg)17Dmc/0
((C57BL/6NTac x DBA/2NTac)F2)
|
increased adrenal gland tumor incidence
|
J:90323
|
Tg(Thy1-cmyc)6Kio/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:129440
|
Tg(Thy1-cmyc)6LKio/0
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:129440
|
Tg(Ttr-Foxo1)305Dac/0
(involves: FVB * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:79560
|
Tg(Ttr-Foxo1)307Dac/0
(involves: FVB * C57BL/6)
|
abnormal pancreatic beta cell morphology
|
J:79560
|
Tg(Vav1-ERG)#Jpim/0
(involves: C57BL/6)
|
abnormal thymus morphology
|
J:174808
|
enlarged thymus
|
J:174808
|
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6)
|
abnormal thymus cell ratio
|
J:189197
|
abnormal thymus cortex morphology
|
J:189197
|
abnormal thymus corticomedullary boundary morphology
|
J:189197
|
decreased thymocyte number
|
J:189197
|
enlarged thymus medulla
|
J:189197
|
increased T cell derived lymphoma incidence
|
J:189197
|
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:88565
|
Tg(VDR*L233S,luc)T807Pike/0 Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6)
|
parathyroid gland hyperplasia
|
J:218709
|
Tg(VIM-Tag)3Pau/0
(involves: C57BL/6 * SJL/J)
|
enlarged thymus
|
J:91542
|
thymus hyperplasia
|
J:91542
|
Tgcog/Tgcog
(AKR/J-Tgcog)
|
abnormal thyroid follicle morphology
|
J:13923
|
abnormal thyroid follicular cell morphology
|
J:13923
|
enlarged thyroid gland
|
J:13923
|
Tgcog/Tgcog
(involves: AKR/J * C57BL/6By)
|
enlarged thyroid gland
|
J:8567
|
tga/tga
(C57BL/6J-tga)
|
thymus hypoplasia
|
J:94456
|
Tgfb1tm1Mki/Tgfb1tm1Mki
(C57BL/6-Tgfb1tm1Mki)
|
enlarged adrenal glands
|
J:194237
|
Tgfb2tm1Doe/Tgfb2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
ectopic adrenal gland
|
J:41682
|
Tgfbitm1Jwu/Tgfbitm1Jwu
(B6.129-Tgfbitm1Jwu)
|
abnormal pancreatic islet morphology
|
J:213611
|
Tgfbr2tm1Karl/Tgfbr2tm1Karl H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal parathyroid gland morphology
|
J:96359
|
absent parathyroid glands
|
J:96359
|
parathyroid hypoplasia
|
J:96359
|
small thymus
|
J:96359
|
Tgfbr2tm1Karl/Tgfbr2tm1Karl Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
small thymus
|
J:77844
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ)
|
abnormal thymus morphology
|
J:132254
|
Thap4em1Nvl/Thap4em1Nvl
(C57BL/6JJcl-Thap4em1Nvl)
|
increased thymus weight
|
J:350810
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
pancreatic islet hyperplasia
|
J:48446
|
ThemisSpotr/ThemisSpotr
(C57BL/6-ThemisSpotr)
|
small thymus medulla
|
J:152601
|
Themistm1Gasc/Themistm1Gasc
(B6.129S-Themistm1Gasc)
|
abnormal thymus medulla morphology
|
J:151074
|
decreased thymocyte number
|
J:151074
|
Themistm1Hasu/Themistm1Hasu
(involves: C57BL/6 * CBA)
|
decreased thymocyte number
|
J:153235
|
ThimTg(Myh6-TGFB1)1Ljf/Thim+
(involves: C3HeB/FeJ)
|
increased T cell derived lymphoma incidence
|
J:59903
|
Thoc1em1(IMPC)Ccpcz/Thoc1+
(C57BL/6NCrl-Thoc1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Thratm1.1Fcas/Thratm1.1Fcas
(B6.Cg-Thratm1.1Fcas)
|
abnormal pancreatic islet morphology
|
J:179839
|
small pancreatic islets
|
J:179839
|
Thratm1Jas/Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal thyroid follicle morphology
|
J:52829
|
thyroid gland hypoplasia
|
J:52829
|
Thratm1Jas/Thratm1Jas Thrbtm1Olc/Thrbtm1Olc
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ)
|
abnormal thyroid follicle morphology
|
J:52829
|
thyroid gland hyperplasia
|
J:52829
|
Thratm1Ven/Thratm1Ven Thrbtm1Df/Thrbtm1Df
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
small pituitary gland
|
J:95391
|
Thratm2Ven/Thratm2Ven
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal thyroid follicle morphology
|
J:72959
|
Thratm2Ven/Thratm2Ven Thrbtm1Df/Thrbtm1Df
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J)
|
abnormal thyroid follicle morphology
|
J:118402
|
Thrbtm1.1Syc/Thrb+
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal thyroid follicle morphology
|
J:65885
|
enlarged thyroid gland
|
J:65885
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
enlarged thyroid gland
|
J:65885
|
increased thyrotroph cell number
|
J:65885
|
thyroid gland hyperplasia
|
J:65885
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
enlarged pituitary gland
|
J:95391
|
increased pituitary adenoma incidence
|
J:95391
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
increased thyroid carcinoma incidence
|
J:92629
|
increased thyroid gland weight
|
J:92629
|
Thrbtm1Df/Thrbtm1.1Syc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
enlarged thyroid gland
|
J:92629
|
increased thyroid carcinoma incidence
|
J:92629
|
Thrbtm1Df/Thrbtm1Df
(involves: 129S1/Sv * C57BL/6J)
|
abnormal thyroid follicle morphology
|
J:34421
|
enlarged thyroid gland
|
J:34421
|
thyroid gland hyperplasia
|
J:34421
|
Thrbtm1Mkni/Thrb+ Hprt1tm1(TG-cre)1Sasr/Y
(involves: 129/Sv * C57BL/6)
|
decreased thyroid gland weight
|
J:208718
|
Thrbtm1Mkni/Thrbtm1Mkni Hprt1tm1(TG-cre)1Sasr/Y
(involves: 129/Sv * C57BL/6)
|
decreased thyroid gland weight
|
J:208718
|
Thrbtm1Olc/Thrbtm1Olc
(involves: 129)
|
abnormal thyroid follicle morphology
|
J:52829
|
thyroid gland hyperplasia
|
J:52829
|
Thrbtm3Few/Thrbtm3Few
(involves: 129 * C57BL/6)
|
enlarged thyroid gland
|
J:85158
|
increased thyrotroph cell number
|
J:85158
|
Thrbtm4Few/Thrbtm4Few
(involves: 129 * C57BL/6)
|
enlarged thyroid gland
|
J:85158
|
increased thyrotroph cell number
|
J:85158
|
Thrbtm5Few/Thrb+
(involves: 129 * C57BL/6)
|
increased thyroid gland weight
|
J:100929
|
Thrbtm5Few/Thrbtm5Few
(involves: 129 * C57BL/6)
|
increased thyroid gland weight
|
J:100929
|
Thyct1C57BL/6J/Thyct1C57BL/6J Thyct2C57BL/6J/Thyct2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
thymus hyperplasia
|
J:85261
|
Thyct1DBA/2J/Thyct1DBA/2J Thyct2DBA/2J/Thyct2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
thymus hypoplasia
|
J:85261
|
Thyls2MSM/Thyls2MSM
(involves: BALB/c * MSM)
|
increased T cell derived lymphoma incidence
|
J:87704
|
Timm13em1(IMPC)Tcp/Timm13+
(C57BL/6NCrl-Timm13em1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
Tk1tm1Vnd/Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pancreatic islet number
|
J:101669
|
Tkfcem1(IMPC)Ccpcz/Tkfcem1(IMPC)Ccpcz
(C57BL/6NCrl-Tkfcem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Tlag2AKR/J/Tlag2C57L/J
(involves: AKR/J * C57L/J)
|
increased T cell derived lymphoma incidence
|
J:74369
|
Tlag2AKR/J/Tlag2C57L/J Tlag1AKR/J/Tlag1AKR/J
(involves: AKR/J * C57L/J)
|
increased T cell derived lymphoma incidence
|
J:74369
|
Tle3tm1Jcc/Tle3tm1Jcc
(involves: 129P2/OlaHsd)
|
abnormal pancreatic alpha cell differentiation
|
J:183486
|
abnormal pancreatic alpha cell morphology
|
J:183486
|
abnormal pancreatic beta cell differentiation
|
J:183486
|
abnormal pancreatic beta cell morphology
|
J:183486
|
abnormal pancreatic delta cell differentiation
|
J:183486
|
abnormal pancreatic epsilon cell differentiation
|
J:183486
|
abnormal pancreatic epsilon cell morphology
|
J:183486
|
abnormal PP cell differentiation
|
J:183486
|
Tle4tm1.2Dasw/Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw)
|
abnormal thymus morphology
|
J:219243
|
decreased DN2 thymocyte number
|
J:219243
|
thymus atrophy
|
J:219243
|
thymus hypoplasia
|
J:219243
|
Tle5tm1Grid/Tle5tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal pituitary diverticulum morphology
|
J:86317
|
abnormal pituitary gland morphology
|
J:86317
|
bifurcated Rathke's pouch
|
J:86317
|
enlarged pituitary gland
|
J:86317
|
Tll1b2b2476Clo/Tll1b2b2476Clo
(C57BL/6J-Tll1b2b2476Clo)
|
thymus hypoplasia
|
J:175213
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
abnormal pancreatic beta cell morphology
|
J:148283
|
small pancreatic islets
|
J:148283
|
Tlr2tm1Kir/Tlr2tm1Kir
(involves: 129)
|
abnormal adrenal cortex morphology
|
J:94463
|
abnormal adrenal gland morphology
|
J:94463
|
enlarged adrenal glands
|
J:94463
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv)
|
abnormal pancreatic islet morphology
|
J:148283
|
decreased pancreatic beta cell mass
|
J:148283
|
increased pancreatic islet number
|
J:148283
|
Tlsm1AKR/JMs/Tlsm1AKR/JMs
(involves: AKR/JMs * SL/Kh)
|
increased T cell derived lymphoma incidence
|
J:21741,
J:41197,
J:33016
|
Tlsm1AKR/JMs/Tlsm1SL/Kh
(involves: AKR/JMs * SL/Kh)
|
increased T cell derived lymphoma incidence
|
J:21741,
J:41197,
J:33016
|
tlss/tlss
(Not Specified)
|
enlarged thymus
|
J:169366
|
Tmem35atm1.1(KOMP)Vlcg/Y
(B6(FVB)-Tmem35atm1.1(KOMP)Vlcg)
|
adrenal gland hyperplasia
|
J:244268
|
Tmem74em1(IMPC)Tcp/Tmem74em1(IMPC)Tcp
(C57BL/6NCrl-Tmem74em1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Tmem237tm1b(EUCOMM)Hmgu/Tmem237+
(C57BL/6N-Tmem237tm1b(EUCOMM)Hmgu/Ccpcz)
|
abnormal adrenal gland morphology
|
J:211773
|
small adrenal glands
|
J:211773
|
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd)
|
abnormal thymus morphology
|
J:211773
|
decreased thymus weight
|
J:211773
|
enlarged adrenal glands
|
J:211773
|
small thymus
|
J:211773
|
Tmprss2em1(IMPC)Ccpcz/Tmprss2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tmprss2em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Tnftm2Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6)
|
thymus hypoplasia
|
J:54056
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2)
|
abnormal pancreatic islet morphology
|
J:110548
|
Tnfrsf8tm1Mak/Tnfrsf8tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
enlarged thymus
|
J:62854
|
increased thymocyte number
|
J:62854
|
Tnfrsf10btm1Wsed/Tnfrsf10btm1Wsed
(involves: 129P2/OlaHsd)
|
enlarged thymus
|
J:96816
|
Tnfrsf11atm1Imx/Tnfrsf11atm1Imx
(involves: 129)
|
abnormal thymus epithelium morphology
|
J:125864
|
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd)
|
enlarged thymus
|
J:84536
|
increased thymocyte number
|
J:84536
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
thymus hyperplasia
|
J:84838,
J:82145
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
thymus hyperplasia
|
J:82145
|
Tnfsf11tles/Tnfsf11tles
(involves: 129S6/SvEvTac * C57BL/6J)
|
thymus hypoplasia
|
J:179743
|
Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymus weight
|
J:52369
|
thymus hypoplasia
|
J:52369
|
Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal thymus epithelium morphology
|
J:173115
|
Tnfsf11tm1Ywc/Tnfsf11tm1Ywc
(involves: 129P2/OlaHsd)
|
abnormal thymus cell ratio
|
J:233265
|
small thymus medulla
|
J:233265
|
Tnk1tm1Sksuf/Tnk1+
(involves: 129X1/SvJ * C57BL/6)
|
pancreatic islet hyperplasia
|
J:140639
|
Tnnc1tm1.1Jrpi/Tnnc1tm1.1Jrpi
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal adrenal gland morphology
|
J:249978
|
Tomm5Gt(OST44663)Lex/Tomm5Gt(OST44663)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
thymus atrophy
|
J:186382
|
Top2aem2(IMPC)Tcp/Top2a+
(C57BL/6NCrl-Top2aem2(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Top3btm1Jcw/Top3btm1Jcw
(involves: 129S6/SvEvTac * C57BL/6)
|
pancreatic islet hyperplasia
|
J:69405
|
Tph1tm1c(KOMP)Wtsi/Tph1tm1c(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell mass
|
J:284574
|
TpoR479C/TpoR479C
(involves: ICR)
|
abnormal thyroid follicle morphology
|
J:112930
|
abnormal thyroid follicular cell morphology
|
J:112930
|
enlarged thyroid gland
|
J:112930
|
Tpotee-2J/Tpotee-2J
(B6.Cg-Tpotee-2J H2g7/GrsrJ)
|
abnormal thyroid follicle morphology
|
J:202956
|
abnormal thyroid gland development
|
J:202956
|
abnormal thyroid gland morphology
|
J:202956
|
small thyroid gland
|
J:202956
|
Tpotee/Tpotee
(C57BL/6J-Tpotee/GrsrJ)
|
abnormal thyroid follicle morphology
|
J:202956
|
abnormal thyroid gland development
|
J:202956
|
abnormal thyroid gland morphology
|
J:202956
|
small thyroid gland
|
J:202956
|
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
thymus atrophy
|
J:133572
|
Tppp3em1(IMPC)Ccpcz/Tppp3+
(C57BL/6NCrl-Tppp3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Tpst2grt/Tpst2grt
(involves: DW/JMuaf)
|
abnormal adenohypophysis morphology
|
J:20343
|
enlarged adenohypophysis
|
J:20343
|
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J)
|
pituitary intermediate lobe hyperplasia
|
J:184948
|
Trabd2bem2(IMPC)Ccpcz/Trabd2bem2(IMPC)Ccpcz
(C57BL/6N-Trabd2bem2(IMPC)Ccpcz/Ccpcz)
|
abnormal adrenal gland morphology
|
J:211773
|
abnormal thymus morphology
|
J:211773
|
enlarged adrenal glands
|
J:211773
|
enlarged thymus
|
J:211773
|
Trabdem1(IMPC)Mbp/Trabdem1(IMPC)Mbp
(C57BL/6NCrl-Trabdem1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
decreased thymocyte number
|
J:44360
|
thymus atrophy
|
J:44360
|
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
decreased thymocyte number
|
J:37065
|
Traf3ip3tm1b(KOMP)Wtsi/Traf3ip3tm1b(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
decreased thymocyte number
|
J:226431
|
Traf6tm1Ywc/Traf6tm1Ywc
(Not Specified)
|
thymus atrophy
|
J:85808
|
Traf6tm2a(EUCOMM)Wtsi/Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi)
|
multiple persisting craniopharyngeal ducts
|
J:239583
|
Trappc10b2b2416Clo/Trappc10b2b2416Clo
(Trappc10b2b2416Clo)
|
thymus hypoplasia
|
J:175213
|
Trat1tm1Lsmn/Trat1tm1Lsmn
(B6.129X1-Trat1tm1Lsmn)
|
thymus hypoplasia
|
J:108406
|
Trex1em1(IMPC)Ccpcz/Trex1em1(IMPC)Ccpcz
(C57BL/6NCrl-Trex1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd)
|
thymus cortex hypoplasia
|
J:92264
|
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA)
|
abnormal pituitary gland development
|
J:59141
|
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA * ICR)
|
abnormal pituitary gland development
|
J:43657
|
Trim13em1(IMPC)Tcp/Trim13em1(IMPC)Tcp
(C57BL/6N-Trim13em1(IMPC)Tcp/Tcp)
|
enlarged thymus
|
J:211773
|
small adrenal glands
|
J:211773
|
Trp53Bbl/Trp53+
(C57BL/6JSfdAnu-Trp53Bbl/Anu)
|
increased T cell derived lymphoma incidence
|
J:104190
|
Trp53bhy/Trp53+
(C57BL/6JSfdAnu-Trp53bhy/Anu)
|
increased T cell derived lymphoma incidence
|
J:104190
|
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:173271
|
Trp53tm1.1Manf/Trp53tm1.1Manf
(Not Specified)
|
abnormal thymus morphology
|
J:201153
|
small thymus
|
J:201153
|
Trp53tm1.1Manf/Trp53tm1.1Manf
(involves: C57BL/6J)
|
abnormal thymus morphology
|
J:201153
|
small thymus
|
J:201153
|
Trp53tm1.1Thst/Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased T cell derived lymphoma incidence
|
J:198482
|
Trp53tm1.1Umol/Trp53tm1.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased T cell derived lymphoma incidence
|
J:228632
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:173271
|
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:126497
|
Trp53tm1Brd/Trp53tm1Brd Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
increased T cell derived lymphoma incidence
|
J:157041
|
Trp53tm1Brd/Trp53tm1Brd Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased T cell derived lymphoma incidence
|
J:109585
|
Trp53tm1Brd/Trp53tm1Ldo
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:73757
|
Trp53tm1Gev/Trp53tm1Gev
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:99305
|
Trp53tm1Glo/Trp53tm1Glo
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:61683
|
Trp53tm1Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:171821
|
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6 * CBA)
|
increased T cell derived lymphoma incidence
|
J:36762
|
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
increased T cell derived lymphoma incidence
|
J:233347
|
increased thymus weight
|
J:233347
|
Trp53tm1Thst/Trp53tm1Thst
(involves: 129S1/Sv * 129X1/SvJ)
|
increased T cell derived lymphoma incidence
|
J:198482
|
Trp53tm1Tyj/Trp53+ Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:98958
|
Trp53tm1Tyj/Trp53+ Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:98958
|
Trp53tm1Tyj/Trp53+ Xrcc2tm1Pmc/Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:111068
|
Trp53tm1Tyj/Trp53tm1.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased T cell derived lymphoma incidence
|
J:228632
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:87501,
J:17728
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
increased T cell derived lymphoma incidence
|
J:251434,
J:221224,
J:88120,
J:95316
|
Trp53tm1Tyj/Trp53tm1Tyj Xrcc2tm1Pmc/Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:111068
|
Trp53tm1Tyj/Trp53tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae)
|
increased T cell derived lymphoma incidence
|
J:95316
|
Trp53tm1Tyj/Trp53tm2.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased T cell derived lymphoma incidence
|
J:228632
|
Trp53tm1Tyj/Trp53tm3.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae)
|
increased T cell derived lymphoma incidence
|
J:95316
|
Trp53tm2.1Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased T cell derived lymphoma incidence
|
J:282255
|
Trp53tm2.1Umol/Trp53tm2.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased T cell derived lymphoma incidence
|
J:228632
|
Trp53tm2Thst/Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased T cell derived lymphoma incidence
|
J:282255
|
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo)
|
increased T cell derived lymphoma incidence
|
J:317504
|
Trp53tm4Glo/Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:171821
|
Trp53tm4Xu/Trp53tm4Xu
(Not Specified)
|
increased T cell derived lymphoma incidence
|
J:126497
|
Trp53tm6Xu/Trp53tm6Xu Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
increased T cell derived lymphoma incidence
|
J:157041
|
Trp53bp1Gt(OST94324)Lex/Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd)
|
small thymus
|
J:83164
|
thymus hypoplasia
|
J:83164
|
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:82512
|
thymus hypoplasia
|
J:82512
|
Trp53bp2tm1Cdlo/Trp53bp2+ Tg(EmuSR-tTa)83Bop/0 Tg(tetO-MYC)36aBop/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased T cell derived lymphoma incidence
|
J:146764
|
Trp53bp2tm1Xlu/Trp53bp2+
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:108701
|
Trp53bp2tm1Xlu/Trp53bp2tm1Xlu
(C.129S6-Trp53bp2tm1Xlu)
|
abnormal pineal gland morphology
|
J:240594
|
absent pineal gland
|
J:240594
|
small thymus
|
J:240594
|
Trp63tm1Fmc/Trp63+ Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:98958
|
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:98958
|
Trp73tm1Mak/Trp73+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:142848
|
Trp73tm1Mak/Trp73tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased T cell derived lymphoma incidence
|
J:142848
|
Trpm7tm1Clph/Trpm7tm1.1Clph Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal thymus cell ratio
|
J:140630
|
abnormal thymus corticomedullary boundary morphology
|
J:140630
|
abnormal thymus medulla morphology
|
J:140630
|
abnormal thymus morphology
|
J:140630
|
decreased thymocyte number
|
J:140630
|
Tsc1em1(IMPC)Ccpcz/Tsc1+
(C57BL/6NCrl-Tsc1em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
abnormal thymus cell ratio
|
J:223992
|
decreased DN3 thymocyte number
|
J:223992
|
decreased thymus weight
|
J:223992
|
increased DN4 thymocyte number
|
J:223992
|
increased pancreatic alpha cell number
|
J:223992
|
Tshrhyt-2J/Tshrhyt-2J
(B6;129P3-Tshrhyt-2J/GrsrJ)
|
abnormal thyroid follicle morphology
|
J:213054
|
increased thyrotroph cell number
|
J:213054
|
Tshrhyt/Tshrhyt
(involves: BALB/cByJ * RF/J)
|
abnormal thyroid follicle morphology
|
J:6479
|
Tshrtm1Rmar/Tshrtm1Rmar
(involves: 129S1/Sv * C57BL/6J)
|
abnormal thyroid follicle morphology
|
J:80513
|
small thyroid gland
|
J:80513
|
Tshrtm1Rmar/Tshrtm1Rmar
(involves: 129S1/Sv)
|
abnormal thyroid follicle morphology
|
J:168249
|
small thyroid gland
|
J:168249
|
Ttc7fsn-Jic/Ttc7fsn-Jic
(C3.INT-Ttc7fsn-Jic)
|
decreased thymus weight
|
J:115742
|
Ttc7fsn/Ttc7fsn
(CByJ.A-Ttc7fsn)
|
small thymus
|
J:29200
|
thymus cortex hypoplasia
|
J:29200
|
Ttc9tm1Vcl/Ttc9+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
thymus hyperplasia
|
J:241703
|
Ttc9tm1Vcl/Ttc9tm1Vcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased thymus weight
|
J:241703
|
thymus hyperplasia
|
J:241703
|
Tubtub/Tubtub
(C57BL/6J-Tubtub)
|
enlarged pancreatic islets
|
J:13772
|
Tulp4tm1a(KOMP)Wtsi/Tulp4tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NRj)
|
abnormal thymus topology
|
J:344151
|
abnormal thyroid gland isthmus morphology
|
J:344151
|
abnormal thyroid gland morphology
|
J:344151
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
decreased thymocyte number
|
J:309768
|
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ)
|
abnormal thymus cortex morphology
|
J:81485
|
abnormal thymus medulla morphology
|
J:81485
|
abnormal thymus morphology
|
J:81485
|
thymus atrophy
|
J:81485
|
Twsg1tm1Nosa/Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus development
|
J:82738
|
decreased thymocyte number
|
J:82738
|
thymus atrophy
|
J:82738
|
Tyk2tm2b(EUCOMM)Hmgu/Tyk2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tyk2tm2b(EUCOMM)Hmgu/Ieg)
|
enlarged thymus
|
J:211773
|
Tyro3em1(IMPC)Ccpcz/Tyro3em1(IMPC)Ccpcz
(C57BL/6NCrl-Tyro3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ubdtm1b(EUCOMM)Wtsi/Ubdtm1b(EUCOMM)Wtsi
(C57BL/6N-Ubdtm1b(EUCOMM)Wtsi/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Ube2nem1(IMPC)Ccpcz/Ube2n+
(C57BL/6N-Ube2nem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ubl4bem1(IMPC)Ccpcz/Ubl4bem1(IMPC)Ccpcz
(C57BL/6N-Ubl4bem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Ubtfem1(IMPC)Mbp/Ubtf+
(C57BL/6NCrl-Ubtfem1(IMPC)Mbp/Mmucd)
|
abnormal adrenal gland morphology
|
J:211773
|
Uimc1tm1.2Amj/Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6)
|
increased T cell derived lymphoma incidence
|
J:191827
|
Unc13atm1Bros/Unc13a+
(involves: 129)
|
abnormal pancreatic islet morphology
|
J:108689
|
Unc13atm2Bros/Unc13a+
(Not Specified)
|
abnormal pancreatic islet morphology
|
J:108689
|
Ungtm1Tld/Ungtm1Tld
(Not Specified)
|
enlarged thymus
|
J:85353
|
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli)
|
decreased pancreatic beta cell mass
|
J:271949
|
Upf3bem1(IMPC)Tcp/Y
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Upf3bem1(IMPC)Tcp/Upf3bem1(IMPC)Tcp
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
small thymus
|
J:211773
|
Usp17lctm1Khb/Usp17lc+
(either: 129-Usp17lctm1Khb or (involves: 129S/SvEv * C57BL/6J))
|
increased thymus weight
|
J:191761
|
Vamp2tm1Sud/Vamp2tm1Sud
(involves: 129P2/OlaHsd)
|
abnormal adrenal chromaffin cell morphology
|
J:138035
|
Vamp4em1(IMPC)Ccpcz/Vamp4em1(IMPC)Ccpcz
(C57BL/6NCrl-Vamp4em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Vamp4em1Tax/Vamp4em1Tax
(involves: C57BL/6J)
|
abnormal pancreatic beta cell morphology
|
J:352764
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas)
|
decreased thymocyte number
|
J:86654
|
thymus hypoplasia
|
J:79323
|
Vav1tm1Tyb/Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
increased DN2 thymocyte number
|
J:190087
|
increased DN3 thymocyte number
|
J:190087
|
Vav1tm1Tyb/Vav1tm1Tyb Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased thymocyte number
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb Vav2tm1Kdf/Vav2tm1Kdf Vav3tm1Swat/Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte number
|
J:86654
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
thymus hypoplasia
|
J:47596
|
Vav1tm2Bbd/Vav1tm2Bbd Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
thymus hypoplasia
|
J:69806
|
Vav1tm4Tyb/Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
increased DN2 thymocyte number
|
J:190087
|
increased DN3 thymocyte number
|
J:190087
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
adrenal medulla hyperplasia
|
J:124056
|
enlarged adrenal medulla
|
J:124056
|
Vax1tm1Pgr/Vax1tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pituitary gland morphology
|
J:257247
|
Vdac2tm1.1Ehyc/Vdac2tm1.1Ehyc Baxtm2Sjk/Baxtm2Sjk Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:220951
|
small thymus
|
J:220951
|
Vdac2tm1.1Ehyc/Vdac2tm1.1Ehyc Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:220951
|
small thymus
|
J:220951
|
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae)
|
enlarged parathyroid gland
|
J:42815
|
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6)
|
increased thymus weight
|
J:107077
|
thymus hyperplasia
|
J:107077
|
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal thymus morphology
|
J:81698
|
absent parathyroid glands
|
J:81698
|
athymia
|
J:81698
|
ectopic thymus
|
J:81698
|
thymus hypoplasia
|
J:81698
|
Vegfdem1(IMPC)Ccpcz/Vegfdem1(IMPC)Ccpcz
(C57BL/6NCrl-Vegfdem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Vgftm1Vlcg/Vgf+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
abnormal adrenal medulla morphology
|
J:212045
|
Vgftm1Vlcg/Vgftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
abnormal adrenal medulla morphology
|
J:212045
|
abnormal noradrenergic chromaffin cell morphology
|
J:212045
|
Vhltm1Lss/Vhltm1Lss Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal pancreatic islet morphology
|
J:148174
|
Vipr1tm1Msod/Vipr1tm1Msod
(B6.129-Vipr1tm1Msod)
|
disorganized pancreatic islets
|
J:177616
|
Vnn3em1(IMPC)Ccpcz/Vnn3em1(IMPC)Ccpcz
(C57BL/6NCrl-Vnn3em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Wastm1Kas/Wastm1Kas
(involves: 129/Sv * C57BL/6)
|
thymus hypoplasia
|
J:87875
|
Wastm1Sbs/Wastm1Sbs Wasltm2Sbs/Wasltm2Sbs Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte number
|
J:125309
|
Wbp11em1Gcha/Wbp11+
(involves: C57BL/6J * FVB/N)
|
ectopic thymus
|
J:300837
|
Wdhd1em1(IMPC)Rbrc/Wdhd1+
(C57BL/6NJcl-Wdhd1em1(IMPC)Rbrc/Rbrc)
|
abnormal thyroid gland morphology
|
J:211773
|
enlarged thyroid gland
|
J:211773
|
Wdr11em1(IMPC)Mbp/Wdr11em1(IMPC)Mbp
(C57BL/6NCrl-Wdr11em1(IMPC)Mbp/Mmucd)
|
absent adrenal gland
|
J:211773
|
Wdr11Gt(Ayu21-KBW205)Imeg/Wdr11Gt(Ayu21-KBW205)Imeg
(B6.Cg-Wdr11Gt(Ayu21-KBW205)Imeg)
|
abnormal adenohypophysis morphology
|
J:257035
|
abnormal neurohypophysis median eminence morphology
|
J:257035
|
abnormal pituitary diverticulum morphology
|
J:257035
|
abnormal pituitary gland development
|
J:257035
|
Rathke's pouch hypoplasia
|
J:257035
|
Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
pancreatic islet hyperplasia
|
J:225111
|
Wfs1tm1Koks/Wfs1tm1Koks
(129S6/SvEvTac-Wfs1tm1Koks)
|
abnormal thyroid follicle morphology
|
J:221941
|
abnormal thyroid gland morphology
|
J:221941
|
Wfs1tm1Perm/Wfs1tm1Perm Tg(Ins2-cre)23Herr/0
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal pancreatic islet morphology
|
J:104712
|
decreased pancreatic beta cell mass
|
J:104712
|
decreased pancreatic beta cell number
|
J:104712
|
disorganized pancreatic islets
|
J:104712
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(involves: 129/Sv * C57BL/6)
|
decreased pancreatic beta cell number
|
J:90420
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(B6.Cg-Wfs1tm1Yoka)
|
decreased pancreatic beta cell number
|
J:90420
|
Whrnwi/Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs)
|
decreased thymus weight
|
J:5037
|
enlarged adrenal glands
|
J:5538,
J:5037
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac)
|
decreased thymocyte number
|
J:74719
|
thymus hypoplasia
|
J:74719
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal thymus morphology
|
J:116168
|
decreased thymus weight
|
J:116168
|
Wlstm1.1Arte/Wlstm1.1Arte Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymus weight
|
J:202499
|
small thymus medulla
|
J:202499
|
thymus atrophy
|
J:202499
|
thymus hypoplasia
|
J:202499
|
Wnt1tm1Brd/Wnt1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte number
|
J:75999
|
Wnt1tm1Brd/Wnt1tm1Brd Wnt4tm1Amc/Wnt4tm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte number
|
J:75999
|
Wnt4tm1Amc/Wnt4tm1Amc
(involves: 129S1/Sv)
|
decreased thymocyte number
|
J:75999
|
Wnt4tm1Amc/Wnt4tm1Amc
(involves: 129/Sv * CD-1)
|
abnormal adenohypophysis morphology
|
J:48144
|
decreased gonadotroph cell number
|
J:48144
|
decreased somatotroph cell number
|
J:48144
|
decreased thyrotroph cell number
|
J:48144
|
Wnt5ab2b3077.1Clo/Wnt5ab2b3077.1Clo
(C57BL/6J-Wnt5ab2b3077.1Clo)
|
thymus hypoplasia
|
J:175213
|
Wrnb2b3121.1Clo/Wrnb2b3121.1Clo
(C57BL/6J-Wrnb2b3121.1Clo)
|
enlarged adrenal glands
|
J:175213
|
thymus hypoplasia
|
J:175213
|
Wt1tm1Jae/Wt1tm1Jae
(involves: 129S4/SvJae * C57BL/6 * MF1)
|
absent adrenal gland
|
J:56651
|
Wt1tm1Mlh/Wt1tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal adrenal gland development
|
J:135449
|
Wwoxtm1.1Mald/Wwoxtm1.1Mald
(involves: C57BL/6 * FVB/N)
|
abnormal thymus cortex morphology
|
J:155406
|
decreased thymus weight
|
J:155406
|
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J)
|
increased adrenal gland weight
|
J:138140
|
increased pituitary gland weight
|
J:138140
|
Xpnpep1tm1a(KOMP)Wtsi/Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi)
|
abnormal thymus morphology
|
J:239583
|
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
thymus hypoplasia
|
J:65218
|
Xrcc5em1(IMPC)Ccpcz/Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
small thymus
|
J:211773
|
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S1/Sv * C57BL/6)
|
thymus hypoplasia
|
J:34834
|
Xrcc5tm1Nus/Xrcc5tm1Nus
(involves: 129S1/Sv * 129X1/SvJ)
|
thymus hypoplasia
|
J:108657
|
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased thymocyte number
|
J:44361
|
increased T cell derived lymphoma incidence
|
J:44361
|
Xrcc6tm1Gcl/Xrcc6tm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
small thymus
|
J:108657
|
thymus hypoplasia
|
J:108657
|
Ythdf3em1(IMPC)Mbp/Ythdf3em1(IMPC)Mbp
(C57BL/6N-Ythdf3em1(IMPC)Mbp/MbpMmucd)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
abnormal thymus cell ratio
|
J:154166
|
Zap70st/Zap70st
(involves: C57BL/6)
|
thymus hypoplasia
|
J:41170
|
Zap70tm2.1Mmal/Zap70tm2.1Mmal Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * DBA/2J)
|
abnormal thymus cell ratio
|
J:71099
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(B6.129S4-Zap70tm2.1Weis)
|
abnormal thymus cell ratio
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
abnormal thymus cell ratio
|
J:154166
|
Zbtb1m1Btlr/Zbtb1m1Btlr
(involves: C3H/HeN * C57BL/6J)
|
abnormal thymus morphology
|
J:178820
|
decreased DN2 thymocyte number
|
J:178820
|
decreased DN3 thymocyte number
|
J:178820
|
decreased DN4 thymocyte number
|
J:178820
|
thymus hypoplasia
|
J:178820
|
Zbtb17tm1Cksn/Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio)
|
decreased DN1 thymic pro-T cell number
|
J:170508
|
decreased DN2 thymocyte number
|
J:170508
|
decreased DN3 thymocyte number
|
J:170508
|
decreased thymocyte number
|
J:170508
|
thymus hypoplasia
|
J:170508
|
Zc2hc1cem1(IMPC)Ccpcz/Zc2hc1cem1(IMPC)Ccpcz
(C57BL/6N-Zc2hc1cem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Zc3h11aem1(IMPC)Mbp/Zc3h11a+
(C57BL/6NCrl-Zc3h11aem1(IMPC)Mbp/Mmucd)
|
abnormal thymus morphology
|
J:211773
|
Zeb1m1Btlr/Zeb1m1Btlr
(involves: C57BL/6J)
|
increased thymocyte number
|
J:185495
|
Zeb1tm1Yhi/Zeb1tm1Yhi
(B6.129P2-Zeb1tm1Yhi)
|
abnormal thymus development
|
J:39865
|
decreased thymocyte number
|
J:39865
|
small thymus
|
J:39865
|
thymus hypoplasia
|
J:39865
|
Zeb1tm1Yhi/Zeb1tm1Yhi
(either: (involves: 129 * C3H * C57BL/6) or (involves: 129 * C57BL/6 * ICR))
|
increased T cell derived lymphoma incidence
|
J:139194
|
Zeb1tm2Yhi/Zeb1tm2Yhi
(B6.129-Zeb1tm2Yhi)
|
decreased thymocyte number
|
J:45575
|
thymus hypoplasia
|
J:45575
|
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw)
|
small thymus
|
J:177274
|
Zfatem1(IMPC)Ccpcz/Zfat+
(C57BL/6NCrl-Zfatem1(IMPC)Ccpcz/Ccpcz)
|
abnormal thymus morphology
|
J:211773
|
enlarged thymus
|
J:211773
|
Zfp14tm1Xch/Zfp14+
(involves: C57BL/6)
|
thymus hyperplasia
|
J:331393
|
Zfp14tm1Xch/Zfp14tm1Xch
(involves: C57BL/6)
|
thymus hyperplasia
|
J:331393
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(Not Specified)
|
abnormal thymus cortex morphology
|
J:33986
|
abnormal thymus medulla morphology
|
J:33986
|
thymus hypoplasia
|
J:33986
|
Zfp36l1tm1.1Tnr/Zfp36l1tm1.1Tnr Zfp36l2tm1.1Tnr/Zfp36l2tm1.1Tnr Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL)
|
abnormal thymus development
|
J:162388
|
increased T cell derived lymphoma incidence
|
J:162388
|
thymus atrophy
|
J:162388
|
Zfp131tm1.1Mytk/Zfp131tm1.2Mytk Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N)
|
decreased DN2 thymocyte number
|
J:271921
|
decreased DN3 thymocyte number
|
J:271921
|
decreased DN4 thymocyte number
|
J:271921
|
decreased thymocyte number
|
J:271921
|
Zfp366b2b2834Clo/Zfp366b2b2834Clo
(C57BL/6J-Zfp366b2b2834Clo)
|
thymus hypoplasia
|
J:175213
|
Zfp521tm1Nohk/Zfp521tm1Nohk
(B6J.Cg-Zfp521tm1Nohk)
|
decreased adrenal gland weight
|
J:214267
|
decreased pituitary gland weight
|
J:214267
|
decreased thymus weight
|
J:214267
|
Zfp800em1Mgn/Zfp800em1Mgn
(B6.Cg-Zfp800em1Mgn)
|
decreased pancreatic alpha cell number
|
J:306470
|
decreased pancreatic beta cell number
|
J:306470
|
decreased pancreatic delta cell number
|
J:306470
|
decreased PP cell number
|
J:306470
|
Zfp871tm1a(EUCOMM)Wtsi/Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd)
|
thymus hyperplasia
|
J:317166
|
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6)
|
abnormal thymus corticomedullary boundary morphology
|
J:76209
|
thymus hypoplasia
|
J:76209
|
Zmynd11em1(IMPC)Wtsi/Zmynd11em1(IMPC)Wtsi
(C57BL/6N-Zmynd11em1(IMPC)Wtsi/WtsiIeg)
|
absent thyroid gland isthmus
|
J:239583
|